SUPPLEMENT

FY2020 — Annual financial statements

FY2020PDF · 198 pages4.7 MB
DISCOVERY
ANNUAL FINANCIAL
STATEMENTS
FOR THE YEAR ENDED 30 JUNE
2020

-- 1 of 198 --

CONTENTS
CONSOLIDATED FINANCIAL STATEMENTS
Directors’ responsibility statement 	2
Certificate by the Company Secretary 	3
Report of the Discovery Limited Audit Committee 	4
Independent auditor’s report 	10
Director’s report 	16
Statement of financial position 	22
Income statement 	23
Statement of other comprehensive income 	24
Statement of cash flows 	25
Statement of changes in equity 	26
Notes to the Group annual financial statements 	28
DISCOVERY LIMITED COMPANY
Statement of financial position 	131
Income statement 	132
Statement of other comprehensive income 	132
Statement of cash flows 	133
Statement of changes in equity 	134
Notes to the Company annual financial statements 	135
ANNEXURE A – ACCOUNTING POLICIES 	151
ANNEXURE B – DIRECTORATE 	175
ANNEXURE C – ANALYSIS OF SHAREHOLDERS 	180
ANNEXURE D – EMBEDDED VALUE
ASSURANCE REPORT OF THE INDEPENDENT
AUDITORS 	181
EMBEDDED VALUE STATEMENT 	182
ANNEXURE E – FIVE-YEAR REVIEW 	192
ANNEXURE F – PRODUCT DESCRIPTIONS 	193
BASIS OF PREPARATION
The consolidated and separate Annual Financial Statements have
been prepared in accordance with International Financial
Reporting Standards (IFRS) as issued by the International
Accounting Standards Board (IASB), its interpretations adopted
by the IASB, the South African Institute of Chartered Accountants
(SAICA) Financial Reporting Guides as issued by the Accounting
Practices Committee, Financial pronouncements as issued by
Financial 	Reporting 	Standards 	Council, 	the 	JSE 	Listings
Requirements as well as the South African Companies Act. They
have been prepared in accordance with the going concern
principle using the historical cost basis except where otherwise
stated in the accounting policies (refer Annexure A).
The Annual Financial Statements have been prepared under the
supervision of Mr DM Viljoen CA(SA) the Group Chief Financial
Officer. The Annual Financial Statements are reviewed by
management, the Discovery Limited Audit Committee and Board
and are audited by the external auditors of the Group.
Embedded value statement prepared by M Curtis (FASSA, FIA) as
well as P Bolink (FASSA) and supervised by A Rayner (FASSA, FIA).
How we report to our
stakeholders
Our INTEGRATED ANNUAL REPORT – our primary report to
our shareholders, providers of financial capital and other
stakeholders – details our financial, economic and social
performance (2023 Ambition and beyond).
Our ANNUAL FINANCIAL RESULTS Presentation provides an
overview of Discovery’s financial performance.
Our 2020 Annual Financial Results Presentation can be accessed
at www.discovery.co.za/corporate/investor-relations
Our FULL ANNUAL FINANCIAL STATEMENTS include the
consolidated financial results of Discovery and its
subsidiaries, the embedded value statement and five-year
review.
Our 2020 Annual Financial Statements can be accessed
at www.discovery.co.za/corporate/investor-relations
Our SUSTAINABLE DEVELOPMENT REPORT, along with our
detailed website, provides information on how the Group
delivered on its commitment to be a powerful force for social
good for our clients, our business and broader society.
Our GOVERNANCE REPORT includes information on our
governance philosophy, leadership and our compliance
with King IV™
DISCOVERY LIMITED
Registration number 1999/007789/06
1 Discovery Annual Financial Statements 2020

-- 2 of 198 --

DIRECTORS’ RESPONSIBILITY STATEMENT
for the year ended 30 June 2020
DIRECTORS’ RESPONSIBILITY TO THE SHAREHOLDERS OF
DISCOVERY LIMITED AND ITS SUBSIDIARIES (DISCOVERY OR THE GROUP)
The directors of Discovery are required by the Companies Act, Act 71 of 2008 (Companies Act), to maintain adequate accounting records
and to prepare financial statements for each financial year which fairly present the state of affairs of Discovery at the end of the financial
year, and of the results and cash flows for the period. In preparing the accompanying Annual Financial Statements, International Financial
Reporting Standards have been used and reasonable estimates have been made. The Annual Financial Statements incorporate full and
responsible disclosure, in line with Discovery’s philosophy on corporate governance.
The directors have reviewed Discovery’s budget and cash flow forecast for the year to 30 June 2021. On the basis of this review, and in light
of the current financial position and available cash resources, the directors have no reason to believe that Discovery will not be a going
concern for the foreseeable future. The going concern basis has therefore been adopted in preparing the Annual Financial Statements.
The directors are responsible for Discovery’s systems of internal control, which include internal financial controls in the various subsidiaries
that are designed to provide reasonable, but not absolute, assurance against material misstatement and loss. Discovery maintains
internal financial controls to provide assurance regarding:
❚ 	Safeguarding of assets against unauthorised use or disposition, and
❚ 	The maintenance of proper accounting records and the reliability of financial information used within the business, or for publication.
The controls contain self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified. Even an effective
system of internal control, no matter how well designed, has inherent limitations, including the possibility of circumvention and the
overriding of controls. An effective system of control therefore aims to provide reasonable assurance with respect to the reliability of
financial information and, in particular, the presentation of Annual Financial Statements.
To the best of their knowledge and belief, based on the above, the directors are satisfied that no material breakdown in the operation of
the systems of internal control and procedures has occurred during the year under review.
Discovery’s external auditors, PricewaterhouseCoopers Inc., have audited the Annual Financial Statements and their unqualified report
appears on pages 10 to 15.
The Annual Financial Statements of Discovery for the year ended 30 June 2020, which appear on pages 22 to 180 as well as Annexure F
have been approved by the Board of Directors on 15 September 2020 and are signed on its behalf by:
A Gore 	DM Viljoen
Chief Executive Officer 	Chief Financial Officer
2 Discovery Annual Financial Statements 2020

-- 3 of 198 --

CERTIFICATE BY THE COMPANY SECRETARY
for the year ended 30 June 2020
It is hereby certified in terms of section 88(2)(e) of the Companies Act, that Discovery Limited has for the year ended 30 June 2020 lodged
with the Registrar of Companies all such returns as are required by a public company in terms of this Act and that all such returns are
true, correct and up to date.
MJ Botha
Company Secretary
15 September 2020
3 Discovery Annual Financial Statements 2020

-- 4 of 198 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
We, the Discovery Limited Audit Committee (DLAC) are pleased to present our report for the financial year ended 30 June 2020. This
report has been prepared based on the requirements of the Companies Act, Act 71 of 2008 (Companies Act), as amended, the King Code
of Governance for South Africa (King IV), the JSE Listings Requirements and other applicable regulatory requirements.
This report aims to provide details on how the DLAC discharged its various responsibilities during the period under review as well as
provide insight to significant matters that arose and how these were addressed by the DLAC so as to ensure the integrity of Discovery’s
financial reporting.
TERMS OF REFERENCE, ROLES AND RESPONSIBILITIES
The DLAC is an independent statutory committee constituted in terms of section 94 (7) of the Companies Act. Below is a summary of the
DLAC statutory and governance mandate. It provides an oversight role underpinned by the JSE’s combined assurance model, following
the King IV principle of good governance. Duties are delegated to the DLAC by way of a formal Terms of Reference, which is reviewed
annually. The DLAC has conducted its affairs in compliance with its Terms of Reference and has discharged the responsibilities contained
therein which include the following:
Finance function
Financial statements/
Integrated report
Internal financial control/
Internal audit
External auditor and
external audit
Consider the
appropriateness and
expertise of the CFO.
Review all financial statements
and reports and deal with any
complaints regarding accounting
practices.
The review considers the integrity
and fairness of the information
as well as review of significant
estimates and judgements made
by management in producing the
financial information.
Responsible 	for 	appointment,
remuneration, performance and
disciplinary action of the CAE.
Nominate an independent auditor
for appointment by shareholders.
Consider the impact of mandatory
audit firm rotation (MAFR) in
conjunction with potential future
requirements for joint auditors for
the insurance regulated group.
Consider the
appropriateness and
expertise of senior
members of the
finance team.
Report from the DLAC on how it
discharged its duties during the
financial reporting period.
Approve the internal audit annual
plan.
Determine terms of engagement
and fees.
Undertake a formal
assessment of the
finance function.
Make submission to Board on the
accounting practices and financial
reports.
Make a submission to the Board
regarding assessment of Internal
Control, Governance and Risk
Management.
Approve the nature and extent of
non-audit services.
Review and approve
of annual budgets
and forecasts.
Review 	the 	annual 	integrated
report.
The information produced in the
annual integrated report must be
fair, balanced and consistent with
other information produced, e.g.
the financial statements.
Undertake a formal assessment
of internal audit performance and
deal appropriately with complaints
about the internal audit.
Satisfy 	itself 	regarding 	the
experience, capacity and skill of
the audit teams.
Deal with any
complaints on the
internal financial
control environment.
Review and assessment of the
combined audit assurance model
for Discovery.
Structure of the audit committees in Discovery Group
The scope of the DLAC extends to all activities of the Discovery Limited Group and its subsidiaries, both locally and internationally. DLAC
also acts as the statutory Audit Committee of Discovery Life Limited, Discovery Insure Limited and Discovery Pref Holding Company (RF)
Limited.
The Discovery Group Europe Limited grouping and Discovery Bank Holdings Limited grouping and the Vitality Group International Inc
grouping each have their own audit committees.
There is regular liaison and communication between the Chairperson of the DLAC and the Chairpersons of the various main subsidiaries
on key matters that are relevant to the Group. The DLAC receives regular reports from the various group audit committees and in
addition, the Chair of the DLAC has the opportunity to attend any of the subsidiary audit committee meetings as an invitee.
4 Discovery Annual Financial Statements 2020

-- 5 of 198 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
COMPOSITION AND GOVERNANCE
The DLAC is constituted as per section 94(4) of the Companies Act and consists of a minimum of three independent non-executive
directors of the Discovery Limited Board of Directors. It meets at least four times per annum as per its Terms of Reference, and in the year
ended 30 June 2020 met six times.
The DLAC has the appropriate balance of knowledge, skill and tenure required to discharge its duties. The membership, qualifications and
attendance of the members of the DLAC are as follows:
Committee member 	Qualifications
Number of meetings
held during the
year ended
30 June 2020
Number of meetings
eligible to attend
Number of meetings
attended
D Macready (Chairman)1 	BCom (Hons), CTA, CA (SA) 	6 	3 	3
AL Owen1 	BSc (Hons), FIA, FPMI 	6 	4 	4
SE De Bruyn 	LLB (Hons), MA 	6 	6 	5
SV Zilwa 	BCompt (Hons), CTA, CA (SA) 	6 	6 	6
1 Mr D Macready took over the chairmanship from Mr AL Owen after Mr AL Owen retired effective 14 February 2020.
The Chairman of Discovery’s Board and non-executive directors are entitled to attend meetings after informing the Chairman of DLAC.
The Chief Executive Officer, Chief Financial Officer, Chairman of the Actuarial Committee and executive directors attend meetings or parts
of meetings by invitation only. The Chief Audit Executive and the external auditors meet with the DLAC, or the Chairman of the DLAC,
before each meeting without management present, and attend meetings by invitation. The DLAC Chairman meets regularly with the Chief
Financial Officer, the external auditor and the heads of internal audit, risk and compliance as well as with executive management where
necessary.
MEETINGS CYCLE FOR THE YEAR
The DLAC meetings held during the financial year were as follows:
October 2019
Review of first-quarter performance. The DLAC self-assessment was completed and reviewed. Review of the governance structure of
subsidiaries, the DLAC constitution, and the evidence supporting the independence, accreditation, skills and capacity of external audit.
Review feedback on the accounting practices, disclosures and annual reports. Reviewed the co-operations and co-ordination between the
internal and external auditors.
November 2019
Review of the external audit plan, the internal audit plan and strategy as well as consideration of the combined assurance model for the
Discovery Group. Review of the external audit budgeted fees. Evaluated the effectiveness of the internal audit function.
February 2020
Feedback from subsidiary audit committees as well as other relevant committees such as Risk and Compliance, and Actuarial. Review of
interim results for the six months to 31 December 2019 and SENS announcement.
April 2020
Review of Terms of Reference, the internal audit charter, outsourcing, the accounting policies and IFRS developments. Review of third-
quarter results.
June 2020.
Review of unaudited year-to-date results and key financial and accounting judgements as well as any relevant tax matters. Formal
evaluation of Group Finance and Group Internal Audit functions.
September 2020
Discussion and review or year-end reports from the external auditors and Group Internal Audit (GIA), feedback from subsidiary audit
committees and other relevant committees such as Risk and Compliance, and Actuarial. Consideration of going concern. Review and
approval of the annual financial statements, related SENS announcements and the Integrated Report.
5 Discovery Annual Financial Statements 2020

-- 6 of 198 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
KEY FOCUS AREAS DURING THE FINANCIAL YEAR ENDED 30 JUNE 2020
Key audit matters
The DLAC has assessed the appropriateness of the key audit matters reported by the external auditors and considered the key judgements
and estimates pertaining to the annual financial statements. These key audit matters were addressed as follows:
Key Audit Matter 	How the DLAC addressed the matter
Valuation of assets and
liabilities arising from
insurance contracts
The DLAC reviewed reports from the Group Chief Actuary and the external auditors on actuarial assumptions
and basis changes. Evaluated the appropriateness of actuarial assumptions used in the setting of reserves
– including negative rand reserves, taking into account recommendations made by the Actuarial Committee.
This includes the supportability of the negative rand reserve (asset) in the Statement of financial position
under a variety of stress scenarios. It has also considered the appropriateness of accounting policies and
normalisation for the effect of losses arising from changes in economic assumptions in excess of
discretionary margins.
Annual assessment of
goodwill for impairment
The DLAC reviewed the goodwill impairment reviews that were based on the latest business planning
inputs. It considered the sensitivity of the outcomes to declining growth rates and increasing discount rates.
Impact of the COVID-19
pandemic
DLAC considered the impact of COVID-19 on the economy, and the resulting impact on the applicability of
the various scenarios, judgements and estimates used by management to prepare the annual financial
statements. In particular, the impact on the valuation of assets and liabilities arising from insurance contracts.
Other significant matters
Significant matters are those matters which, in the view of the DLAC, were considered significant or material in nature requiring either the
exercise of judgement or matters which were otherwise considered to be subjective from an accounting or auditing perspective.
The following areas deserved a key focus from DLAC during the year:
❚ 	Considered the accounting and operation impact of the COVID-19 pandemic and mitigating steps taken.
– Requested management to provide feedback on impacts on systems, control environments, the finance function and the ability to
perform both effective internal and external audits;
– Requested and reviewed revised internal and external COVID-19 audit plans;
– Initiated a specific group-wide key controls review given work from home; and
– Reviewed the COVID-19 SENS trading updates issued in June 2020 and August 2020 respectively as to ensure transparent, fair,
balanced and understandable reporting.
❚ 	Formulated a framework on ‘Making Material judgements’ in the application of IFRS for Discovery
❚ 	Evaluated the accounting and disclosures of the economic hedge entered into by VitalityLIfe to economically hedge its exposure to
declining interest rates in the UK market.
❚ 	Oversaw the implementation of IFRS 16 Leases which became effective on 1 July 2019 for Discovery and applied to the interim results
for the first time.
❚ 	Reviewed the progress of the IFRS 17 Insurance Contracts project work and considered the implications if Discovery chose to early
adopt IFRS 17.
❚ 	Reviewed the license application to the Prudential Authority for Discovery to be regulated as an Insurance Group.
❚ 	Oversaw the change in segmental disclosures to reflect the emerging significance of Discovery Bank and Discovery Insure.
❚ 	Evaluated management’s assessment of impairment of specified assets in accordance with IAS 36 Impairment of Assets, particularly in
light of the effects of COVID-19.
❚ 	Evaluated management’s assessment on the findings contained in the JSE’s reports, of issuers listed on the JSE and the applicability of
any such findings to Discovery Limited and its Annual Financial Statements. This incorporated the ”Report on proactive monitoring of
financial statements 2019”, “Final Findings of our Thematic review of compliance with IFRS 9 and IFRS 15” as well as “Activities of the
Financial reporting investigation Panel (FRIP) 2019”.
❚ 	Reviewed the supportability of deferred tax assets raised on assessed losses.
6 Discovery Annual Financial Statements 2020

-- 7 of 198 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
Financial statement and accounting practices
The DLAC has reviewed the accounting policies and the consolidated and separate financial statements of Discovery and is satisfied that
they are appropriate and comply with International Financial Reporting Standards (IFRS). The DLAC concluded that Discovery is a going
concern.
A process has been established to receive and deal appropriately with any concerns and complaints relating to the accounting and
reporting practices of Discovery. Any issues raised are immediately dealt with by the DLAC. No complaints were received during the year.
EXTERNAL AUDIT
Appointment and mandatory audit firm rotation (MAFR)
DLAC, having considered the matters set out in section 94 of the Companies Act , has nominated PricewaterhouseCoopers Inc. (PwC ) for
appointment as external auditor of the Discovery Group. PwC, with the specific approval of the DLAC, works closely in conjunction with
Nexia SAB&T (a black owned auditing firm) for portion of the scope of the audit on a rotational basis.
The DLAC has satisfied itself that the external auditors are independent of Discovery and requisite assurance was sought and provided
by the auditors that internal governance processes within the audit firm support and demonstrate its claim to independence.
PwC, as external auditors, are required to rotate the lead audit partner every five years. Accordingly, Mr Andrew Taylor replaced Mr Jorge
Goncalves as lead audit partner for the 2019/20 financial year.
The DLAC further considered the following in relation to the appointment of the external auditors:
❚ 	The MAFR requirement which mandates the rotation of PwC from 1 July 2023. This, together with the future probable requirement by
the Regulator to appoint joint auditors for an Insurance Group, means that any future rotation requires careful thought and planning
to ensure appropriate continuity for Discovery Limited; and
❚ 	The current state of turmoil in the audit profession in South Africa and the fundamental demand on audit quality, specialisation,
capacity, footprint and experience needed for auditing a global financial services group.
Given these circumstances the MAFR transition plan is an important deliverable for the DLAC in the forthcoming year.
Fees for audit and non-audit services
The DLAC, following consultation with executive management, approved the engagement letter, terms, audit plan and budgeted audit
fees for the year ending 30 June 2020.
A formal policy exists in respect of the provision of non-audit services by the external auditors of Discovery and its subsidiaries, and a
formal procedure governs the process whereby the auditors are appointed to provide any non-audit services, including a limitation on
fees for non-audit services which shall not exceed 25% of the audit fees.
The Chairman of the DLAC approves the nature and extent of any non-audit services that the external auditors provide in terms of the
agreed pre-approval policy and a schedule of approved non-audit services is reviewed annually by the DLAC.
Audit accreditation and quality
In terms of the amended JSE Listings Requirements, the evaluation of suitability and relevant accreditation requirements of the external
audit partner is now the responsibility of the DLAC, together with specific responsibility around audit quality. The following considerations
were taken into account by the DLAC in the assessment in this regard:
❚ 	Any reputational, legal or impending issues impacting the firm;
❚ 	Review of local and international firm audit quality control processes;
❚ 	The results of the last audit firm wide and individual partner quality reviews by the regulatory body IRBA, together with the internal
firm quality control reviews; and
❚ 	Detail of partners and managers on the Discovery assignment including relevant audit experience, succession, continuity and rotation
plans.
In terms of the conditions laid out in section 94(8) of the Companies Act and based on its assessment taking consideration of the criteria
of King IV, the JSE and general guidance to Audit Committees, the DLAC is satisfied with the performance and quality of the external audit,
the external auditors and lead partners.
The DLAC is recommending to the Board the re-election of PwC as auditors for the Discovery Group at the AGM on 26 November 2020.
7 Discovery Annual Financial Statements 2020

-- 8 of 198 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
INTERNAL AUDIT
Internal audit provides independent objective assurance that the governance processes, including professional ethics, the management
of risk and systems of internal controls are both adequate and effective. The Chief Audit Executive (CAE) has a functional reporting line to
the DLAC Chairman and an administrative reporting line to the Group Chief Financial Officer (CFO).
In assessing the quality, performance and delivery of the internal audit plan including the scope of the work performed, the level of
resources and coverage of the audit plan, the DLAC took cognisance of the following.
❚ 	Reviewed and approved the internal audit charter and audit plan and evaluated the independence, effectiveness and performance in
line with its charter.
❚ 	Challenged both the focus, relevance and risk based emphasis of the audit plan in response to the extroadinary circumstances
presented by the COVID-19 pandemic and the potential impact on the control environments.
❚ 	Considered reports on the Group’s systems of internal control, including effective internal financial controls and the control environment.
❚ 	Reviewed significant issues raised by the internal audit processes and the adequacy of corrective action and accountability taken in
response to such findings.
❚ 	Assessed the independence and effectiveness of the CAE, the internal audit function and the quality and extent of audit resources and
found them to be satisfactory.
❚ 	Reviewed the external auditors annual assessment of internal audit in terms of the requirements of ISA 610 which reaffirmed the
extent of reliance that could be placed on the work of internal audit.
❚ 	Noted that the external independent quality review of internal audit in accordance with King IV and IIAS standards was due next year,
the last such review being conducted in 2016.
❚ 	Received the annual review and assessment provided by internal audit confirming the effectiveness of Discovery’s governance, risk
management and control processes.
The DLAC considers that internal audit exhibits a high level of professional objectivity, ethics and due care in fulfilling its responsibility
across the Discovery Group.
FINANCIAL CONTROLS
The DLAC is responsible for assessing Discovery’s system of internal financial and accounting controls. In this regard, the DLAC has, inter
alia, evaluated the adequacy and effectiveness of Discovery’s system of internal controls and made appropriate recommendations to the
Board. This has included a formal documented review by the internal audit function of the design, implementation and effectiveness of
Discovery’s system of internal financial controls.
Based on the results of this review, it is the view of the DLAC that Discovery’s internal financial controls are effective in producing accurate
financial information and a fair presentation of the financial performance of Discovery in the Annual Financial Statements.
8 Discovery Annual Financial Statements 2020

-- 9 of 198 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
OTHER MATTERS CONSIDERED BY THE DLAC
In further fulfilling its duties and discharging its obligations for the year ended 30 June 2020, the DLAC also considered:
Matter considered 	Outcome
Evaluation of the expertise and
experience of the finance function
and financial director
The DLAC reviewed and satisfied itself of the appropriateness of the expertise, resources and
experience of Discovery’s finance function, including the Chief Financial Officer, Mr DM Viljoen.
Assessment of the effectiveness of
DLAC
The Terms of Reference requires that the DLAC performs an assessment of its effectiveness
every two years. An internally managed assessment of the effectiveness of the DLAC was
carried out in the year ended 30 June 2019, and the next assessment will be in 2021.
Whistleblowing 	The DLAC receives and deals with any whistleblowing, whether from within or outside
Discovery, relating to the accounting practices and internal audit of Discovery, the content or
auditing of Discovery’s financial statements, the internal financial controls of Discovery and
related matters. No such whistleblowing was received during the financial year.
Ethics and compliance 	The DLAC is responsible for reviewing any major breach of Discovery’s code of conduct and
ethics and relevant legal, regulatory and other obligations as reported to the DLAC by the
Social and Ethics Committee. The DLAC is satisfied that there has been no material breach of
these standards or material non-compliance with laws and regulations. The DLAC is satisfied
that it has complied with all its legal, regulatory and other obligations during the period
under review.
Combined assurance 	The combined assurance model provides an integrated plan of the various activities and
sources of assurance including risk and compliance, external and internal audit, corporate
finance functions and the Actuarial Committees. The DLAC has reviewed the combined
assurance model, which has been implemented throughout the Group and has concluded
that the model is both appropriate and effective in addressing the risks facing Discovery.
Going Concern 	The DLAC considered management’s assessment of the going concern, with particular focus
on the assumptions within the COVID-19 pandemic climate, and determined that the going
concern was appropriate.
KEY FOCUS AREAS FOR 2020/21
The DLAC has listed the following key focus areas for the financial year ending 30 June 2021:
❚ 	A post-COVID-19 impact review to evaluate and assess the estimates made as at 30 June 2020;
❚ 	External independent assessment of the Internal Audit function;
❚ 	A transition plan to implement MAFR as well as any joint audit requirements so as to ensure appropriate continuity of external audit.;
❚ 	Review project progress for the implementation of IFRS 17 including an analysis of policies, methodology and disclosures;
❚ 	Perform an assessment of the effectiveness of the DLAC;
❚ 	Review progress and implications of the Part VII transfer in Vitality Life UK; and
❚ 	Consider the adequacy of the assurance regarding the internal financial control environment to which the CEO and CFO will attest
from 30 June 2021.
CONCLUSION
Based on the information and explanations given by management, and discussions with the independent external auditors regarding the
results of their audit, DLAC is satisfied that there was no material breakdown in the internal financial controls during the financial year
under review.
The DLAC has reviewed the consolidated and separate financial statements of Discovery Limited for the year ended 30 June 2020 and,
based on the information provided to the DLAC, considers that Discovery complies, in all material respects, with the requirements of the
Companies Act and International Financial Reporting Standards (IFRS).
The DLAC has recommended the Annual Financial Statements to the Board for approval. The Board has subsequently approved the
Annual Financial Statements which will be open for discussion at the forthcoming Annual General Meeting.
D Macready
Chairman: Discovery Limited Audit Committee
15 September 2020
9 Discovery Annual Financial Statements 2020

-- 10 of 198 --

TO THE SHAREHOLDERS OF DISCOVERY LIMITED
REPORT ON THE AUDIT OF THE CONSOLIDATED AND SEPARATE
FINANCIAL STATEMENTS
Our opinion
In our opinion, the consolidated and separate financial statements present fairly, in all material respects, the consolidated and separate
financial position of Discovery Limited (the Company) and its subsidiaries (together the Group) as at 30 June 2020, and its consolidated
and separate financial performance and its consolidated and separate cash flows for the year then ended in accordance with International
Financial Reporting Standards and the requirements of the Companies Act of South Africa.
What we have audited
Discovery Limited’s consolidated and separate financial statements set out on pages 22 to 179 comprise:
❚ 	the group and company statements of financial position as at 30 June 2020;
❚ 	the group and company income statements for the year then ended;
❚ 	the group and company statements of other comprehensive income for the year then ended;
❚ 	the group and company statements of changes in equity for the year then ended;
❚ 	the group and company statements of cash flows for the year then ended; and
❚ 	the notes to the financial statements, which include a summary of significant accounting policies.
Certain required disclosures have been presented elsewhere in the document titled “Discovery Annual Financial Statements for the year
ended 30 June 2020”, rather than in the notes to the financial statements. These are cross-referenced from the financial statements and
are identified as audited.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are
further described in the Auditor’s responsibilities for the audit of the consolidated and separate financial statements section of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Independence
We are independent of the Group in accordance with the Independent Regulatory Board for Auditors’ Code of Professional Conduct for
Registered Auditors (IRBA Code) and other independence requirements applicable to performing audits of financial statements in South
Africa. We have fulfilled our other ethical responsibilities in accordance with the IRBA Code and in accordance with other ethical
requirements applicable to performing audits in South Africa. The IRBA Code is consistent with the corresponding sections of the
International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International
Independence Standards).
Our audit approach
Overview
Materiality
Group
scoping
Key audit
matters
Overall Group materiality
❚ 	R398 million, which represents 5% of adjusted consolidated profit before tax.
Group audit scope
❚ 	Our group scoping included full scope audits for twenty seven components based on financial significance,
audit risks and statutory audit requirements for twenty seven components.
Key audit matters
❚ 	Valuation of assets and liabilities arising from insurance contracts; and
❚ 	Annual assessment of goodwill for impairment.
INDEPENDENT AUDITOR’S REPORT
for the year ended 30 June 2020
10 Discovery Annual Financial Statements 2020

-- 11 of 198 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2020
As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the consolidated and
separate financial statements. In particular, we considered where the directors made subjective judgements; for example, in respect of
significant accounting estimates that involved making assumptions and considering future events that are inherently uncertain. As in all
of our audits, we also addressed the risk of management override of internal controls, including among other matters, consideration of
whether there was evidence of bias that represented a risk of material misstatement due to fraud.
Materiality
The scope of our audit was influenced by our application of materiality. An audit is designed to obtain reasonable assurance whether the
financial statements are free from material misstatement. Misstatements may arise due to fraud or error. They are considered material
if individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the
consolidated financial statements.
Based on our professional judgement, we determined certain quantitative thresholds for materiality, including the overall group
materiality for the consolidated financial statements as a whole as set out in the table below. These, together with qualitative
considerations, helped us to determine the scope of our audit and the nature, timing and extent of our audit procedures and to evaluate
the effect of misstatements, both individually and in aggregate on the financial statements as a whole.
Overall Group materiality 	R398 million
How we determined it 	5% of the consolidated profit before tax
Rationale for the materiality
benchmark applied
We chose consolidated profit before tax as the benchmark because, in our view, it is an appropriate
measure of underlying performance and the benchmark against which the performance of the
Group is most commonly measured by users.
The consolidated profit before tax was adjusted for unusual items included within the transfer
from assets/liabilities under insurance contracts financial statement line item. The following impacts
have been excluded because they are considered unusual and not reflective of the normal
operational performance of the Group:
❚ 	future mortality, morbidity and economic effects of the Covid-19 pandemic; and
❚ 	economic assumption adjustments net of discretionary margins and interest rate derivative.
We chose 5% which is consistent with quantitative materiality thresholds used for profit-oriented
companies in this sector.
How we tailored our group audit scope
We tailored the scope of our audit in order to perform sufficient work to enable us to provide an opinion on the consolidated financial
statements as a whole, taking into account the structure of the Group, the accounting processes and controls, and the industry in which
the Group operates.
The Group has nine operating segments comprising thirty nine components (including unit trust funds) that operate across various
countries but predominantly in South Africa, the United Kingdom and the United States of America. Full scope audits were performed for
twenty seven of the Group’s components due to their financial significance, significance of audit risks within the components and their
statutory audit requirements. For the remaining components, we performed analytical reviews.
In establishing the overall approach to the Group audit, we determined the type of work that needed to be performed by us, as the Group
engagement team, and component auditors from other PwC network firms and other firms operating under our instruction. Where the
work was performed by component auditors, we determined the level of involvement we needed to have in the audit work at those
components to be able to conclude whether sufficient appropriate audit evidence had been obtained as a basis for our opinion on the
consolidated financial statements as a whole.
Key audit matters
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated and
separate financial statements of the current period. These matters were addressed in the context of our audit of the consolidated and
separate financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
11 Discovery Annual Financial Statements 2020

-- 12 of 198 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2020
Consolidated financial statements
Key audit matter 	How our audit addressed the key audit matter
Valuation of assets and liabilities arising from
insurance contracts
Refer to Section 13 of Annexure A – Accounting policies and Notes 2,
4.2, 5 and 18 to the financial statements
The Group has recognised assets arising from insurance contracts
to the value of R 48 billion, and liabilities arising from insurance
contracts of R82 billion at 30 June 2020.
The actuarial value of assets and liabilities arising from insurance
contracts is determined based on a prospective discounted cash
flow valuation basis calculated as the difference between the
present value of future benefit payments plus expenses and the
present value of future premiums.
In valuing the assets and liabilities arising from insurance
contracts, various assumptions are made, which include best
estimate assumptions regarding the future expected claims
experience, premium income, expenses and commission.
Changes to these assumptions may result in a material change to
the valuation. The most significant assumptions made in
determining the value of the assets and liabilities arising from
insurance contracts relate to:
Using our actuarial expertise, we performed, the following
procedures with respect to these balances:
❚ 	Obtained an understanding of the Group’s actuarial control
environment and governance, including the functioning of the
Actuarial Committee (and subsidiary Actuarial Committees).
❚ 	Evaluated the effectiveness of the liability build-up control
performed by management to explain the sources of profit
and corroborated to relevant information.
❚ 	Challenged the appropriateness of all significant
assumptions adopted by management by comparing the
assumptions to results of actuarial experience investigations
conducted by management and benchmarking the
assumptions to relevant life insurance industry trends. We
accepted management’s assumptions as they were
comparable to these benchmarks.
Impact of the Vitality programme on the valuation of assets and
liabilities arising from insurance contracts:
As for most life insurers, assumptions relating to mortality,
morbidity and the level of lapses are significant in the determination
of the value of policyholder liabilities and assets. The Group is
unique due to its Vitality programme. In terms of this programme,
policyholders are provided access to a number of services and
benefits to encourage them to become healthier. Policyholders earn
Vitality points which determine their Vitality status. The mortality,
morbidity and lapse assumptions within the valuation of
policyholder liabilities and assets in the Group are specifically
impacted by the Discovery Vitality policyholder statuses.
The Discovery Vitality policyholder statuses inform the policyholder
behaviour experience expected in future and therefore these
assumptions. The Vitality status distribution is updated every year
based on the actual Vitality status of the policyholders.
Impact of the Vitality programme on the valuation of assets and
liabilities arising from insurance contracts:
We assessed the assumptions used by the Group in the
valuation of the insurance contract assets and liabilities in terms
of the Financial Soundness Valuation (FSV) basis as described in
the Standard of Actuarial Practice (SAP) 104 and the Group
accounting policy as set out in Section 13 of Annexure A -
Accounting policies. In particular, we tested:
❚ 	The reasonability of the assumptions used by the Group in
setting the Vitality status distribution and the progression
between statuses by comparing these to historical experience;
and
❚ 	The data inputs into the model by verifying that these are
consistent with actual experience.
We found the assumptions to be comparable with the
underlying evidence.
Use of discretionary margins with respect to profit recognition:
The life insurance operations sell profitable insurance products.
Applying the reserving basis using only compulsory margins as
prescribed by regulations would result in an upfront profit being
recognised at the inception of new business contracts. Profits
recognised at initial recognition of the insurance contracts are,
however, limited to the extent of actual acquisition costs incurred
through the addition of discretionary margins. The discretionary
margins are reset at every valuation date to reflect the underlying
profitability of the portfolio and are released over the term of a
policy in line with the risk borne. 	Changes to the discretionary
margins have a direct impact on the profit recognition in a period
and therefore need careful consideration to ensure compliance
with the Section 13 of Annexure A - Accounting policies.
Use of discretionary margins with respect to profit recognition:
Our work included, amongst others, the following procedures:
❚ 	We agreed the acquisition costs incurred to the group
income statement to assess whether that all acquisition costs
were captured in the determination of the discretionary
margins at 30 June 2020. No exceptions were noted in this
regard.
❚ 	We assessed whether the calculation of the discretionary
margin transfer is consistent with the methodology outlined
by the accounting policy. No inconsistencies were noted in
this regard.
Allowance for COVID-19 within the valuation basis:
COVID-19 is expected to have an impact on future demographic
and economic experience. Management has allowed for this in the
best estimate assumptions of the assets and liabilities arising from
insurance contracts. Given the lack of historical experience, these
assumptions are highly subjective and judgement based.
We considered the valuation of assets and liabilities arising from
insurance contracts to be a matter of most significance to our audit
as it involves complex and subjective judgement about future
events, policyholder behaviour and economic conditions.
Allowance for COVID-19 within the valuation basis:
Our work included, the following procedures:
❚ 	We obtained an understanding of the process followed by
management to determine the adjustments to the best
estimate assumptions due to COVID-19. We noted that the
adjustments made agreed to those that were approved by
those charged with governance.
12 Discovery Annual Financial Statements 2020

-- 13 of 198 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2020
Key audit matter 	How our audit addressed the key audit matter
❚ 	We tested the magnitude of the impact on the assets and
liabilities arising from insurance contracts due to the
additional COVID-19 allowances by stressing the valuation
for these allowances. We compared this to management’s
calculation and noted no material differences.
Annual assessment of Goodwill for impairment
Refer to Section 7 of Annexure A – Accounting policies and Notes 4.1
and 10 to the financial statements
We obtained management’s calculation of the recoverable amount
of the CGUs and performed, amongst others, the following
procedures:
❚ 	We assessed whether the methodology and source of
information for the calculation was consistent with International
Accounting Standard (IAS) 36 - Impairment of assets and to that
used in prior years. No exceptions were noted.
❚ 	We obtained an understanding of the assumptions used by
management in the valuation models by inspecting the valuation
calculation and impairment testing memorandum prepared by
management.
❚ 	We performed a sensitivity analysis on the key model
assumptions used in determining the recoverable amount of the
CGUs and noted the inputs listed below to be the most sensitive
inputs into the valuations.
❚ 	In respect of the Vitality Health CGU and the Vitality Life CGU:
– We agreed the cash flows used in the calculation to the cash
flows used in the insurance contract and embedded value
valuations of the books of business associated with these
entities, which we have assessed as part of the testing
performed on the valuation of assets and liabilities arising
from insurance contracts.
– Using our valuation expertise, we developed our own range
of acceptable discount rates considering other similar
entities or transactions. We noted that the discount rate
used by management was below the range of acceptable
discount rates. We assessed the materiality of this by using
our range of acceptable discount rates to perform an
independent valuation in the procedure below.
– We performed an independent valuation of the value-in-use
of the Vitality Health and Vitality Life CGUs, using cash flows
that incorporate the future expected mortality, morbidity
and economic effects of the COVID-19 pandemic and our
independent range of acceptable discount rates. We noted
that sufficient headroom is available when compared to the
carrying value of the CGUs.
❚ 	In respect of the Discovery Bank CGU:
– Using our valuation expertise, we assessed the significant
inputs and assumptions used in the valuation model, which
include the terminal growth rate, discount rate, estimated
customer numbers and customer profits, by developing an
independent expectation that incorporates the impact of
COVID-19 and performed sensitivity analyses for these
assumptions.
– We performed an independent valuation of the Discovery
Bank CGU and noted that sufficient headroom is available
when compared to the carrying value of the CGU.
The Group tests each cash-generating unit (CGU) containing
goodwill for impairment on an annual basis. The recoverable
amount of each CGU is estimated as the present value of future
cash flows that are expected to be derived from the CGU (i.e. its
value-in-use).
As at 30 June 2020 the Group has recognised goodwill of
R5.1 billion which arose from the following historic acquisitions:
❚ 	The acquisitions of Vitality Health, Insure Your Health and KYS
Paid Limited (Vitality Health CGU) and Vitality Life (Vitality Life
CGU) as part of business combinations in the UK with a
balance of R2.7 billion at year-end; and
❚ 	The acquisition of the DiscoveryCard business (Discovery Bank
CGU) which resulted in the recognition of goodwill of
R2.4 billion.
The methodology and assumptions applied in determining the
recoverable amounts of these CGUs are set out below:
Vitality Health CGU and Vitality Life CGU
The methodology and assumptions applied by the Group in
determining the recoverable amounts of these CGUs are
consistent with prior years. The value-in-use is calculated as the
present value of the best-estimate pre-tax cash flows of the CGU
for the in-force policies at the valuation date and 10 years of new
business. The most significant input relates to the determination
of the discount rate. Management applied judgement in
determining the risk-free rate, equity risk premium as well as Beta
risk, which are factors used in determining the discount rate.
Discovery Bank CGU
In determining the recoverable amount of the Discovery Bank
CGU management has applied assumptions and judgement
relating to forecasted cash flows, the cost of equity applied in
discounting the cash flows, customer growth rates and the
expensing of system build costs and intangible assets acquired in
the business combination over the useful lives of 10 years.
We considered management’s annual impairment assessment of
goodwill to be a matter of most significance to our audit, as it is
subject to estimation uncertainty and significant judgement by
management with respect to the inputs into the calculation of the
recoverable amount.
13 Discovery Annual Financial Statements 2020

-- 14 of 198 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2020
Separate financial statements
We have determined that there are no key audit matters in respect of the separate financial statements.
Other information
The directors are responsible for the other information. The other information comprises the information included in the document titled
“Discovery Annual Financial Statements for the year ended 30 June 2020”, which includes the Directors’ Report, the Report of the Audit
Committee and the Certificate by the Company Secretary as required by the Companies Act of South Africa, which we obtained prior to
the date of this auditor’s report, and the document titled “Discovery Integrated Annual Report 2020”, which is expected to be made
available to us after that date. The other information does not include the consolidated or the separate financial statements and our
auditor’s report thereon.
Our opinion on the consolidated and separate financial statements does not cover the other information and we do not and will not
express an audit opinion or any form of assurance conclusion thereon.
In connection with our audit of the consolidated and separate financial statements, our responsibility is to read the other information
identified above and, in doing so, consider whether the other information is materially inconsistent with the consolidated and separate
financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated.
If, based on the work we have performed on the other information that we obtained prior to the date of this auditor’s report, we conclude
that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Responsibilities of the directors for the consolidated and separate
financial statements
The directors are responsible for the preparation and fair presentation of the consolidated and separate financial statements in
accordance with International Financial Reporting Standards and the requirements of the Companies Act of South Africa, and for such
internal control as the directors determine is necessary to enable the preparation of consolidated and separate financial statements that
are free from material misstatement, whether due to fraud or error.
In preparing the consolidated and separate financial statements, the directors are responsible for assessing the Group and the Company’s
ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the Group and/or the Company or to cease operations, or have no realistic
alternative but to do so.
Auditor’s responsibilities for the audit of the consolidated and separate
financial statements
Our objectives are to obtain reasonable assurance about whether the consolidated and separate financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable
assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material
misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate,
they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated and separate
financial statements.
As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the
audit. We also:
❚ 	Identify and assess the risks of material misstatement of the consolidated and separate financial statements, whether due to fraud or
error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to
provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting
from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
❚ 	Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s and the Company’s internal
control.
❚ 	Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures
made by the directors.
❚ 	Conclude on the appropriateness of the directors’ use of the going concern basis of accounting and, based on the audit evidence
obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s and the
Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention
in our auditor’s report to the related disclosures in the consolidated and separate financial statements or, if such disclosures are
14 Discovery Annual Financial Statements 2020

-- 15 of 198 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2020
inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report.
However, future events or conditions may cause the Group and / or Company to cease to continue as a going concern.
❚ 	Evaluate the overall presentation, structure and content of the consolidated and separate financial statements, including the
disclosures, and whether the consolidated and separate financial statements represent the underlying transactions and events in a
manner that achieves fair presentation.
❚ 	Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group
to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of
the group audit. We remain solely responsible for our audit opinion.
We communicate with the directors regarding, among other matters, the planned scope and timing of the audit and significant audit
findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide the directors with a statement that we have complied with relevant ethical requirements regarding independence, and
to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where
applicable, actions taken to eliminate threats or safeguards applied.
From the matters communicated with the directors, we determine those matters that were of most significance in the audit of the
consolidated and separate financial statements of the current period and are therefore the key audit matters. We describe these matters
in our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances,
we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably
be expected to outweigh the public interest benefits of such communication.
REPORT ON OTHER LEGAL AND REGULATORY REQUIREMENTS
In terms of the IRBA Rule published in Government Gazette Number 39475 dated 4 December 2015, we report that PricewaterhouseCoopers
Inc. has been the auditor of Discovery Limited for 20 years.
PricewaterhouseCoopers Inc.
Director: Andrew Graham Taylor
Registered Auditor
Johannesburg
16 September 2020
15 Discovery Annual Financial Statements 2020

-- 16 of 198 --

The directors present their 21st annual report, which forms part of the consolidated and separate financial statements of Discovery
Limited for the year ended 30 June 2020.
NATURE OF BUSINESS
Discovery Limited (the Company) is listed on the Johannesburg Stock Exchange and is an integrated financial services organisation
specialising in health insurance, life assurance, wellness, investments and savings products, short-term insurance and banking products.
The Company is directly and indirectly the holding company of:
Audited information
Percentage
holding 	Country
Discovery Central Services Proprietary Limited 	100% 	SA
Discovery Connect Distribution Services Proprietary Limited 	100% 	SA
Discovery Health Proprietary Limited which holds the interests in: 	100% 	SA
– Discovery Third Party Recovery Services Proprietary Limited 	100% 	SA
– PrimeMed Administrators Proprietary Limited 	100% 	SA
– Discovery HealthCare Services Proprietary Limited which holds the interests in: 	100% 	SA
○ Discovery Medical Suppliers Proprietary Limited 	100% 	SA
○ Grove Nursing Services Proprietary Limited 	100% 	SA
○ Southern RX Distributors Proprietary Limited 	100% 	SA
– Medical Services Organisation International Proprietary Limited which holds the interest in: 	70% 	SA
○ MSO Eswatini Swaziland 	51% 	Swaziland
– MSO International (Isle of Man) which holds the interest in: 	70% 	Isle of Man
○ Global Access Health Network SARL 	80% 	DRC
○ MSOI Health Risk Managers Limited 	85% 	Nigeria
Discovery Insure Limited which holds the interest in: 	100% 	SA
– Discovery Telematic Services Proprietary Limited1 	100% 	SA
Discovery Investment Management Proprietary Limited (dormant) 	100% 	SA
Discovery Life Collective Investments Proprietary Limited 	100% 	SA
Discovery Life Investment Services Proprietary Limited which holds the interest in: 	100% 	SA
– Discovery Life Nominees Proprietary Limited 	100% 	SA
Discovery Life Limited 	100% 	SA
Discovery Pref Holding Company (RF) Limited 	100% 	SA
Discovery Bank Holdings Limited which holds the interest in: 	100% 	SA
– Discovery Bank Limited 	100% 	SA
Discovery Vitality Proprietary Limited 	100% 	SA
Discovery Partner Markets Asia Private Limited which holds the interest in: 	100% 	Singapore
– Discovery Partner Markets Services Private Limited 	100% 	Singapore
Discovery Finance Company Europe Limited 	100% 	UK
Discovery Group Europe Limited which holds the interests in: 	100% 	UK
– Discovery Offshore Holdings No 2 Limited (dormant) 	100% 	UK
– Discovery Holdings Europe Limited which holds the interest in: 	100% 	UK
○ Better Health Insurance Advice (previously Insure Your Health Limited) 	100% 	UK
○ Vitality Corporate Services Limited which holds the interests in: 	100% 	UK
◼ Vitality Healthy Workplace Limited 	100% 	UK
○ Vitality Life Limited which holds the interest in: 	100% 	UK
◼ Vitality Health Insurance Limited which holds the interest in: 	100% 	UK
• Vitality Health Limited 	100% 	UK
○ Vitality Invest Trustee Company Limited 	100% 	UK
Vitality Group International Inc., which holds the interests in: 	100% 	USA
– Discovery Vitality Australia Proprietary Limited 	100% 	Australia
– Vitality Management Company LLC 	100% 	USA
– The Vitality Group Inc*., which holds the interest in: 	99.9% 	USA
○ The Vitality Group LLC 	100% 	USA
Abbreviations: SA – South Africa, DRC – Democratic Republic of the Congo, UK – United Kingdom, USA – United States of America
* The balance of the interest is held by senior management of this subsidiary.
1 Change effective 1 July 2020.
DIRECTORS’ REPORT
for the year ended 30 June 2020
16 Discovery Annual Financial Statements 2020

-- 17 of 198 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2020
In addition to the above subsidiaries, Discovery consolidates unit trusts in which the Group has control in terms of IFRS 10 Consolidated
Financial Statements. The consolidated unit trusts include:
❚ 	Discovery Aggressive Dynamic Asset Optimiser Fund of Funds
❚ 	Discovery Balanced Fund
❚ 	Discovery Cautious Balanced Fund
❚ 	Discovery Conservative Dynamic Asset Optimiser Fund of Funds
❚ 	Discovery Diversified Income Fund
❚ 	Discovery Equity Fund
❚ 	Discovery Flexible Property Fund
❚ 	Discovery Global Balanced Fund of Funds (amalgamated into
Discovery Worldwide Best Ideas Fund)
❚ 	Discovery Global Equity Feeder Fund
❚ 	Discovery Global Real Estate Securities Feeder Fund
❚ 	Discovery Global Value Equity Feeder Fund
❚ 	Discovery Moderate Balanced Fund
❚ 	Discovery Moderate Dynamic Asset Optimiser Fund of Funds
❚ 	Discovery Money Market Fund
❚ 	Discovery Target Retirement 2010 Fund (amalgamated into
Discovery Target Retirement 2015 Fund)
❚ 	Discovery Target Retirement 2015 Fund
❚ 	Discovery Target Retirement 2020 Fund
❚ 	Discovery Target Retirement 2025 Fund
❚ 	Discovery Target Retirement 2030 Fund
❚ 	Discovery Target Retirement 2035 Fund
❚ 	Discovery Target Retirement 2040 Fund
❚ 	Discovery Target Retirement 2045 Fund
❚ 	Discovery Target Retirement 2050 Fund
❚ 	Discovery Target Retirement 2055 Fund
❚ 	Discovery Target Retirement 2060 Fund
❚ 	Discovery Worldwide Best Ideas Fund
REVIEW OF RESULTS AND COVID-19 IMPACTS
Resilient operating performance during the pandemic; financial strength
and strategic relevance going forward
The full-year period to 30 June 2020 was uniquely complex, with the COVID-19 pandemic creating considerable economic uncertainty,
market volatility and societal need, against an already challenging economic backdrop. Discovery’s response was focused on three areas:
protecting its people, protecting and supporting its clients, and supporting the country – underpinned by a disciplined strategy to maintain
Group financial strength and resilience.
Financial Performance
Performance over the period was framed by the following key issues:
OPERATING PERFORMANCE WAS RESILIENT
For the full year ended 30 June 2020, normalised operating profit was up 9% to R8 409 million (before providing for COVID 19-related
impacts, decreasing by 22% after the provision to R6 069 million) and normalised headline earnings decreased by 26% to R3 747 million.
Normalised headline earnings per share (diluted) decreased by 27% to 566.7 cents and headline earnings per share (diluted) decreased
by 94% to 44.7 cents.
The following table summarises the position:
Metrics
% change over
prior year
Group normalised profit from operations (before allowing for COVID-19 provision) 	9%
Group normalised profit from operations (after allowing for COVID-19 provision) 	(22%)
Group normalised headline earnings 	(26%)
Headline earnings (after economic assumption changes due to long-term interest rates) 	(94%)
17 Discovery Annual Financial Statements 2020

-- 18 of 198 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2020
Per-business performance was also resilient as outlined below:
Business
Operating profit
before reserving
for future COVID-19
COVID impacts 	Strategic observation
Discovery Health 	+5% 	Showed continued operational excellence and provided significant
support to members and society
Discovery Life 	+25%
(-8% after COVID-19 reserve)
Rebounded after a challenging FY19 with positive operational
experience variances and cash generation
Discovery Invest 	-14% 	Continued strong asset gathering amid a weak market
Discovery Insure 	+59% 	Continued scaling while demonstrating high quality of business
Discovery Bank 	+296%
operating
loss increase
Successfully completed client migrations, fully deposit funded; rapid
learnings to improve user experience and value proposition
Vitality Health 	+104%
(+9% after COVID-19 reserve)
Operational excellence with a continued focus on quality of business
and relevance resulting in excellent retention
Vitality Life 	-49%
(-147% after COVID-19 reserve)
Executed on its turnaround plan; set up for future recovery
Vitality Group 	+91% 	Resilient revenue and strong operational leverage driving growth;
increasing relevance with partners adopting Shared-Value model
Ping An Health 	+72% 	Exceptional growth; continuing to invest for long-term opportunity
Actuarial dynamics also performed well and demonstrated particular resilience during the final quarter of the year. Over the period, SA
and the UK experienced severe lockdowns, however lapse experience was contained within Discovery’s actuarial assumptions for all
businesses, except Discovery Invest. Claims experience was also better than assumptions for all operations, except Vitality Life, where the
effects of the pandemic emerged sooner. New business was curtailed during the severe lockdowns, but the impact was mitigated by
increased digital enablement. This was particularly evident in Ping An Health, which delivered significant growth during China’s lockdown
period through its digital channel.
A CONSERVATIVE COVID-19 RESERVE OF R3.4 BILLION WAS CREATED
The Group provided R3.4 billion for future COVID-19-related impacts on claims and lapses, so the expected effects are fully recognised
and reserved for in the 2020 reporting year. This resulted in a R2.3 billion profit impact, net of discretionary margins. Discovery’s own data
and insights have been overlaid onto global and local data to build sophisticated models to consider three scenarios, with the provisions
established in the medium scenarios, as a prudent best estimate. By middle September 2020, 16% of the Discovery Life had been used,
with the balance sufficient for a potential second wave.
INTEREST RATES HAD A R4.8 BILLION (PRE-TAX) EFFECT ON HEADLINE EARNINGS
In terms of long-term interest rates, the significant movements in positive real rates of return in SA and negative real rates of return in
the UK has a significant effect on policy values and headline earnings, but none on cash flows, solvency and capital in SA; and since the
implementation of the hedge strategy - little impact in the UK. The impact in the period was R3.6 billion for Discovery Life and GBP 60.5
million (R1 195 million) net of the valuation of the hedge for Vitality Life, with no bearing on operating performance. These have been
normalised out of the Group’s financial result.
Business-specific performance
Discovery’s Ambition 2023 remains the strategic focus for the medium-term, with the goal of being a leading financial services organisation
globally, and being a powerful force for social good. Refer to the Integrated Annual Report for a review of the business-specific results.
SHARE CAPITAL
The share capital of the Company at 30 June 2020 was as follows:
Class of shares
Authorised
number of
shares
Issued
number of
shares
Ordinary shares of 0.1 cent per share 	1 000 000 000 	658 290 736
A preference shares 	40 000 000 	–
B preference shares 	20 000 000 	8 000 000
C preference shares 	20 000 000 	–
18 Discovery Annual Financial Statements 2020

-- 19 of 198 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2020
DIVIDENDS
Dividends paid during the current and prior financial year
B preference shares
Payment date 	Nature and financial period 	Dividend declared per share
16 March 2020 	Interim dividend
Financial year 2020
505.41097 cents
(404.32878 cents net of dividend withholding tax)
23 September 2019 	Final dividend
Financial year 2019
508.28767 cents
(406.63014 cents net of dividend withholding tax)
11 March 2019 	Interim dividend
Financial year 2019
506.71233 cents
(504.36986 cents net of dividend withholding tax)
Ordinary shares
Payment date 	Nature and financial period 	Dividend declared per share
23 March 2020 	Interim dividend
Financial year 2020
101 cents
(80.8 cents net of dividend withholding tax)
7 October 2019 	Final dividend
Financial year 2019
114 cents
(91.2 cents net of dividend withholding tax)
18 March 2019 	Interim dividend
Financial year 2019
101 cents
(80.8 cents net of dividend withholding tax)
Final dividends declaration in respect of the 2020 financial year
The directors are of the view that the Group is adequately capitalised at this time.
B preference share cash dividend declaration:
On 7 September 2020, the directors declared a final gross cash dividend of 433.21918 cents (346.57534 cents net of dividend withholding
tax) per B preference share for the period 1 January 2020 to 30 June 2020, payable from the income reserves of the Company. A dividend
withholding tax of 20% will be applicable to all shareholders who are not exempt.
The issued preference share capital at the declaration date is 8 million B preference shares.
The salient dates for the dividend will be as follows:
Last day of trade to receive a dividend 	Monday, 21 September 2020
Shares commence trading ex-dividend 	Tuesday, 22 September 2020
Record date 	Friday, 25 September 2020
Payment date 	Monday, 28 September 2020
B preference share certificates may not be dematerialised or rematerialised between Tuesday, 22 September 2020 and Friday
25 September 2020, both days inclusive.
Ordinary share cash dividend declaration:
Due to the uncertain and potentially volatile economic environment caused by the COVID-19 pandemic, Discovery will not be
recommending the payment of ordinary dividends. The reintroduction of dividends will be considered when appropriate.
19 Discovery Annual Financial Statements 2020

-- 20 of 198 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2020
Capital
With effect from 1 July 2018, the Insurance Act 18 of 2017 (Insurance Act), and the related Prudential Standards were implemented in
South Africa. Discovery Life and Discovery Insure are regulated under the Insurance Act, while Vitality Health and VitalityLife are regulated
under the European Solvency II regulatory regime, which was implemented from 1 January 2016. The values below are estimated based
on information extracted from the audited financial statements.
2020 	2019
Statutory Capital Requirements 	Cover 	Statutory Capital Requirements 	Cover
Discovery Life 	R14 835 million 	1.8 times 	R17 396 million 	1.6 times
Discovery Insure 	R885 million 	1.8 times 	R789 million 	1.7 times
Vitality Health 	GBP 102.3 million (R2 194 million) 	1.7 times 	GBP 97 million (R1 777 million) 	1.4 times
Vitality Life Ltd 	GBP 228.3 million (R4 896 million) 	2 times 	GBP 208 million (R3 810 million) 	1.5 times
DIRECTORS AND PRESCRIBED OFFICERS
The following were directors and prescribed officers of the Company during the current and prior financial year unless otherwise indicated:
Executive directors 	Non-executive directors
A Gore 	ME Tucker
HD Kallner 	HL Bosman
NS Koopowitz 	Dr BA Brink
Dr A Ntsaluba 	SE De Bruyn
A Pollard 	R Farber
B Swartzberg 	F Khanyile
DM Viljoen 	Dr TV Maphai
D Macready (appointed 3 February 2020)
HP Mayers (non-executive, effective 28 November 2019)
AL Owen (resigned 14 February 2020)
SV Zilwa
The notice for the forthcoming Annual General Meeting of shareholders will include those names of individuals that retire by rotation and
are eligible and available for re-election.
The Companies Act and associated regulations introduced the concept of prescribed officers and related remuneration disclosure. The
Remuneration Committees considered the Act, obtained legal opinion and assesses this definition on annual basis against the roles and
responsibilities of its people. Following the restructure of reporting lines and composites for the year ended 30 June 2020, the
Remuneration Committee resolved that the executive directors of Discovery Limited are the prescribed officers of the group.
Details of the directors’ emoluments, participation in share incentive schemes and interests in the Company are reflected in Annexure B.
20 Discovery Annual Financial Statements 2020

-- 21 of 198 --

COMPANY SECRETARY
Mr MJ Botha continues in office as Company Secretary.
Registered office 	Postal address
1 Discovery Place 	PO Box 786722
Sandton 	Sandton
2196 	2146
DIRECTORS’ INTERESTS IN CONTRACTS
No material contracts involving directors’ interests were entered into in the current year. The directors had no interest in any third party
or company responsible for managing any of the business activities of Discovery.
BORROWING POWERS
The directors may exercise all the powers of the Company to borrow money. In terms of the Memorandum of Incorporation, the borrowing
powers of the Company are unlimited. In terms of the Insurance Act, both Discovery Life and Discovery Insure may not encumber its assets
or directly or indirectly borrow.
INDEMNIFICATION AND INSURANCE OF DIRECTORS AND OFFICERS
The Company entered into agreements to indemnify its directors to the extent permitted by law against all liabilities including legal costs
incurred by the director in connection with or as a consequence of the director acting in any capacity, including as an authorised
representative of a Group company.
During the financial year, the Company paid insurance premiums in respect of a Directors and Officers Liability insurance contract, which
insures directors and officers of the Company against certain liabilities arising in the course of their duties to the Company or Group
companies. Details of the nature of the liabilities covered and the amount of premium paid are not disclosed as such disclosure is
prohibited under the terms of the contract.
EVENTS AFTER THE REPORTING DATE
The events after the reporting date are noted in Group Note 42. There are no other significant events after the reporting date, being
30 June 2020, to the date of the approval of the Annual Financial Statements, namely, 15 September 2020.
AUDITORS
It will be proposed at the Annual General Meeting of shareholders, that PricewaterhouseCoopers Inc. continue in office in accordance
with section 90(1) of the Companies Act.
DIRECTORS’ REPORT continued
for the year ended 30 June 2020
21 Discovery Annual Financial Statements 2020

-- 22 of 198 --

GROUP STATEMENT OF FINANCIAL POSITION
at 30 June 2020
R million 	Notes
Group
2020
Group
2019
Assets
Goodwill 	10 	5 070 	4 642
Intangible assets 	7 	6 381 	5 597
Property and equipment 	6 	4 643 	4 212
Assets arising from insurance contracts 	5 	48 042 	48 781
Deferred acquisition costs 	8 	632 	536
Assets arising from contracts with customers 	9 	954 	752
Investment in equity-accounted investees 	11 	2 713 	1 950
Deferred income tax asset 	23 	3 511 	2 372
Financial assets
– Loans and advances to customers at amortised cost 	12 	1 848 	–
– Investments at amortised cost 	12 	2 523 	1 943
– Investments at fair value through profit or loss 	12 	102 714 	90 205
– Derivative financial instrument 	13 	1 370 	375
Insurance receivables, contract receivables and other receivables 	14 	11 436 	9 015
Current income tax asset 	182 	136
Reinsurance contracts 	15 	400 	314
Cash and cash equivalents 	16 	17 909 	9 403
TOTAL ASSETS 	210 328 	180 233
Equity
Capital and reserves
Ordinary share capital and share premium 	17.1 	10 148 	10 142
Perpetual preference share capital 	17.2 	779 	779
Other reserves 	3 269 	452
Retained earnings 	30 353 	31 710
44 549 	43 083
Non-controlling interest 	4 	*
TOTAL EQUITY 	44 553 	43 083
Liabilities
Liabilities arising from insurance contracts 	18 	82 411 	70 522
Liabilities arising from reinsurance contracts 	19 	12 465 	10 835
Deferred income tax liability 	23 	8 514 	8 697
Contract liabilities to customers 	9 	808 	433
Financial liabilities
– Borrowings at amortised cost 	20 	19 836 	14 682
– Other payables at amortised cost 	22 	14 233 	10 262
– Deposits from customers 	2 427 	–
– Investment contracts at fair value through profit or loss 	21 	23 012 	20 674
– Derivative financial instrument 	13 	992 	509
Employee benefits 	24 	284 	260
Current income tax liability 	793 	276
TOTAL LIABILITIES 	165 775 	137 150
TOTAL EQUITY AND LIABILITIES 	210 328 	180 233
* Amount is less than R500 000.
The order in which individual line items are presented in the Statement of financial position has been amended to better reflect their respective liquidity, as far as
possible, from least liquid to the most liquid items. No values were reclassified or restated between line items.
22 Discovery Annual Financial Statements 2020

-- 23 of 198 --

GROUP INCOME STATEMENT
for the year ended 30 June 2020
R million 	Notes
Group
June
2020
Audited
Group
June
2019
Audited
Insurance premium revenue 	49 775 	43 036
Reinsurance premiums 	(6 308) 	(5 595)
Net insurance premium revenue 	25 	43 467 	37 441
Fee income from administration business 	11 337 	10 404
Net banking fee and commission income 	150 	–
Banking fee and commission income 	182 	–
Banking fee and commission expense 	(32) 	–
Vitality income 	3 875 	3 653
Other income 	1 100 	1 063
Investment income using the effective interest rate method 	26 	379 	398
Net bank interest and similar income 	71 	29
Bank interest and similar income using the effective interest rate 	162 	29
Bank interest and similar expense using the effective interest rate 	(91) 	–
Net fair value gains on financial assets at fair value through profit or loss 	27 	4 093 	4 265
Net income 	64 472 	57 253
Net claims and policyholders’ benefits 	28 	(23 246) 	(20 879)
Claims and policyholders' benefits 	(26 856) 	(24 538)
Insurance claims recovered from reinsurers 	3 610 	3 659
Acquisition costs 	29 	(6 547) 	(6 100)
Marketing and administration expenses 	30 	(22 118) 	(19 954)
Amortisation of intangibles from business combinations 	(76) 	(99)
Expected credit losses 	(181) 	–
Recovery of expenses from reinsurers 	2 876 	2 830
Net transfer to/from assets and liabilities under insurance contracts 	(13 497) 	(4 706)
– change in assets arising from insurance contracts 	2 038 	5 321
– change in assets arising from reinsurance contracts 	53 	7
– change in liabilities arising from insurance contracts 	(9 418) 	(8 050)
– change in liabilities arising from reinsurance contracts 	(462) 	(1 984)
– economic assumption adjustments net of discretionary margins 	(5 708) 	–
Fair value adjustment to liabilities under investment contracts 	(151) 	(809)
Profit from operations 	1 532 	7 536
Finance costs 	32 	(1 568) 	(1 375)
Gain on previously held interests in DiscoveryCard business 	– 	761
Gain on dilution and disposal of equity-accounted investments 	3 	844
Impairment of goodwill 	(9) 	(17)
Foreign exchange gains 	33 	578 	*
Share of net profits from equity-accounted investments 	264 	170
Profit before tax 	800 	7 919
Income tax expense 	34 	(624) 	(1 305)
Profit for the year 	176 	6 614
Profit/(loss) attributable to:
– ordinary shareholders 	97 	6 533
– preference shareholders 	81 	81
– non-controlling interest 	(2) 	*
176 	6 614
Earnings per share for profit attributable to ordinary shareholders of the Company
during the year (cents): 	35
– basic 	14.8 	1 001.5
– diluted 	14.7 	1 001.1
* Amount is less than R500 000.
23 Discovery Annual Financial Statements 2020

-- 24 of 198 --

GROUP STATEMENT OF OTHER COMPREHENSIVE INCOME
for the year ended 30 June 2020
R million
Group
June
2020
Audited
Group
June
2019
Audited
Profit for the year 	176 	6 614
Items that are or may be reclassified subsequently to profit or loss:
Currency translation differences 	2 800 	(140)
– unrealised gains/(losses) 	2 768 	(142)
– tax on unrealised (gains)/losses 	32 	2
Cash flow hedges 	(430) 	(175)
– unrealised losses 	(762) 	(91)
– tax on unrealised losses/gains 	59 	(7)
– losses/(gains) recycled to profit or loss 	319 	(98)
– tax on recycled losses/gains 	(46) 	21
Share of other comprehensive income from equity-accounted investments 	293 	(19)
– change in fair value of debt instruments at fair value through other comprehensive income 	3 	–
– currency translation differences 	290 	(19)
Other comprehensive income/(losses) for the year, net of tax 	2 663 	(334)
Total comprehensive income for the year 	2 839 	6 280
Attributable to:
– ordinary shareholders 	2 760 	6 199
– preference shareholders 	81 	81
– non-controlling interest 	(2) 	*
Total comprehensive income for the year 	2 839 	6 280
* Amount is less than R500 000.
24 Discovery Annual Financial Statements 2020

-- 25 of 198 --

GROUP STATEMENT OF CASH FLOWS
for the year ended 30 June 2020
R million 	Notes
Group
June
2020
Audited
Group
June
2019
Audited
Cash flow from operating activities 	8 065 	1 738
Cash generated by operations 	36.1 	19 000 	12 779
Purchase of investments held to back policyholder liabilities 	(37 316) 	(35 109)
Proceeds from disposal of investments held to back policyholder liabilities 	26 218 	23 831
7 902 	1 501
Dividends received 	342 	339
Interest received 	2 516 	2 274
Interest paid 	(1 406) 	(1 219)
Taxation paid 	36.2 	(1 289) 	(1 157)
Cash flow from investing activities 	(3 030) 	(2 844)
Purchase of financial assets 	(26 497) 	(21 725)
Proceeds from disposal of financial assets 	25 532 	21 831
Purchase of property and equipment 	(290) 	(510)
Proceeds from disposal of property and equipment 	4 	95
Purchase of software and other intangible assets 	(1 726) 	(1 999)
Proceeds from disposal of intangible assets 	– 	22
Proceeds from the disposal of equity-accounted investments 	– 	402
Acquisition of business net of cash 	16 	(736)
Additional investment in equity-accounted investments 	(69) 	(224)
Cash flow from financing activities 	2 202 	(344)
Proceeds from issuance of ordinary shares 	36.3 	– 	1 854
Shares issue costs 	36.3 	– 	(19)
Acquisition of additional interest in subsidiary 	– 	(1 104)
Purchase of treasury shares 	(4) 	–
Dividends paid to ordinary shareholders 	(1 413) 	(1 400)
Dividends paid to preference shareholders 	(81) 	(81)
Proceeds from borrowings 	36.4 	10 339 	2 147
Repayment of borrowings 	36.4 	(6 639) 	(1 741)
Net increase/(decrease) in cash and cash equivalents 	7 237 	(1 450)
Cash and cash equivalents at beginning of the year 	9 403 	10 888
Exchange gains/(losses) on cash and cash equivalents 	1 269 	(35)
Cash and cash equivalents at end of the year 	16 	17 909 	9 403
25 Discovery Annual Financial Statements 2020

-- 26 of 198 --

GROUP STATEMENT OF CHANGES IN EQUITY
for the year ended 30 June 2020
Attributable to equity holders of the Company 	Attributable to equity holders of the Company
R million
Share
capital
and share
premium
Preference
share
capital
Share-based
payment
reserve
Investment
reserve1
Foreign
currency
translation
reserve
Hedging
reserve
Retained
earnings 	Total
Non-
controlling
interest 	Total
Year ended 30 June 2019
At beginning of the year 	8 308 	779 	327 	– 	744 	1 	27 362 	37 521 	* 	37 521
Total comprehensive income for the year 	– 	81 	– 	– 	(159) 	(175) 	6 533 	6 280 	* 	6 280
Profit for the year 	– 	81 	– 	– 	– 	– 	6 533 	6 614 	– 	6 614
Other comprehensive income 	– 	– 	– 	– 	(159) 	(175) 	– 	(334) 	– 	(334)
Transactions with owners 	1 834 	(81) 	(286) 	– 	– 	– 	(2 185) 	(718) 	– 	(718)
Share issue 	1 854 	– 	– 	– 	– 	– 	– 	1 854 	– 	1 854
Share issue costs 	(19) 	– 	– 	– 	– 	– 	– 	(19) 	– 	(19)
Change in ownership without change in control 	– 	– 	– 	– 	– 	– 	(1 104) 	(1 104) 	– 	(1 104)
Increase in treasury shares 	(5) 	– 	– 	– 	– 	– 	– 	(5) 	– 	(5)
Delivery of treasury shares 	4 	– 	– 	– 	– 	– 	– 	4 	– 	4
Transfer of vested equity-settled share schemes 	– 	– 	(319) 	– 	– 	– 	319 	– 	– 	–
Employee share option schemes:
– Value of employee services 	– 	– 	33 	– 	– 	– 	– 	33 	– 	33
Dividends paid to preference shareholders 	– 	(81) 	– 	– 	– 	– 	– 	(81) 	– 	(81)
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	– 	– 	(1 400) 	(1 400) 	– 	(1 400)
At end of the year 	10 142 	779 	41 	585 	(174) 	31 710 	43 083 	* 	43 083
Year ended 30 June 2020
At beginning of the year 	10 142 	779 	41 	– 	585 	(174) 	31 710 	43 083 	* 	43 083
IFRS transitional adjustments 	– 	– 	– 	– 	– 	– 	(41) 	(41) 	– 	(41)
Adjusted balance at beginning of the year 	10 142 	779 	41 	– 	585 	(174) 	31 669 	43 042 	* 	43 042
Total comprehensive income for the year 	– 	81 	– 	3 	3 090 	(430) 	97 	2 841 	(2) 	2 839
Profit for the year 	– 	81 	– 	– 	– 	– 	97 	178 	(2) 	176
Other comprehensive income 	– 	– 	– 	3 	3 090 	(430) 	– 	2 663 	– 	2 663
Transactions with owners 	6 	(81) 	154 	– 	– 	– 	(1 413) 	(1 334) 	6 	(1 328)
Delivery of treasury shares 	10 	– 	(10) 	– 	– 	– 	– 	– 	– 	–
Increase in treasury shares 	(4) 	– 	– 	– 	– 	– 	– 	(4) 	– 	(4)
Acquisition of subsidiaries with non-controlling interest 	– 	– 	– 	– 	– 	– 	– 	– 	6 	6
Employee share option schemes:
– Value of employee services 	– 	– 	164 	– 	– 	– 	– 	164 	– 	164
Dividends paid to preference shareholders 	– 	(81) 	– 	– 	– 	– 	– 	(81) 	– 	(81)
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	– 	– 	(1 413) 	(1 413) 	– 	(1 413)
At end of the year 	10 148 	779 	195 	3 	3 675 	(604) 	30 353 	44 549 	4 	44 553
1 This relates to fair value adjustments on those equity instruments designated at fair value through other comprehensive income and those debt instruments
measured at fair value through other comprehensive income.
* Amount is less than R500 000.
Discovery Annual Financial Statements 2020 27	26 Discovery Annual Financial Statements 2020

-- 27 of 198 --

1. 	SEGMENT INFORMATION
Discovery’s operating segments are reported in a manner consistent with the internal reporting provided to the chief operating
decision-maker (CODM). The CODM have been identified as the Chief Executive Officers of Discovery’s businesses, as identified
in the segment information, who make strategic decisions regarding these businesses.
An operating segment is a component of an entity:
(a) 	That engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses
relating to transactions with other components of the same entity);
(b) Whose operating results are regularly reviewed by the entity’s CODM to make decisions about resources to be allocated to
the segment and assess its performance; and
(c) 	For which discrete financial information is available.
An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations
may be operating segments before earning revenues.
Discovery will report separately information about an operating segment that meets any of the following quantitative thresholds:
(a) 	Its reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 per cent or more
of the combined revenue, internal and external, of all operating segments;
(b) The absolute amount of its reported profit or loss is 10 per cent or more of the greater, in absolute amount, of (i) the
combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all
operating segments that reported a loss; and
(c) 	Its assets are 10 per cent or more of the combined assets of all operating segments.
Operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately disclosed,
if management believes that information about the segment would be useful to users of the financial statements.
Discovery may combine information about operating segments that do not meet the quantitative thresholds with information
about other operating segments that do not meet the quantitative thresholds to produce a reportable segment only if the
operating segments have similar economic characteristics.
The Group has identified its reportable segments based on a combination of products and services offered to customers and the
location of the markets served.
The following summary describes the operations of each of the Group’s reportable segments:
(i) 	Health South Africa: administers and provides managed care services to medical schemes and renders administration
services to other business segments within the Group.
(ii) 	Life South Africa: offers a range of insurance and financial solutions to the Group’s clients against the financial impact of
lifestyle-changing events in South Africa.
(iii) Invest South Africa: offers, through a range of investment fund choices, including Discovery managed unit trusts, a
comprehensive and flexible range of investment choices. These products are sold through a number of investment wrappers
including Discovery Life policies and are offered to individuals in South Africa.
(iv) Vitality South Africa: offers health and lifestyle benefits with selected partners to the Group’s clients.
(v) 	Insure South Africa: offers a range of personal line insurance (motor, building, household content and portable processions)
to the Group’s clients against the financial impact of loss or damage. The segment also includes Discovery’s interest in
Cambridge Mobile Telematics (CMT).
(vi) Bank South Africa: offers retail banking solutions, including deposits and loans and advances, to clients in the South African
market. The Bank is still in start-up phase. It also includes DiscoveryCard.
(vii) Health United Kingdom: offers consumer-engaged private medical insurance products to employer groups and individuals
in the United Kingdom. All contracts in this segment are short-term insurance contracts.
(viii) Life United Kingdom: offers a risk-only life assurance product. All contracts in this segment are long-term assurance
contracts offered to both employer groups and individuals in the United Kingdom.
(ix) All other segments: includes those segments that do not meet the quantitative thresholds set out in IFRS 8 and cannot be
aggregated with another reportable segment. It includes the following operating segments:
– Insure South Africa commercial: provides commercial short-term risk insurance products to the South African market.
– SA Distribution: provides sales and distribution services in respect of all SA products.
– Vitality Group: provides a Vitality platform to international insurance businesses.
– Other new business development costs: expenses incurred to investigate new products and markets.
– UK, US, SA and Singapore head office costs, where not allocated to another segment.
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS
for the year ended 30 June 2020
28 Discovery Annual Financial Statements 2020

-- 28 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	SEGMENT INFORMATION continued
The Chief Executive Officers assess the performance of the reportable segments based on normalised profit/loss from operations.
Items which are excluded from the normalised profit/loss from operations are separately disclosed in the segmental information
to reconcile back to the segmental results.
The segment information is presented on the same basis as reported to the Chief Executive Officer. The segment total is then
adjusted for accounting reclassifications and entries required to produce IFRS compliant results. These adjustments include the
following:
(i) The VitalityLife results are reclassified to account for the contractual arrangement in respect of the business written on the
Statement of financial position of Prudential Assurance Company Limited, as a reinsurance contract under IFRS 4 Insurance
Contracts;
(ii) The Discovery Unit Trusts (DUT) are consolidated into Discovery’s results for IFRS purposes. In the Segment information the
DUT column includes the effects of consolidating the unit trusts into Discovery’s results, effectively being the income and
expenses relating to units held by third parties;
(iii) The effects of eliminating intercompany transactions on consolidation and normalised operating profit adjustments; and
(iv) The effects of reclassifying items to align to IFRS results.
Change in presentation
At each reporting date, Discovery must review whether the segments being disclosed still comply with IFRS 8 Segment reporting.
During the current financial year segmental information has been changed to align with the change in reportable segments, i.e.
Insure South Africa and Bank South Africa are disclosed. The comparative information has been accordingly restated.
29 Discovery Annual Financial Statements 2020

-- 29 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	SEGMENT INFORMATION continued
R million
SA
Health
SA
Life
SA
Invest
SA
Insure
SA
Vitality
SA
Bank2
UK
Health
UK
Life
All other
segments
Segment
total
IFRS reporting
adjustments
IFRS
total
30 June 2020
Income statement
Insurance premium revenue 	252 	12 984 	15 602 	3 544 	– 	– 	9 100 	5 705 	3 330 	50 517 	(742) 	49 775
Reinsurance premiums 	(1) 	(2 564) 	– 	(66) 	– 	– 	(1 589) 	(2 789) 	(41) 	(7 050) 	742 	(6 308)
Net insurance premium revenue 	251 	10 420 	15 602 	3 478 	– 	– 	7 511 	2 916 	3 289 	43 467 	– 	43 467
Fee income from administration businesses 	7 238 	– 	2 246 	12 	– 	137 	30 	– 	1 687 	11 350 	(13) 	11 337
Net banking fee and commission income 	– 	– 	– 	– 	– 	150 	– 	– 	– 	150 	– 	150
Banking fee and commission income 	– 	– 	– 	– 	– 	182 	– 	– 	– 	182 	– 	182
Banking fee and commission expense 	– 	– 	– 	– 	– 	(32) 	– 	– 	– 	(32) 	– 	(32)
Vitality income 	– 	– 	– 	– 	2 401 	121 	452 	212 	689 	3 875 	– 	3 875
Other income 	883 	39 	– 	– 	– 	120 	69 	– 	18 	1 129 	(29) 	1 100
Investment income earned on assets backing policyholder liabilities 	– 	13 	– 	119 	– 	1 	9 	37 	1 	180 	(180) 	–
Net bank interest and similar income 	– 	– 	– 	– 	– 	63 	– 	– 	– 	63 	8 	71
Bank interest and similar income using the effective interest rate 	– 	– 	– 	– 	– 	162 	– 	– 	– 	162 	– 	162
Bank interest and similar expense using the effective interest rate 	– 	– 	– 	– 	– 	(99) 	– 	– 	– 	(99) 	8 	(91)
Finance charge on negative reserve funding 	– 	– 	– 	– 	– 	– 	– 	(838) 	– 	(838) 	838 	–
Inter-segment funding 1 	– 	(762) 	762 	– 	– 	– 	– 	– 	– 	– 	– 	–
Net fair value gains on financial assets at fair value through
profit or loss 	(20) 	867 	834 	32 	(2) 	92 	29 	768 	59 	2 659 	1 434 	4 093
Net income 	8 352 	10 577 	19 444 	3 641 	2 399 	684 	8 100 	3 095 	5 743 	62 035 	2 058 	64 093
Net claims and policyholders’ benefits 	(100) 	(6 079) 	(10 542) 	(1 915) 	– 	– 	(3 623) 	(798) 	(189) 	(23 246) 	– 	(23 246)
Claims and policyholders’ benefits 	(100) 	(7 926) 	(10 542) 	(1 939) 	– 	– 	(4 796) 	(1 964) 	(229) 	(27 496) 	640 	(26 856)
Insurance claims recovered from reinsurers 	– 	1 847 	– 	24 	– 	– 	1 173 	1 166 	40 	4 250 	(640) 	3 610
Acquisition costs 	(30) 	(1 566) 	(1 080) 	(479) 	(66) 	– 	(797) 	(1 814) 	123 	(5 709) 	(838) 	(6 547)
Credit impairment charges 	– 	– 	– 	– 	– 	(181) 	– 	– 	– 	(181) 	– 	(181)
Marketing and administration expenses 	– 	–
– depreciation and amortisation 	(176) 	(7) 	(9) 	(84) 	(15) 	(236) 	(359) 	(46) 	(612) 	(1 544) 	(210) 	(1 754)
– derecognition of intangible assets and property and equipment 	(29) 	– 	– 	(74) 	(9) 	– 	– 	– 	(84) 	(196) 	– 	(196)
– impairment of intangible assets 	– 	– 	– 	– 	– 	– 	– 	– 	(63) 	(63) 	– 	(63)
– other expenses 	(4 844) 	(1 976) 	(984) 	(824) 	(2 302) 	(1 438) 	(3 297) 	(2 063) 	(2 625) 	(20 353) 	260 	(20 093)
Recovery of expenses from reinsurers 	– 	– 	– 	– 	– 	– 	826 	2 050 	– 	2 876 	– 	2 876
Transfer from assets/liabilities under insurance contracts
– change in assets arising from insurance contracts 	– 	1 557 	– 	– 	– 	– 	– 	(2 788) 	29 	(1 202) 	3 240 	2 038
– change in assets arising from reinsurance contracts 	– 	27 	– 	7 	– 	– 	8 	11 	– 	53 	– 	53
– change in liabilities arising from insurance contracts 	– 	(238) 	(5 809) 	(39) 	– 	– 	(28) 	(18) 	(3 110) 	(9 242) 	(176) 	(9 418)
– change in liabilities arising from reinsurance contracts 	– 	678 	– 	– 	– 	– 	– 	2 099 	– 	2 777 	(3 239) 	(462)
Fair value adjustment to liabilities under investment contracts 	– 	(2) 	(190) 	– 	– 	– 	– 	– 	4 	(188) 	37 	(151)
Share of net profits from equity-accounted investments 	17 	– 	– 	13 	– 	– 	– 	– 	222 	252 	– 	252
Normalised profit/(loss) from operations 	3 190 	2 971 	830 	246 	7 	(1 171) 	830 	(272) 	(562) 	6 069 	1 132 	7 201
Investment income earned on shareholder investments and cash 	65 	21 	45 	10 	27 	– 	1 	12 	746 	927 	(548) 	379
Economic assumptions adjustments net of discretionary margins and
interest rate derivative 	– 	(3 635) 	– 	– 	– 	– 	– 	(1 195) 	– 	(4 830) 	(878) 	(5 708)
Economic assumptions adjustments net of discretionary margins 	– 	(3 635) 	– 	– 	– 	– 	– 	(2 073) 	– 	(5 708) 	– 	(5 708)
Fair value gains on VitalityLife interest rate derivative 	– 	– 	– 	– 	– 	– 	– 	878 	– 	878 	(878) 	–
Net fair value gains/(losses) on financial assets at fair value through
profit or loss 	– 	128 	4 	– 	– 	– 	– 	(120) 	263 	275 	(275) 	–
Restructuring costs 	– 	– 	– 	– 	– 	– 	– 	(100) 	– 	(100) 	100 	–
Gains from dilution of equity accounted investments 	– 	– 	– 	3 	– 	– 	– 	– 	– 	3 	– 	3
Impairment of goodwill 	– 	– 	– 	– 	– 	– 	– 	– 	(9) 	(9) 	– 	(9)
Initial expenses related to Prudential Book transfer 	– 	– 	– 	– 	– 	– 	– 	(71) 	– 	(71) 	71 	–
Transaction costs related to VitalityLife interest rate derivatives 	– 	– 	– 	– 	– 	– 	– 	(45) 	– 	(45) 	45 	–
Amortisation of intangibles from business combinations 	– 	– 	– 	– 	– 	– 	– 	– 	(76) 	(76) 	– 	(76)
Market rentals related to Head Office building adjusted for finance
costs and depreciation 	– 	– 	– 	– 	– 	– 	– 	– 	(259) 	(259) 	259 	–
Finance costs 	(286) 	– 	– 	– 	– 	– 	(7) 	(257) 	(1 389) 	(1 939) 	371 	(1 568)
Foreign exchange gains 	15 	– 	36 	– 	– 	– 	– 	– 	527 	578 	– 	578
Profit before tax 	2 984 	(515) 	915 	259 	34 	(1 171) 	824 	(2 048) 	(759) 	523 	277 	800
Income tax expense 	(826) 	147 	(256) 	(64) 	(10) 	270 	(129) 	239 	282 	(347) 	(277) 	(624)
Profit for the year 	2 158 	(368) 	659 	195 	24 	(901) 	695 	(1 809) 	(477) 	176 	– 	176
1 The inter-segment funding of R762 million reflects a notional allocation of interest earned on the negative reserve backing policyholders’ funds of
guaranteed investment products and hence is transferred to Discovery Invest.
Discovery Annual Financial Statements 2020 31	30 Discovery Annual Financial Statements 2020

-- 30 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	SEGMENT INFORMATION continued
R million
SA
Health
SA
Life
SA
Invest
SA
Insure
SA
Vitality
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
IFRS reporting
adjustments
IFRS
total
30 June 2019
Income statement
Insurance premium revenue 	167 	12 131 	14 267 	3 158 	– 	– 	8 429 	4 750 	801 	43 703 	(667) 	43 036
Reinsurance premiums 	(1) 	(2 410) 	– 	(261) 	– 	– 	(1 393) 	(2 177) 	(20) 	(6 262) 	667 	(5 595)
Net insurance premium revenue 	166 	9 721 	14 267 	2 897 	– 	– 	7 036 	2 573 	781 	37 441 	– 	37 441
Net fee and commission income 	6 815 	– 	2 050 	12 	– 	219 	15 	– 	1 311 	10 422 	(18) 	10 404
Fee income from administration businesses 	6 815 	– 	2 050 	12 	– 	219 	15 	– 	1 311 	10 422 	(18) 	10 404
Banking fee and commission income 	– 	– 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Banking fee and commission expense 	– 	– 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Vitality income 	– 	– 	– 	– 	2 329 	120 	501 	157 	546 	3 653 	– 	3 653
Other income 	782 	42 	– 	– 	– 	224 	39 	– 	(2) 	1 085 	(22) 	1 063
Investment income earned on assets backing policyholder liabilities 	– 	14 	1 	142 	– 	– 	10 	42 	(1) 	208 	(208) 	–
Net bank interest and similar income 	– 	– 	– 	– 	– 	29 	– 	– 	– 	29 	– 	29
Bank interest and similar income using the effective interest rate 	– 	– 	– 	– 	– 	29 	– 	– 	– 	29 	– 	29
Bank interest and similar expense using the effective interest rate 	– 	– 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Finance charge on negative reserve funding 	– 	– 	– 	– 	– 	– 	– 	(243) 	– 	(243) 	243 	–
Inter-segment funding 1 	– 	(754) 	754 	– 	– 	– 	– 	– 	– 	– 	– 	–
Net fair value gains on financial assets at fair value through
profit or loss 	7 	1 056 	1 849 	1 	– 	– 	40 	211 	32 	3 196 	1 069 	4 265
Net income 	7 770 	10 079 	18 921 	3 052 	2 329 	592 	7 641 	2 740 	2 667 	55 791 	1 064 	56 855
Net claims and policyholders’ benefits 	(64) 	(6 037) 	(8 989) 	(1 734) 	– 	– 	(3 525) 	(513) 	(17) 	(20 879) 	– 	(20 879)
Claims and policyholders’ benefits 	(65) 	(8 205) 	(8 989) 	(1 903) 	– 	– 	(4 613) 	(1 133) 	(30) 	(24 938) 	400 	(24 538)
Insurance claims recovered from reinsurers 	1 	2 168 	– 	169 	– 	– 	1 088 	620 	13 	4 059 	(400) 	3 659
Acquisition costs 	(6) 	(1 705) 	(1 138) 	(405) 	(87) 	(14) 	(732) 	(1 888) 	118 	(5 857) 	(243) 	(6 100)
Marketing and administration expenses
– depreciation and amortisation 	(223) 	(4) 	(4) 	(70) 	(8) 	(51) 	(251) 	(34) 	(399) 	(1 044) 	(210) 	(1 254)
– impairment of intangibles assets 	(4) 	– 	– 	(5) 	– 	– 	– 	(23) 	(32) 	– 	(32)
– other expenses 	(4 423) 	(1 876) 	(904) 	(744) 	(2 169) 	(823) 	(3 148) 	(2 060) 	(2 458) 	(18 605) 	(63) 	(18 668)
Recovery of expenses from reinsurers 	– 	– 	– 	– 	– 	– 	814 	2 016 	– 	2 830 	– 	2 830
Transfer from assets/liabilities under insurance contracts
– change in assets arising from insurance contracts 	– 	3 475 	– 	– 	– 	– 	– 	1 570 	(4) 	5 041 	280 	5 321
– change in assets arising from reinsurance contracts 	– 	10 	– 	(5) 	– 	– 	(8) 	10 	– 	7 	– 	7
– change in liabilities arising from insurance contracts 	(9) 	(251) 	(6 837) 	53 	– 	– 	(33) 	(17) 	(791) 	(7 885) 	(165) 	(8 050)
– change in liabilities arising from reinsurance contracts 	– 	(458) 	– 	– 	– 	– 	– 	(1 246) 	– 	(1 704) 	(280) 	(1 984)
Fair value adjustment to liabilities under investment contracts 	– 	(3) 	(83) 	– 	– 	– 	– 	– 	– 	(86) 	(723) 	(809)
Share of net profits from equity-accounted investments 	3 	– 	– 	8 	– 	– 	– 	– 	159 	170 	– 	170
Normalised profit/(loss) from operations 	3 044 	3 230 	966 	155 	60 	(296) 	758 	578 	(748) 	7 747 	(340) 	7 407
Investment income earned on shareholder investments and cash4 	57 	8 	35 	30 	42 	– 	1 	14 	635 	822 	(424) 	398
Net fair value gains/(losses) on financial assets at fair value through
profit or loss 	– 	224 	(9) 	– 	– 	– 	– 	– 	(144) 	71 	(71) 	–
Gains from dilution of equity accounted investments 	– 	– 	– 	808 	– 	– 	– 	– 	15 	823 	21 	844
Gain on previously held interests in DiscoveryCard business 	– 	– 	– 	– 	– 	– 	– 	– 	761 	761 	– 	761
Impairment of goodwill 	– 	– 	– 	– 	– 	– 	– 	– 	(17) 	(17) 	– 	(17)
Initial expenses related to Prudential Book transfer 	– 	– 	– 	– 	– 	– 	– 	(28) 	– 	(28) 	28 	–
Amortisation of intangibles from business combinations 	– 	– 	– 	– 	– 	– 	– 	– 	(99) 	(99) 	– 	(99)
Market rentals related to Head Office building adjusted for
finance costs and depreciation 	– 	– 	– 	– 	– 	– 	– 	– 	(281) 	(281) 	281 	–
Finance costs4 	(270) 	(2) 	– 	– 	– 	– 	– 	(210) 	(1 185) 	(1 667) 	292 	(1 375)
Foreign exchange gains/(losses) 	1 	– 	6 	– 	– 	– 	– 	– 	(7) 	– 	– 	–
Profit before tax 	2 832 	3 460 	998 	993 	102 	(296) 	759 	354 	(1 070) 	8 132 	(213) 	7 919
Income tax expense 	(741) 	(880) 	(280) 	(195) 	(29) 	113 	(38) 	(138) 	670 	(1 518) 	213 	(1 305)
Profit for the period 	2 091 	2 580 	718 	798 	73 	(183) 	721 	216 	(400) 	6 614 	– 	6 614
1 The inter-segment funding of R754 million reflects a notional allocation of interest earned on the negative reserve backing policyholders’ funds of
guaranteed investment products and hence is transferred to Discovery Invest.
Discovery Annual Financial Statements 2020 33	32 Discovery Annual Financial Statements 2020

-- 31 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK
Discovery ’s accounting policy to recognise and measure insurance contracts can be viewed in Annexure A, accounting policy 13.
Discovery issues both short-term and long-term contracts that transfer significant insurance risk. Such contracts may also
transfer financial risk. An insurance contract is a contract in which Discovery as issuer and/or insurer accepts significant insurance
risk from the policyholder by agreeing to compensate the policyholder if a specified uncertain future event (the insured event)
adversely affects the policyholder. A significant insurance risk is the possibility of having to pay benefits, on the occurrence of an
insured event, that are significantly more than the benefits payable if the insured event did not occur. There is uncertainty around
the timing and/or the value of the resulting claim.
A large portfolio of independent but similar insurance contracts, allow for the use of probability theory to predict the number and
value of claims over a defined period. Insurance risk, when considering a large portfolio of insurance contracts, is thus the
probability that the actual number of claims over a defined period is different to those expected. This could in turn result in the
value of insurance liabilities being over or under estimated.
Experience shows that the larger the portfolio of similar insurance contracts, the smaller the relative variability of the expected
outcome will be. Discovery reduces claims variability by underwriting policies and by using reinsurance to protect against single
large claims or catastrophe reinsurance to mitigate concentration risks.
Discovery classifies its insurance contracts into five main categories, depending on the duration of the risk and the type of risk
insured. These are:
Contracts which are long term in nature
– Individual life insurance: These contracts insure against a comprehensive spectrum of risks, including life cover, severe illness,
disability and income continuation cover.
– Investment products with insurance risk: These contracts attract insurance risk arising from additional benefits offered which
mostly insure against life risks.
Contracts which are short term in nature
– Health insurance: These contracts insure policyholders against healthcare-related claims.
– Short-term insurance: These monthly contracts insure policyholders against a comprehensive spectrum of short-term risks
including, but not limited to, motor vehicle, household and liability cover.
– Group life insurance: These contracts insure against a comprehensive spectrum of protection benefits on a group basis. Life
cover, severe illness, disability and income continuation benefits are offered.
Annexure F includes a detailed description of all products that Discovery offers and whether the contract transfers insurance risk,
financial risk or both. The annexure also summarises the number of policies held and the annual premium income from these
products.
Refer to note 1 Segmental information for premium revenue per segment.
Discovery manages its insurance risk in terms of its risk management framework and holds regulatory and economic capital for
protection against adverse experience. The following summarises the insurance risk associated with the various contracts offered
by Discovery, and how Discovery manages these risks.
Insurance risk 	Description 	How Discovery manages the risk
Risks significant to all insurance business lines
Lapse and surrender
risk
Policyholders have the option to discontinue or
reduce contributions at any time.
Accordingly, there is a risk of financial loss
due to the withdrawal rate, lapses or premium
reductions (with associated reduced cover)
being higher than expected. The risk is highest
during the early duration of the policy since
the 	acquisition 	costs 	and 	commission
incurred at the inception of the policy would
not yet have been recouped.
Lapse risk is managed as follows:
PRODUCT DESIGN
Products are designed to be sustainable in the long
term. New product offerings are made available
to existing policyholders as far as possible to
prevent lapse and re-entry risk.
Integration between different product offerings
across Discovery enhances the value proposition
of the overall package of products from Discovery.
34 Discovery Annual Financial Statements 2020

-- 32 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
Lapse and surrender
risk continued
Contracts that are long term in nature
For individual life insurance products there is a
risk:
– of reduced profits arising from lower than
expected withdrawals at later durations of
certain policies in cases where the reserves
have turned positive. This is since withdrawals
on such policies allow the reserves to be
released as profits in the absence of surrender
values being offered; and
– that withdrawals are selective from a claims
experience point of view. For example, healthy
lives may find it easier to obtain cover
elsewhere compared to less healthy lives.
Future earnings on individual life plans are
dependent on the number of policies remaining
in future years and thus future earnings are
dependent on the lapse rate. The future
expected earnings vary by the premium funding
method chosen by the policyholder. In general,
the higher the increases, the higher the
withdrawal risk to future earnings.
For investment products with insurance risk,
there is a risk:
– that the surrender value may exceed the policy
value, net of expenses, at early durations; and
– that withdrawals are higher than expected.
Future earnings arising from Invest plans
are dependent on the value of assets under
management and thus future earnings are
dependent on the withdrawal and surrender
rate.
Contracts that are short term in nature
For Discovery Insure there is a risk of reduced
profits arising from higher than expected
withdrawals at early durations of policies,
resulting in acquisition costs not being recovered.
For example, Discovery provides unique rewards
and benefits as well as integration to members
which has proven to be a credible risk differentiator.
Premium discounts or cover increases are
available to policyholders who actively engage
in a healthier lifestyle and utilise the Vitality
benefits. Better terms are thus offered to healthy
lives compared to less healthy lives.
No surrender benefit is offered on risk benefits
and thus the loss on withdrawal is reduced.
COMMISSION CLAW BACK
Discovery 	predominantly 	distributes 	via
independent brokers, intermediaries and tied
agents.
Commissions are clawed back from intermediaries
where a policy lapses within a specified timeframe
since inception. The amount of commission
clawback depends on the duration of the policy
in months and gradually reduces from 100% to
0% and is over a specified period depending on
product sold.
EXPERIENCE MONITORING
Lapse experience is monitored on a monthly basis
and data is analysed to establish possible trends
for which management action can be taken.
Where there is insufficient historic data to provide
credible results, for example within VitalityLife
Whole of Life, reliance is placed on reinsurers’
advice, industry experience as well as experience
from Discovery Life.
PROACTIVE CONSERVATION
Targeted conservation campaigns are run pro-
actively. For example, financial advisors are
notified of clients that do not have certain
features on their policies that are correlated
with good persistency. Financial advisors are
thus encouraged to add such features.
35 Discovery Annual Financial Statements 2020

-- 33 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Modelling and data risk 	Actuarial liabilities are calculated using complex
discounted cash flow models. There is a risk that
the models do not accurately project the policy
cash flows in the future.
The models rely on data from the administration
system and there is thus a further risk that the
data does not accurately reflect the policies
being valued.
Contracts that are short term have simplified
models reducing modelling risk.
The risk is controlled using specialist actuarial
software that is widely used and accepted in the
life insurance industry throughout the world.
This is tailored for Discovery.
The original actuarial models were tested and
verified using an independent but identical
parallel model. Any changes made are externally
and independently reviewed. Parallel models
are developed to test any modelling changes.
The data for the model is extracted from modern
administration 	systems 	and 	subjected 	to
detailed 	checks 	together 	with 	high-level
reasonability checks. Discovery does not have
any legacy systems that could impact on the data
quality. Data is checked at each valuation date.
Capital adequacy
requirements and
protection against
adverse experiences
There is a risk that future premiums, investment
returns and estimates used to calculate liabilities
are insufficient to provide for variations in actual
future experience. Insurance liabilities are
calculated using best estimates plus the addition
of various margins to avoid premature recognition
of profits and to provide for a buffer against
future adverse experience. In addition, Discovery
maintains shareholder capital to meet substantial
deviations in experience beyond those provided
for in the liability calculations.
For discussion on how Discovery manages its
capital adequacy requirements, refer to note 2.1.
Liquidity risk 	Liquidity risk is the risk that an entity will
encounter difficulty in meeting obligations
associated with insurance liabilities due to
insufficient cash being available to meet
commitments as and when they become due.
This is exacerbated by timing mismatches
between assets and liabilities.
Discovery maintains sufficient liquid assets to
meet short-term liabilities and to allow for the
initial cash flow strain when writing new business.
Contracts that are long-term in nature
Currently, Discovery Life’s and VitalityLife’s
expected outflows are mostly long-term and the
main liquidity requirement is to fund acquisition
expenses on new business and unexpected
fluctuations in benefit payments. As discussed
in note 3.4.3, Discovery invests primarily in
liquid financial assets.
For Discovery Life, large sums assured above a
defined retention level are reinsured, providing
stability in claims experienced and further
reducing liquidity risk.
36 Discovery Annual Financial Statements 2020

-- 34 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Liquidity risk continued 	VitalityLife also receives partial financing for
new business strain from financing reinsurance
treaties with reinsurers.
There is a need to meet liquidity requirements
arising from Invest’s Guaranteed Plan book.
Liquidity requirements are managed to ensure
a liquidity buffer is maintained to meet potential
outflows if exit rates are higher than expected.
The liquidity risk on the existing portfolio is thus
relatively small.
For discussion on managing liquidity risk, refer
to note 2.2.
Contracts that are short-term in nature
VitalityHealth mostly has expected outflows
which are short-term in nature as the vast
majority of claims are expected to be settled
within 12 months of reporting. The existing
book is mature and is cash generative which
covers liquidity required for the cash flow strain
of writing new business.
Discovery Insure holds the majority of working
and solvency capital in cash or near cash
instruments to minimise liquidity risk. Large
sums assured above a defined retention level
are reinsured, providing stability in claims
experience and further reducing the liquidity
risk. Catastrophe reinsurance further reduces
this risk.
Concentration risk 	CLAIMS EXPERIENCE RISK
There is a risk that a concentration of risk can
lead to worse than expected experience. The
concentration risk is the highest in group
business, since assured lives live in the same
geographical location and generally work in the
same industry or at the same location.
Discovery has a well-diversified book of business
by source of new business and spread across
brokers and agents.
Furthermore, this risk is mitigated through
catastrophe reinsurance.
For details of diversification refer to note 2.3.
WITHDRAWAL CONCENTRATION RISK
There is a financial risk of the withdrawal of a
block of policies written by a single independent
intermediary.
Operational and
implementation risk
Operational risk is defined as the risk of loss
arising from inadequate or failed internal
processes, people and systems or from external
events. Discovery offers a wide product range,
which grows over time due to further product
enhancements and development.
In order to mitigate operational risk, Discovery
maintains and follows a set of documented
processes and procedures which are reviewed
internally and externally to be in line with
industry 	best 	practice. 	Testing 	protocols
implemented prior to launching new systems/
products 	or 	businesses. 	Embedded 	in
Discovery’s 	processes 	is 	the 	concept 	of
segregation of duties which ensures that there
are multiple checks on outputs by different
areas within the business and protects against
operational and implementation risk. Discovery
does not have any legacy systems and processes
to deal with, thereby reducing operational risk.
2. 	MANAGEMENT OF INSURANCE RISK continued
37 Discovery Annual Financial Statements 2020

-- 35 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Policy wording/
legal risk
There is a risk that Discovery could be financially
exposed 	to 	obligations 	that 	differ 	from
expectations and are not adequately provided
for. The risk could also arise from legal
proceedings.
The risk is managed when new products are
developed and all policy wording is reviewed by
legal advisors and external advice is obtained
where necessary to ensure that terms and
conditions are clearly defined and unambiguous.
Regulatory risk 	Discovery operates in a highly regulated
environment which is currently being scrutinised
and questioned by both consumers and
regulators. This has resulted in the constant review
of the in-force regulations and the interpretation
thereof.
The regulatory risk can thus be defined as the
potential detrimental impact unexpected changes
in regulations, or the interpretation thereof,
may have on Discovery.
This risk is managed through constantly seeking
legal advice on new product developments.
Further, all insurance products issued by
Discovery have to be signed off, including sign-
off from a market conduct perspective.
Depending on the business line, these are
signed off either by the Head of the Actuarial
Function or an Actuarial Committee.
Discovery is a member of industry-wide bodies
that engage in discussions with policymakers
and regulators.
Although Discovery endeavours to design
insurance and financial solutions which meet
the requirements of the current regulations in
force, the risk does exist that changes in the
regulations 	or 	the 	interpretation 	of 	the
regulations, over time may result in the current
products not fully complying with the regulations
in force in future.
Discovery’s compliance department enhances
regulatory compliance through audits and by
monitoring developments in the regulatory
environment.
Tax risk 	Tax risk is the risk that the actual future tax liability
is different to what is currently expected. This
could be as a result of an incorrect interpretation
or application of tax legislation or as a result of
changes to tax legislation.
External tax advice is obtained as required to
ensure that products are structured in a tax
efficient way.
VitalityLife specific
Tax relief on expenses does not apply to
protection business sold from January 2013
onwards.
Expense risk 	Expense risk is the risk of actual expenses being
higher than expected. Expenses could exceed
expectations due to an increase in expense
inflation or due to a reduction in the number of
in-force policies. A reduction in the assets under
management could be an expense risk due to
the number of fixed costs.
Expenses are monitored on a monthly basis
against budgeted expenses. Any deviation from
the budget is investigated, reported and where
necessary, remedial action is taken.
2. 	MANAGEMENT OF INSURANCE RISK continued
38 Discovery Annual Financial Statements 2020

-- 36 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Reputational risk 	Reputational risk is the risk of negative market
reaction towards Discovery. Discovery may thus
not be able to apply management policies to
reduce risk.
Reputational risk is carefully controlled. Decisions
to repudiate claims are reviewed by a review
committee comprising of a senior underwriter
and claims assessor, representatives of the legal
department and the medical team, as well as a
compliance officer.
Marketing material and policy wording are
reviewed and designed to be clear and
unambiguous to avoid creating unreasonable
policyholder expectations.
All products are approved prior to launch, by
either the Head of the Actuarial Function or
Actuarial Committee, depending on the business
line. Sign-off is also done prior to launch from a
market conduct perspective.
For investment products with insurance risk, the
risk on investment returns is mitigated through
the use of reputable experienced fund managers
and unique, innovative products covering specific
risks.
Discovery Life offers policies that integrate with
the product offerings within the Discovery
Group. The reputational risk to Discovery Life is
thus extended to the reputational risk of the
entire 	Discovery 	Group. 	Discovery 	Life
management reviews all product offerings to
minimise the reputational risk.
Reputational risk may also arise on investment
products with insurance risk, if these products
experience worse investment returns than
competitors. This may lead to lower future new
business and higher surrenders.
For VitalityHealth, reputational risk arises from
exclusions of treatments which is provided by
competitors.
Risks significant to long-term insurance
Mismatching and
market risk
Mismatching is the risk that insurance-related cash
outflows (e.g. benefit payments, administration
expenses) do not match expected future cash
inflows (predominately future premiums).
Mismatching risk can also arise when movements
in assets and liabilities are out of line given changes
in market risk, i.e. equity price risk, interest rate risk
or currency risk.
The value of assets and liabilities arising from
insurance contracts are subject to interest rate
risk, thus a risk that a change in the discount
rate could cause a change in the value of the
assets and liabilities arising from insurance
contracts.
For assets arising from contracts, Discovery
covers the insurance related outflows by expected
future cash inflows (predominately future
premiums). This is supported by positive future
net cash flows arising from insurance contracts.
For liabilities arising from insurance contracts,
the insurance related cash outflows are matched
with a combination of a release of policyholder
assets (net of retained fees), investment return
on these assets and cash flows.
For further discussion on how Discovery
manages this risk, refer to note 2.4. More
specifically:
– For mismatching risk, refer note 2.4.1 and
2.4.2
– For interest rate risk, refer note 2.4.3
– For currency risk, refer note 2.4.4
2. 	MANAGEMENT OF INSURANCE RISK continued
39 Discovery Annual Financial Statements 2020

-- 37 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk –
Individual life plans and
investment products
with insurance risk
For individual life plans, there is a risk that actual
mortality and morbidity experience is higher
than expected. This could arise as a result of the
number of claims or the value of claims being
higher than expected. In addition, there is a risk
that the emergence of a new disease or
epidemic can increase the number of claims.
On guaranteed annuities there is a risk that
mortality experience is lower than expected and
thus income payments continue for longer than
expected. The guaranteed annuity book of
Discovery Life was insignificant at 30 June 2020.
Discovery Life does not offer any deferred
annuities where the annuity rate at a future
point in time is guaranteed for new entrants.
Investment products with insurance risk are not
directly impacted by mortality and morbidity
risks. The Annuity Integrator’s Ill-health booster
boosts retirement income on severe illness. The
Annuity Integrator’s Longevity booster boosts
retirement income every 10 years. The Life
Booster increases the investment fund value by
between 5% and 15% on death, depending on
Vitality status. The costs of the benefits were
allowed for in the product design and pricing of
the benefits.
The risks are managed through various
mechanisms:
PRODUCT DESIGN AND PRICING
Products are carefully designed to minimise
adverse selection. Rating factors are applied to
standard 	premium 	rates 	to 	differentiate
between different levels of risk. For example,
premiums 	are 	differentiated 	by 	income,
education level, smoker status, gender, medical
history and age.
– From January 2013 onwards, no
differentiation of premiums or benefits on
the basis of gender is allowed in the UK.
– Discovery Life has the unique ability to take
additional rating factors into account for
example the current medical scheme claims
and lifestyle factors.
All new premium rates are reviewed and
approved by either the Head of Actuarial Function
or Actuarial Committee. Product integration
between the different product offerings in
Discovery helps to attract healthier lives than
average in the market, leading to positive
selection. The product integration incentivises
engagement in the Vitality programme, which
has a positive impact on risk experience.
Selection risk is the risk that worse risks than
expected are attracted and these risks are then
charged inadequate premiums. Selection could
also lead to higher than expected mortality and
morbidity experience on individual life plans or
lower mortality on guaranteed annuity policies.
For certain of the product options offered under
the individual life plans, Discovery has retained
the option to review premium rates annually
throughout the life of the contract because of
uncertainties underlying the value of the
benefits offered. Only premiums that can be
predicted with confidence are guaranteed.
Where guarantees are offered, Discovery
guarantees that premiums can only be reviewed
every 10 years and increased by a maximum of
25% over and above contractual premium
increases. The guarantee provided to the
policyholder will, however, be strengthened
based on the policyholder’s actual annual
historic Vitality status.
Discovery Life predominantly operates in the
high end of the South African insurance market
where the risk of HIV/AIDS is lower than for the
South African market as a whole. The impact of
HIV/AIDS is considered and allowed for during
the product development and pricing.
2. 	MANAGEMENT OF INSURANCE RISK continued
40 Discovery Annual Financial Statements 2020

-- 38 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk –
Individual life plans and
investment products
with insurance risk
continued
UNDERWRITING
Underwriting ensures that only insurable risks
are accepted and that premiums reflect the
unique circumstances of each risk.
Financial underwriting is applied to ensure that
the policyholder can justify the amount of cover
applied for. Premium loadings and exclusions
are applied where high risks are identified.
For Integrated policies, Discovery Life can
dynamically adjust certain premiums using the
information from the health claims experience
of a policyholder who is also a member of the
Discovery Health Medical Scheme and Vitality.
This 	provides 	Discovery 	Life 	with 	an
advantageous position in the market.
Monthly internal quality assurance audits are
performed on underwriting to minimise the risk
of incorrect underwriting decisions.
REINSURANCE
Reinsurance protects against volatility in claims
experience and against an accumulation of risk.
Reinsurance is further utilised on a facultative
basis if uncertainty exists over the terms that
should be offered to a particular risk.
In addition, reinsurers provide specialist advice
when designing new products.
Discovery Life utilises surplus and facultative
reinsurance to reinsure amounts in excess of
defined retention levels. Discovery Life is thus
protected against large individual claims.
In addition, catastrophe reinsurance reduces
the risk of an accumulation of risk due to a
single event. Both individual life and group
business 	are 	covered 	by 	catastrophe
reinsurance which covers man-made or natural
catastrophe events.
For VitalityLife, the life, serious illness, disability
and income protection benefits are reinsured
with a maximum retention of GBP 150 000. The
unemployment benefit offered as part of the
VitalityLife product is fully reinsured.
EXPERIENCE MONITORING
Experience investigations are conducted and
corrective action is taken where adverse
experience is noted. Experience monitoring is
done on at least a quarterly basis, and in some
business lines monthly.
Where there is insufficient historic data to provide
credible results, such as VitalityLife, reliance is
placed on reinsurers’ advice, industry experience
as well as experience from Discovery Life.
2. 	MANAGEMENT OF INSURANCE RISK continued
41 Discovery Annual Financial Statements 2020

-- 39 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Risks significant to short-term insurance
Underwriting
experience risk
The risk is that claims experience turns out to be
worse than anticipated in the pricing of the
product and that claims reserves are insufficient
to meet insurance liabilities as they fall due.
The principal risk is that the frequency and/or
severity of claims are greater than expected.
Insurance events are, by their nature, random
and the actual number and size of events during
any one year may vary from those estimated
and experienced in prior periods.
Frequency of claims can vary depending on, for
instance, the levels of engagement with the
Vitality programme, and severity of claims can
be influenced by new treatments or changes in
medical inflation. In addition to renewal pricing
changes, 	standard 	terms 	and 	conditions
applicable to the company’s products mitigate
the risk of late reporting of claims.
GROUP LIFE
Group Life business is reviewed on a contract by
contract basis, with the review period never
exceeding two years. AIDS risk is specifically
allowed for in the pricing of individual groups.
Group business is underwritten on an employer
by employer basis and additional allowance is
made for the impact of industry class, income
and geographic location on expected claims
experience. The free cover limit is the sum
assured that will be given automatically to a
specific life without further specific underwriting.
The free cover limits are set separately for each
scheme depending on the size and cover chosen
by the specific scheme.
VITALITYHEALTH
New business is written in accordance with
approved pricing assumptions. Underwriting
criteria is defined and aligned to the approved
pricing assumptions.
VitalityHealth’s overall premium levels are
determined by its pricing, lapse experience as
well as the level of new business written.
VitalityHealth can manage the risk of new
business 	policies 	through 	the 	ability 	to
underwrite policies at inception or at the point
of claim. Aside from large corporate clients, all
other lives covered were underwritten through
either full medical underwriting, continuation of
previous exclusions (if the policy is moving from
another UK health insurer), or moratorium
conditions which limit claims for a specified
period relating to previous conditions.
VitalityHealth is able to manage the insurance
risk in existing business premiums through the
annual repricing of policies at renewal on a risk-
related basis; this is a key differentiator as to
why the UK market is less susceptible to volatility
from insurance risk. Whilst policyholders can
choose to cancel their contract mid-term
between renewals, this is not often experienced
in either the SME or corporate products.
Individual contracts can and do cancel between
renewals however retaining these policies is a
key activity for the business. VitalityHealth is
only obligated to continue to pay for any
authorised treatment whilst premiums are
being received from the policyholder.
2. 	MANAGEMENT OF INSURANCE RISK continued
42 Discovery Annual Financial Statements 2020

-- 40 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk
continued
DISCOVERY INSURE
Discovery Insure aims to manage risk through
diversifying the pool of insured risks by
establishing a balanced portfolio of insurance
risks over a wide geographical area. Short-term
insurance risks are priced on an individual basis,
therefore a minimal cross subsidy exists
between risks.
Premiums 	are 	calculated 	using 	statistical
regression techniques. Insurance risk factors
identified would typically include past insurance
history, type and value of asset covered,
measures taken to protect the asset, primary
use of covered item and various other pertinent
factors.
Discovery Insure’s quotation and administration
system calculates risk on an individual basis
based on information captured by brokers and
agents for each risk. Individual risks are
accepted automatically up to cut-off limits which
vary by risk type. Insurance conditions and
exclusions are also automatically set at an
individual risk level.
Individual risks greater than the limit are
automatically referred and underwritten by the
underwriting department. No risks are accepted
which exceed the upper limits of the reinsurance
contracts without the necessary facultative
cover being arranged.
Discovery Insure uses telematics to manage
risk. The telemetry received in respect of
vehicles in which the devices are installed,
highlights speeding, harsh breaking, harsh
cornering and other risk related incidents. By
informing the driver of how they are driving and
in turn rewarding them for driving well, the risk
of an accident is reduced. The ’deep install’
device is also equipped with a stolen vehicle
recovery 	transponder 	that 	increases 	the
probability of recovering a vehicle should it be
stolen.
REINSURANCE – VITALITYHEALTH
VitalityHealth 	currently 	utilises 	financial
reinsurance to better match the high upfront costs
of acquisition with the profit emergence across
the lifetime of the policies written. VitalityHealth
currently has quota share agreements in place
with three reinsurers with an outstanding balance
of GBP 175.8 million (R3 770 million) at year end
(2019: GBP 154.2 million (R2 773 million)).
2. 	MANAGEMENT OF INSURANCE RISK continued
43 Discovery Annual Financial Statements 2020

-- 41 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk
continued
REINSURANCE – DISCOVERY INSURE
Discovery Insure mitigates its insurance risk
through its reinsurance programme which is
structured to protect the company against
material losses to either a single insured risk, or
group of insured risks in the case of a
catastrophe where there would tend to be a
concentration of insured risks
Furthermore, Discovery Insure reinsures a
portion of the risk it underwrites to protect the
profitability and the capital of the company. A
variety of treaties are entered into in order to
limit losses resulting from individual and
collective insurance risks.
Additional facultative reinsurance is purchased
for certain individual risks that are in excess of
the relevant treaty limits. Discovery Insure only
enters into reinsurance arrangements with
reinsurers that have adequate credit ratings.
EXPERIENCE MONITORING
Across both premiums and claims, recent actual
experience 	is 	compared 	against 	financial
forecasts, with any deviations investigated. The
results provide a feedback loop into the overall
pricing approach, enabling Discovery to react
quickly to any changes in behaviour.
2.1 	Capital adequacy requirements and protection against adverse
experience
Refer to the Directors’ report for a breakdown of Statutory Capital Requirement cover ratios. Discovery manages its capital
requirements in line with the statutory requirements of the relevant Prudential Authorities. During the period Discovery met the
Statutory Capital Requirements.
2.1.1 Discovery Life
Discovery Life is required to demonstrate solvency to the Prudential Authority (PA) in accordance with the Insurance Act 18 of
2017. Discovery Life thus needs to maintain sufficient shareholder assets (Own Funds), over and above the assets required to
meet policyholder liabilities (best-estimate liabilities plus a prescribed risk margin), to support a multiple of the Solvency Capital
Requirement (SCR). Discovery Life is required to undertake an internal assessment of its risks and capital needs, in addition to
meeting the minimum capital requirements set by the PA. The SCR is calculated in accordance with the Prudential Standards as
issued by the PA. The SCR calculation is intended to approximate a risk-based capital measure and covers the major areas of
insurance risk. It explicitly covers the following key areas of risk to Discovery Life:
– Lapse and withdrawal risk
– Fluctuations in mortality and morbidity experience including catastrophe risk
– Interest rate risk
– Equity and property risk
– Expense risk
– Operational risk
– Spread and counterparty default risk
– Currency risk
– Concentration risk.
2. 	MANAGEMENT OF INSURANCE RISK continued
44 Discovery Annual Financial Statements 2020

-- 42 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.1 	Capital adequacy requirements and protection against adverse
experience continued
2.1.1 Discovery Life continued
Discovery Life regularly reviews the capital position and also considers various new business scenarios. Typically, a five-year new
business projection horizon is allowed for and the capital position is assessed at each valuation date during the projection to
ensure an acceptable capital cover is maintained.
Discovery Life has calculated its solvency position in accordance with the Insurance Act and related Prudential Standards since
30 June 2013. A consistent level of solvency cover, comfortably in excess of the statutory minimum, was observed at all
valuation dates.
2.1.2 VitalityLife
VitalityLife obtained its own life insurance license at the end of calendar year 2015. This significant milestone, together with the
implementation of Solvency II in the UK from 1 January 2016 required a change to the capital requirements of VitalityLife.
The business that was written on Prudential Assurance Company’s (PAC’s) life insurance license (up to 31 December 2015) will, as
per contractual agreement with PAC, still be valued under the Solvency I or old capital requirement rules described below until it
is transferred to the VLL license. After this date this business would need to be fully Solvency II compliant. The business written
on the own life insurance license within VitalityLife (from 1 January 2016) needs to be fully Solvency II compliant.
SOLVENCY I
The Financial Services Authority (FSA) was replaced by two distinct regulators in 2013 namely the Prudential Regulation Authority
(PRA) and the Finance Conduct Authority (FCA). The PRA is a part of the Bank of England and responsible for the prudential regulation
and supervision of insurers. It sets standards and supervises financial institutions. The FCA regulates the financial services industry
in the UK. Their aim is to protect consumers, ensure the industry remains stable and promote healthy competition between financial
services providers. The Prudential Sourcebook for Insurers (INSPRU) contains standards for capital management.
Capital requirements are calculated based on the concept of two pillars:
– Pillar 1, which covers public solvency information that appears within the regulatory returns on the basis of prescriptive rules.
This includes the statutory valuation of liabilities together with a prescribed measure of additional capital, the Long-Term
Insurance Capital Requirement (LTICR); and
– Pillar 2, the Individual Capital Assessment (ICA), which covers a confidential company-specific assessment of solvency. This
assessment is done on a realistic basis with the aim to protect against risks up to the 99.5 percentile over a one-year period.
The LTICR is a minimum required margin for solvency on the statutory valuation basis and covers the following basic risks:
– Mortality risk
– Expense risk
– Market risk
– Health risk.
The amount of capital that ultimately needs to be held by a life insurance company in the UK is the larger of the Pillar1 and Pillar2
result. VitalityLife is required to provide capital to the Prudential Assurance Company (PAC) equal to one times the Pillar1 capital
requirement. The cover requirements were observed at all valuation dates.
SOLVENCY II
Capital requirements under Solvency II are calculated using the regulations and guidance published by European Insurance and
Occupational Pensions Authority (EIOPA) and enforced by the PRA in the UK. A Solvency II balance sheet is calculated which has
several components:
– Best estimate liabilities (BEL): policyholder liabilities are calculated on a best estimate basis (excluding any margins) and
discounted at the latest swap curve published by EIOPA;
– Solvency Capital Requirement (SCR): 1-in-200 year stresses are applied to the BEL to stress the key risks and are combined
correlation matrices;
– Risk Margin (RM): 6% of the SCR run-off projected over time is discounted at the latest swap curve;
– Technical Provisions (TP): the sum of the BEL and the RM; and
– Own Funds: the net assets of the company needed to cover the SCR and other liquidity requirements; a negative TP can be
included in the sum of Own Funds to cover the SCR.
A consistent level of solvency cover was observed at all valuation dates.
45 Discovery Annual Financial Statements 2020

-- 43 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.1 	Capital adequacy requirements and protection against adverse
experience continued
2.1.3 VitalityHealth
VitalityHealth maintains shareholder capital to meet substantial deviations in experience and to support business growth.
The objective of the VitalityHealth’s capital management policy is to define the principles and guiding philosophy for capital
management that ensure capital and solvency levels are managed effectively in line with the defined risk appetites. The policy
and objectives are reviewed at least annually. Alongside ensuring the Company complies with capital requirements imposed by
its regulator (the PRA), the guiding principles for the policy are to:
– Foster an environment of regulatory compliance within the Company’s culture, strategy and decision making;
– Continually develop and enhance the Group’s regulatory compliance capability;
– Actively communicate the effectiveness and benefits of compliance management to all stakeholders; and
– To provide reasonable and independent assurance to the Company’s key management, board and regulator.
The Company is required to hold sufficient capital (measured in accordance with PRA valuation rules) to meet the PRA capital
requirements. The capital requirements were met at all valuation dates.
With effect from 1 January 2016 the insurance regulatory regime Solvency II was implemented in the UK. Refer to earlier in the
report for discussion on Solvency II. Under this solvency regime, firms have the opportunity to either follow the standard formula
approach, or apply to the regulators to move away from this. VitalityHealth follows a standard formula, and as such has a
Solvency Capital Requirement in line with that prescribed. Annually, the business publically discloses a Solvency and Financial
Condition Report (SFCR) alongside private disclosures to the regulators on its Own Risk and Solvency Assessment (ORSA). The
standard formula approach is also annually reviewed to determine its appropriateness for the business and as at 30 June 2020
the standard formula review determined it was not an inappropriate assessment of the risks present in VitalityHealth.
The actual and projected capital position of the Company is monitored on a regular basis through a number of forums and
governance committees including the Board of Directors as well as through VitalityHealth’s ORSA. In the event that sufficient
capital is not projected to be available, actions would be taken to obtain additional capital or to reduce the amount of risk
accepted and therefore reduce the capital requirement through, for example, reinsurance or investment strategy.
2.1.4 Discovery Insure
Similar to Discovery Life, Discovery Insure is required to demonstrate solvency to the Prudential Authority (PA) in accordance with
the Insurance Act 18 of 2017. Discovery Insure thus needs to maintain sufficient shareholder assets (Own Funds), over and above
the assets required to meet policyholder liabilities (best-estimate liabilities plus a prescribed risk margin), to support a multiple
of the Solvency Capital Requirement (SCR). In addition, Discovery Insure is required to undertake an internal assessment of its
risks and capital needs, in addition to meeting the minimum capital requirements set by the PA. The SCR is calculated in
accordance with the Prudential Standards as issued by the PA. The SCR calculation is intended to approximate a risk-based
capital measure and covers the major areas of short-term insurance risk. It explicitly covers the following key areas of risk to
Discovery Insure:
– Catastrophe risk
– Premium and reserve risk
– Lapse risk
– Interest rate risk
– Equity and property risk
– Expense risk
– Operational risk
– Spread and counterparty default risk
– Currency risk
– Concentration risk.
The internal assessment of risks and capital needs usually considers, amongst others, the following risks:
– Lapse risk not captured in the SCR
– New business volume risk
– Expense risk over and above ALAE risk
Discovery Insure regularly reviews the capital position and also considers various new business scenarios. Typically, a five-year
new business projection horizon is allowed for and the capital position is assessed at each financial year during the projection to
ensure an acceptable capital cover is maintained. The solvency cover was observed at all valuation dates.
46 Discovery Annual Financial Statements 2020

-- 44 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.2 	Liquidity risk
2.2.1 Contracts that are long-term in nature
DISCOVERY LIFE AND DISCOVERY INVEST
For Discovery Life and Discovery Invest, the discounted expected embedded value cash flows arising from in-force contracts after
policyholder liabilities have been met, net of tax, as at 30 June were as follows:
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2020
Discovery Life 	25 247 	1 424 	8 168 	6 093 	5 623 	3 939
Discovery Invest 	6 518 	612 	1 718 	2 112 	1 723 	353
2019
Discovery Life 	29 138 	2 755 	7 500 	6 861 	7 215 	4 808
Discovery Invest 	6 989 	656 	1 793 	2 130 	1 982 	428
The cash flows in the table above differ from those disclosed on notes 2.4.1 and 2.4.2 since the cash flows in the table above are
based on best estimate free cash flows after meeting policyholder liabilities, are discounted at the risk discount rate and are
capped at 40 years as per the Discovery Life and Discovery Invest embedded value methodology. Cash flows arising from
investment management contracts are also included. No allowance has been made for new business and related expenses.
VITALITYLIFE, INCLUDING VITALITYINVEST
VitalityLife maintains sufficient liquid assets to meet short-term liabilities and to allow for the initial cash flow strain when writing
new business. Currently, VitalityLife’s expected liabilities are mostly long-term and the main liquidity requirement is to fund
acquisition expenses on new business. The liquidity risk on the existing portfolio is thus relatively small.
2.2.2 Contracts that are short-term in nature
VITALITYHEALTH
VitalityHealth maintains sufficient liquid assets to meet short-term liabilities and to allow for the initial cash flow strain when
writing new business. Currently, VitalityHealth’s expected liabilities are mostly short-term and the main liquidity requirement is
to fund acquisition expenses on new business, with the existing book mature enough to generate sufficient liquidity to cover this
cash flow strain.
DISCOVERY INSURE
Discovery Insure holds the majority of working and solvency capital in cash or near cash instruments to minimise liquidity risk.
Large sums assured above a defined retention level are reinsured, providing stability in claims experience and further reducing
the liquidity risk. Catastrophe reinsurance further reduces this risk.
47 Discovery Annual Financial Statements 2020

-- 45 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.3 	Concentration risk
2.3.1 Claims experience risk
DISCOVERY LIFE
Discovery Life maintains a well-diversified portfolio of policies. Reinsurance is further used to protect against the concentration
of risk. Catastrophe reinsurance protects against the accumulation of claims from a single event, for example an airplane crash.
The catastrophe reinsurance for Discovery Life covers single event disasters for up to R830 million where the net of reinsurance
impact is greater than R42 million. For its biggest four group schemes, a further layer of catastrophe reinsurance cover of R3 250
million in excess of R872 million is in place.
Reinsurance removes the exposure to large individual claims. The following graph demonstrates that the distribution of policies
by sum assured is shifted towards lower sum assured due to the reinsurance cover. The profile is largely the same as the prior
period, although a shift towards higher sums assured due to annual benefit increases and inflationary impacts on new business
was observed as expected.
Small concentration (0 – 99 policies)
Medium concentration (100 – 999 policies)
Large concentration (1 000+ policies)
21%	24%
55%
API concentation by intermediary
0
40 000
60 000
80 000
100 000
0 – 0.5
Before reinsurance 	After reinsurance
20 000
	Number of Lives
>5.0	4.5 – 5.0	4.0 – 4.5	3.5 – 4.0	3.0 – 3.5	2.5 – 3.0	2.0 – 2.5	1.5 – 2.0	1 – 1.5	0.5 – 1.0
Distribution of Sums Retained: before and after reinsurance (Sum retained – Rm)
VITALITYLIFE
VitalityLife maintains a well-diversified portfolio of policies. Reinsurance removes the exposure to large individual claims. The
following graph demonstrates that the distribution of policies by sum assured is shifted towards lower sum assured due to the
reinsurance cover. The profile is largely the same as the prior period, although a shift towards higher sums assured due to annual
benefit increases and inflationary impacts on new business was observed as expected.
Reinsurance results in a reduction in exposure to
large individual sums-at-risk, leading to this transfer
from large to small case sizes.
0
200 000
250 000
300 000
350 000
0 – 25
Before reinsurance 	After reinsurance
150 000
100 000
50 000
Number of Lives
>250	225 – 250	200 – 225	175 – 200	150 – 175	125 – 150	100 – 125	75 –100	50 –75	25 – 50
Distribution of Sums Retained: before and after reinsurance (Sum retained – GBP’000)
48 Discovery Annual Financial Statements 2020

-- 46 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.3 	Concentration risk continued
2.3.1 Claims experience risk continued
VITALITYHEALTH
VitalityHealth has the risk of single large medical expense claims arising abroad, or multiple small travel claims due to a single
event which could cause losses. In order to manage these risks VitalityHealth holds a reinsurance policy specifically on travel
benefits which can help to cover the concentration risks from these events. The threshold for a potential claim on the reinsurance
for either of these reasons is GBP 250 000.
DISCOVERY INSURE
There is a risk that a concentration of risk can lead to a worse than expected claims experience. In order to manage this
concentration of insurance risk, Discovery has entered into a catastrophe excess of loss reinsurance treaty that would limit the
loss of the company to pre-determined levels following the occurrence of a localised catastrophe in this area.
Discovery Insure is exposed to a concentration of insurance risk in the Gauteng province in South Africa where 47.1% (2019:
48.5%) of the total sum insured is domiciled.
2.3.2 Withdrawal concentration risk
DISCOVERY LIFE AND VITALITYLIFE
There is a financial risk of the withdrawal of a block of policies written by a single independent intermediary. In order to manage
these risks. Discovery diversifies its book of business by source of new business and spread across its brokers and agents.
Brokers and agents
Maximum exposure to single
intermediary % of total premium
income
2020 	2019 	2020 	2019
Long term insurance
– Discovery Life 	7 683 	8 000 	2.1% 	1.2%
– VitalityLife 	28 580 	26 581 	3.1% 	1.56%
Small concentration (0 – 99 policies)
Medium concentration (100 – 999 policies)
Large concentration (1 000+ policies)
21%	24%
55%
API concentation by intermediary – Discovery Life
49 Discovery Annual Financial Statements 2020

-- 47 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching and market risk
2.4.1 Assets arising from insurance contracts
Assets under insurance contracts in the Statement of financial position include assets for Discovery Life, VitalityLife and
VitalityInvest. Reconciliation of the assets under insurance contracts disclosed in the cash flows below to the Statement of
financial position (refer to note 5):
R million 	2020 	2019
Assets arising from insurance contracts relating to:
– Discovery Life 	31 992 	33 873
– VitalityLife 	16 023 	14 908
– VItalityInvest 	27 	–
48 042 	48 781
Cash flows are calculated in accordance with the accounting policies. Contractual premium and benefit increases are recognised
in the cash flow projections.
The expected discounted future cash flows utilised in the calculation of assets arising from insurance contracts are disclosed in
the table below. Discounting is performed using:
– the prevailing risk-free SA gilt yield curve for Discovery Life; and
– a modified passive rate (2019: passive rates) for VitalityLife whereby the one-year average of the risk-free gilt yield is used. The
assumption is only changed if the one-year average changes by more than a predetermined range around the set passive rate.
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2020
Discovery Life 	31 992 	1 314 	9 225 	8 576 	7 738 	5 139
VitalityLife 	16 023 	4 346 	12 120 	7 880 	5 755 	(14 078)
2019
Discovery Life 	33 873 	2 687 	8 481 	8 345 	8 828 	5 532
50 Discovery Annual Financial Statements 2020

-- 48 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching risk continued
2.4.2 Liabilities arising from insurance contracts continued
Refer to page 57 for a breakdown of the assets backing these liabilities. A reconciliation of the liabilities arising from insurance
contracts disclosed in the cash flows below to the Statement of financial position (refer to note 18):
R million 	2020 	2019
Long-term insurance contract liabilities with fixed and guaranteed terms 	19 998 	14 697
Negative insurance liability included in unit-linked insurance contracts 	(4 894) 	(4 372)
Discovery Invest value of liabilities arising from insurance contracts 	15 104 	10 325
The expected discounted future cash flows in the calculation of liabilities arising from insurance contracts are disclosed in the
table below, allowing for compulsory and discretionary margins. Discounting is performed using the prevailing risk free SA gilt
yield curve.
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2020
Discovery Invest 	(15 104) 	(4 158) 	(13 790) 	1 447 	1 429 	(32)
2019
Discovery Invest 	(10 325) 	(2 713) 	(10 099) 	1 243 	1 281 	(37)
2.4.3 Market risk – Interest rate risk
DISCOVERY LIFE
For Discovery Life, increased nominal or real interest rates would result in an adverse impact on the present value of future
profits. Cash flows on a material segment of the book is linked to inflation. While this retains cash flows in real terms, this
segment is exposed to real interest rate movements. The balance of the book is exposed to changes in the nominal rates.
VITALITYLIFE
As a long-term insurance provider in the United Kingdom (UK), VitalityLife has significant exposure to long-term interest rate risk,
given the impact on reserves of lower investment rate assumptions related to fixed future premium receipts to meet policy
obligations. Accordingly, lower long-term interest rates and yield assumptions may negatively impact on the valuation of future
policy obligations and result in a valuation loss.
Interest rates in the UK have displayed significant volatility and have generally been on a downward trend in recent years. In the
financial year under review, VitalityLife implemented an interest rate risk mitigation strategy to protect itself against further
declines in interest rates by entering into derivative contracts. This strategy ensures that the VitalityLife business operates well
within its pre-determined risk appetite.
The derivative instruments comprise of:
– Two interest rate swaps, with a nominal value of GBP 350 million (R7 505 million) and GBP 90 million (R1 930 million)
respectively. These interest rate swap derivatives swap exposure to variable interest rates in return for a fixed interest rate
referenced to the 25-year UK swap rate as at 25 October 2019 (’reference swap rate 1’) and 10 June 2020 (’reference swap
rate 2’) respectively. Both interest rate swap derivatives are in place for an extended period of time; and
– Two put swap options (payer swaption) acquired during the period. Swaption one which was acquired at a premium of
GBP 6.2 million (R133 million) and was settled before year-end. Swaption two was acquired for GBP 12.3 million (R264 million)
and is valid until May 2023. These swaptions give Discovery the participation in the benefit should interest rates rise by more
than 0.45% above reference rate 1 and 0.88% above reference rate 2.
51 Discovery Annual Financial Statements 2020

-- 49 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching risk continued
2.4.3 Market risk – Interest rate risk continued
VITALITYLIFE continued
Due to the nature of the underlying exposures, the hedge accounting requirements of IFRS were not met. Therefore, these two
derivative instruments were classified at fair value with changes recognised in profit or loss throughout the term which may result
in volatility in the reported IFRS earnings of VitalityLife. As at 30 June 2020, the following mark-to-market positions were recorded:
Line item in financial statements 	June 2020
Statement of financial position
Interest rate swap valuation 	Financial assets: Derivative – financial instruments
at fair value through profit or loss 	GBP 44.3 million (R950 million)
Swaption valuation 	Financial assets: Derivative – financial instruments
at fair value through profit or loss 	GBP 0.1 million (R2 million)
Original premium 	GBP 18.5 million (R396 million)
Deferred payments 	(GBP 12.3 million) ((R264 million))
Fair value remeasurement 	(GBP 6.1 million) ((R120 million))
Income statement
Fair value remeasurement loss 	Net fair value gains/(losses) on financial assets at
fair value through profit or loss 	GBP 38.4 million (R758 million)
Transaction costs 	Marketing and administration expenses 	GBP 2.3 million (R45 million)
From an economic perspective, VitalityLife effectively fixed the reference swap rate as at 25 October 2019 (being 0.96%). In doing
so, VitalityLife limited its exposure to approximately GBP 43.7 million (R937 million) as a result of the valuation of specified future
policy obligations. This estimate excludes the cost of option premiums and ignores any potential basis risk.
DISCOVERY LIFE AND DISCOVERY INVEST
The outstanding claims and incurred but not reported claims are mostly short-term in nature and have consequently been
matched with cash. Reserves backing Income Continuation Benefits in payment are backed by a combination of cash, money
market, gilts and negative rand reserves of appropriate duration.
The risk arising from the Global Linkage Benefit is fully reinsured and Discovery does not face any net direct market risk.
For Discovery Invest, guaranteed return plan liabilities are backed by a combination of negative rand reserves and bonds of
appropriate duration. As maturity approaches, cash flows from negative reserves are invested in bonds and therefore a
reinvestment risk exists. Furthermore, investment policy fee income is dependent on the underlying value of policyholders’
investments, which may be interest rate sensitive.
2.4.4 Market Risk – Currency risk
All of VitalityLife’s insurance benefits and premiums are Sterling denominated as all business is sold in the UK market. A significant
part of operational expenses are Rand denominated as systems and administration are based in South Africa. This creates a
potential mismatching risk.
Other insurance business lines do not have significant currency risk.
52 Discovery Annual Financial Statements 2020

-- 50 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.5 	Sensitivity analysis
The financial impact of the key risks that Discovery is exposed to can be demonstrated by considering the sensitivity of the
financial results to a hypothetical change in the underlying assumptions or prevailing market conditions.
Although the sensitivities demonstrate the impact of a change in assumption, the results generally cannot be extrapolated to
demonstrate the impact on future earnings and earnings forecasts.
For each sensitivity illustrated, all other assumptions have been left unchanged. No allowance has been made for any management
action, for example premium increases, to react to the worse-than-expected experience.
The ranges of sensitivity were chosen for illustration purposes and do not represent the extremes of possible experience. The
sensitivities shown under insurance risks consider a change in the long-term assumption used in the projection model.
The following sensitivities are provided under insurance risk:
❚ 	Lapses: The lapse, surrender and withdrawal rates are increased or decreased across all policies and investment plans.
❚ 	Long-term investment return and inflation: A parallel shift is assumed in the yield curve. The investment return, inflation,
renewal expense inflation and inflation-linked premium increases are adjusted consistently.
❚ 	Renewal expenses: Renewal expense per policy is increased or decreased across all policies and investment plans.
❚ 	Mortality and morbidity: The mortality rate, disability rate and severe illness rates are increased and decreased across all
policies and investment plans.
2.5.1 Discovery Life
Gross exposure 	Net of reinsurance
Assets under
insurance
contracts
R million
Change
from base
assumption
%
Assets under
insurance
contracts
R million
Change
from base
assumption
%
Base: June 2020 assumptions 	31 992 	28 819
Lapses +10% (e.g. from x% to 1.1x%) 	28 583 	(10.7) 	25 572 	(11.3)
Lapses –10% (e.g. from x% to 0.9x%) 	36 092 	12.8 	32 744 	13.6
Investment return and inflation –1% (e.g. from 5% to 4%) 	33 050 	3.3 	29 801 	3.4
Investment return and inflation +1% (e.g. from 5% to 6%) 	30 857 	(3.5) 	27 762 	(3.7)
Expense assumption +10% 	31 505 	(1.5) 	28 332 	(1.7)
Expense assumption –10% 	32 479 	1.5 	29 306 	1.7
Mortality and morbidity +10% 	25 932 	(18.9) 	24 124 	(16.3)
Mortality and morbidity –10% 	38 244 	19.5 	33 712 	17.0
Real curve –1% and inflation +1% 	33 816 	5.7 	30 399 	5.5
Real curve +1% and inflaton –1% 	30 360 	(5.1) 	27 407 	(4.9)
Base: June 2019 assumptions 	33 873 	30 061
Lapses +10% (e.g. from x% to 1.1x%) 	30 008 	(11.4) 	26 378 	(12.3)
Lapses –10% (e.g. from x% to 0.9x%) 	38 557 	13.8 	34 547 	14.9
Investment return and inflation –1% (e.g. from 5% to 4%) 	35 033 	3.4 	31 111 	3.5
Investment return and inflation +1% (e.g. from 5% to 6%) 	32 759 	(3.3) 	29 039 	(3.4)
Expense assumption +10% 	33 375 	(1.5) 	29 563 	(1.7)
Expense assumption –10% 	34 371 	1.5 	30 559 	1.7
Mortality and morbidity +10% 	27 373 	(19.2) 	25 041 	(16.7)
Mortality and morbidity –10% 	40 602 	19.9 	35 312 	17.5
Real curve –1% and inflation +1% 	36 032 	6.4 	31 928 	6.2
Real curve +1% and inflaton –1% 	32 089 	(5.3) 	28 522 	(5.1)
Liabilities arising from insurance contracts consist of outstanding reported claims, IBNR claims and long-term liabilities relating
to fixed and guaranteed contracts and unit-linked contracts. For outstanding reported claims and IBNR claims any deviation from
the best estimate liabilities would have a direct impact on profit.
The above sensitivities reflect the impact on profit or loss if there not discretionary margins.
53 Discovery Annual Financial Statements 2020

-- 51 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.5 	Sensitivity analysis continued
2.5.1 Discovery Life continued
For long-term insurance liabilities relating to fixed and guaranteed contracts and unit-linked contracts (refer to reconciliation on
note 2.4.2), the sensitivities are detailed in the table below:
Liabilities
under
insurance
contracts
R million
Change
from base
assumption
%
Base: June 2020 assumptions 	15 104
Lapses +10% (e.g. from x% to 1.1x%) 	15 225 	0.8
Lapses –10% (e.g. from x% to 0.9x%) 	15 028 	(0.5)
Investment return and inflation –1% (e.g. from 5% to 4%) 	15 680 	3.8
Investment return and inflation +1% (e.g. from 5% to 6%) 	14 554 	(3.6)
Expense assumption +10% 	15 199 	0.6
Expense assumption –10% 	15 008 	(0.6)
Mortality and morbidity +10% 	15 133 	0.2
Mortality and morbidity –10% 	15 073 	(0.2)
Real curve –1% and inflation +1% 	15 000 	(0.7)
Real curve +1% and inflaton –1% 	15 230 	0.8
Base: June 2019 assumptions 	10 325
Lapses +10% (e.g. from x% to 1.1x%) 	10 346 	0.2
Lapses –10% (e.g. from x% to 0.9x%) 	10 361 	0.3
Investment return and inflation –1% (e.g. from 5% to 4%) 	10 792 	4.5
Investment return and inflation +1% (e.g. from 5% to 6%) 	9 880 	(4.3)
Expense assumption +10% 	10 423 	0.9
Expense assumption –10% 	10 225 	(1.0)
Mortality and morbidity +10% 	10 353 	0.3
Mortality and morbidity –10% 	10 295 	(0.3)
Real curve –1% and inflation +1% 	10 464 	1.4
Real curve +1% and inflaton –1% 	10 210 	(1.1)
2.5.2 VitalityLife – assets arising from insurance contracts
Gross exposure 	Net of Reinsurance
Assets
arising from
insurance
contracts
R million
Change
from base
assumption
%
Assets
arising from
insurance
contracts
R million
Change
from base
assumption
%
Base: June 2020 assumptions 	16 023 	8 153
Lapses +10% (e.g. from x% to 1.1x%) 	15 667 	(2.2) 	7 992 	(2.0)
Lapses –10% (e.g. from x% to 0.9x%) 	16 380 	2.2 	8 321 	2.1
Investment return and inflation –1% (e.g. from 5% to 4%) 	13 440 	(16.1) 	5 284 	(35.2)
Investment return and inflation +1% (e.g. from 5% to 6%) 	17 587 	9.8 	9 987 	22.5
Expense assumption +10% 	15 767 	(1.6) 	7 897 	(3.1)
Expense assumption –10% 	16 279 	1.6 	8 409 	3.1
Mortality and morbidity +10% 	13 939 	(13.0) 	7 277 	(10.7)
Mortality and morbidity –10% 	18 115 	13.1 	8 987 	10.2
Real curve -1% and inflation +1% 	17 487 	9.1 	9 959 	22.2
Real curve +1% and inflaton –1% 	13 344 	(16.7) 	5 088 	(37.6)
Base: June 2019 assumptions 	14 908 	9 347
Lapses +10% (e.g. from x% to 1.1x%) 	14 464 	(3.0) 	9 019 	(3.5)
Lapses –10% (e.g. from x% to 0.9x%) 	15 387 	3.2 	9 704 	3.8
Investment return and inflation –1% (e.g. from 5% to 4%) 	13 545 	(9.1) 	7 794 	(16.6)
Investment return and inflation +1% (e.g. from 5% to 6%) 	15 729 	5.5 	10 345 	10.7
Expense assumption +10% 	14 726 	(1.2) 	9 166 	(1.9)
Expense assumption –10% 	15 096 	1.3 	9 536 	2.0
Mortality and morbidity +10% 	13 523 	(9.3) 	8 643 	(7.5)
Mortality and morbidity –10% 	16 307 	9.4 	10 048 	7.5
Real curve –1% and inflation +1% 	15 608 	4.7 	10 267 	9.8
Real curve +1% and inflaton –1% 	13 564 	(9.0) 	7 758 	(17.0)
The above sensitivities reflect the impact on profit or loss if there not discretionary margins.
54 Discovery Annual Financial Statements 2020

-- 52 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
2. 	MANAGEMENT OF INSURANCE RISK continued
2.5 	Sensitivity analysis continued
2.5.3 VitalityHealth – IBNR Reserves
VitalityHealth’s reserves are set based on traditional actuarial chain ladder models. The chain ladder models assume that there
is stability in the delays from treatment date to payment date (therefore future payments can be estimated using historical
experience). Within the monthly reserving process, adjustments to the model results are made where evidence arises that there
are changes in development patterns.
The Reserving Committee considers both the model results and other business indicators when setting the actual reserves and
it is attended by colleagues from across the relevant business areas including operational, clinical and risk specialists.
The IBNR is GBP 27.7 million (R497 million) at 30 June 2020 (2019: GBP 26.7 million (R485 million)), which approximates 1.2 months’
worth of claims – which is the expected delay in claims reporting discussed above. Claims provisions at 30 June 2020 includes a
supplier settlement and disputed claims provision reflecting the probability weighted settlement of supplier invoices and claims
in dispute. The total of such provisions is GBP 1.5 million (R27 million) (2019: GBP 3 million (R54 million)).
VitalityHealth’s IBNR reserves are sensitive to changes in the business’s invoice processing speeds – which has seen significantly
improved stability over the most recent two years. Currently the IBNR is set as an 80th percentile reserve in recognition of the
volatility in the reserving environment. A 50th and 95th percentile reserve would result in the following:
Million
2020
Rands
2019
Rands
2020
GBP
2019
GBP
Base case 	603 	497 	28.1 	27.7
Lower bound 	493 	445 	23.0 	24.8
Upper bound 	658 	551 	29.3 	30.7
2.5.4 INSURE – IBNR Reserves
Insure’s IBNR reserves are set based on the Bornhuetter-Ferguson model – a reserving model widely used in the short-term
insurance industry. As with other traditional chain ladder models, the model assumes stability in the reporting and settlement
delays and an expected loss ratio to arrive at a view of ultimate claims. In contrast, the OCR is set predominantly by claims assessors.
The claims reserve for the personal lines business – made up of both the IBNR and OCR reserves – is R295 million at 30 June 2020
(2019: R280 million). Sensitivity tests were performed with the results on the outlined below. Currently the IBNR reserve is set at the
71st percentile level. Given the OCR is not probabilistic in nature, the sensitivity tests are performed purely on the IBNR reserve.
Million
2020
Rands
2019
Rands
Base case (71st percentile) 	295.0 	280.3
50th percentile 	261.0 	273.6
95th percentile 	355.0 	292.2
55 Discovery Annual Financial Statements 2020

-- 53 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK
Discovery’s activities expose it to a variety of financial risks. Financial risks include market risk, credit risk and liquidity risk.
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
prices and investment return. Market risk that could impact on future cash flows and hence the value of a financial instrument
arises from:
❚ 	Equity price risk: The impact of changes in equity prices and dividend income.
❚ 	Interest rate risk: The impact of changes in market interest rates.
❚ 	Currency risk: The impact of changes in foreign exchange rates.
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge
an obligation.
Liquidity risk is the risk that Discovery will encounter difficulty in meeting obligations associated with financial liabilities due to
insufficient cash being available to meet commitments as and when they become due.
Financial risks are managed by Discovery as follows:
❚ 	Discovery has appointed reputable external asset managers to manage its investments;
❚ 	The Actuarial Committee reviews the overall matching of shareholder and policyholder assets to their respective liabilities;
❚ 	The Capital, Currency and Investment Committee (CCIC) is a sub-committee of the Group Executive Committee and meets
quarterly to focus on shareholder assets and the performance of asset managers responsible for managing these assets. The
CCIC also sets exposure limits for exposures to individual counterparties;
❚ 	Discovery periodically engages external consultants to review past investment decisions; and
❚ 	The Investment Committee is a sub-committee of the CCIC and meets monthly to make operational decisions regarding
Discovery’s liquidity and foreign currency exposure.
Discovery has not significantly changed the processes used to manage its financial risks from previous periods.
To assist in the analysis of the financial risks that Discovery and its policyholders are exposed to, the Statement of financial
position has been divided into five categories, based on the nature of the products provided by Discovery and the nature of the
financial assets held to back the policyholder liabilities. Annexure F lists the contracts that Discovery offers and the category they
are included in for financial risk disclosure.
❚ 	Unit-linked investment contracts: this category relates to contracts issued by Discovery where there is a direct relationship
between the returns earned on the underlying portfolio and the returns credited to the contract. Discovery holds the assets
on which the unit prices are based and as a result there is no mismatch. The market risk (including equity price, interest rate
and currency risk) as well as the credit risk for these contracts is therefore borne by the policyholder and not the Discovery
shareholders.
❚ 	Unit-linked insurance contracts: this category relates to insurance contracts issued by Discovery which have a component
that is linked to the units of an underlying portfolio. For this component, Discovery holds the assets on which the unit prices
are based. However, the gross unit liabilities are reduced by the present value of future charges less the present value of
future expenses and risk claims. The unit-linked component is not accounted for separately from the host insurance contract.
These contracts expose both Discovery shareholders and policyholders to financial risks.
❚ 	Insurance contracts: this category relates to insurance contracts issued by Discovery which Discovery funds with a portfolio
of matching assets, exposing the Discovery shareholders to financial risk. The financial assets in this category include those
financial assets held within specific portfolios matched to specific liabilities, for example claims reserves and claims incurred
but not reported (IBNR).
❚ 	Shareholder financial assets and liabilities: this category includes the financial assets and financial liabilities that expose
the Discovery shareholders to financial risks, including financial assets and cash backing insurance reserves and statutory
capital. This category includes those financial assets that are not held in specific portfolios matched to insurance related
liabilities.
❚ 	Shareholder non-financial assets and liabilities: No financial risk disclosures are required for these items.
56 Discovery Annual Financial Statements 2020

-- 54 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
The following tables reconcile the Group Statement of financial position to the classes of risks and the categories listed on the
previous page. The look-through basis has been applied to investments in mutual funds to assist in the identification of Discovery’s
financial risks and will not agree to the investment disclosure in note 12.
Group
R million
Shareholder
Total
Unit-linked
investment
contracts
Unit-linked
insurance
contracts
Insurance
contracts 1
Financial
assets and
liabilities
Other
assets and
liabilities
30 June 2020
Assets arising from insurance contracts 	48 042 	– 	– 	48 042 	– 	–
Financial instruments mandatorily at
fair value through profit or loss:
Listed:
– Equity securities 	44 748 	13 638 	30 563 	258 	289 	–
– Equity linked notes 	639 	103 	513 	1 	22 	–
– Debt securities 	35 886 	5 872 	12 840 	15 370 	1 804 	–
– Inflation linked securities 	1 896 	– 	428 	1 466 	2 	–
– Money market securities 	8 984 	1 286 	3 281 	63 	4 354 	–
Unlisted:
– Equity securities 	208 	11 	165 	– 	32 	–
– Equity linked notes 	1 785 	35 	1 739 	– 	11 	–
– Debt securities 	23 	3 	8 	12 	– 	–
– Inflation linked securities 	20 	– 	20 	– 	– 	–
– Money market securities 	8 525 	1 381 	2 923 	3 080 	1 141 	–
At amortised cost:
Unlisted:
– Debt 	439 	– 	– 	– 	439 	–
– Fixed deposits 	2 084 	– 	– 	– 	2 084 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	14 	– 	– 	– 	14 	–
– not designated as hedging
instruments 	1 356 	– 	– 	– 	1 356 	–
Receivables:
– Insurance receivables 	6 179 	– 	– 	– 	6 179 	–
– Contract receivables 	1 413 	– 	– 	– 	1 413 	–
– Other receivables 	3 844 	420 	806 	15 	1 522 	1 081
Loans and advances 	1 848 	– 	– 	– 	1 848 	–
Reinsurance contracts 	400 	– 	– 	400 	– 	–
Cash and cash equivalents 	17 909 	483 	2 014 	5 	15 407 	–
Other assets 	24 086 	– 	854 	– 	– 	23 232
Total assets 	210 328 	23 232 	56 154 	68 712 	37 917 	24 313
Liabilities arising from insurance
contracts 	82 411 	– 	49 783 	32 628 	– 	–
Liabilities arising from reinsurance
contracts 	12 465 	– 	– 	12 465 	– 	–
Borrowings at amortised cost 	19 836 	– 	– 	– 	19 836 	–
Investment contracts at fair value
through profit or loss 	23 012 	23 012 	– 	– 	– 	–
Derivative financial instruments at fair
value:
– used as cash flow hedges 	854 	– 	– 	– 	854 	–
– not designated as hedging
instruments 	138 	1 	2 	– 	135 	–
Other payables at amortised cost 	14 233 	219 	621 	315 	12 778 	300
Customer deposits 	2 427 	– 	– 	– 	2 427 	–
Other liabilities 	10 399 	– 	– 	– 	– 	10 399
Total liabilities 	165 775 	23 232 	50 406 	45 408 	36 030 	10 699
57 Discovery Annual Financial Statements 2020

-- 55 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
Shareholder
Group
R million 	Total
Unit-linked
investment
contracts
Unit-linked
insurance
contracts
Insurance
contracts
Financial
assets and
liabilities
Other
assets and
liabilities
30 June 2019
Assets arising from insurance contracts 	48 781 	– 	– 	48 781 	– 	–
Financial instruments mandatorily at
fair value through profit or loss:
Listed:
– Equity securities 	42 290 	13 462 	28 068 	148 	612 	–
– Equity linked notes 	2 066 	135 	1 910 	– 	21 	–
– Debt securities 	25 942 	3 478 	10 128 	10 224 	2 112 	–
– Inflation linked securities 	1 222 	47 	176 	998 	1 	–
– Money market securities 	4 276 	452 	1 678 	31 	2 115 	–
Unlisted:
– Equity securities 	1 052 	327 	697 	8 	20 	–
– Equity linked notes 	1 062 	47 	995 	1 	19 	–
– Debt securities 	177 	49 	125 	– 	3 	–
– Inflation linked securities 	28 	– 	28 	– 	– 	–
– Money market securities 	12 090 	1 933 	4 024 	3 988 	2 145 	–
At amortised cost:
Unlisted:
– Debt 	26 	– 	– 	– 	26 	–
– Fixed deposits 	1 917 	– 	– 	– 	1 917 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	176 	– 	– 	– 	176 	–
– not designated as hedging
instruments 	199 	4 	14 	– 	181 	–
Receivables:
– Insurance receivables 	4 920 	– 	– 	– 	4 920 	–
– Contract receivables 	1 369 	– 	– 	– 	1 369 	–
– Other receivables 	2 726 	219 	478 	2 	1 178 	849
Reinsurance contracts 	314 	– 	– 	314 	– 	–
Cash and cash equivalents 	9 403 	691 	2 053 	7 	6 652 	–
Other assets 	20 197 	– 	728 	– 	– 	19 469
Total assets 	180 233 	20 844 	51 102 	64 502 	23 467 	20 318
Liabilities arising from insurance
contracts 	70 522 	– 	45 448 	25 074 	– 	–
Liabilities arising from reinsurance
contracts 	10 835 	– 	– 	10 835 	– 	–
Borrowings at amortised cost 	14 682 	– 	– 	– 	14 682 	–
Investment contracts at fair value
through profit or loss 	20 674 	20 674 	– 	– 	– 	–
Derivative financial instruments at fair
value:
– used as cash flow hedges 	250 	– 	– 	– 	250 	–
– not designated as hedging
instruments 	259 	4 	11 	– 	244 	–
Other payables at amortised cost 	10 262 	166 	543 	189 	9 222 	142
Other liabilities 	9 666 	– 	– 	– 	– 	9 666
Total liabilities 	137 150 	20 844 	46 002 	36 098 	24 398 	9 808
58 Discovery Annual Financial Statements 2020

-- 56 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
The financial risks associated with each category are discussed below.
3.1 	Unit-linked investment contracts
Unit-linked investment contracts relate to contracts where there is a direct relationship between the returns earned on the
underlying portfolio and the returns credited to the contract. The market risk (including equity price, interest rate and currency
risk) for these contacts are therefore borne by the policyholder. Discovery holds the assets on which the unit prices are based
and as a result there is no mismatch.
Group
R million
June
2020
June
2019
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity securities 	13 638 	13 462
– Equity linked notes 	103 	135
– Debt securities 	5 872 	3 478
– Inflation linked securities 	– 	47
– Money market securities 	1 286 	452
Unlisted:
– Equity securities 	11 	327
– Equity linked notes 	35 	47
– Debt securities 	3 	49
– Money market securities 	1 381 	1 933
Derivative financial instruments at fair value:
– not designated as hedging instruments 	– 	4
Receivables:
– Other receivables 	420 	219
Cash and cash equivalents 	483 	691
Total assets 	23 232 	20 844
Investment contracts at fair value through profit or loss 	23 012 	20 674
Derivative financial instruments at fair value:
– not designated as hedging instruments 	1 	4
Other payables at amortised cost 	219 	166
Total liabilities 	23 232 	20 844
3.1.1 Market risk
Discovery’s primary exposure to market risk from these contracts is the volatility in asset management fees earned by Discovery,
due to the impact of interest rate, equity price and currency movements on the fair value of the assets held in the linked funds,
on which the investment management fees are based. A decrease of 10% in the value of the assets would reduce the asset
management fees by R45 million per annum (2019: R43 million).
In respect of IFRS-defined investment management contracts there may be an associated asset for the costs of obtaining
contracts. There is a risk that in the event of adverse market movements, future expected management fees may reduce and
consequently this asset may not be realised and therefore necessitate impairment. There were no impairments necessary in the
current or previous financial year.
59 Discovery Annual Financial Statements 2020

-- 57 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.1 	Unit-linked investment contracts continued
3.1.2 Credit risk
Credit risk is borne by the policyholder. For the majority of the unit-linked investments, Discovery has invested in mutual funds
in order to provide for obligations under unit-linked investment contract liabilities. Each mutual fund has its own legal constitution
and operates within a mandate that is delegated to the appointed fund manager. Credit risks assumed within the assets held are
controlled by various protection mechanisms within the mandate and in law. For example, the Collective Investment Schemes
Control Act of 2002, in South Africa prescribes maximum limits to concentration risk exposures. Each fund’s trustees or board
appoints administrators who are responsible to ensure that the fund’s mandate and any internal and legislated control
procedures are adhered to. In the event of breach they are obligated to bring it immediately to the attention of the fund’s trustees
or board and management of the administrators for remedial action.
In the case where unit-linked investment contracts are linked to structured products, Discovery’s policy dictates that these obligations
are matched exactly. At inception of these contracts, assets which have proceeds that exactly match the pay-out under the policy,
with the exception of credit risk, are purchased. Credit risk on these products is therefore also borne by the policyholder.
3.1.3 Liquidity risk
Certain contracts can be surrendered before maturity for a cash surrender value specified in the contractual terms and conditions.
This surrender value is equal to or less than the carrying amount of the contract liabilities. If all the contracts with this option were
surrendered at the financial year-end, a loss of R533 million (2019: R447 million) would have been recorded in profit or loss. This
loss would result from an impairment to the asset raised for costs of obtaining contracts, but the impact is reduced by the
surrender penalties receivable. A maturity analysis based on the earliest contractual repayment date would present 100% (2019:
100%) of the policyholder liabilities due within one year. The assets held to match these policyholder liabilities are realisable in
the short-term.
3.2 	Unit-linked insurance contracts
A unit-linked insurance contract is an IFRS-defined insurance contract with a component that is linked to the units of an underlying
portfolio. For this component, Discovery holds the assets on which the unit prices are based. However, the gross unit liabilities are
reduced by the present value of future charges less the present value of future expenses and risk claims. Some market risk is
therefore retained on these contracts. The unit-linked component is not accounted for separately from the host insurance contract.
Investments held at risk of
investment policyholders
Group
R million
June
2020
June
2019
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity securities 	30 563 	28 068
– Equity linked notes 	513 	1 910
– Debt securities 	12 840 	10 128
– Inflation linked securities 	428 	176
– Money market securities 	3 281 	1 678
Unlisted:
– Equity securities 	165 	697
– Equity linked notes 	1 739 	995
– Debt securities 	8 	125
– Inflation linked securities 	20 	28
– Money market securities 	2 923 	4 024
Derivative financial instruments at fair value:
– not designated as hedging instruments 	– 	14
Receivables:
– Other receivables 	806 	478
Cash and cash equivalents 	2 014 	2 053
Other assets 	854 	728
Total assets 	56 154 	51 102
Liabilities arising from insurance contracts 	49 783 	45 448
Borrowings at amortised cost 	–
Derivative financial instruments at fair value:
– not designated as hedging instruments 	2 	11
Other payables at amortised cost 	621 	543
Total liabilities 	50 406 	46 002
60 Discovery Annual Financial Statements 2020

-- 58 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.2 	Unit-linked insurance contracts continued
The assets are greater than the liabilities as a result of the Negative insurance liability of R4 894 million (2019: R4 372 million)
included in unit-linked insurance contracts (refer to note 18) and the deferred tax asset of R854 million (2019: R728 million) in
relation to the Individual Policyholder Fund.
3.2.1 Market risk
Discovery’s primary exposure to market risk from these contracts is the volatility in asset management fees due to the impact of
interest rate, equity price and currency movements on the fair value of the assets held in the linked funds, on which the investment
management fees are based. A decrease of 10% in the value of the assets would reduce the asset management fees by
R111 million per annum (2019: R109 million).
3.2.2 Credit risk
Credit risk is borne by the policyholder. For the majority of the unit-linked investments, Discovery has invested in mutual funds
in order to provide for obligations under unit-linked insurance contract liabilities. Each mutual fund has its own legal constitution
and operates within a mandate that is delegated to the appointed fund manager. Credit risks assumed within the assets held are
controlled by various protection mechanisms within the mandate and in law. For example, the Collective Investment Schemes
Control Act of 2002, in South Africa prescribes maximum limits to concentration risk exposures. Each fund’s trustees or board
appoints administrators who are responsible to ensure that the fund’s mandate and any internal and legislated control
procedures are adhered to. In the event of breach they are obligated to bring it immediately to the attention of the fund’s trustees
or board and management of the administrators for remedial action.
In the case where unit-linked insurance contracts are linked to structured products, Discovery’s policy dictates that these
obligations are matched exactly. At inception of these contracts, assets which have proceeds that exactly match the pay-out
under the policy, with the exception of credit risk, are purchased. Credit risk on these products is therefore also borne by the
policyholder.
3.2.3 Liquidity risk
All contracts can be surrendered before maturity for a cash surrender value specified in the contractual terms and conditions.
This surrender value is equal to or less than the carrying amount of the contract liabilities. If all the contracts with this option were
surrendered at the financial year-end, a loss of R5 175 million (2019: R4 481 million) would have been recorded in profit or loss.
This loss results from the impairment of assets arising from insurance contracts relating to these contracts, but the impact is
reduced by the surrender penalties receivable.
A maturity analysis based on the earliest contractual repayment date would present R54 433 million (2019: R48 780 million) of
the liabilities as due on the earliest period of the table (between 0 and one year), R23 million (2019: R38 million) of the liabilities
would be due between one and two years, and R190 million (2019: R155 million) of the liabilities would be due between three and
five years. The assets held to match these policyholder liabilities are very liquid.
61 Discovery Annual Financial Statements 2020

-- 59 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.3 	Insurance contracts
For insurance contracts, Discovery funds the insurance liabilities with a portfolio of matching assets.
Group
R million
June
2020
June
2019
Assets arising from insurance contracts 	48 042 	48 781
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity securities 	258 	148
– Equity linked notes 	1 	–
– Debt securities 	15 370 	10 224
– Inflation linked securities 	1 466 	998
– Money market securities 	63 	31
Unlisted:
– Equity securities 	– 	8
– Equity linked notes 	– 	1
– Debt securities 	12 	–
– Money market securities 	3 080 	3 988
Receivables:
– Other receivables 	15 	2
Reinsurance contracts 	400 	314
Cash and cash equivalents 	5 	7
Total assets 	68 712 	64 502
Liabilities arising from insurance contracts 	32 628 	25 074
Liabilities arising from reinsurance contracts 	12 465 	10 835
Other payables at amortised cost 	315 	189
Total liabilities 	45 408 	36 098
3.3.1 Market risk
When calculating the liabilities arising from insurance contracts, an increase/decrease in the investments would result in an
increase/decrease in the liability but it may not be an equal Rand value movement, resulting in the difference being accrued to
the shareholders. Discovery aims to closely match liabilities with appropriate assets and maintains sufficient assets to protect
against residual mismatches between assets and liabilities at a 99.5% confidence interval over a one-year time horizon.
3.3.2 Credit risk
Discovery is exposed to credit risk through financial investments comprising money market and debt instruments entered into
to match policyholders’ insurance contract liabilities. Discovery is exposed to the issuer’s credit standing on these instruments
which is monitored by the CCIC by setting a minimum credit rating. Discovery has appointed reputable asset managers to manage
these instruments. Information regarding the aggregated credit risk exposure for debt and money market instruments
categorised by Moody’s credit ratings is provided below. Refer to www.moodys.com for rating definitions.
62 Discovery Annual Financial Statements 2020

-- 60 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.3 	Insurance contracts continued
3.3.2 Credit risk continued
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1
A2
A3
Baa1
Baa2
Baa3 	Govt1
Not
rated
30 June 2020
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Equity securities 	258 	– 	– 	– 	– 	– 	258
– Equity linked notes 	1 	– 	– 	– 	– 	– 	1
– Debt securities 	15 370 	718 	69 	8 	– 	14 554 	21
– Inflation linked securities 	1 466 	245 	176 	– 	– 	1 045 	–
– Money market securities 	63 	– 	38 	25 	– 	– 	–
Unlisted:
– Debt securities 	12 	12 	– 	– 	– 	– 	–
– Money market securities 	3 080 	1 811 	782 	481 	– 	– 	6
Cash and cash equivalents 	5 	4 	1 	– 	– 	– 	–
20 255 	2 790 	1 066 	514 	– 	15 599 	286
30 June 2019
Financial instruments at fair value
through profit or loss:
Listed:
– Equity securities 	148 	– 	– 	– 	– 	– 	148
– Debt securities 	10 224 	54 	145 	4 	– 	10 020 	1
– Inflation linked securities 	998 	– 	20 	– 	– 	978 	–
– Money market securities 	31 	– 	18 	10 	– 	– 	3
Unlisted:
– Equity securities 	8 	– 	– 	– 	– 	– 	8
– Equity linked notes 	1 	– 	– 	– 	– 	– 	1
– Money market securities 	3 988 	50 	1 137 	2 346 	406 	– 	49
– Cash and cash equivalents 	7 	1 	6 	– 	– 	– 	–
15 405 	105 	1 326 	2 360 	406 	10 998 	210
1 These instruments are held in the South African government.
3.3.3 Liquidity risk
The liquidity risk for assets and liabilities arising from insurance contracts are discussed in insurance risks on pages 36 and 37.
The financial investments held at fair value through profit or loss are realisable in the short term.
63 Discovery Annual Financial Statements 2020

-- 61 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities
The shareholders are exposed to financial risk through the following financial assets and liabilities:
Investments held at risk of
shareholders
Group
R million
June
2020
June
2019
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity securities 	289 	612
– Equity linked notes 	22 	21
– Debt securities 	1 804 	2 112
– Inflation linked securities 	2 	1
– Money market securities 	4 354 	2 115
Unlisted:
– Equity securities 	32 	20
– Equity linked notes 	11 	19
– Debt securities 	– 	3
– Money market securities 	1 141 	2 145
At amortised cost:
Unlisted:
– Debt 	439 	26
– Fixed deposits 	2 084 	1 917
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	176
– not designated as hedging instruments 	1 356 	181
Receivables:
– Insurance receivables 	6 179 	4 920
– Contract receivables 	1 413 	1 369
– Other receivables 	1 522 	1 178
Loans and advances 	1 848 	–
Cash and cash equivalents 	15 407 	6 652
Total assets 	37 917 	23 467
Borrowings at amortised cost 	19 836 	14 682
Derivative financial instruments at fair value:
– used as cash flow hedges 	854 	250
– not designated as hedging instruments 	135 	244
Customer deposits 	2 427 	–
Other payables at amortised cost 	12 778 	9 222
Total liabilities 	36 030 	24 398
64 Discovery Annual Financial Statements 2020

-- 62 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.1 Market risk
EQUITY PRICE RISK
INVESTMENTS
Discovery is exposed to equity price risk because of investments held by the Group which have been classified as investments at
fair value through profit or loss (FVTPL), on the Statement of financial position. To manage its equity risk arising from investments
in equity securities and equity linked notes of R311 million (2019: R633 million), the Group diversifies its portfolio and uses
experienced asset managers.
For shareholder investments, a 10% increase in the equity markets would result in a profit of R9 million before tax (2019:
R63 million). A 10% decrease in the equity markets would result in a loss of R9 million before tax (2019: R5 million). This impact
would be recognised in the Income statement. The sensitivity is based on the assumption that the equity markets had increased/
decreased by 10% with all other variables held constant.
HEDGE DERIVATIVE INSTRUMENTS
Discovery is also exposed to equity price risk through its cash-settled share incentive schemes, namely the Phantom share
scheme and the Acquisition share scheme, the details of which are described in note 31. This liability has been included in Other
payables at amortised cost in the table in note 3.4. To manage this risk, Discovery has purchased a combination of total return
equity swaps (TRS) and call options from Ba2 – Baa3 (2019: Baa or A-rated) South African banks to hedge a portion of its exposure
to changes in the Discovery share price.
Hedge ineffectiveness for TRS and call options can arise from:
– differences between the strike price/initial price per the derivative contract and the Discovery spot price on hedge designation
date;
– difference due to the fixed funding element inherent in TRS which does not exist in the hedged item (IFRS 2);
– differences between the dividend yield for the call options and the option contracts; and
– day one profit or loss on the derivative.
The Group sets the hedging ratio by matching the notional of the designated hedged items to the notional amount of the
corresponding total return equity swaps or call options used as the hedging instruments, after applying expected forfeiture rates
to each vesting. The hedge ratio is 1:1. The hedge accounting relationship is reviewed on a monthly basis and the hedging
instruments and hedged items are de-designated, if necessary, based on the effectiveness test results and changes in the hedged
exposure. The Group hedges the hedged item in its entirety against equity price risk as opposed to just a component of this risk.
Discovery hedges circa 90% of its exposure for those hedges is substantively matching the critical terms of the hedging instrument
and hedged item (such as the settlement dates, maturity dates, notional amounts).
65 Discovery Annual Financial Statements 2020

-- 63 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.1 Market risk continued
I. PHANTOM SHARE SCHEME (INCLUDING CERTAIN OTHER DEVELOPMENT SEGMENT SCHEMES)
As at 30 June 2020, approximately 100% (2019: 92%) of this exposure is hedged. The hedges were designed to be highly
effective, where the critical terms of the hedge or return swaps substantially match that of the phantom share scheme on
a per instrument basis. Combinations of total return, total return equity swaps and call options were designated on a unit
for unit basis to substantially match the terms of the phantom share and call option units.
When these hedges are entered into, they are designated as the hedge of a highly probable forecast transaction and
accounted for as a cash flow hedge.
The cash-settled call options held by the Group at 30 June were:
Maturity date
Strike
price
Number of
call options
2020
Year end June 2021 	110.40 – 141.65 	754 076
Year end June 2022 	110.40 – 141.65 	272 942
Year end June 2023 	141.65 	170 827
2019
Year end June 2020 	97.89 – 141.65 	1 330 267
Year end June 2021 	110.40 – 141.65 	754 076
Year end June 2022 	110.40 – 141.65 	272 942
Year end June 2023 	141.65 	170 827
The notional value of the outstanding cash-settled call options held by the Group at 30 June 2020 was R161 million (2019:
R319 million).
The fair value of the call options is repriced at each reporting date and was calculated on a Black-Scholes model using the
same assumptions as tabled in note 33.
The total return equity swaps held by the Group at 30 June were:
Maturity date
Reference
price
Number of
total return
equity swaps
2020
Year end June 2021 	114.96 – 173.59 	2 058 914
Year end June 2022 	114.96 – 173.59 	1 655 491
Year end June 2023 	141.65 – 173.59 	1 085 365
Year end June 2024 	147.04 – 173.59 	499 954
2019
Year end June 2020 	97.89 – 171.04 	1 727 832
Year end June 2021 	114.96 – 173.59 	1 941 355
Year end June 2022 	129.13 – 173.59 	1 641 637
Year end June 2023 	141.65 – 173.59 	1 071 511
Year end June 2024 	173.59 	486 100
The notional value of the outstanding total TRS held by the Group at 30 June 2020 was R791 million (2019: R990 million).
The fair value of the TRS is calculated by discounting the future cash flows of the instruments.
66 Discovery Annual Financial Statements 2020

-- 64 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
II. ACQUISITION SHARE SCHEME
As at 30 June 2020, approximately 98% (2019: 89%) of this exposure is hedged. The hedges were designed to be highly
effective, where the terms of the hedge or total return equity swaps substantially match that of the acquisition share
scheme on a per instrument basis.
When these hedges are entered into, they are designated as the hedge of a highly probable forecast transaction and
accounted for as a cash flow hedge.
The total return equity swaps held by the Group at 30 June were:
Maturity date
Reference
price
Number of
total return
equity swaps
2020
Year ended June 2021 	118.31 – 150.38 	618 591
Year ended June 2022 	129.00 – 150.51 	698 716
Year ended June 2023 	147.50 – 150.51 	579 914
Year ended June 2024 	150.38 – 150.51 	119 956
Year ended June 2025 	150.51 	97 818
2019
Year ended June 2020 	118.31 – 150.38 	620 348
Year ended June 2021 	118.31 – 150.38 	618 591
Year ended June 2022 	129.00 – 150.38 	592 267
Year ended June 2023 	147.50 – 150.38 	78 422
Year ended June 2024 	150.38 	19 261
The notional value of the outstanding total return equity swaps held by the Group at 30 June 2020 was R324 million
(2019: R270 million). The fair value of the total return equity swaps is calculated by discounting the future cash flows of the
instruments.
At 30 June 2020, the fair value of the derivative instruments purchased to hedge the Phantom and Acquisition share schemes, is
R324 million (2019: R90 million) (refer to note 13). To reduce the credit risk exposure from the hedge derivative instruments
purchased, Discovery has entered into collateral agreements with the relevant financial institutions to post cash collateral
periodically, equal to the fair value of the derivatives.
Discovery does not hold any cash collateral at 30 June 2020 (2019: R285 million) (refer to note 22). A total of R407 million cash
collateral is being held by counterparty banks (refer to note 14) at 30 June 2020. The posting of the collateral does not result in
legal settlement of the outstanding derivative balance. The collateral will only be used to settle the derivative upon default or
bankruptcy of either party. The offsetting requirements of IAS 32 are therefore not met.
Discovery recognises the effective portion of fair value changes of derivatives that are designated and qualify as cash flow hedges
and prove to be highly effective in relation to the hedged risk, in the cash flow hedging reserve in the Statement of other
comprehensive income. The gain or loss relating to the ineffective portion is recognised immediately in profit or loss. A loss of
R13 million (2019: R5 million gain) was recognised in profit or loss during the current year as a result of ineffectiveness. This amount
has been included under ’Net fair value gains on financial assets at fair value through profit or loss’, in the Income statement (refer to
note 27).
The movement in the hedging reserve relating to the Phantom and Acquisition share schemes, is summarised in the table below:
Group
R million
June
2020
June
2019
Balance at beginning of the year 	– 	(57)
Unrealised losses accumulated in equity 	(409) 	(33)
Tax on unrealised losses 	59 	7
Recycled to profit or loss during the current year1 	309 	104
Tax on recycled gains 	(46) 	(21)
Balance at end of the year 	(87) 	–
1 Presented in ’Marketing and administration expenses’ and ’Acquisition costs’.
67 Discovery Annual Financial Statements 2020

-- 65 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
June
2020
June
2019
Recycled to profit or loss within one year 	(12) 	(2)
Recycled to profit or loss within two to five years 	(75) 	3
(87) 	1
INTEREST RATE RISK
Sensitivity to changes in interest rates is relevant to financial assets and financial liabilities bearing floating interest rates due to
the risk that future cash flows will fluctuate. However, sensitivity will also be relevant to fixed-rated financial assets and financial
liabilities that are re-measured to fair value. The table below details the specific interest rate risk that the Group is exposed to:
Group
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
June 2020
Financial instruments mandatorily at fair value through
profit or loss:
Listed:
– Equity securities 	289 	– 	– 	289
– Equity linked notes 	22 	– 	– 	22
– Debt securities 	1 804 	1 264 	529 	11
– Inflation linked securities 	2 	2 	– 	–
– Money market securities 	4 354 	2 337 	1 991 	26
Unlisted:
– Equity securities 	32 	– 	– 	32
– Equity linked notes 	11 	– 	– 	11
– Money market securities 	1 141 	330 	755 	56
At amortised cost:
Unlisted:
– Debt 	439 	439 	– 	–
– Fixed deposits 	2 084 	246 	1 838 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	14 	– 	–
– not designated as hedging instruments 	1 356 	– 	1 093 	263
Receivables
– Insurance receivables 	6 179 	23 	– 	6 156
– Contract receivables 	1 413 	– 	39 	1 374
– Other receivables 	1 522 	29 	620 	873
Loans and advances 	1 848 	– 	1 848 	–
Cash and cash equivalents 	15 407 	1 308 	13 924 	175
Total financial assets 	37 917 	5 992 	22 637 	9 288
Borrowings at amortised cost 	19 836 	10 172 	9 664 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	854 	853 	– 	1
– not designated as hedging instruments 	135 	41 	5 	89
Customer deposits 	2 427 	599 	– 	1 828
Other payables at amortised cost 	12 778 	158 	7 405 	5 215
Total financial liabilities 	36 030 	11 823 	17 074 	7 133
68 Discovery Annual Financial Statements 2020

-- 66 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Group
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
30 June 2019
Financial instruments mandatorily at fair value through
profit or loss:
Listed:
– Equity securities 	612 	– 	– 	612
– Equity linked notes 	21 	– 	– 	21
– Debt securities 	2 112 	1 878 	234 	–
– Inflation linked securities 	1 	– 	1 	–
– Money market securities 	2 115 	1 098 	1 017 	–
Unlisted:
– Equity securities 	20 	– 	– 	20
– Equity linked notes 	19 	– 	– 	19
– Debt securities 	3 	1 	1 	1
– Money market securities 	2 145 	627 	1 448 	70
At amortised cost:
Unlisted:
– Debt 	26 	26 	– 	–
– Fixed deposits 	1 917 	230 	1 687 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	176 	166 	– 	10
– not designated as hedging instruments 	181 	144 	– 	37
Receivables:
– Insurance receivables 	4 920 	72 	– 	4 848
– Contract receivables 	1 369 	127 	– 	1 242
– Other receivables 	1 178 	27 	206 	945
Cash and cash equivalents 	6 652 	1 454 	5 195 	3
Total financial assets 	23 467 	5 850 	9 789 	7 828
Borrowings at amortised cost 	14 682 	8 414 	6 268 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	250 	244 	– 	6
– not designated as hedging instruments 	244 	5 	– 	239
Other payables at amortised cost 	9 222 	58 	3 728 	5 436
Total financial liabilities 	24 398 	8 721 	9 996 	5 681
INVESTMENTS
For shareholder investments, a 1% increase in the local interest rate would result in an increase of R7 million of investment
income from these investments (2019: R59 million). A 1% decrease in the local interest rate would result in a decrease of R5 million
of investment income from these investments (2019: R55 million). The sensitivity is based on the assumption that the interest
rate had increased/decreased by 1% with all other variables held constant.
BORROWINGS AT AMORTISED COST AND RELATED HEDGES
Discovery is exposed to interest rate risk through long-term borrowings held with various financial institutions.
2020 	2019
Group
R million 	Ref
Carrying
value
Facility
value
Carrying
value
Facility
value
Interest rate risk from borrowings from banks
Fixed rate loan facility 	i 	5 792 	5 796 	4 818 	4 850
Floating interest rate facility with floating-to-fixed
interest rate swap 	ii 	4 536 	4 500 	3 844 	3 825
Floating interest rate facilities 	iii 	1 630 	1 500 	760 	675
Foreign floating interest rate facilities 	iii 	3 498 	4 460 	1 612 	2 697
Total bank borrowings (refer to note 20) 	15 456 	16 256 	11 034 	12 047
69 Discovery Annual Financial Statements 2020

-- 67 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
i. The fixed rate loan facilities have the following profiles, with interest payable quarterly in arrears other than footnote 2:
Interest rate per annum 	Maturity date
Capital
repayment
Facility value
2020
Facility value
2019
Fixed at 10.94% 	10 June 2021 	Maturity 	– 	500
Fixed at 10.59% 	10 June 2021 	Annually 	– 	1 100
Fixed at 10.20% 	17 March 2020 	Maturity 	– 	800
Fixed at 10.23% 	16 May 20200 	Maturity 	– 	200
Fixed at a weighted average rate of 11.56% 	Various maturities 	Instalments 	596 	650
Fixed at 10.46%1 	21 November 2024 	Maturity 	200 	200
Fixed at 10.60% 	20 December 2023 	Maturity 	1 400 	1 400
Fixed at 9.62% 	22 February 2025 	Maturity 	2 500 	–
Fixed at 8.92% 	10 March 2023 	Maturity 	1 100 	–
Total fixed rate loan facilities 30 June 	5 796 	4 850
1 Interest is payable semi-annually in arrears.
ii. During prior years and in the current financial year, Discovery entered into long-term borrowing facilities at a floating interest
rate, which exposes Discovery to cash flow interest rate risk. This risk has been managed by using floating-to-fixed interest
rate swaps. These interest rate swaps have the economic effect of converting the borrowings from floating to fixed rates.
Interest is payable quarterly in arrears, with capital repayable on maturity. The hedge ratio is 1:1.
Hedge ineffectiveness for interest rate swaps can arise from:
– day one fair value of the swap,
– events leading to mismatch in terms.
The fair value movement of the notional cash flow interest rate hedge accumulated in equity is as follows:
Group
R million 	2020 	2019
Balance at beginning of the year 	173 	56
Unrealised losses accumulated in equity 	353 	124
Tax on unrealised losses 	– 	–
Recycled to profit or loss during the current year1 	(10) 	(7)
Tax on recycled gains 	– 	–
Balance at end of the year 	516 	173
The cash flow hedge will be recycled to profit or loss as follows:
Recycled to profit or loss within one year 	– 	7
Recycled to profit or loss within two to five years 	377 	75
Recycled to profit or loss within six to ten years 	139 	91
516 	173
1 Disclosed as finance costs in profit or loss.
70 Discovery Annual Financial Statements 2020

-- 68 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
The interest rate swaps held by the Group at 30 June were:
Group
R million
2020 	2019
Nominal
value
Fair value
liability
Nominal
value
Fair value
liability
Maturity date:
30 September 2021 	– 	– 	375 	(10)
15 December 2021 	– 	– 	450 	(11)
21 November 2022 	500 	(47) 	500 	(19)
2 March 2023 	1 000 	(99) 	1 000 	(32)
21 November 2024 	800 	(110) 	800 	(46)
21 November 2024 	1 200 	(121) 	– 	–
21 August 2026 	700 	(107) 	700 	(45)
21 August 2026 	300 	(32) 	– 	–
4 500 	(516) 	3 825 	(163)
Also see Group note 20 for further details.
iii. Discovery has long-term borrowings at floating rates in the UK and South Africa. The floating rate is managed by aligning the
interest rate exposure to the underlying operational assets for which these borrowings have been raised. The interest rates
earned on the underlying operational assets are at a higher margin.
NON-HEDGE DERIVATIVE FINANCIAL INSTRUMENTS
I. INTEREST RATE SWAP
As a long term insurance provider in the United Kingdom (UK), VitalityLife has significant exposure to long-term interest rate
risk, given the impact on reserves of lower investment rate assumptions related to fixed future premium receipts to meet
policy obligations. Accordingly, lower long-term interest rates and yield assumptions may negatively impact on the valuation
of future policy obligations and result in a valuation loss. Refer to note 2.4.3 for details of the interest rate mitigation strategy
implemented.
In addition to the above, VitalityLife has an exposure to the ’FTSE Actuaries UK Conventional Gilts over 15 Year Index (“the
index”) as a result of products underwritten by the Prudential Assurance Company on behalf of VitalityLife. In order to
economically hedge the Vitality UK group’s exposure to the index, Discovery Holdings Europe Limited (DHEL) has been party
to a number of over-the-counter total return interest rate swap derivatives during the financial year. These derivatives provide
DHEL with the capital depreciation/appreciation and coupon payments on a basket of Gilts designed to closely match that of
the index in return for a payment of fixed interest to the counterparty.
At 30 June 2020 DHEL is party to one (2019: one) open derivative contract. The fixed interest payable is 0.99% (2019: 1.03%)
on a notional derivative value of GBP 279.8 million (2019: GBP 184.5 million). At 30 June 2020 the fair value of the derivative
was an asset of GBP 6.5 million (R139 million) (2019 GBP 8 million (R144 million)).
Although the instrument reduces the exposure to the volatility of the index, the derivative instrument does not qualify for
hedge accounting. Accordingly, the derivative has been classified as a financial asset or liability carried at fair value through
profit or loss. The fair value adjustment of GBP 6.5 million (R128.4 million) has been recognised in ‘Net fair value gains on
financial assets at fair value through profit or loss’. (2019: GBP 7 million (R128.2 million)). The current open derivative contract
expires on 30 September 2020.
II. DERIVATIVE INSTRUMENTS USED BY DISCOVERY’S ASSET MANAGERS
Discovery’s asset managers use derivative instruments as mandated to limit or reduce risk. The majority of derivatives are
exchange traded (SAFEX or Yield-X). Exchange traded derivatives are settled daily by reducing exposures (and hence credit
risk) to zero at the end of each day. Discovery also has interest rate swap agreements and the value of exposure towards these
parties was calculated by taking into consideration the ISDA agreements in place which allow for netting off between positive
and negative exposures.
71 Discovery Annual Financial Statements 2020

-- 69 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
The table below details the Group’s total derivative exposure:
Group
R million
Notional
amount
Fair value
asset
Fair value
liability
June 2020
Interest rate contracts:
– fixed for floating swaps 	– 	– 	–
– floating for fixed swaps 	70 	– 	5
70 	– 	5
June 2019
Interest rate contracts:
– fixed for floating swaps 	– 	* 	*
– floating for fixed swaps 	(3 825) 	– 	*
(3 825) 	* 	*
* Amount is less than R500 000.
CURRENCY RISK
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and recognised
assets and liabilities. The following table segregates the currency exposure by major currency:
Group
R million 	Total 	Rand
GBP in UK
subsidiary
GBP
other
USD in US
subsidiary
USD
other
Other
currencies
30 June 2020
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Equity securities 	289 	49 	3 	25 	– 	181 	31
– Equity linked notes 	22 	21 	– 	– 	– 	– 	1
– Debt securities 	1 804 	617 	1 174 	– 	– 	3 	10
– Inflation linked securities 	2 	– 	2 	– 	– 	– 	–
– Money market securities 	4 354 	754 	3 596 	– 	– 	4 	–
Unlisted:
– Equity securities 	32 	21 	– 	– 	– 	11 	–
– Equity linked notes 	11 	11 	– 	– 	– 	– 	–
– Money market securities 	1 141 	1 141 	– 	– 	– 	– 	–
At amortised cost:
Unlisted:
– Debt 	439 	439 	– 	– 	– 	– 	–
– Fixed deposits 	2 084 	1 864 	220 	– 	– 	– 	–
Derivative financial instruments
at fair value:
– used as cash flow hedges 	14 	14 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	1 356 	252 	1 092 	– 	– 	12 	–
Receivables
– Insurance receivables 	6 179 	1 810 	4 333 	– 	– 	36 	–
– Contract receivables 	1 413 	758 	– 	– 	456 	1 	198
– Other receivables 	1 522 	1 377 	140 	– 	1 	– 	4
Loans and advances 	1 848 	1 848 	– 	– 	– 	– 	–
Cash and cash equivalents 	15 407 	4 941 	9 426 	193 	455 	339 	53
Total financial assets 	37 917 	15 917 	19 986 	218 	912 	587 	297
Borrowings at amortised cost 	19 836 	15 920 	3 905 	– 	11 	– 	–
Derivative financial instruments
at fair value:
– used as cash flow hedges 	854 	854 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	135 	135 	– 	– 	– 	– 	–
Customer deposits 	2 427 	2 427 	– 	– 	– 	– 	–
Other payables at amortised cost 	12 778 	2 578 	9 835 	6 	253 	68 	38
Total financial liabilities 	36 030 	21 914 	13 740 	6 	264 	68 	38
A 10% increase or decrease in the respective foreign exchange rates of USD, GBP and EUR would result in additional gains of
R179 million, or in the case of decrease, a loss of R179 million, recognised in profit or loss.
72 Discovery Annual Financial Statements 2020

-- 70 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Group
R million 	Total 	Rand
GBP in UK
subsidiary
GBP
other
USD in US
subsidiary
USD
other
Other
currencies
30 June 2019
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Equity securities 	612 	291 	42 	22 	– 	195 	62
– Equity linked notes 	21 	21 	– 	– 	– 	– 	–
– Debt securities 	2 112 	1 007 	1 099 	– 	– 	6 	–
– Inflation linked securities 	1 	1 	– 	– 	– 	– 	–
– Money market securities 	2 115 	495 	1 620 	– 	– 	– 	–
Unlisted:
– Equity securities 	20 	8 	– 	2 	– 	10 	–
– Equity linked notes 	19 	19 	– 	– 	– 	– 	–
– Debt securities 	3 	2 	– 	1 	– 	– 	–
– Money market securities 	2 145 	2 132 	– 	2 	– 	10 	1
At amortised cost:
Listed:
– Debt 	– 	– 	– 	– 	– 	– 	–
Unlisted:
– Debt 	26 	26 	– 	– 	– 	– 	–
– Fixed deposits 	1 917 	1 735 	182 	– 	– 	– 	–
Derivative financial instruments
at fair value:
– used as cash flow hedges 	176 	176 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	181 	37 	144 	– 	– 	– 	–
Receivables:
– Insurance receivables 	4 920 	1 860 	3 043 	– 	– 	17 	–
– Contract receivables 	1 369 	828 	– 	20 	381 	5 	135
– Other receivables 	1 178 	1 047 	83 	– 	8 	14 	26
Cash and cash equivalents 	6 652 	2 236 	3 554 	69 	493 	246 	54
Total financial assets 	23 467 	11 921 	9 767 	116 	882 	503 	278
Borrowings at amortised cost 	14 682 	13 065 	1 617 	– 	– 	– 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	250 	250 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	244 	244 	– 	– 	– 	– 	–
Other payables at amortised cost 	9 222 	2 804 	6 057 	20 	120 	215 	6
Total financial liabilities 	24 398 	16 363 	7 674 	20 	120 	215 	6
Financial assets and financial liabilities in respect of the Group’s US and UK subsidiaries are accounted for in their functional
currency. Foreign currency movements will be recognised in the foreign currency translation reserve.
The exchange rates at year-end are detailed in the table below (quoted as Rand per foreign currency):
USD 	GBP
30 June 2020 	17.41 	21.44
30 June 2019 	14.15 	17.98
73 Discovery Annual Financial Statements 2020

-- 71 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
INVESTMENTS
Discovery has offshore assets in its investment portfolios. These offshore investments are made for the purpose of seeking
international diversification. There is a risk to future earnings that the value of these assets reduces due to a strengthening in the
Rand. Performance of foreign currency assets is benchmarked against the MSCI World Index, an international index that represents
large and mid-capitalisation companies across 23 developed market countries. Refer to www.msci.com for further detail.
CURRENCY DERIVATIVE CONTRACTS
To manage its foreign exchange risk arising from future commercial transactions, Discovery enters into various currency
derivative contracts. Discovery entered into these contracts with third party banks which have short term rated risk of P-2 and
P-1, as rated by Moody’s. The fair value of these contracts have been included in financial assets and liabilities. (Refer to note 13).
Discovery entered into these agreements as an economic hedge against foreign currency risk for expenses to be paid in the
future. These transactions are not designated as hedges and as a result gains and losses are recognised in profit and loss. The
amount recognised in profit or loss for the current year was a gain of R284 million (2019: R162 million), with a corresponding
derivative asset and liability of R263 million and R6 million respectively. (2019: Derivative asset R35 million and derivative liability
R64 million). The notional value of these contracts are GBP 118.65, USD 39.4million and EUR 7.9 million (2019: GBP 123.2 million
and USD 1.5million).
Currency risk for FEC contracts are determined with reference to the designated pricing (settlement) currency of each respective
contract. The pricing currency is usually the functional currency of the entity taking out the contract. For the purposes of currency
risk, Discovery discloses FEC contracts using the pricing currency.
BORROWINGS
Discovery has long-term borrowings in the UK, which exposes the Group to currency risks. These risks are managed by aligning
the currency exposure to the underlying operational assets for which these borrowings have been raised. The currency risk is
mitigated as the cash flows emerging from the underlying assets are in the same currency (GBP) as the interest and capital
payments.
3.4.2 Credit risk
Key areas where Discovery is exposed to credit risk are:
❚ 	Financial investments comprising money market and debt instruments entered into to invest surplus shareholder
funds: Discovery is exposed to the issuer’s credit standing on these instruments which is monitored by the CCIC by setting a
minimum credit rating and maximum exposures per issuer. Discovery has appointed reputable asset managers to manage
these instruments. Information regarding the aggregated credit risk exposure for debt and money market instruments
categorised by credit ratings is provided below.
❚ 	Cash and cash equivalents: This risk is managed by monitoring exposure to external financial institutions against approved
limits per institution. Credit ratings are provided below.
❚ 	Certain accounts within the Statement of financial position category of ’Insurance receivables, contract receivables
and other non-financial receivables’.
❚ 	Reinsurance assets comprising receivables raised for expected recoveries on projected claims (Discovery’s liability as
primary insurer is not discharged) and amounts due from reinsurers in respect of claims already paid: This risk is
limited as risk premiums are paid monthly to reinsurers and claims can be offset against risk premiums. Further, it is expected
that there will be little build-up of actuarial liability on the reinsurers’ side. The risk thus mainly arises following a period of
higher than expected claims. Credit ratings of reinsurers are taken into account in reinsurance placement decisions. Credit
exposure to reinsurers is also limited through the use of several reinsurers. Reinsurance is placed with reputable international
companies directly or through their national offices. The reinsurance companies used by Discovery are rated A or higher by
A.M.Best, a rating agency with an exclusive insurance industry focus. Refer to www.ambest.com for further detail.
74 Discovery Annual Financial Statements 2020

-- 72 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
CREDIT EXPOSURE FOR DEBT INSTRUMENTS, MONEY MARKET INSTRUMENTS AND CASH AND
CASH EQUIVALENTS
The following table provides information regarding the aggregated credit risk exposure for debt instruments, money market
instruments and cash and cash equivalents, categorised by Moody’s credit ratings.
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1
A2
A3
Baa1
Baa2
Baa3
Ba1
Ba2
Ba3 	Govt1
Not
rated
30 June 2020
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Equity securities 	289 	– 	9 	– 	– 	– 	– 	280
– Equity linked notes 	22 	– 	1 	– 	– 	– 	– 	21
– Debt securities 	1 804 	171 	453 	428 	700 	– 	52 	–
– Inflation linked securities 	2 	– 	2 	– 	– 	– 	– 	–
– Money market securities 	4 354 	34 	1 546 	942 	1 762 	– 	68 	2
Unlisted:
– Equity securities 	32 	– 	1 	– 	– 	– 	– 	31
– Equity linked notes 	11 	– 	– 	– 	– 	– 	– 	11
– Money market securities 	1 141 	30 	1 064 	5 	– 	– 	42 	–
At amortised cost:
Unlisted:
– Debt 	439 	– 	– 	– 	– 	– 	439 	–
– Fixed deposits 	2 084 	– 	220 	– 	1 619 	245 	– 	–
Cash and cash equivalents 	15 407 	657 	10 816 	459 	301 	2 223 	781 	170
25 585 	892 	14 112 	1 834 	4 382 	2 468 	1 382 	515
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1
A2
A3
Baa1
Baa2
Baa3
Ba1
Ba2
Ba3 	Govt
Not
rated
30 June 2019
Financial instruments mandatorily at fair
value through profit or loss:
Listed:
– Equity securities 	612 	86 	– 	27 	– 	121 	– 	378
– Equity linked notes 	21 	– 	– 	– 	– 	– 	– 	21
– Debt securities 	2 112 	108 	304 	475 	499 	– 	726 	–
– Inflation linked securities 	1 	1 	– 	– 	– 	– 	– 	–
– Money market securities 	2 115 	59 	151 	1 064 	770 	55 	6 	10
Unlisted:
– Equity securities 	20 	– 	– 	– 	– 	– 	– 	20
– Equity linked notes 	19 	– 	– 	– 	– 	– 	– 	19
– Debt securities 	3 	– 	1 	1 	– 	– 	– 	1
– Money market securities 	2 145 	88 	1 574 	356 	– 	72 	7 	48
At amortised cost:
Unlisted:
– Debt 	26 	– 	– 	– 	– 	– 	26 	–
– Fixed deposits 	1 917 	– 	– 	182 	1 505 	230 	– 	–
Cash and cash equivalents 	6 652 	46 	3 322 	390 	1 242 	708 	21 	924
15 643 	388 	5 352 	2 495 	4 016 	1 186 	785 	1 421
1 These instruments are held in the South African government.
Financial instruments included in cash and cash equivalents, fixed deposits and treasury bills have high credit quality based on
the rating of counterparties and/or have relatively short term maturities. Impairment based on the expected credit loss approach
was assessed and considered immaterial. There are no amounts within these balances which are credit impaired or where there
has been a significant increase in credit risk since initial recognition.
75 Discovery Annual Financial Statements 2020

-- 73 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
CREDIT RISK RELATING TO RECEIVABLES
The table below summarises Discovery’s shareholder insurance receivables, contract receivables and other receivables, at
30 June. This table only relates to shareholder’s credit exposure and will therefore not agree to note 14. Refer to tables provided
on page 57 and 58.
Group
R million 	Ref
June
2020
June
2019
Receivables arising from insurance and reinsurance contracts:
– Premium debtors 	i 	692 	558
– Less provision for impairment of premium debtors 	(93) 	(83)
– Reinsurance debtors 	ii 	5 580 	4 445
Contract receivables:
– Closed scheme debtors 	iii 	103 	100
– Discovery Health Medical Scheme 	iii 	650 	670
– Other contract receivables 	709 	599
– Less allowance for expected credit losses 	(49) 	–
Other loans and receivables:
– Agents and brokers 	iv 	491 	390
– BEE partners' rights-issue funding 	19 	17
– Cash-in-transit debtors 	5 	4
– Discovery Unit Trust debtors 	1 	8
– Expired hedge receivables 	– 	24
– FNB – DiscoveryCard receivable 	52 	70
– Loans to BEE initiatives 	214 	165
– Security deposit on derivatives1 	407 	39
– Vitality partner debtors 	116 	76
– Other debtors 	653 	728
– Less provision for impairment of financial other loans and receivables –
simplified approach 	(132) 	–
– Less provision for impairment of other loans and receivables 	(304) 	(343)
9 114 	7 467
1 Refer to page 66 for an explanation of the nature of the security deposit (cash collateral).
Credit risk relating to receivables is managed as follows:
i. Premium debtors are not rated by Discovery as exposure to any single customer is insignificant. The premium debtors
comprise amounts receivable from individuals and corporates. In addition, Discovery suspends benefits when contributions
are not received. Premium debtors that are past due are handled by a specialist area in business. Where amounts remain
uncollected for more than six months, the debtors are then handed to specialist debt collection agencies.
ii. VitalityHealth makes use of financial reinsurance as a financing tool for new business acquisition costs. The receipt from the
reinsurer is recognised in profit or loss upfront in the year received. GBP 175.8 million (R3 770 million) (2019: GBP 154.2 million
(R2 773 million)) is outstanding in respect of cashless reinsurance treaties. The credit ratings of these reinsurers are Aa2 and Aa3.
Refer to page 73 for detail regarding the management of risk in respect of reinsurance receivables raised for expected
recoveries on projected claims and amounts due from reinsurers in respect of claims already paid. Discovery’s liability as
primary insurer is not discharged.
iii. The Discovery Health Medical Scheme (DHMS) has been rated AAA(za) by Global Credit Ratings. The closed schemes have not
been rated. Payments by DHMS and the other closed schemes are managed by Discovery and are paid by the seventh of the
following month.
iv. Agents and brokers are subject to a comprehensive relationship management programme including credit assessment.
Agents and brokers are not rated by Discovery as exposure to any single intermediary is insignificant. The widespread nature
of the individual amounts combined with this close management relationship reduces credit risk. Most commission claw
backs are offset against future payments and hence the risk of outstanding commission clawbacks is reduced.
76 Discovery Annual Financial Statements 2020

-- 74 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Discovery ages and pursues unpaid accounts on a monthly basis. The ageing of the components of receivables at 30 June was:
Group
R million
Gross
2020
Impairment
2020
Gross
2019
Impairment
2019
Not past due (current) 	8 196 	(132) 	7 257 	(120)
30 days 	254 	(33) 	131 	(19)
60 days 	137 	(20) 	65 	(11)
90 days 	133 	(17) 	50 	(8)
120 days 	149 	(35) 	61 	(25)
150 days 	96 	(9) 	22 	(11)
>150 days 	727 	(332) 	307 	(232)
9 692 	(578) 	7 893 	(426)
Discovery establishes an allowance for credit losses that represents its estimate of expected losses in respect of those receivables
which are financial assets. The allowance comprises of a specific loss component that relates to individually significant exposures,
and a collective loss component, established for groups of similar assets. The loss allowance is determined based on historical
data of payment statistics for similar financial assets, and where available without undue cost or effort incorporates forward-
looking information.
For an analysis of the movement in the allowance for expected credit losses as well as provision for impairment of premium
debtors during the year refer to notes 12 Financial assets and note 14 Insurance receivables, contract receivables and other non-
financial receivables.
77 Discovery Annual Financial Statements 2020

-- 75 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.3 Liquidity risk
Cash flow forecasting is performed in the operating entities of the Group and aggregated by group finance. Group finance
monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs at all
times so that the Group does not breach borrowing limits or covenants (where applicable) on any of its borrowing facilities (refer
to note 20). Such forecasting takes into consideration the Group’s debt financing plans, covenant compliance and, if applicable,
external regulatory or legal requirements – such as capital requirements.
Cash held by the operating entities is managed by Group treasury. Group treasury invests it in interest-bearing accounts, time
deposits and money market deposits, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient
headroom as determined by the above-mentioned forecasts. At the reporting date, the shareholders held money market funds
and cash and cash equivalents of R20 902 million (2019: R11 325 million).
The table below analyses the Group’s financial liabilities and net-settled interest rate swap derivative financial liabilities into
relevant maturity groupings based on the remaining period at the reporting date to the contractual maturity date. The amounts
are the undiscounted contractual payments and will therefore not agree to the Statement of financial position.
Group
R million 	Total 	<1 year
1 – 2
year
3 – 5
years
6 – 10
years
> 10
years
30 June 2020
Borrowings net of interest rate swap 	26 810 	2 186 	3 489 	14 687 	4 612 	1 836
Derivative financial instruments at fair value:
– used as cash flow hedges 	854 	157 	131 	427 	139 	–
– not designated as hedging instruments 	135 	109 	17 	9 	– 	–
Other payables at amortised cost 	12 778 	5 656 	123 	801 	20 	6 178
Deposits from customer 	2 427 	2 146 	281 	– 	– 	–
Total financial liabilities 	43 004 	10 254 	4 041 	15 924 	4 771 	8 014
Group
R million 	Total 	<1 year
1 – 2
year
3 – 5
years
6 – 10
years
> 10
years
30 June 2019
Borrowings net of interest rate swap 	25 151 	2 897 	3 309 	9 396 	6 634 	2 915
Derivative financial instruments at fair value:
– used as cash flow hedges 	250 	10 	48 	101 	91 	–
– not designated as hedging instruments 	243 	239 	3 	1 	– 	–
Other payables at amortised cost 	9 222 	8 121 	972 	116 	13 	–
Total 	34 866 	11 267 	4 332 	9 614 	6 738 	2 915
Discovery Bank manages its liquidity risk by comparing the credit utilisation on its loans and advances against the deposits it
holds. Discovery Bank performs normal stresses as well as additional stresses to ensure that it can meet its obligations
continuously. The stresses during the financial period included stresses as a result of COVID-19 impacts.
78 Discovery Annual Financial Statements 2020

-- 76 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.5 	Capital management
The Group’s objectives when managing capital are:
❚ 	To comply with the statutory capital requirements required by the regulators of the insurance markets where the Group operates;
❚ 	To maintain a capital buffer in excess of the statutory capital requirements in order to reduce the risk of breaching the
statutory requirement in the event of deviations from the main assumptions affecting the Group’s insurance businesses;
❚ 	To ensure that sufficient capital is available to fund the Group’s working capital and strategic capital requirements;
❚ 	To achieve an optimal and efficient capital funding profile; and
❚ 	To consider capital management needs both in the short term and over a five-year planning horizon.
A range of capital raising options are available to manage the capital structure of the Group, which includes the issue of new
shares, debt, reinsurance arrangements and other hybrid instruments.
FINANCIAL LEVERAGE RATIO
As part of the capital management process, the Group monitors its capital structure utilising the Financial Leverage Ratio (FLR).
This ratio is calculated as total debt1 divided by total debt plus total equity. The Group’s strategy is to maintain a prudent FLR of
28% per the Group Risk Appetite statement. The table below summarises the FLR at 30 June.
Group
R million 	2020 	2019
– Amount owed to Prudential Assurance Company Limited2 	– 	1 760
– Borrowings at amortised cost (refer to note 20) 	14 956 	11 361
Total debt and guarantees 	14 956 	13 121
Total equity 	44 553 	43 083
Financial Leverage Ratio (%) 	25.1 	23.3
1. Excluding all IFRS 16 lease liabilities of R4 380 million (2019: R3 321 million (only the lease liability relating to the new office building, recognised in
terms of IAS 17 was excluded). It further excludes non-guaranteed deposit facilities of R500 million.
2. The liability represents the acquisition costs in respect of business written on Prudential Assurance Company’s (Prudential) life insurance license and
were funded by Prudential. The liability is repaid on a matched basis as the cash flows emerge from this business. In the event that the cash flows do
not emerge as anticipated, VitalityLife would be required to repay these liabilities from other resources. The liability is net of capital injected by
Discovery for solvency I requirements and retained losses. 2020 Reflects a nil amount as in terms of the level premium reinsurance treaty entered into,
a security deposit was required to be placed by the reinsurer, to reduce counterparty risk. During the 2020 financial year, additional amounts were
received as ‘deposit back’ in excess of the negative reserve funding. The agreements indicate that offset is applicable up to the amount of the negative
reserve funding. Any additional amounts of the deposit back received thereafter, are included in cash. The corresponding liability to the reinsurer has
been accounted for in Other payables at amortised cost (refer to note 22).
The FLR at 30 June 2020 is in line with Discovery’s risk appetite.
Minimum capital requirements
For Group subsidiaries that operate in the insurance and financial services sectors, the regulator specifies the minimum amount
and type of capital that must be held by each of the subsidiaries in addition to their insurance liabilities. The minimum required
capital must be maintained at all times throughout the period.
With effect from 1 July 2018, the Insurance Act 18 of 2017 and the related Prudential Standards were implemented in South
Africa. Discovery Life and Discovery Insure are regulated under the Insurance Act, while VitalityHealth and VitalityLife are
regulated under the European Solvency II regulatory regime, which was implemented from 1 January 2016.
79 Discovery Annual Financial Statements 2020

-- 77 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.6 	Fair value estimation
The Group’s financial instruments measured at fair value have been disclosed using a fair value hierarchy. The hierarchy has
three levels that reflect the significance of the inputs used in measuring fair value.
Level 1: includes financial instruments that are measured using unadjusted, quoted prices in an active market for identical
financial instruments. Quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing
service or regulatory agency and those prices represent actual and regularly occurring market transactions on an arm’s
length basis.
Level 2: includes financial instruments that are valued using techniques based significantly on observable market data.
Instruments in this category are valued using:
❚ 	Quoted prices for similar instruments or identical instruments in markets which are not considered to be active; or
❚ 	Valuation techniques where all the inputs that have a significant effect on the valuation are directly or indirectly based on
observable market data.
Level 3: includes financial instruments that are valued using valuation techniques that incorporate information other than
observable market data and where at least one input (which could have a significant effect on instruments’ valuation) cannot be
based on observable market data.
For the amounts disclosed in the fair value hierarchy table, the look-through basis has not been applied to the mutual fund
balances and the amounts will therefore agree to the amounts disclosed in the Statement of financial position.
Group
R million 	Level 1 	Level 2 	Level 3 	Total
30 June 2020
Financial assets
Financial instruments mandatorily at fair value
through profit or loss:
– Equity securities 	32 953 	120 	– 	33 073
– Equity linked notes 	– 	2 318 	– 	2 318
– Debt securities 	29 965 	1 708 	– 	31 673
– Inflation linked securities 	1 332 	156 	– 	1 488
– Money market securities 	2 688 	10 289 	– 	12 977
– Mutual funds 	21 185 	– 	– 	21 185
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	14 	– 	14
– not designated as hedging instruments 	– 	1 356 	– 	1 356
Total financial assets 	88 123 	15 961 	– 	104 084
Financial liabilities
Investment contracts at fair value through profit or loss: 	– 	23 012 	– 	23 012
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	854 	– 	854
– not designated as hedging instruments 	– 	138 	– 	138
Total financial liabilities 	– 	24 004 	– 	24 004
80 Discovery Annual Financial Statements 2020

-- 78 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.6 	Fair value estimation continued
Group
R million 	Level 1 	Level 2 	Level 3 	Total
30 June 2019
Financial assets
Financial instruments mandatorily at fair value through
profit or loss:
– Equity securities 	33 966 	1 015 	– 	34 981
– Equity linked notes 	23 	3 178 	– 	3 201
– Debt securities 	19 531 	1 599 	– 	21 130
– Inflation linked securities 	554 	– 	– 	554
– Money market securities 	7 362 	6 403 	– 	13 762
– Mutual funds 	16 574 	– 	– 	16 574
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	176 	– 	176
– not designated as hedging instruments 	– 	199 	– 	199
Total financial assets 	78 010 	12 570 	– 	90 580
Financial liabilities
Investment contracts at fair value through profit or loss 	– 	20 674 	– 	20 674
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	250 	– 	250
– not designated as hedging instruments 	– 	259 	– 	259
Total financial liabilities 	– 	21 183 	– 	21 183
There were no transfers between level 1 and 2 during the current financial year.
Specific valuation techniques used to value financial instruments in level 2
❚ 	Discovery Life has invested in equity linked notes offered by international banks in order to back certain unit-linked contract
liabilities. The calculation of the daily value of the equity linked investments is made by the provider of the note. Discovery Life
has procedures in place to ensure that these prices are correct. Aside from the daily reasonableness checks versus similar
funds and movement since the prior day’s price, the fund values are calculated with reference to a specific formula or index,
disclosed to the policyholders, which is recalculated by Discovery Life in order to check if the price provided by the provider is
correct.
❚ 	If a quoted market price is not available on a recognised stock exchange or from a broker for non-exchange traded financial
instruments, the fair value of the instrument is estimated by the asset managers, using valuation techniques including the use
of recent arm’s length market transactions, reference to the current fair value of another instrument that is substantially the
same, discounted cash flow techniques, option pricing models or other valuation techniques that provide a reliable estimate
of prices obtained in actual market transactions.
❚ 	The fair value of the hedged derivatives is calculated, as follows:
– The fair value of call options is calculated based on a Black-Scholes model;
– The fair value of the return swaps is calculated by discounting the future cash flows of the instruments; and
– The fair value of interest rate swaps is calculated as the present value of the estimated future cash flows based on
observable yield curves.
81 Discovery Annual Financial Statements 2020

-- 79 of 198 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.7 	Offsetting financial assets and financial liabilities
Financial assets
The following financial assets are subject to offsetting:
Group
R million
Gross
financial
assets
Gross
offsetting
financial
liabilities
Net amount
presented
30 June 2020
Cash and cash equivalents 	21 099 	(3 190) 	17 909
30 June 2019
Cash and cash equivalents 	9 473 	(70) 	9 403
Offsetting of cash and cash equivalents takes place as a result of sweeping arrangements that Discovery has in force with various
financial institutions. No other amounts presented on the financial statements are subject to netting arrangements.
Cash collateral
To reduce the credit risk exposure from the hedge derivative instruments purchased (refer to note 3.4.1), Discovery has entered
into collateral agreements with the relevant financial institutions to post cash collateral periodically, equal to the fair value of the
derivatives. A total of R1 150 million cash collateral is being held by Discovery and R407 million was being held by the various
financial institutions as at 30 June 2020 (2019: R285 million held by Discovery and R39 million held by various financial institutions).
The posting of the collateral does not result in legal settlement of the outstanding derivative balance. The collateral will only be
used to settle the derivative upon default or bankruptcy of either party. The offsetting requirements of IAS 32 Financial Instruments:
Presentation are therefore not met.
82 Discovery Annual Financial Statements 2020

-- 80 of 198 --

83 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
4. 	CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES
Assumptions and estimates form an integral part of financial reporting and have an impact on the amounts reported. Assumptions
are based on historical experience and expectations of future outcomes and anticipated changes in the environment. Assumptions
are further regularly reviewed in the light of emerging experience and adjusted where required.
4.1 	Annual assessment of goodwill impairment
Discovery has, in accordance with IFRS, assessed Goodwill for impairment as at 30 June 2020. In determining the recoverable amount
of the cash generating units (CGUs) to which the goodwill was allocated (refer note 10), the following key estimates were made:
VitalityHealth and VitalityLife
The goodwill allocated to these CGUs represent the value of future new business expected to be written by VitalityHealth and
VitalityLife and has been allocated between VitalityHealth and VitalityLife based on management’s estimate of the present value
of future new business for each entity as at 31 July 2010.
The value-in-use is calculated as the present value of the best-estimate pre-tax cash flows of the CGU for the in-force policies at
the valuation date and 10 years of new business. The 10-year forecast was considered appropriate to better reflect the long term
specific growth prospects, rather than applying a straight terminal value. For the policies in-force at the valuation date and for
each tranche of new business, the cash flows are projected over a 10-year period and a terminal value is applied in the final year
of the projection, calculated using a growth rate assumption appropriate for the decline in the best-estimate, pre-tax cash flows.
The methodologies and assumptions applied in determining the recoverable amount is consistent with those in the prior periods,
updated for new information. The information is consistent with actual results relative to budgeted amounts. During the reporting
period, the recoverable amount for VitalityHealth and VitalityLife was higher than the carrying amount, therefore no impairment is
necessary. The key assumptions were stressed. The stresses performed was not only limited to the impact of COVID-19, but
extended further. The stresses performed include significant drop in new business, stresses relating to mortality, lapses and
morbidity. The result is that there was still sufficient headroom and no impairment necessary.
The cash flows have considered both the ‘value-in-force’ business as well as new business. The significant inputs related to the
determination of the discount rates for both VitalityLife and VitalityHealth:
– A long-term Bank of England gilt of 0.5% was used as the risk free rate;
– An equity risk premium for United Kingdom of 3.5% was added; and
– For Beta Risk:
○ VitalityLIfe: The Beta Risk is the beta of the FTSE Life insurance index relative to the FTSE 350 Index over a five-year period.
○ VitalityHealth: The Beta Risk as per VitalityLife, adjusted based on the ration of the specialist US listed health insurers to the
average S&P 500 Life and Health Insurance Index over a four-year period. There are no specialist health insurers listed in
the UK.
Discovery Bank
The Discovery Bank CGU was identified by considering the various assets that collectively produce independent cash flows for
Discovery Bank. Discovery Bank’s income streams comprise of interest earned on loans to customers, interest on excess cash invested,
fees (e.g. banking fees, interchange fees, transaction fees) from the banking activities and profits from the DiscoveryCard business.
In determining the assets to attribute to the Discovery Bank CGU, Discovery considered the assets required to performing
banking operations (being the banking license costs), the internally developed software brought into use and the goodwill that is
associated with the DiscoveryCard business acquisition.

-- 81 of 198 --

84 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
4. 	CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
4.1 	Annual assessment of goodwill impairment continued
Management has reviewed its 20-year business forecast, which comprise:
– A detailed 10-year business plan. The 10-year plan takes into consideration regulatory capital requirements, macro-economic
forecasts and customer behaviour assumptions when forecasting a statement of financial position, income statement and
resultant equity cash flows to/from shareholders. The 10-year period used to assess impairment is longer than the standard
5 year forecast model and is supported by the fact that the business is still in the start-up phase, resulting in a 5 year forecast
not adequately reflecting the business plan. In addition, through the DiscoveryCard business, management has insights from
16 years of customer data to model.
– A terminal value at end of year 10. This is calculated using an extended cash flow forecasting method until the growth in
earnings has stabilised (year 20) and a final value considering perpetual terminal growth. This terminal value, discounted to
year 10, is then assessed for reasonability by calculating an implied Price/Earnings ratio at that point in time.
– In the near term, expected credit losses and customer spending patterns were stressed for the impact of COVID-19.
The key assumptions used in the estimation are as follows:
– Cash flows are discounted at the cost of equity which includes a risk free base rate of 9.39%, based on a 10-year SA Bond
Curve and a blended risk free rate of 9.09% based on SA Bond Curves for 10 to 20 years. The adjusted cost of equity is
reflective of the risk specific to the assets;
– Conservative customer growth has been assumed, targeting an achievable level of customers in year 10. Thereafter, the
customer base was treated as stable, with projected growth in profits in line with estimate nominal GDP; and
– System build costs as well as intangible assets acquired in the business combination have been expensed over their useful life
of 10 years.
Based on management’s assessment, no impairment was identified.
4.2 	Policyholder liabilities assumptions and estimates (including assets
arising from insurance contracts)
The discount and growth rates have been stressed to reflect inflationary terminal growth and a higher risk in the cash flows. The
base case and stressed case did not identify any impairment.
Discovery Life and VitalityLife
The insurance policies issued are valued using various methodologies and assumptions. The methodology is described in accounting
policy 13.1. The assumptions used are best estimate assumptions, with the addition of explicit compulsory margins required by:
❚ 	SAP 104 of the Actuarial Society of South Africa for Discovery Life;
❚ 	INSPRU of the Prudential Regulatory Authority (PRA) in the UK;
and discretionary margins described in accounting policy 13.1.1. The process used to decide on best estimate assumptions is
described below.
EXPERIENCE INVESTIGATIONS
Experience investigations into lapse, mortality, morbidity, expenses and other key accounting estimates are performed at every
valuation date. The data for the months since the previous valuation date forms the basis of each investigation. The experience
of prior periods is also considered to establish trends and add credibility to the results.
The most recent experience investigations were performed at 30 June 2020.

-- 82 of 198 --

85 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
4. 	CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
4.2 	Policyholder liabilities assumptions and estimates (including assets
arising from insurance contracts) continued
MORTALITY AND MORBIDITY
Assumptions of future mortality and morbidity experience are derived based on data from reinsurers and compared to actual
past experience. Where appropriate, the assumptions are adjusted to reflect actual past experience or for expected changes in
future experience.
The assumptions are modified for each policy based on actual data available from underwriting performed on the policy and
compared against standard industry tables for reasonability. The key mortality and morbidity assumptions are reviewed and
benchmarked against the industry by independent actuarial consultants to ensure that the assumptions are reasonable, upon
implementation of significant new products. An adjustment is made to the standard mortality and morbidity assumptions to
reflect the expected impact of engagement in the Vitality programme. It has been observed that higher rates of engagement
result in lower lapses.
An allowance is made for the impact of AIDS on South African mortality rates. This is described in detail under the AIDS
assumption below.
SURRENDER AND LAPSE RATES
Lapse rates are based on actual past experience where available. The lapse analysis is done by considering the in–force duration
of policies. For durations longer than existing actual data, lapse rates are set based on expectations of future experience based
on internal and external expert advice. The lapse experience investigation covers at least the last two years of lapse experience
to allow trends to be identified.
Lapse assumptions are varied between different types of policies where the lapse experience is expected to differ significantly.
Allowance is made for the estimated impact of the economic environment. An adjustment is made to the lapse assumptions to
reflect the expected impact of engagement in the Vitality programme because it has been observed that higher rates of
engagement results in lower lapses.
For Discovery Life, the surrender rates are also based on actual past experience where available.
COVID-19 PROVISIONS FOR DISCOVERY LIFE AND VITLALITYLIFE
At June 2020, Discovery Life and Invest and VitalityLife raised COVID-19 provisions of R2 160 million and R569 million respectively
to allow for an expected increase in lapses and claims over the short term. The estimate for excess mortality was based on an
assessment of various internal and external COVID-19 projection models. The expected increase in lapses over the short term
was set in light of the worsening economic factors and experience in the book over previous stress periods.
Sensitivities from the base estimate have been tested against internal targets for capital adequacy and liquidity. Our sensitivities
affirmed we remain well capitalised.
TAXATION
Future tax is allowed for according to the current tax legislation and current tax rates. It is assumed that future tax on statutory
profits will be payable at the prevailing company tax rate of 28% (2019: 28%) in South Africa. The prevailing tax rate in the UK is 19%
(2019: 19%). Tax amendments for Life Insurance companies introduced a Risk Policy Fund for all new risk business written after 1
July 2016. In terms of this legislation Discovery Life elected to move existing risk business to this Fund. As a result of these changes
the assessed loss in the Individual Policyholder Fund is now expected to stop increasing and will be utilised over time. Therefore, in
terms of IAS 12: Income Taxes, a value of R854 million (2019: R728 million), which was previously implicit in the valuation of insurance
contract liabilities, was recognised as an explicit deferred tax asset. The value is net of deferred capital gains tax liabilities.
To calculate this value, Discovery Life performed a probability weighted cash flow forecast of the annual cash flows expected to
arise from the utilisation of the assessed loss. The primary factors that management have taken into account when arriving at the
probability are the expected market growth and withdrawal rate of the Linked Asset and Guaranteed Endowment book. For
Linked Assets, given the uncertainty inherent in market growth assumptions and the fact that discounting of cash flows is not
permitted by IAS 12, future market growth was assumed to be 0% for the purpose of calculating the deferred tax asset. The
expected income on the bond portfolio held to match policyholder liabilities has been fully allowed for at current rates. For both
the Linked and bond portfolio, cash flows arising from the tax asset were further reduced to account for the uncertainty of future
lapse rates and product mix as well as the broader economic and legislative environment.
Deferred tax arises on the other temporary differences between the accounting basis and the tax basis.

-- 83 of 198 --

86 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
4. 	CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
4.2 	Policyholder liabilities assumptions and estimates (including assets
arising from insurance contracts) continued
ECONOMIC ASSUMPTIONS/INVESTMENT RETURNS
For Discovery Life and Invest, the discount rate is based on the risk free rates at 30 June 2020. The real rate assumption is based on the
average of the real rate curves for the preceding twelve months. This real rate assumption will remain unchanged over time unless the
equivalent single rate which is derived based on the weighted duration of the cash flows moves by more than 25 basis points since the
preceding valuation. The inflation assumption is set as the differential between the assumed nominal and real interest rates.
Refer to note 2.5.1 for sensitivity analysis on the real rates.
Previously the nominal interest rate was based on a cash flow weighted implied single interest rate derived from the risk-free
yield curve. The real rate assumption was set equal to an assumed single rate. A change has been made to the Discovery Life and
Invest economic basis to align the nominal interest rate assumptions with the shape of the risk free yield curve. Consistent with
this, the real yield assumption was set relative to the observed real yield curve, adjusted to remove volatility due to the nature of
the index linked government bond market.
For comparison purposes, it is noted that the single risk free rate at 30 June 2020 would have increased to 12.5% (2019: 10.50%).
The implied single real interest rate has also increased to 4.17% at June 2020 (2019: 3.26%).
Other investment returns and economic assumptions are set relative to this yield curve. The assumptions for Discovery Life are
as follows:
Cash: 	Risk free – 1.5%
Fixed interest: 	Risk free
Equity: 	Risk free + 3.5%
Property: 	Risk free +1%
For VitalityLife, previously the investment rate is set in line with the expected long-term return on a portfolio of UK government
and corporate fixed interest assets of appropriate term and nature, less a margin to protect against adverse experience.
VitalityLife adopts a modified passive approach for setting economic assumptions. The nominal investment return is set as the
active market rate on UK long-term swap rates plus a fixed adjustment (based on long-term averages) for liquidity premium, the
gilt/ swap spread and cash flow weighting. The best estimate inflation assumption is set in line with long-term UK inflation
expectations and observed real yields consistent with the term of the liabilities. The risk free rate at 30 June 2020 was set at 0.89%
(2019: 2.10% p.a.), unchanged from the prior period.
The investment fees and tax rates are taken into account in setting the economic assumptions. Refer to note 2.5.2 for sensitivity
analysis on the real rates.
EXPENSE ASSUMPTIONS
Renewal expense assumptions are based on the results of the latest expense and budget information. Expenses are considered
to be non-recurring when they relate to the start-up of a new business area or when they are material and are specific to an event
that is not expected to occur in the future.
The allocation of expenses between initial and renewal expenses is based on the latest expense analysis where expenses are
directly allocated based on the function performed. Where an expense could relate to both initial and renewal functions, the
expenses are allocated proportionately based on estimates of the functions performed.
Per policy expenses are projected to increase in line with consumer price inflation.
Non-recurring expenses are excluded from the expense analysis used to derive the assumption.
HIV/AIDS
For individual life South African business a fixed loading is applied to the expected best estimate mortality rates to allow for the
expected effect of AIDS. The loading varies based on socio-economic class. Discovery Life further operates in the high end of the
market where the AIDS risk is lower compared to the full market. The additional loading for AIDS is set in consultation with
external independent actuaries and reinsurers.
For Group policies, a loading is applied at the underwriting stage to allow for the expected effect of AIDS. The loading varies based
on the industry and geographic area and composition of the group and is derived from advice received from the reinsurers. The
loading then forms the AIDS assumption for Group policies.

-- 84 of 198 --

87 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
4. 	CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
4.2 	Policyholder liabilities assumptions and estimates (including assets
arising from insurance contracts) continued
REINSURANCE
All prospective liabilities are valued gross of reinsurance and then adjusted for the expected effect of reinsurance. For outstanding
reported claims and IBNR, a specific allowance is made for reinsurance recoveries.
The Global Linkage Benefit is fully reinsured. The cost of the future reinsurance is dependent on the cost at which the reinsurer
can buy assets to match the liability under this benefit. Assumptions are made around the cost at which the reinsurer can
purchase these benefits, based on current and historic costs of these assets.
AUTOMATIC PREMIUM INCREASES
Automatic premium increases could include both contractual and voluntary increases. No allowance is made for voluntary
premium increases when calculating liabilities under insurance contracts.
Contractual premium increases are defined as increases that cannot be cancelled by the policyholder without altering the terms
of the benefits provided under the policy. Contractual increases are included in the calculation of policyholder liabilities.
POLICY ALTERATIONS
In the calculation of policyholder liabilities, no allowance is made for policy alterations over time in accordance with actuarial
guidance.
CHANGES IN ASSUMPTIONS
Expected profits in respect of future options on products are not recognised but expected losses in respect of such options are
allowed for, in line with actuarial guidance.
Modelling and assumptions changes were made to the valuation at 30 June 2020 to ensure that assumptions are in line with the
best estimate of future experience. For Discovery Life, the total effect of these changes on the Assets arising from insurance
contracts was a decrease in the assets on the Financial Soundness Valuation basis of R5 572 million (2019: R1 261 million decrease).
For VitalityLife, the total effect of these changes was a decrease in the assets of R2 489 million (2019: R42 million increase).
In addition to this, the discretionary margins were reset to reflect the underlying profitability of the overall portfolio. The reset of
margins decreased the assets on the Financial Soundness Valuation basis by R1 367 million (2019: R529 million decrease). Refer
to note 5 for an analysis of these changes.
SENSITIVITIES
The sensitivity of the policyholder liabilities on the Financial Soundness Valuation basis is set out in note 2.1.1. The sensitivity of
the policyholder liabilities on the INSPRU basis is set out in note 2.2.1.
4.3 	Recognition of deferred tax assets
Discovery recognises deferred tax assets to the extent that it is probable that taxable profit will be available against which these
deductible temporary differences can be utilised. Management annually assesses the probability of future taxable profits to
evaluate appropriateness of the deferred tax to raise. As a result of the assessment, management has raised the following
additional, individually significant, deferred tax assets:
Discovery Life Individual Policyholder Fund
Refer to section 4.2 ‘Policyholder liabilities assumptions and estimates (including assets arising from insurance contracts) –
Taxation’.

-- 85 of 198 --

88 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
5. 	ASSETS ARISING FROM INSURANCE CONTRACTS
R million
Group
2020
Group
2019
Long-term insurance contracts – gross 	48 042 	48 781
Less: ceded to reinsurers (refer to note 19) 	(11 043) 	(9 373)
Long-term insurance contracts – net 	36 999 	39 408
Current 	3 652 	4 013
Non-current 	33 347 	35 395
36 999 	39 408
Movement in assets arising from insurance contracts
Balance at beginning of the year 	39 408 	36 202
Movement for the year:
Expected movement in policyholder liabilities2 	(2 625) 	(2 953)
Unwinding of discount rate2 	2 170 	2 003
New business written 	3 834 	4 747
Experience variances 	(660) 	(812)
Economic 	(129) 	(132)
Operational 	(531) 	(680)
Modelling and method changes 	(111) 	1 419
Benefit changes 	– 	2 066
Changes in assumptions 	(7 950) 	(2 638)
Economic 	(5 478) 	(679)
Operational 	(2 472) 	(1 959)
Changes in margins1 	1 367 	(529)
Translation differences 	1 566 	(97)
Balance at end of the year 	36 999 	39 408
1 In line with accounting policy 13.1.1, the best estimate assumptions and margins are reset at every valuation date to reflect the underlying profitability
of the overall portfolio. Assumptions and margins are not set on new business in isolation but on a portfolio level.
2 In June 2018, Discovery Life changed the discount rate assumption used in the calculation of its IFRS reserves from an implied single interest rate
derived from the risk-free yield curve (i.e. a single flat rate), to the nominal risk-free curve. This change in methodology impacted the unwind in the
reserve in future periods and ensured closer alignment to the run-off pattern implied by the yield curve. However, the nominal curve tends to include
a risk premium at longer durations, contributing to the observed upward sloping yield curve. To compensate for this risk premium and to fairly
represent the unwinding of the reserve in the near future, Discovery Life rebases the yield curve annually to reflect the run-off. For the year ended
30 June 2019, the impact of rebasing of the yield curve was R360 million, and was included in the line item ‘expected movements in policyholder
liabilities’. For this financial year-ended 30 June 2020, and future reporting periods, the impact of rebasing of the yield curve will be included in
‘unwinding of the discount rate’. For the year ended 30 June 2020, the impact was R622 million. Prior period information was not restated.

-- 86 of 198 --

89 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
6. 	PROPERTY AND EQUIPMENT
Group
R million
Land and
buildings
Furniture,
fittings and
equipment
Computer
equipment
and
operating
systems
Leasehold
improve-
ments
Motor
Vehicles
Telematics
devices 	Total
Year ended 30 June 2020
Opening carrying amount 	3 007 	82 	221 	796 	16 	90 	4 212
IFRS 16 Transition 	573 	– 	64 	– 	1 	– 	638
Adjusted balance at 1 July 2019 	3 580 	82 	285 	796 	17 	90 	4 850
Translation differences 	66 	4 	14 	13 	– 	– 	97
Additions 	93 	23 	155 	33 	13 	48 	365
Disposals
– Cost 	– 	– 	(1) 	– 	– 	(3) 	(4)
– Accumulated depreciation 	– 	– 	1 	– 	– 	2 	3
Derecognition
– Cost 	– 	(10) 	(13) 	– 	– 	(33) 	(56)
– Accumulated depreciation 	– 	3 	10 	– 	– 	18 	31
Depreciation charge 	(302) 	(32) 	(153) 	(102) 	(9) 	(45) 	(643)
Closing carrying amount 	3 437 	70 	298 	740 	21 	77 	4 643
At 30 June 2020
Cost 	4 081 	301 	1 061 	1 145 	74 	246 	6 908
Accumulated depreciation 	(644) 	(231) 	(763) 	(405) 	(53) 	(169) 	(2 265)
Carrying amount 	3 437 	70 	298 	740 	21 	77 	4 643
Year ended 30 June 2019
Opening carrying amount 	3 029 	75 	228 	827 	17 	96 	4 272
Translation differences 	(3) 	* 	* 	* 	– 	– 	(3)
Additions 	193 	51 	116 	149 	7 	54 	570
Disposals
– Cost 	– 	(50) 	(9) 	(77) 	– 	(4) 	(140)
– Accumulated depreciation 	– 	32 	9 	– 	– 	2 	43
Derecognition and impairment
– Cost 	– 	* 	* 	– 	– 	(26) 	(26)
– Accumulated depreciation 	– 	– 	– 	– 	– 	15 	15
Depreciation charge 	(212) 	(26) 	(123) 	(103) 	(8) 	(47) 	(519)
Closing carrying amount 	3 007 	82 	221 	796 	16 	90 	4 212
At 30 June 2019
Cost 	3 345 	268 	786 	1 089 	60 	234 	5 782
Accumulated depreciation 	(338) 	(186) 	(565) 	(293) 	(44) 	(144) 	(1 570)
Carrying amount 	3 007 	82 	221 	796 	16 	90 	4 212
* Amount is less than R500 000.
Derecognition
In Discovery Insure, when policies relating to motor vehicle insurance lapse, the telematics devices installed in those vehicles are
not always recovered. The value of these unrecovered units are derecognised.

-- 87 of 198 --

90 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
6. 	PROPERTY AND EQUIPMENT continued
LEASED ASSETS
The table below summarises leased assets. For the financial year ended 30 June 2020 the information relates to those assets held
in accordance with IFRS 16 Leases where a right-of-use asset is recognised. For the financial year ended 30 June 2019 the
information relates to those assets held as a finance lease in accordance with IAS 17 Leases.
R million
Group
2020
Group
2019
Land and buildings 	3 232 	2 832
Computer equipment and operating systems 	100 	53
Leasehold improvements 	133 	212
Motor vehicles 	1 	–
Total 	3 466 	3 097
7. 	INTANGIBLE ASSETS
Group
R million
Software
Development1
Business
acquisitions:
Identifiable
Intangibles
Banking
license 	Total
Year ended 30 June 2020
Opening carrying amount 	5 034 	534 	29 	5 597
Translation differences 	296 	69 	– 	365
Additions 	1 840 	– 	– 	1 840
Amortisation charge 	(1 111) 	(76) 	– 	(1 187)
Impairment
– Cost 	(107) 	– 	– 	(107)
– Accumulated amortisation 	44 	– 	– 	44
Derecognition
– Cost 	(235) 	– 	– 	(235)
– Accumulated amortisation 	64 	– 	– 	64
Closing carrying amount 	5 825 	527 	29 	6 381
At 30 June 2020
Cost 	9 116 	1 780 	29 	10 925
Accumulated amortisation 	(3 291) 	(1 253) 	– 	(4 544)
Carrying amount 	5 825 	527 	29 	6 381

-- 88 of 198 --

91 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
7. 	INTANGIBLE ASSETS continued
Group
R million
Software
development1
Business
acquisitions:
Identifiable
intangibles
Banking
license 	Total
Year ended 30 June 2019
Opening carrying amount 	3 830 	458 	1 203 	5 491
Translation differences 	(7) 	(3) 	– 	(10)
Additions 	1 949 	– 	– 	1 949
Disposals
– Cost 	(22) 	– 	(1 337) 	(1 359)
– Accumulated amortisation 	– 	– 	191 	191
Acquisitions of business 	– 	150 	– 	150
Amortisation charge 	(735) 	(71) 	(28) 	(834)
Amortisation capitalised to new asset 	51 	– 	– 	51
Impairment
– Cost 	(36) 	– 	– 	(36)
– Accumulated amortisation 	27 	– 	– 	27
Derecognition
– Cost 	(52) 	– 	– 	(52)
– Accumulated amortisation 	29 	– 	– 	29
Closing carrying amount 	5 034 	534 	29 	5 597
At 30 June 2019
Cost 	7 322 	1 711 	29 	9 062
Accumulated amortisation 	(2 288) 	(1 177) 	– 	(3 465)
Carrying amount 	5 034 	534 	29 	5 597
* Amount is less than R500 000.
1 Software development additions includes an amount of R47 million of finance costs that have been capitalised during the prior year.
Business acquisitions
Intangibles identified in the acquisition of business combinations are amortised over their remaining useful lives and only tested
for impairment if an indication of impairment arises. There was no indication of impairment for the current reporting period.
Included in the value of business acquisitions are:
❚ 	Customer contracts represented by value-in-force business acquired in the Standard Life Healthcare and PrimeMed business
combinations. The carrying amount as at 30 June 2020 is R396 million (2019: R390 million); and
❚ 	Client relationships and Core Deposit Funding Benefit acquired in the DiscoveryCard business combination. The carrying
amounts as at 30 June 2020 are R113 million and R17 million respectively (2019: R125 million and R19 million).
Banking license
– During the 2018 financial year, Discovery incurred costs of R29 million in respect of the application for a banking license.
Discovery has capitalised these costs in terms of IAS 38 Intangible Assets. This asset has an indefinite useful life.

-- 89 of 198 --

92 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
8. 	DEFERRED ACQUISITION COSTS
R million
Group
2020
Group
2019
Balance at beginning of the year 	536 	469
Translation differences 	93 	(5)
Additions 	1 439 	163
Deferred acquisition costs amortised 	(1 436) 	(91)
Balance at end of the year 	632 	536
For the current year, the asset relates to acquisition costs incurred in relation to health contracts that are expected to be
recovered out of future revenue margins.
9. 	ASSETS ARISING FROM CONTRACTS WITH CUSTOMERS AND
CONTRACT LIABILITIES
Group
R million
Assets
arising from
contracts
with
customer1
Costs of
obtaining
contracts 1
Contract
liabilities
Contract
receivables2
Year ended 30 June 2020
Balance at beginning of the year 	8 	744 	(433) 	1 369
Accrued income recognised during the year 	91 	– 	– 	–
Payments received 	(1) 	– 	– 	(11 098)
Costs of obtaining new contracts 	– 	309 	– 	–
Amortised during the year 	– 	(210) 	– 	–
Contract liabilities recognised in the current year 	– 	– 	(669) 	–
Revenue recognised in the year 	– 	– 	367 	11 064
Provision of impairment of contract receivables 	– 	– 	– 	(49)
Foreign exchange revaluations 	– 	– 	– 	30
Revenue recognised for changes related to prior year 	– 	– 	(12) 	–
Translation differences 	10 	3 	(61) 	97
Balance at end of the year 	108 	846 	(808) 	1 413
1 Presented as assets arising from contracts with customers.
2 Presented as part of insurance receivables, contract receivables and other receivables.
Where either party to a contract has performed, Discovery presents either a contract asset or contract liability, depending on the
relationship between Discovery’s performance and the customer’s payment. Unconditional rights to consideration is presented
separately as a receivable.
Group
R million
Assets
arising from
contracts
with
customer1
Costs of
obtaining
contracts1
Contract
liabilities
Contract
receivables2
Year ended 30 June 2019
Balance at beginning of the year 	– 	681 	(324) 	971
Accrued income recognised during the year 	94 	– 	– 	–
Payments received 	(86) 	– 	– 	(1 937)
Costs of obtaining new contracts 	– 	215 	– 	–
Amortised during the year 	– 	(152) 	– 	–
Contract liabilities recognised in the current year 	– 	– 	(253) 	–
Revenue recognised in the year 	– 	– 	139 	2 336
Revenue recognised for changes related to prior year 	– 	– 	5 	–
Translation differences 	– 	– 	– 	(1)
Balance at end of the year 	8 	744 	(433) 	1 369
1 Presented as assets arising from contracts with customers.
2 Presented as part of insurance receivables, contract receivables and other receivables.

-- 90 of 198 --

93 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
9. 	ASSETS ARISING FROM CONTRACTS WITH CUSTOMERS AND
CONTRACT LIABILITIES continued
The contract liability primarily relates to the advance consideration received from customers for initial advisor fees, for which
revenue will be recognised over the expected terms of the arrangement.
Transaction price allocated to remaining performance obligations under contracts:
Group
R million
Contract
amount
for future
service 	< 1 year 	2 – 3 years 	4 – 5 years 	> 5 years
Year ended 30 June 2020
Provision of stand ready Intellectual Property services 	146 	25 	44 	38 	39
Total 	146 	25 	44 	38 	39
Group
R million
Contract
amount
for future
service 	< 1 year 	2 – 3 years 	4 – 5 years 	> 5 years
Year ended 30 June 2019
Provision of stand ready Intellectual Property services 	536 	115 	166 	132 	123
Total 	536 	115 	166 	132 	123
Where performance obligations are discharged within 12 months or where contracts are cancellable giving 12 months or less
notice, without the payment of a significant penalty, a practical expedient has been applied. Discovery has excluded these
contracts from the disclosures above. Contracts that include variable considerations have also not been included in the table
above.
10. 	GOODWILL
Goodwill is not amortised, but is tested on an annual basis for impairment. Any impairment is recognised immediately in profit
or loss and is not subsequently reversed.
The table below sets out the goodwill allocated to the respective cash generating units (CGU’s) which is expected to benefit from
the synergies of the combination. Impairment of goodwill is assessed at this CGU level.
R million
Reconciliation of goodwill
Value in functional currency on
date of acquisition
Group
2020
Group
2019
Goodwill
– VitalityHealth1, 2 	GBP 100.3 million 	2 151 	1 804
– VitalityLife 1 	GBP 23.4 million 	502 	421
– Discovery Bank3 	ZAR 2 417 million 	2 417 	2 417
– Medical Services Organisation Group4 	ZAR 9 million 	– 	–
Total 	5 070 	4 642
1 GBP 96.7 million and GBP 23.4 million of the goodwill was allocated to VitalityHealth and VitalityLife respectively as at 31 July 2010.The goodwill arose
from the acquisition of Standard Life Healthcare and related capital restructure of the Prudential joint venture.
2 GBP 2.5 million goodwill from the acquisition of Insure Your Health (25 March 2013) and GBP 1.1 million of goodwill from the acquisition of KYS Paid
Limited (30 April 2014) were allocated to the VitalityHealth CGU.
3 R2 417 million goodwill from the acquisition of the DiscoveryCard business on 1 March 2019 was allocated to the Discovery Bank CGU.
4 At the end of December 2019 Discovery acquired controlling stakes in Medical Services Organisation and MSO International which performs medical
administration services across Africa for expatriates. Subsequent to the acquisition this goodwill was fully impaired.

-- 91 of 198 --

94 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
11. 	EQUITY-ACCOUNTED INVESTEES
R million
Group
2020
Group
2019
Carrying value of material interest in associates and joint ventures 	1 815 	1 243
Carrying value of individually immaterial interest in associates 	873 	688
Carrying value of individually immaterial interest in joint ventures 	25 	19
Investment in equity-accounted investees 	2 713 	1 950
Material interests in associates and joint ventures
The table below provides summarised financial information for the Group’s material joint ventures and associates. The
information disclosed reflects the amounts presented in the financial statements of the relevant associates and joint ventures
and not Discovery’s share of those amounts.
Ping An Health Insurance Company of China, Limited (Ping An Health or PAH)
Ping An Health offers policyholders in China cover for a range of private healthcare-related claims. PAH is a strategic partnership
for the group, providing access to new clients and markets in China.
Ping An Health
Ownership structure 	Equity-accounted Associate
Nature 	Insurance
Place of business 	China
R million 	2020 	2019
% of ownership interest 	25% 	25%
Summarised statement of comprehensive income
Revenue 	18 023 	9 557
Net Profit 	1 141 	667
Other comprehensive income 	74 	–
Total comprehensive income 	1 215 	667
Summarised statement of financial position
Current assets 	17 515 	8 415
Non-current assets 	17 953 	9 119
Current liabilities 	(6 711) 	(3 171)
Non-current liabilities 	(22 664) 	(10 399)
Net assets 	6 093 	3 964
Reconciliation to carrying amounts:
Opening net assets 	3 964 	2 714
Profit for the year 	1 141 	667
Other comprehensive income 	74 	–
Increase in share capital and share premium 	– 	640
Translation differences 	914 	(57)
Closing net assets 	6 093 	3 964
Group’s share of net assets 	1 523 	991
Goodwill 	292 	252
Carrying value at 30 June 	1 815 	1 243

-- 92 of 198 --

95 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
11. 	EQUITY-ACCOUNTED INVESTEES continued
Individually immaterial associates and joint ventures
Cambridge Mobile Telematics transaction
During the prior financial year, Cambridge Mobile Telematics (CMT), an associate investment of Discovery and strategic partner
to Discovery Insure since 2014, announced a USD 500 million (R7.2 billion) investment from the SoftBank Vision Fund.
This transaction resulted in Discovery’s effective shareholding in CMT reducing from 16.5% to 10% on a fully diluted basis.
Discovery’s profit from the transaction was USD 55.7 million (R790 million), R402 million of which was realised in cash in return
for the disposal of shares held in CMT. The remainder of the gain was as a result of a net increase in assets of CMT. The profit has
been included in the ‘Gain on dilution and disposal of equity-accounted investments’ in the Income statement.
Discovery’s strategic partnership with CMT remains in place following the transaction. Discovery still has significant influence as
Discovery has representation on the Board of Directors.
Summary of financial information
The table below provides summarised information of the aggregate carrying amounts and aggregate amounts of the Group’s
share of total income:
Group
R million
Associates 	Joint ventures
2020 	2019 	2020 	2019
Aggregate carrying amount 	873 	688 	25 	19
Aggregate amounts of the group’s share of (loss)/profit for the year 	(37) 	(24) 	16 	27
Gain on dilution and disposal of equity-accounted investments 	3 	844 	– 	–

-- 93 of 198 --

96 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
12. 	FINANCIAL ASSETS
R million
Group
2020
Group
2019
The Group’s investment in financial assets are summarised by
measurement category in the table below:
Financial assets at amortised cost 	4 371 	1 943
Investment at amortised cost1 	2 523 	1 943
– Debt securities 	439 	25
– Fixed term deposits 	2 084 	1 918
Loans and advances to customers 	12.1 	1 848 	–
Investments at fair value through profit and loss – mandatorily 	102 714 	90 205
– Equity securities 	33 073 	34 981
– Equity linked notes2 	2 318 	3 201
– Debt securities 	31 673 	21 130
– Inflation linked securities 	1 488 	554
– Money market securities 	12 977 	13 765
– Mutual funds 	21 185 	16 574
Total investments 	107 085 	92 148
Listed 	92 043 	76 990
Unlisted 	15 042 	15 158
107 085 	92 148
Shareholder investments 	12 026 	8 991
– Investments at amortised cost 	4 371 	1 943
– Investments at fair value through profit and loss – mandatorily 	7 655 	7 048
Policyholder investments 	95 059 	83 157
– Investments at fair value through profit and loss – mandatorily 	95 059 	83 157
Total investments 	107 085 	92 148
1 The fair value of instruments at amortised cost approximates the carrying amount due to the relatively short term nature of the instrument.
2 Majority of the equity linked notes are Rand denominated investments providing equity exposure together with either a floor of 80% of the highest price
observed since inception or a return after five years based on the best of three different unit trusts or indices.

-- 94 of 198 --

97 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
12. 	FINANCIAL ASSETS continued
Maturity profile:
❚ 	Shareholder investments
– these investments are held at fair value through profit and loss (mandatorily) as a long-term investment but may be
utilised when required by business in line with the entities’ business model for these assets.
– investments at amortised cost have a maturity of less than one year, except for R425 million (2019: R439 million) that will
mature between one and two years. All loans and advances have a maturity of less than one year.
❚ 	Policyholder investments are those financial assets at fair value through profit or loss that are held to back policyholder
liabilities. Except for R23 million (2019: R38 million) which will be held to back unit-linked insurance contracts with a maturity
profile between one and two years and R190 million (2019: R155 million) which will be held to back unit-linked insurance
contracts with a maturity profile between three and five years (refer to note 3.2.3), the balance can be withdrawn in the
short term.
12.1 Loans and advances to customers
Group
R million 	2020
Loans and advances (gross) – unsecured 	2 014
Accrued interest 	16
Total Gross advances 	2 030
Less: IFRS9 Expected credit losses (ECL) 	(182)
Total net loans and advances 	1 848
12.1.1 Loans and advances per credit risk rating
As at 30 June 2020
Group
R million 	DRG 1 – 4 	DRG 5 – 7 	DRG 8 – 10 	Not rated 	Total
Stage 1 	998 	547 	– 	48 	1 593
Stage 2: SICR 1 	* 	* 	303 	1 	304
Stage 2: Arrears 	9 	20 	51 	6 	86
Stage 3 	3 	6 	16 	6 	31
Total gross advances 	1 010 	573 	370 	61 	2 014
* Amount is less than R500 000.
1 Significant increase in credit risk.
The analysis above excludes accrued interest.
Discovery risk grade (DRG), is an internal client rate allocated on the basis of their risk profile. An adjusted DRG is allocated for
the purposes of calculating the expected credit losses.

-- 95 of 198 --

98 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
12. 	FINANCIAL ASSETS continued
12.1.2 Reconciliation of the expected credit loss (ECL)
As at 30 June 2020
Group
R million 	Stage 1
Stage 2:
SICR
Stage 2:
Arrears
Stage 3:
Default 	Total
30 June 2020
Balance at beginning of the year 	* 	* 	* 	* 	*
Total changes in ECL due to changes
in balances of advances 	84 	38 	20 	3 	145
New loans originated and acquired1 	45 	38 	21 	4 	108
Repayments and other movements2 	39 	* 	(1) 	* 	38
Changes in ECL due to derecognition
other than write-off 	* 	* 	* 	(1) 	(1)
84 	38 	20 	3 	145
Transfers between stages
Transfer (to)/from stage 1 	– 	16 	7 	15 	38
Transfer (to)/from stage 2: SICR 	(2) 	– 	1 	2 	1
Transfer (to)/from stage 2: Arrears 	* 	(2) 	– 	3 	1
Transfer (to)/from stage 3 	(1) 	* 	(2) 	– 	(3)
Balance at end of the year 	81 	52 	26 	23 	182
* Amount is less than R500 000.
The Group’s policy is to transfer closing balances based on the ECL stated at the end of the reporting period.
1 During the financial year ended 30 June 2020, the increase in new loans originated and acquired was primarily as a result of migrating customers
from the FNB platform to the Discovery Bank platform. Gross Loans and advances as a result of migration amounted to R836 million with a related
ECL of R77 million.
2 During the financial year under review, management has adjusted for the effects of COVID-19 in considering forward looking macro-economic factors.
The adjustment specifically associated with the factors had an increase in ECL of R31 million.
3 During the financial year under review, management implemented specified changes in ECL model assumptions as it improves and enhances its ECL
model. The effects of these changes increased the ECL by R13 million.
13. 	DERIVATIVE FINANCIAL INSTRUMENTS
R million
Group
2020
Assets
Group
2020
Liabilities
Group
2019
Assets
Group
2019
Liabilities
Derivatives used as cash flow hedges:
Equity price risk derivatives 	14 	(338) 	176 	(86)
Interest rate swaps 	– 	(516) 	– 	(163)
Derivatives not designated as hedging instruments:
Interest rate swaps 	1 091 	(8) 	144 	–
Swaptions 	2 	– 	– 	–
Equity price risk derivatives 	– 	(41) 	– 	(5)
Expected credit loss derivatives 	– 	(83) 	– 	(175)
Currency derivative contracts 	263 	(6) 	55 	(80)
1 370 	(992) 	375 	(509)
Current 	259 	(854) 	281 	(90)
Non-current 	1 111 	(138) 	94 	(419)
1 370 	(992) 	375 	(509)
Total return swaps and call options are entered into to hedge exposure to equity price risk related to share schemes. This includes
a day one profit or loss balance of R102 million (2019: R41 million).

-- 96 of 198 --

99 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
13. 	DERIVATIVE FINANCIAL INSTRUMENTS continued
The effects of the derivatives used in cash flow hedges on the group’s financial position and performance are as follows:
Year ended 30 June 2020
Group
R million
Notional
amount of
the hedging
instrument
Carrying amount of the
hedging instrument
Line item in
the Statement
of financial
position
where the
hedging
instrument is
presented
Changes
in fair value
of hedging
instrument
used for
calculating
hedge
ineffective-
ness
Ineffective-
ness
recognised
in profit
or loss
Line item in
which hedge
ineffective-
ness is presented	Assets Liabilities
Equity price risk 	1 145 	14 	(338) 	402 	13
Total return swaps 	984 	– 	(338) 	Financial
Liability –
Derivative
341 	12 	Net fair value
gains on financial
assets at fair
value through
profit or loss
Call options 	161 	14 	– 	Financial
Asset –
Derivative
61 	1 	Net fair value
gains on financial
assets at fair
value through
profit or loss
Interest rate risk 	4 500 	– 	(516) 	372 	–
Interest rate swaps 	4 500 	– 	(516) 	Financial
Liability –
Derivative
372 	– 	Net fair value
gains on financial
assets at fair
value through
profit or loss
* Amount is less than R500 000.
Refer to note 3.4.1 for a detailed description of the derivative financial instruments listed above.
Group
R million
Changes in
the value of
the hedging
instrument
recognised
in other
comprehen-
sive income
Amount
reclassified
from the
cash flow
hedge
reserve to
profit or
loss
Line item
in which
the recycled
amount is
presented
Carrying amount of the
hedged item
Changes in
fair value of
hedged item
used for
calculating
hedge
ineffective-
ness
Cash flow
hedge
reserve	Assets 	Liabilities
Equity price risk 	(409) 	309 	– 	(389) 	27 	(87)
Total return swaps 	(348) 	249 	Cash flow
hedges –
gains
recycled to
profit or loss
– 	(381) 	68 	(81)
Call options 	(61) 	60 	Cash flow
hedges –
gains
recycled to
profit or loss
– 	(8) 	(41) 	(6)
Interest rate risk 	(353) 	10 	– 	(4 536) 	366 	(516)
Interest rate
swaps
(353) 	10 	Cash flow
hedges –
gains
recycled to
profit or loss
– 	(4 536) 	366 	(516)

-- 97 of 198 --

100 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
13. 	DERIVATIVE FINANCIAL INSTRUMENTS continued
Year ended 30 June 2019
Group
R million
Notional
amount of
the hedging
instrument
Carrying amount of the
hedging instrument
Line item in
the Statement
of financial
position
where the
hedging
instrument is
presented
Changes
in fair value
of hedging
instrument
used for
calculating
hedge
ineffective-
ness
Ineffective-
ness
recognised
in profit
or loss
Line item in
which hedge
ineffective-
ness
is presented	Assets 	Liabilities
Equity price risk 	1 579 	176 	(86) 	(419) 	5
Total return swaps 	1 260 	85 	(86) 	Financial
Assets –
Derivatives
(341) 	5 	Net fair value
gains on
financial
assets at fair
value through
profit or loss
Call options 	319 	91 	– 	Financial
Assets –
Derivatives
Financial
Liabilities –
Derivatives
(78) 	* 	Net fair value
gains on
financial
assets at fair
value through
profit or loss
Interest rate risk 	3 825 	– 	(163) 	(154) 	–
Interest rate swaps 	3 825 	– 	(163) 	Financial
Liabilities –
Derivatives
(154) 	– 	Net fair value
gains on
financial
assets at fair
value through
profit or loss
* Amount is less than R500 000.
Refer to note 3.4.1 for a detailed description of the derivative financial instruments listed above.
Group
R million
Changes in
the value of
the hedging
instrument
recognised
in other
comprehen-
sive income
Amount
reclassified
from the
cash flow
hedge
reserve to
profit or
loss
Line item in
which the
recycled
amount is
presented
Carrying amount of the
hedged item
Changes in
fair value of
hedged item
used for
calculating
hedge
ineffective-
ness
Cash flow
hedge
reserve	Assets 	Liabilities
Equity price risk 	(33) 	104 	– 	741 	459 	1
Total return swaps 	(15) 	79 	Cash flow
hedges
– gains
recycled to
profit or loss
– 	679 	376 	3
Call options 	(18) 	25 	Cash flow
hedges –
gains recycled
to profit or
loss
– 	62 	83 	(2)
Interest rate risk 	124 	(7) 	– 	3 854 	146 	(175)
Interest rate
swaps
124 	(7) 	Cash flow
hedges
– gains
recycled to
profit or loss
– 	3 854 	146 	(175)

-- 98 of 198 --

101 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
14. 	INSURANCE RECEIVABLES, CONTRACT RECEIVABLES AND OTHER
RECEIVABLES
R million
Group
2020
Group
2019
Receivables arising from insurance and reinsurance contracts: 	6 179 	4 920
– Premium debtors 	692 	558
– Less provision for impairment of premium debtors 	14.1 	(93) 	(83)
– Reinsurance debtors 	5 580 	4 445
Contract receivables 	1 413 	1 369
– Closed scheme debtors 	103 	100
– Discovery Health Medical Scheme 	650 	670
– International partner market receivables 	196
– Other contract receivables 	709 	403
– Less allowance for expected credit losses 	14.2 	(49) 	–
Other non-financial receivables1 	1 081 	849
– Prepayments 	898 	729
– Value-added tax asset 	104 	75
– Other debtors 	79 	45
Other financial receivables: 	2 763 	1 877
– Discovery Unit Trust debtors 	1 169 	626
– Expired hedge receivables 	– 	24
– FNB – DiscoveryCard receivable 	52 	70
– Cash-in-transit debtors 	96 	86
– Loans to BEE initiatives 	213 	165
– Security deposit on derivatives 	407 	39
– Vitality partner debtors 	116 	76
– BEE partners’ rights-issue funding 	19 	17
– Agents and brokers 	491 	390
– Other debtors1 	636 	727
– Less allowance for expected credit losses 	14.2 	(436) 	(343)
Total insurance receivables, contract receivables and other receivables 	11 436 	9 015
Current 	7 140 	6 018
Non-current 	4 296 	2 997
11 436 	9 015
1 These non-financial assets have been excluded from the risk disclosures presented in note 3.
The carrying value approximates the fair value due to the short term nature of these receivables, or for longer term receivables,
they are interest bearing at market rates and fully secured.

-- 99 of 198 --

102 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
14.1 Provision for impairment of premium debtors
Group
R million 	<30 days
30 – 60
days
60 – 120
days
more than
120 days 	Total
Year ended 30 June 2020
Balance at beginning of the year 	44 	25 	9 	5 	83
Increase in provision 	11 	25 	7 	5 	48
Amount utilised during the period 	(9) 	(18) 	(9) 	(4) 	(40)
Translation difference 	* 	1 	* 	1 	2
Balance at end of the year 	46 	33 	7 	7 	93
Year ended 30 June 2019
Balance at beginning of the year 	31 	22 	6 	4 	63
Increase in provision 	13 	19 	11 	5 	48
Amount utilised during the period 	* 	(16) 	(8) 	(4) 	(28)
Translation difference 	* 	* 	* 	* 	*
Balance at end of the year 	44 	25 	9 	5 	83
* Amount is less than R500 000.
14.1 Reconciliation of expected credit losses (ECL)
Group
R million
General model 	Simplified model
Stage 1
(12month
ECL)
Stage 2
(Lifetime
ECL)
Stage 3
(Lifetime
ECL/ credit
impaired)
Not
Credit
impaired
90 days
past due/
credit
impaired 	Total
Year ended 30 June 2020
Balance at beginning of the year 	44 	3 	192 	80 	26 	345
Increase in provision 	6 	5 	57 	51 	92 	211
Amount utilised during the period 	(9) 	– 	– 	(8) 	(61) 	(78)
Translation difference 	7 	– 	– 	– 	– 	7
Balance at end of the year 	48 	8 	249 	123 	57 	485
Year ended 30 June 2019
Balance at beginning of the year 	31 	2 	177 	7 	15 	232
Increase in provision 	16 	* 	15 	73 	43 	147
Amount utilised during the period 	(3) 	– 	– 	– 	(33) 	(36)
Translation difference 	* 	– 	– 	– 	– 	*
Balance at end of the year 	44 	2 	192 	80 	25 	343
* Amount is less than R500 000.
15. 	REINSURANCE CONTRACTS
R million
Group
2020
Group
2019
Reinsurers’ share of insurance contract liabilities 	400 	314
Current 	400 	314
Amounts due from reinsurers in respect of claims paid and reported by the Group on the contracts that are reinsured are
included in Insurance receivables, contract receivables and other receivables (refer to note 14).

-- 100 of 198 --

103 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
16. 	CASH AND CASH EQUIVALENTS
R million
Group
2020
Group
2019
Cash at bank and in hand 	16 990 	7 972
Short-term deposits 	919 	1 431
17 909 	9 403
The fair value of cash and cash equivalents approximates the carrying amount due to the relatively short term nature of
the instrument.
17. 	SHARE CAPITAL AND SHARE PREMIUM
17.1 Ordinary share capital and share premium
Issued 	Treasury shares
Group
R million
Share
capital
Share
premium
Discovery
Health
BEE
share trust
Total
outstanding
At 1 July 2018 	1 	8 379 	(14) 	(58) 	8 308
Share movements:
– share issue 	* 	1 854 	– 	– 	1 854
– treasury shares delivered 	– 	– 	– 	4 	4
– treasury share purchases 	– 	– 	– 	(5) 	(5)
Share issue costs 	– 	(19) 	– 	– 	(19)
At 30 June 2019 	1 	10 214 	(14) 	(59) 	10 142
Share movements
– treasury shares delivered 	– 	– 	– 	10 	10
– treasury share purchases 	– 	– 	– 	(4) 	(4)
At 30 June 2020 	1 	10 214 	(14) 	(53) 	10 148
* Amount is less than R500 000.
Treasury shares
Number of shares 	Issued
Discovery
Health
BEE
share trust
Total
outstanding
At 1 July 2018 	646 844 992 	(680 268) 	(1 106 742) 	645 057 982
Share movements:
– share issue 	11 445 744 	– 	– 	11 445 744
– treasury shares delivered 	– 	– 	139 252 	139 252
– treasury shares purchased 	– 	– 	(40 000) 	(40 000)
At 30 June 2019 	658 290 736 	(680 268) 	(1 007 490) 	656 602 978
Share movements
– treasury shares delivered 	– 	– 	81 030 	81 030
– treasury share purchases 	– 	– 	(40 000) 	(40 000)
At 30 June 2020 	658 290 736 	(680 268) 	(966 460) 	656 644 008
The total authorised number of ordinary shares is 1 billion (2019: 1 billion), with a par value of 0.1 cent per share.
Share issue in 2019 financial reporting period
Discovery raised capital by way of a vendor consideration placement as contemplated in the JSE Listing Requirements and allowed
for in its Memorandum of Incorporation. This resulted in an increase in the capital of R1.85 billion. Costs of R19 million were incurred
in respect of the vendor consideration placement and have been written-off against share premium. Shares in issue have increased
by 11 445 744 shares (9 963 483 shares on 12 November 2018 and 1 482 261 shares on 29 November 2018) to 658 290 736 shares.

-- 101 of 198 --

104 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
17. 	SHARE CAPITAL AND SHARE PREMIUM continued
17.2 Preference share capital
R million
Group
2020
Group
2019
Authorised
40 000 000 A no par value preference shares 	– 	–
20 000 000 B preference shares of R100 each 	2 000 	2 000
20 000 000 C no par value preference shares 	– 	–
2 000 	2 000
Issued
8 000 000 B preference shares of R100 each 	800 	800
Share issue costs 	(21) 	(21)
At 30 June 	779 	779
The B preference shares are non-compulsory, non-cumulative, non-participating, non-convertible, voluntarily redeemable (at
option of Discovery) preference shares and were issued at a coupon rate of 85% of prime rate. With the introduction of dividend
withholding tax on 1 April 2012, the coupon rate on the preference shares was increased to 100% of the prime rate.
18. 	LIABILITIES ARISING FROM INSURANCE CONTRACTS
R million
Group
2020
Group
2019
Gross
– claims reported and loss adjustment expenses 	9 290 	8 428
– claims incurred but not reported 	1 754 	1 382
– EFA liability 	69 	60
– unearned premiums 	1 548 	544
– unit-linked insurance contracts 	49 752 	45 411
– with fixed and guaranteed terms 	19 998 	14 697
Total liabilities arising from insurance contracts, gross 	82 411 	70 522
Recoverable from reinsurers
– claims incurred but not reported 	(394) 	(312)
– unearned premiums 	(6) 	(2)
Total reinsurers’ share of liabilities arising from insurance contracts (refer to note 15) 	(400) 	(314)
Net
– claims reported and loss adjustment expenses 	9 290 	8 428
– claims incurred but not reported 	1 360 	1 070
– EFA liability 	69 	60
– unearned premiums 	1 542 	542
– unit-linked insurance contracts 	49 752 	45 411
– with fixed and guaranteed terms 	19 998 	14 697
Total liabilities arising from insurance contracts, net 	82 011 	70 208
Current1 	66 677 	57 405
Non-current 	15 334 	12 803
82 011 	70 208
1 Includes R54 646 million (2019: R49 783 million) which is repayable to policyholders on demand. For contractual maturity refer to note 3.2.3.
Included in the change in liabilities arising from insurance contracts on the Statement of comprehensive income is R115 million (2019: R113 million)
of benefit expenses which is a reconciling item due to the cash flow impact of these benefit expenses in this note.

-- 102 of 198 --

105 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
18. 	LIABILITIES ARISING FROM INSURANCE CONTRACTS continued
Movements in the liabilities are as follows.
2020 	2019
Group
R million 	Gross Reinsurance 	Net 	Gross Reinsurance 	Net
Claims reported and loss
adjustment expenses and IBNR
Notified claims 	8 428 	* 	8 428 	7 296 	– 	7 296
Incurred but not reported 	1 382 	(312) 	1 070 	1 351 	(304) 	1 047
Balance at beginning of the year 	9 810 	(312) 	9 498 	8 647 	(304) 	8 343
Cash paid for claims settled in the year 	(11 441) 	23 	(11 418) 	(10 380) 	156 	(10 224)
Increase/(decrease) in liabilities:
– arising from current year claims 	13 121 	(137) 	12 984 	12 134 	(201) 	11 933
– arising from prior year claims 	(742) 	65 	(677) 	(577) 	35 	(542)
Translation differences 	296 	(33) 	263 	(14) 	2 	(12)
Balance at end of the year 	11 044 	(394) 	10 650 	9 810 	(312) 	9 498
Notified claims 	9 290 	– 	9 290 	8 428 	* 	8 428
Incurred but not reported 	1 754 	(394) 	1 360 	1 382 	(312) 	1 070
Balance at end of the year 	11 044 	(394) 	10 650 	9 810 	(312) 	9 498
EFA liability
Balance at beginning of the year 	60 	– 	60 	53 	– 	53
Increase in the year 	20 	– 	20 	17 	– 	17
Cash paid 	(11) 	– 	(11) 	(10) 	– 	(10)
Balance at end of the year 	69 	– 	69 	60 	– 	60
Provisions for unearned premiums
Balance at beginning of the year 	544 	(2) 	542 	551 	(4) 	547
Increase in the year 	1 942 	(6) 	1 936 	981 	(2) 	979
Release in the year 	(1 098) 	2 	(1 096) 	(982) 	4 	(978)
Translation differences 	160 	– 	160 	(6) 	– 	(6)
Balance at end of the year 	1 548 	(6) 	1 542 	544 	(2) 	542
* Amount is less than R500 000.
R million
Group
2020
Group
2019
Unit-linked insurance contracts
Balance at beginning of the year 	45 411 	40 631
Premiums received 	12 542 	10 502
Fair value adjustment 	57 	1 466
Withdrawals 	(7 008) 	(5 538)
Fees 	(1 143) 	(1 042)
Movement in negative insurance liability 	(522) 	(594)
Translation differences 	415 	(14)
Balance at end of the year 	49 752 	45 411
Balance is made up as follows:
Unit-linked liabilities 	54 646 	49 783
Negative insurance liability 	(4 894) 	(4 372)
49 752 	45 411
With fixed and guaranteed terms
Balance at beginning of the year 	14 697 	11 606
Expected movement in policyholder liabilities 	(2 716) 	(2 539)
Unwinding of discount rate 	835 	703
New business written 	6 352 	4 200
Experience variances 	830 	727
Balance at end of the year 	19 998 	14 697

-- 103 of 198 --

106 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
19. 	LIABILITIES ARISING FROM REINSURANCE CONTRACTS
R million
Group
2020
Group
2019
Financial reinsurance 	1 422 	1 462
Reinsurance recoveries relating to assets arising from insurance contracts (refer to note 5) 	11 043 	9 373
12 465 	10 835
Balance at beginning of the year 	10 835 	8 918
Increase in liability 	462 	1 984
– gross increase in liability 	598 	1 512
– receipt arising from reinsurance contracts 	2 588 	2 246
– reinsurance premiums paid 	(2 724) 	(1 774)
Translation differences 	1 168 	(67)
Balance at end of the year 	12 465 	10 835
Current 	1 278 	1 417
Non-current 	11 187 	9 418
12 465 	10 835
The liabilities arising from reinsurance contracts releases with the associated underlying insurance contracts.
20. 	BORROWINGS AT AMORTISED COST
R million 	Ref
Group
2020
Group
2019
Borrowings from banks 	(i) 	15 456 	11 034
Lease liabilities (2019: finance lease liability) 	(ii) 	4 380 	3 648
19 836 	14 682
Current 	1 345 	1 795
Non-current 	18 491 	12 887
19 836 	14 682
(i) 	Borrowings from banks
Movement analysis of borrowings
R million
Group
2020
Group
2019
Balance at beginning of the year 	11 034 	9 050
Loans raised 	10 339 	2 147
Loans repaid 	(6 389) 	(207)
Settlement of derivative capitalised to loan by counterparty 	(6) 	(7)
Interest accrued 	1 033 	875
Interest paid 	(957) 	(807)
Raising fees capitalised 	(29) 	(4)
Translation differences 	431 	(13)
Balance at end of the year 	15 456 	11 034

-- 104 of 198 --

107 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
20. 	BORROWINGS AT AMORTISED COST continued
(i) 	Borrowings from banks continued
SA borrowing facilities
DISCOVERY LIMITED
In 2017, Discovery registered an unsecured R10 billion Domestic Medium Term Note (DMTN) programme. In terms of this
programme, Discovery had issued a cumulative amount of R2.2 billion in JSE Listed Notes to 30 June 2019. Discovery further
issued, via bond placements, 5-year and 7-year Floating Rate Notes of R1.2 billion and R300 million respectively on
26 November 2019. During the current year, Discovery Limited refinanced 5-year bank facility loans totalling R3.6 billion entered
into in 2016 for a further 3 and 5 years, through the issue of a series unlisted DMTN notes totalling R1.1 billion and R2.5 billion
ultimately maturing in March 2023 and February 2025, respectively. IFRS treated the refinance as a derecognition event, resulting
in a net modification loss of R4 million in profit or loss. These unlisted notes have been structured through an underwritten
subscription agreement with a bank and guaranteed by Discovery Health and Discovery Vitality.Discovery Limited has other
borrowings of R1 billion (2019: R4.6 billion) for long term funding requirements. The borrowings were acquired for general
corporate purposes in order to fund the various growth initiatives within the Group.
The facilities have the following profile and salient terms.
Facility amount
R million 	Interest rate per annum Variable rate 	Maturity date
Capital
repayment
500 	Fixed at 9.71% 1 	3 month Jibar 	21 November 2022 	Maturity
1 000 	Fixed at 10.28%1 	3 month jibar + 245bps 	02 March 2023 	Maturity
1 100 	Fixed at 8.92% 	– 	10 March 2023 	Maturity
200 	Fixed at 10.46%2 	– 	21 November 2024 	Maturity
800 	Fixed at 10.31%1 	3 month jibar + 191bps 	21 November 2024 	Maturity
1 200 	Fixed at 9.21%1 	3 month jibar + 191bps 	21 November 2024 	Maturity
2 500 	Fixed at 9.62% 	– 	22 February 2025 	Maturity
700 	Fixed at 10.29%1 	3 month jibar + 180bps 	21 August 2026 	Maturity
300 	Fixed at 9.40%1 	3 month jibar + 180bps 	21 November 2026 	Maturity
8 300
1 The interest rate has been fixed through interest rate swaps. Refer to discussion on “Interest Rate Risk” in note 3.4.1.
2 Interest is payable semi-annually in arrears.
The borrowings are unsecured senior debt and are not callable or convertible. Interest is payable quarterly in arrears, other than
footnote 2 in the table above.
As indicated above, certain borrowing facilities which have floating interest rates have been hedged using interest rate swaps.
This is aligned with the Group’s strategy to manage exposure to interest rate. The change in the fair value of the related borrowing
facility used as the basis for calculating and recognising any hedge effectiveness for the period is R366 million. Please refer to
note 13 for more detail on the interest rate swaps.
For variable rate loans, the amortised cost approximates fair value. For fixed rate loans, the fair value does not materially differ
from the amortised cost.
DISCOVERY CENTRAL SERVICES
Discovery Central Services, a subsidiary of the Discovery Limited, entered into a new unsecured R1.4 billion five year loan facility
in December 2018. Interest on this facility has been fixed at 10.60% per annum. Interest is payable quarterly in arrears and capital
is repayable in full at maturity on 20 December 2023.
Discovery Central Services previously also entered into borrowing facilities for an amount of R650 million. Interest rates on the
utilised amount is fixed at a weighted average rate of 11.56% per annum, with capital and interest repayable in instalments over
the duration of the loan facility.
During the current financial year R68 million (2019: R82 million) of this facility was repaid. The balance owing at 30 June 2020
amounts to R543 million (2019: R548 million) which includes accrued interest.
Discovery Health Proprietary Limited, Discovery Vitality Proprietary Limited and Discovery Limited have provided guarantees in
respect of the Discovery Central Services facilities.
Discovery Central Services also drew down on an unsecured revolving credit facilities of R0.5 billion, interest rates between 6.7%
and 7.94% per annum, which were repaid during the year.

-- 105 of 198 --

108 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
20. 	BORROWINGS AT AMORTISED COST continued
DISCOVERY BANK
Discovery Bank, a subsidiary of the Discovery Limited, entered into a 2 year revolving credit facility of R1 billion. The facility is
structured with R0.5 billion guaranteed by Discovery Limited, Discovery Vitality and Discovery Health, while the remaining
R0.5 billion is not guaranteed. Interest on both facilities is linked to the 3-month JIBAR plus a margin of 1.25% per annum and
1.35% per annum. Interest is payable quarterly in arrears and capital is repayable in full at maturity on 19 July 2021.
UK borrowing facilities
Discovery Finance Company Europe Limited (DFinCo), registered in the UK and a wholly-owned subsidiary of Discovery Limited,
previously entered into term facilities totalling GBP 150 million. These borrowings were used to fund the new business acquisition
costs incurred by VitalityLife, which were previously funded by The Prudential Assurance Company Limited (Prudential).
Discovery had GBP 90 million owing on this facility at 30 June 2019. A further GBP10 million of this facility was repaid during the year.
The remaining GBP 80 million was refinanced into a new amortising facility in March 2020, for a further 40 months to 31 July 2023.
DFinCo also entered into a credit facility agreement totalling GBP 28 million on 17 April 2020. These facilities are short-term in nature
repayable on 17 April 2021.
The salient terms of the facilities are as follows:
FACILITY 1
Facility amount: 	GBP 80 million
Facility utilised: 	GBP 80 million
Type of borrowings: 	Senior unsecured
Capital repayable: 	Bi-annual instalments of GBP 7.5 million commences on 1 April 2021, with a final bullet payment at
maturity of GBP 42.5 million
Interest rate: 	Floating, linked to 3 month London Interbank Offered Rate (LIBOR plus a margin of 2.65%
Security: 	None
Maturity date: 	31 July 2023
Callable/Convertible: 	Not applicable
Interest payable: 	Quarterly in arrears
FACILITY 2
Facility amount: 	GBP 28 million
Facility utilised: 	GBP 28 million
Type of borrowings: 	Senior unsecured
Capital repayable: 	Repayable at maturity
Interest rate: 	Fixed at 1% per annum
Security: 	None
Maturity date: 	17 April 2021
Callable/Convertible: 	Not applicable
Interest payable: 	Quarterly in arrears
Discovery Holdings Europe Limited, registered in the UK and ultimately a wholly-owned subsidiary of Discovery Limited, entered into
term facilities totalling GBP 55 million. These facilities are earmarked to fund the new business acquisition costs incurred by VitalityLife.
The salient terms of the refinanced facility is as follows:
FACILITY
Facility amount: 	GBP 55 million
Facility utilised: 	GBP 55 million
Type of borrowings: 	Senior unsecured
Capital repayable: 	Repayable at maturity
Interest rate: 	Floating, linked to 3 month London Interbank Offered Rate (LIBOR plus a margin of 2.29%
Security: 	None
Maturity date: 	31 July 2023
Callable/Convertible: 	Not applicable
Interest payable: 	Quarterly in arrears
Discovery Limited, Discovery Health Proprietary Limited and Discovery Vitality Proprietary Limited have provided guarantees in
respect of all of the UK borrowing facilities. The UK borrowing facilities impose limitations on total borrowings applicable to the UK
entities. A breach of these restrictions would require immediate repayment of any outstanding balance. At 30 June 2020 there was
no breach.

-- 106 of 198 --

109 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
20. 	BORROWINGS AT AMORTISED COST continued
(ii) 	Leases
R million
Group
2020
Balance at beginning of the year – old finance leases 	3 648
Balance at beginning of the year – IFRS 16 transition 	748
New leases entered into 	44
Interest payable 	441
Repayments 	(576)
Translation difference 	75
Balance at the end of the year 	4 380
Total payments for leases for the year is R826 million.
Group
R million
Minimum
lease
payments
Finance
cost
Present
value
30 June 2019
Due within one year 	408 	(51) 	357
Due between two and five years 	1 823 	(532) 	1 291
Due between six and ten years 	2 821 	(1 517) 	1 304
Due between eleven and fifteen years 	2 490 	(1 794) 	696
7 542 	(3 894) 	3 648
During the 2018 financial year Discovery took occupation of a new head office building under a finance lease. A lease liability and
related asset (refer to note 6) of R3 155 million was raised. At year end, R3 370 million (2019: R3 321 million) remained outstanding.
Finance charges of R362 million (2019: R357 million) have been recognised in profit or loss and repayments of R313 million (2019:
R286 million) have been made.
21. 	INVESTMENT CONTRACTS AT FAIR VALUE THROUGH PROFIT OR LOSS
R million
Group
2020
Group
2019
The movements during the year were as follows:
Balance at beginning of the year 	20 674 	17 927
Deposits received 	8 085 	5 342
Account balances paid on withdrawal and other terminations in the year 	(5 898) 	(3 404)
Fair value adjustment 	151 	809
Balance at end of the year 	23 012 	20 674
Current 1 	23 012 	20 674
1 There is no maturity profile for these liabilities as this will depend on policyholder behaviour. Contractually, policyholders may disinvest on demand.
The fair value of cash and cash equivalents approximates the carrying amount due to the relatively short term nature of
the instrument.
The benefits offered under the Group’s unit-linked investment contracts are based on the return of selected equities, debt securities
and money market securities. The Group communicates the actual performance of these contracts to its contract holders.
Investment contracts at fair value through profit or loss (are exactly matched with related assets and managed collectively as a
pool). Discovery’s credit risk is not reflected in the measurement of the assets or consequently the liability, which is measured
with reference to the underlying assets. Own credit risk has been assessed and determined to be immaterial.

-- 107 of 198 --

110 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
22. 	OTHER PAYABLES AT AMORTISED COST
R million
Group
2020
Group
2019
Commissions payable 	300 	231
Digicore payable 	9 	11
Discovery Unit Trust creditors 	432 	421
Due to reinsurers 	667 	326
Intermediary payables 	90 	92
Payables and accrued liabilities 	2 399 	2 422
Payroll creditors 	845 	963
Policyholder unallocated funds 	564 	414
Security deposits on derivatives1 	1 150 	285
Straight-lining operating lease payments 	– 	53
Unsettled trades 	148 	49
VitalityLife working capital funding2 	6 627 	4 199
Expired hedge payables 	29 	–
Other financial payables 	673 	529
Other non-financial payables 	300 	267
Value-added tax liability3 	155 	142
Premiums received in advance 	145 	125
14 233 	10 262
Current 	5 956 	5 665
Non-current 	8 277 	4 597
14 233 	10 262
1 2020 Reflects a nil amount as in terms of the level premium reinsurance treaty entered into, a security deposit was required to be placed by the
reinsurer, to reduce counterparty risk. During the 2020 financial year, additional amounts were received as ‘deposit back’ in excess of the negative
reserve funding. The agreements indicate that offset is applicable up to the amount of the negative reserve funding. Any additional amounts of the
deposit back received thereafter, are included in cash. This value represents the corresponding liability.
2 Includes the ‘deposit back’ of GBP 288 million (R6 176 million) (2019: GBP 194 million (R3 491 million)) related to the level premium reinsurance treaty
in respect of business written on Prudential Assurance Company’s (Prudential’s) life license, payable to the reinsurer. Refer to note 3.5.
3 Value-added tax liabilities and premiums received in advance are non-financial liabilities and have been excluded from the risk disclosures presented
in note 3.
23. 	DEFERRED INCOME TAX
R million
Group
2020
Group
2019
Deferred tax asset – non-current 	3 511 	2 372
Deferred tax liability – non-current 	(8 514) 	(8 697)
Total 	(5 003) 	(6 325)
Movement summary
Balance at beginning of the year 	(6 325) 	(6 033)
Income statement charge 	1 122 	(258)
Capital gains taxations charged to other comprehensive income 	14 	1
Deferred tax on cash flow hedge charged to other comprehensive income 	13 	12
Deferred tax recognised on business combination 	1 	(42)
Translation differences 	172 	(5)
Balance at end of the year 	(5 003) 	(6 325)

-- 108 of 198 --

111 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
23. 	DEFERRED INCOME TAX continued
Deferred taxation comprises:
Group
R million
Opening
balance
Charge for
the year
Translation
differences
Closing
balance
Year ended 30 June 2020
Assessed loss in Company Policyholder's Fund 	226 	(23) 	– 	203
Assessed loss in Individual Policyholder's Fund 	728 	126 	– 	854
Assessed loss in subsidiaries 	1 313 	394 	78 	1 785
Unrealised gains/(losses) on financial instruments 	(50) 	43 	– 	(7)
Cash flow hedge 	(13) 	65 	– 	52
Deferred acquisition costs 	(167) 	(5) 	6 	(166)
Contract liability 	24 	(13) 	7 	18
Difference between accounting and tax balances arising
from insurance contracts 	(8 854) 	173 	– 	(8 681)
Difference between wear and tear and depreciation 	(1 150) 	(108) 	(1) 	(1 259)
Leases 	1 014 	72 	2 	1 088
Intangibles recognised on acquisition of businesses 	(72) 	10 	(12) 	(74)
Prepayments 	(41) 	1 	– 	(40)
Provisions 	161 	64 	– 	225
Share-based payments 	93 	(43) 	1 	51
Unutilised special transfer balances 	477 	111 	– 	588
Other 	(14) 	283 	91 	360
(6 325) 	1 150 	172 	(5 003)
Group
R million
Opening
balance
Charge for
the year
Translation
differences
Closing
balance
Year ended 30 June 2019
Assessed loss in Company Policyholders’ Fund 	69 	157 	– 	226
Assessed loss in Individual Policyholders’ Fund 	579 	149 	– 	728
Assessed loss in subsidiaries 	655 	662 	(4) 	1 313
Unrealised gains/(losses) on financial instruments 	(117) 	67 	– 	(50)
Cash flow hedge 	(36) 	23 	– 	(13)
Deferred acquisition costs 	(198) 	31 	– 	(167)
Contract liability 	55 	(31) 	– 	24
Difference between accounting and tax balances arising
from insurance contracts 	(7 875) 	(979) 	– 	(8 854)
Difference between wear and tear and depreciation 	(131) 	(1 019) 	– 	(1 150)
Finance leases 	5 	1 005 	– 	1 010
Intangibles recognised on acquisition of businesses 	(85) 	13 	– 	(72)
Operating leases 	4 	– 	– 	4
Prepayments 	(10) 	(31) 	– 	(41)
Provisions 	144 	18 	(1) 	161
Share-based payments 	89 	4 	– 	93
Unutilised special transfer balances 	570 	(93) 	– 	477
Pre-trade expenditure 	127 	(127) 	– 	–
Other 	116 	(130) 	– 	(14)
(6 039) 	(281) 	(5) 	(6 325)

-- 109 of 198 --

112 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
23. 	DEFERRED INCOME TAX continued
Assessed losses
Discovery did not recognise deferred tax assets in respect of the following assessed losses:
R million
Group
2020
Group
2019
Vitality Group International, Inc (will begin to expire in 2021) 	– 	1 150
Discovery Central Services (Pty) Ltd 	1 356 	681
Discovery Connect Distribution Services (Pty) Ltd 	524 	445
Discovery Group Europe Ltd 	50 	11
Discovery Life – Individual Policyholders’ Fund 	9 994 	11 427
Discovery Medical Suppliers (Pty) Ltd 	– 	3
Discovery Partner Market Services PTE LTD 	51 	49
Grove Nursing Services (Pty) Ltd 	36 	31
PrimeMed Administrators (Pty) Ltd 	– 	2
Southern Rx (Pty) Ltd 	80 	70
Discovery Vitality Australia (Pty) Ltd 	126 	70
12 217 	13 869
A deferred tax asset has been recognised on assessed losses in the Discovery Life Individual Policyholder Fund. Refer to note 4.3.
Deferred tax assets have been raised in respect of tax losses in Discovery Life Investment Services, Discovery Vitality, Vitality
Health and Discovery Insure. The Group recognises deferred tax assets on carried forward losses to the extent there are sufficient
estimated future taxable profits and/or taxable temporary differences against which the tax losses can be utilised.
24. 	EMPLOYEE BENEFITS
R million
Group
2020
Group
2019
Leave pay
Balance at beginning of the year 	260 	232
Additional provisions raised 	331 	335
Used during the year 	(283) 	(282)
Paid to terminated employees 	(24) 	(25)
Balance at end of the year 	284 	260
Current 	229 	215
Non-current 	55 	45
284 	260

-- 110 of 198 --

113 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
25. 	NET INSURANCE PREMIUM REVENUE
R million
Group
2020
Group
2019
Health 	7 688 	7 157
Recurring premiums 	9 278 	8 552
Reinsurance premiums 	(1 590) 	(1 395)
Individual life and invest 	30 176 	25 368
Recurring premiums 	23 883 	19 547
Single premiums 	10 777 	9 603
Reinsurance premiums 	(4 484) 	(3 782)
Group life 	1 945 	1 964
Recurring premiums 	2 131 	2 108
Reinsurance premiums 	(186) 	(144)
Short-term insurance 	3 658 	2 952
Recurring premiums 	3 706 	3 226
Reinsurance premiums 	(48) 	(274)
43 467 	37 441
Insurance premium revenue 	49 775 	43 036
Outward reinsurance premiums 	(6 308) 	(5 595)
43 467 	37 441
26. 	INVESTMENT INCOME
R million
Group
2020
Group
2019
At amortised cost interest income using the effective interest rate method 	36 	5
Cash and cash equivalents interest income using the effective interest rate method 	343 	393
379 	398
Attributable to:
– shareholders 	207 	190
– policyholders 	172 	208
379 	398

-- 111 of 198 --

114 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
27. 	NET FAIR VALUE GAINS ON FINANCIAL ASSETS AT FAIR VALUE
THROUGH PROFIT OR LOSS
R million
Group
2020
Group
2019
Investment income 	2 496 	2 231
– Interest 	2 155 	1 891
– Dividends 	341 	340
Net realised gains 	426 	324
Net fair value (losses)/gains 	(215) 	599
Hedge ineffectiveness 	(13) 	5
Mutual fund contributions 	1 399 	1 106
4 093 	4 265
28. 	NET CLAIMS AND POLICYHOLDERS’ BENEFITS
R million
Group
2020
Group
2019
Health insurance claims 	3 700 	3 580
Gross claims 	4 875 	4 669
Less: Reinsurance recoveries 	(1 175) 	(1 089)
Individual life insurance claims 	3 984 	4 117
Death 	2 139 	2 532
Disability 	2 704 	2 679
Payback benefits 	1 343 	1 119
Less: Reinsurance recoveries 	(2 202) 	(2 213)
Group life insurance claims 	1 566 	1 699
Death 	819 	791
Disability 	911 	1 078
Payback benefits 	8 	5
Less: Reinsurance recoveries 	(172) 	(175)
Individual investment benefits 	10 721 	9 010
Surrenders 	10 106 	8 476
Guaranteed payments 	57 	59
Annuity payments 	558 	475
Short-term insurance claims 	3 275 	2 473
Gross claims 	3 336 	2 655
Less: Reinsurance recoveries 	(61) 	(182)
23 246 	20 879
Claims and policyholders’ benefits 	26 856 	24 538
Insurance claims recovered from reinsurers 	(3 610) 	(3 659)
Net claims and policyholders’ benefits 	23 246 	20 879
29. 	ACQUISITION COSTS
R million
Group
2020
Group
2019
Commission and other costs obtaining contracts 	6 550 	6 172
Movement in deferred acquisition costs (refer to note 8) 	(3) 	(72)
6 547 	6 100

-- 112 of 198 --

115 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
30. 	MARKETING AND ADMINISTRATION EXPENSES
R million
Group
2020
Group
2019
Auditors remuneration
Audit fees 	69 	55
Fees for other services 	14 	1
Prior year 	1 	6
84 	62
Lease charges
Operating lease charges – property 	– 	149
Operating lease charges – computer and office equipment 	– 	143
Short-term leases 	74 	–
Low value item leases 	176
250 	292
Staff costs including executive directors1
Salaries, wages and allowances 	7 061 	6 082
Medical aid fund contributions 	421 	368
Defined contribution provident fund contributions 	336 	296
Social security levies 	263 	239
Share-based payment expenses
– equity-settled 	164 	13
– cash-settled 	54 	455
– loss on cash flow hedge 	360 	26
Staff training 	51 	68
Recruitment fees 	36 	54
Temporary staff 	216 	237
Provision for leave pay 	48 	53
Other 	247 	203
9 257 	8 094
Other operating costs
Amortisation of software (note 7) 2 	1 111 	735
Building related and office costs 	524 	495
Depreciation of property and equipment (note 6) 	643 	519
Loss on derecognition of assets 	196 	–
(Gains)/losses on disposal of property and equipment 	(3) 	2
Impairment of intangible assets 	63 	32
Allowance for expected credit losses on receivables 	90 	50
Insurance 	37 	34
IT systems and consumables 	1 971 	1 597
Marketing and distribution costs 	1 254 	1 282
Non-executive directors fees 	27 	27
Professional fees 	707 	656
Vitality benefit expenses 	3 964 	3 856
Other operating expenses 	1 943 	2 240
12 527 	11 506
Total marketing and administration expenses 	22 118 	19 954
1 Executive directors’ and prescribed officers’ remuneration is included in employee costs. Refer to Directorate for detailed disclosure.
2 The transactions relating to business combinations are not included in marketing and administration expenses as it is disclosed separately in the
income statement.

-- 113 of 198 --

116 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
31. 	SHARE-BASED PAYMENTS AND LONG TERM INCENTIVES
Incentive schemes
Discovery operates various share-based payment and long term incentive arrangements. The details of these arrangements are
described below:
1. BEE STAFF SHARE TRUST
In 2005, 5 290 000 shares in Discovery Limited’s shares were issued to the BEE staff share trust for current and future
employees. These shares had all been allocated during prior years. 980 000 additional shares have been purchased
accumulatively in prior years, for future allocation to employees. An additional 40 000 shares were purchased by the BEE staff
share trust during the current year. The trusts consists of two components; the allocation scheme and the option scheme as
described below.
ALLOCATION SCHEME
Shares have been allocated to senior black employees based on level of seniority and length of past service. The shares vest
to employees two, three, four and five years after allocation at a rate of 25% per annum. On each vesting date, the trustees
shall distribute to the employees the allocated shares to which the employee may be entitled.
OPTION SCHEME
Options granted to black employees may be exercised two, three, four and five years after the option is granted at a rate of
25% per annum. Any options not exercised by the end of the fifth year from the grant date shall lapse. On exercise of the
option, the employee pays cash to the trust for the full purchase price of the option.
2. DISCOVERY’S PHANTOM SCHEME
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the performance of the
Discovery Limited share price. The bonus is earned if the participant is employed on each vesting date. For units issued in
September, the vesting of the units is two, three, four and five years after allocation of the bonus units. The bonus may not
be carried forward.
The 2013 – 2018 allocations were pre-determined combinations of units that replicate the economics of a Discovery Limited
share and units that replicate the economics of a call option over a Discovery Limited share.
3. DISCOVERY’S LONG-TERM INCENTIVE PLAN (EQUITY SETTLED)
The Discovery Long-term incentive plan (LTIP) was introduced in the financial year ended 30 June 2020 and replaces the cash-
settled Discovery Phantom scheme (see point 2 above) with an equity-settled LTIP.
Participants will receive Discovery Limited shares subject to performance criteria and if the participant is employed on each
vesting date. The performance conditions are aligned to the organic growth methodology of the Group and will vest from
between the 3rd and 5th anniversary of these awards.
4. ACQUISITION SCHEMES
There are various schemes offered to franchise directors, agents and employees where participants are allocated share units
which replicate the economics of a Discovery Limited share. The share units are settled as a cash bonus on vesting. The
bonus is earned if the participant is employed on the vesting date. The vesting periods on the schemes vary from two to five
years. The bonus may not be carried forward.
5. THE VITALITY GROUP PHANTOM STOCK PLAN
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the performance of
Vitality Group Inc. share price. The bonus is earned if the participant is employed on each vesting date. The units typically vest
equally over a four year period but three year vesting grants are offered as well.
Other long term incentive schemes
The following schemes are long term staff incentives where the value is determined with reference to something other than the
Discovery Limited share price. These schemes are accounted for in terms of IAS 19: Employee benefits.
6. THE VITALITYHEALTH AND VITALITYLIFE PHANTOM SHARE SCHEME
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the performance of
VitalityLife and VitalityHealth, and more specifically the Value of In Force (ViF) of VitalityLife and the Embedded Value (EV) of
VitalityHealth. The bonus is earned if the participant is employed on each vesting date. For units issued, the vesting of the
units is two, three and four years after allocation of the bonus units. The bonus may not be carried forward.

-- 114 of 198 --

117 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
31. 	SHARE-BASED PAYMENTS AND LONG TERM INCENTIVES continued
7. THE VITALITYHEALTH AND VITALITYLIFE SCHEME
Shares in Discovery Holdings Europe Limited were issued to participants. The participants had the option to sell the shares
at any point in time until 12 March 2019 at which time their holding company, Discovery Group Europe Limited, had an
obligation to purchase the shares from them.
8. OTHER DEVELOPMENT SEGMENT SCHEMES
Various other long term incentive schemes exist in the Discovery Group in the development segments. These schemes are
individually and in aggregate immaterial and as a result no further information is disclosed.
The share/option schemes mentioned in bullet 1 and 3 have been classified as equity-settled schemes and therefore a share-
based payment reserve has been recognised. The schemes mentioned in bullets 2, 3 and 5 have been classified as cash-settled
schemes and a liability is raised in terms of IFRS 2. The other long term incentive schemes, have been accounted for in terms of
IAS 19.
The following is a summary of the terms and conditions of the units granted:
Date granted
Share/
Option
price
Final
vesting
date
Shares
under
option at
beginning
of year
Share/
Options
granted
during
year
Share/
Options
vested
during
year
Share/
Options
cancelled
or adjusted
during year
Shares
under
option
at end
of year
1. BEE staff share trust
01/07/2013 – 30/06/2014 	R0.00 	30/09/2019 	1 944 	– 	(626) 	(1 318) 	–
01/07/2014 – 30/06/2015 	R0.00 	28/02/2020 	8 253 	– 	(8 253) 	– 	–
01/07/2015 – 30/06/2016 	R0.00 	30/09/2021 	23 394 	– 	(10 856) 	(1 691) 	10 847
01/07/2015 – 30/06/2016 	R122.40 	01/03/2021 	11 029 	– 	– 	– 	11 029
01/07/2015 – 30/06/2016 	R121.50 	30/03/2021 	24 692 	– 	– 	– 	24 692
01/07/2016 – 30/06/2017 	R0.00 	02/05/2022 	103 435 	– 	(31 280) 	(6 874) 	65 281
01/07/2016 – 30/06/2017 	R113.00 	30/11/2021 	3 186 	– 	(1 062) 	– 	2 124
01/07/2016 – 30/06/2017 	R122.50 	30/11/2021 	106 671 	– 	– 	(5 224) 	101 447
01/07/2017 – 30/06/2018 	R0.00 	22/05/2023 	87 377 	– 	(28 835) 	4666 	63 208
01/07/2018 – 30/06/2019 	R0.00 	30/04/2024 	19 303 	– 	(1 124) 	11 947 	30 126
01/07/2018 – 30/06/2020 	R0.00 	30/09/2025 	– 	61 050 	– 	(4 158) 	56 892
2. The Discovery Limited
phantom scheme
01/07/2014 – 30/06/2015 	R0.00 	30/09/2019 	259 764 	– 	(253 979) 	(5 785) 	–
01/07/2014 – 30/06/2015 	R97.89 	30/09/2019 	519 534 	– 	(507 963) 	(11 571) 	–
01/07/2015 – 30/06/2016 	R0.00 	30/04/2021 	454 652 	– 	(224 068) 	(12 918) 	217 666
01/07/2015 – 30/06/2016 	R122.50 – R134.94 	30/04/2021 	899 546 	– 	(443 259) 	(25 837) 	430 450
01/07/2016 – 30/06/2017 	R0.00 	30/04/2022 	1 626 233 	– 	(539 402) 	(56150) 	1 030 681
01/07/2016 – 30/06/2017 	R110.40 – R115.23 	30/04/2022 	319 797 	– 	(105 646) 	(8 064) 	206 087
01/07/2017 – 30/06/2018 	R0.00 	31/03/2023 	2 341 474 	– 	(579 193) 	(73 408) 	1 688 873
01/07/2017 – 30/06/2018 	R84.76 – R141.65 	31/03/2023 	721 580 	– 	(181 466) 	(8 360) 	531 754
01/07/2018 – 30/06/2019 	R0.00 	31/03/2024 	1 981 744 	– 	(15 952) 	(52 905) 	1 912 887
3. Discovery LTIP
(equity settled)
01/07/2019 – 30/06/2020 	R0.00 	30/09/2024 	– 	3 606 216 	– 	(25 544) 	3 580 672
4. Acquisition schemes
01/07/2013 – 30/06/2014 	R0.00 	30/06/2019 	2 168 	– 	– 	(329) 	1 839
01/07/2014 – 30/06/2015 	R0.00 	30/06/2020 	37 345 	– 	(31 262) 	(1 943) 	4 140
01/07/2015 – 30/06/2016 	R0.00 	30/06/2021 	93 473 	– 	(46 424) 	(8 990) 	38 059
01/07/2016 – 30/06/2017 	R0.00 	30/06/2022 	747 282 	– 	(635 562) 	(20 436) 	91 284
01/07/2017 – 30/06/2018 	R0.00 	30/06/2023 	640 099 	– 	(36 437) 	(38 071) 	565 591
01/07/2018 – 30/06/2019 	R0.00 	30/06/2024 	684 445 	– 	(9 061) 	(26 434) 	648 950
01/07/2019 – 30/06/2020 	R0.00 	30/06/2025 	– 	766 481 	– 	– 	766 481
5. The Vitality Group
phantom stock plan
01/10/2015 	USD 0.00 	01/10/2019 	517 847 	– 	(517 847) 	– 	–
01/10/2016 	USD 0.00 	01/10/2020 	1 204 590 	– 	(602 295) 	(63 699) 	538 596
01/10/2017 	USD 0.00 	01/10/2021 	930 319 	– 	– 	(930 319) 	–
01/10/2018 	USD 0.00 	01/10/2022 	673 305 	– 	– 	(673 305) 	–

-- 115 of 198 --

118 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
31. 	SHARE-BASED PAYMENTS AND LONG TERM INCENTIVES continued
The Black-Scholes model was used to calculate the fair value of the following options based on the assumptions in the below
table:
Spot price 	Risk free rate 	Exercise price 	Option term 	Volatility
Dividend
yield
BEE staff share trust
Issued in prior years 	R113 – R127.14 	7.35% – 8.50% 	R113 – R122.50 	up to 1.25 years 	26.19% – 27.37% R0.71 – R1.07
Phantom scheme
01/07/2015 –
30/06/2016 	R104.55 	3.59% – 3.89% 	R122.50 – R134.94 	up to 0.83 years 	61.14% – 73.14% R0.85 – R0.90
01/07/2016 –
30/06/2017 	R104.55 	3.59% – 3.89% 	R114.96 – R115.23 	up to 1.25 years 	54.49% – 73.14% R0.88 – R0.98
01/07/2017 –
30/06/2018 	R104.55 	3.59% – 3.89% 	R134.94 – R141.65 	up to 2.25 years 	44.14% – 73.14% R1.01 – R1.07
The VitalityHealth and VitalityLife phantom share scheme is cash settled and thus repriced at each reporting date. The value of
the shares and options allocated are dependent on the performance of VitalityLife and VitalityHealth, more specifically the ViF of
VitalityLife and the EV of VitalityHealth. The valuation of the Discovery Holdings Europe Limited equity share scheme options, is
calculated on the same basis.
The Discovery Limited phantom scheme, long term incentive plan scheme and Acquisition schemes are cash-settled and are thus
repriced at each reporting date.
As noted in Note 3.4.1, Discovery is exposed to equity price risk through its cash-settled share incentive schemes, namely the
Phantom share scheme and the Acquisition share scheme, the details of which have been described above. To manage this risk,
Discovery has purchased a combination of total return swaps and call options from Ba2 – Baa3 (2019: Baa or A–) rated South
African banks to hedge a portion of its exposure to changes in the Discovery share price.
Please refer to note 13 for more detail on the derivatives.
32. 	FINANCE COSTS
R million
Group
2020
Group
2019
Interest expense on:
– Borrowings measured at amortised cost using the effective interest rate method 	1 033 	827
– Release from other comprehensive income 	10 	7
– Cash flow hedge recycled from other comprehensive income 	50 	39
– Redeemable preference shares 	– 	90
Breakage fee 	– 	33
Interest using the effective interest rate method 	– 	57
– Finance lease (IAS 17) 	– 	400
– Lease liabilities (IFRS 16) 	441 	–
– Interest on other payables using the effective interest rate method 	34 	12
1 568 	1 375
33. 	FOREIGN EXCHANGE GAINS/LOSSES
R million
Group
2020
Group
2019
Net foreign exchange gains/(losses) 	578 	*
* Amount is less than R500 000.
The total amount of foreign exchange gains losses recognised in profit or loss is R734 million (2019: R13 million) presented within
various within various line. The net foreign exchange gains and losses arise primarily from the foreign denominated loans.

-- 116 of 198 --

119 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
34. 	TAXATION
R million
Group
2020
Group
2019
Charge for the year:
Current taxation 	1 746 	1 047
Normal taxation 	1 723 	1 047
Capital gains taxation 	23 	–
Deferred taxation 	(1 122) 	258
624 	1 305
% 	%
Taxation rate reconciliation
Effective taxation rate 	78.0 	16.5
Subsidiary losses not provided for 	(95.5) 	(1.8)
Prior year (under)/ over provision 	(0.3) 	(0.6)
Deferred tax asset raised on prior year losses/unrecognised prior period losses utilised
in current period 	27.6 	8.7
Alignment to 'new IFRS tax-adjusted basis' 	(0.1) 	(1.5)
Tax on Individual Policyholder Fund 	3.3 	2.5
Tax on Company Policyholder Fund 	0.8 	2.0
Capital profits and dividend income 	14.4 	0.5
Capital gains tax 	0.8 	0.7
Non-deductible expenditure: Capital in nature 	(7.5) 	(1.3)
Non-deductible expenditure: Other individually immaterial 	(0.2) 	(1.7)
Non-taxable income: Gain on previously held interest 	– 	2.7
Non-taxable income: Other individually immaterial 	0.2 	2.1
Tax rate change – decrease 	1.4 	0.4
Tax rate differences 	4.6 	1.8
Tax on eliminated intergroup transactions 	0.5 	(3)
Standard rate of taxation 	28.0 	28.0
For South African entities that are in a tax paying position, tax has been provided at 28% (2019: 28%). Discovery uses the South
African tax rate in respect of its tax rate reconciliation as Discovery Limited (holding company listed on the JSE) is domiciled in
South African and the most significant operations are in South Africa.
Taxation in respect of the South African life insurance operations is determined in accordance with the rates and basis applicable
to section 29A of the Income Tax Act at the reporting date.
35. 	EARNINGS PER SHARE
Group
2020
Group
2019
Basic earnings per share
Earnings per share is based on net profit after tax attributable to ordinary shareholders
and the weighted number of ordinary shares in issue.
Net profit attributable to ordinary shareholders (R million) 	97 	6 533
Weighted number of ordinary shares in issue (000’s) 	656 648 	652 295
Basic earnings per share (cents) 	14.8 	1 001.5
Diluted earnings per share
Diluted earnings per share is calculated adjusting the weighted average number of ordinary
shares outstanding to assume conversion of all dilutive potential ordinary shares.
Weighted average ordinary shares in issue (000’s) adjusted for: 	656 648 	652 295
– Weighted average ordinary shares in the staff share trusts (000’s) 	181 	273
– Weighted average ordinary shares related to long term share incentive scheme (000’s) 	4 414 	–
661 242 	652 568
Diluted earnings per share (cents) 	14.7 	1 001.1

-- 117 of 198 --

120 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
35. 	EARNINGS PER SHARE continued
Group
2020
Group
2019
Headline earnings
Headline earnings per share is based on the net profit after tax attributable to ordinary
shareholders adjusted for items of a capital nature and the weighted average number
of ordinary shares in issue.
Headline earnings reconciliation (R million)
Net profit attributable to ordinary shareholders 	97 	6 533
Adjusted for:
– gain on dilution and disposal of equity-accounted investments 	(3) 	(844)
– tax on gain on dilution and disposal of equity-accounted investments 	– 	178
– gain on previously held interests in DiscoveryCard business 	– 	(761)
– impairment of goodwill 	9 	17
– (gain)/loss on disposal of property and equipment 	(3) 	2
– tax on gain/loss on disposal of property and equipment 	1 	(1)
– impairment of intangible assets 	63 	32
– tax on impairment of intangible assets 	(19) 	(9)
– derecognition of intangible assets and property and equipment 	196 	–
– tax on derecognition of intangible assets and property and equipment 	(47) 	–
– Discovery Limited’s share of headline earnings adjustments made by
equity-accounted investees:
○ derecognition of intangible assets and property and equipment 	2 	–
○ tax on derecognition of intangible assets and property and equipment 	– 	–
Headline earnings 	296 	5 147
Headline earnings per share (cents):
– basic 	45.0 	789.0
– diluted 	44.7 	788.7
Normalised headline earnings is calculated by adjusting headline earnings with
significant items that are not considered to be part of Discovery’s normal operations.
These adjustments include those gains or losses associated with changes in economic
assumptions recognised in profit or loss, net of any gains or losses on derivatives to
offset such changes in economic assumptions. Adjustments are shown net of tax.
Headline earnings 	296 	5 147
– amortisation of intangibles from business combinations 	76 	99
– deferred tax on amortisation of intangibles from business combinations 	(16) 	(15)
– costs relating to disposal of equity-accounted investments 	– 	21
– tax on costs relating to disposal of equity-accounted investments 	– 	(6)
– debt restructuring costs resulting from DiscoveryCard business transaction 	– 	33
– deferred tax assets raised on assessed losses 	(275) 	(326)
– deferred tax timing difference related to new ‘adjusted IFRS’ tax basis and
Corporate Policyholder Fund assessed loss 	– 	(38)
– unrealised (gains)/losses on foreign exchange contracts not designated as a hedge 	(263) 	134
– tax on unrealised on foreign exchange contracts not designated as a hedge 	74 	(37)
– initial expenses related to Prudential Book transfer 	71 	28
– tax on initial expenses related to Prudential Book transfer 	(14) 	(5)
– changes in economic assumptions in excess of available discretionary margin 	5 708 	–
– tax on charges in economic assumptions in excess of available discretionary margin 	(1 413) 	–
– intrinsic fair value changes on VitalityLife derivatives 	(758) 	–
– tax on intrinsic fair value change on VitalityLife derivatives 	144 	–
– restructuring costs 	100 	–
– tax on restructuring costs, net of tax 	(20) 	–
– transaction costs related to interest rate derivatives 	45 	–
– tax on transaction costs related to VitalityLife interest rate derivatives 	(8) 	–
Normalised headline earnings 	3 747 	5 035
Normalised headline earnings per share (cents):
– basic 	570.7 	771.9
– diluted 	566.7 	771.6

-- 118 of 198 --

121 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
36. 	CASH FLOW INFORMATION
Group
2020
Group
2019
36.1 Cash generated by operations
Profit before taxation 	800 	7 919
Adjusted for:
Investment income 	(4 274) 	(3 724)
Realised investment gains and losses 	(426) 	(335)
Finance costs 	1 568 	1 375
Premiums,claims, benefits and investment charges for liabilities under investment contracts 	2 187 	1 820
Non cash items:
Allowance for expected credit losses 	136 	50
Amortisation of intangibles from business combinations 	76 	99
Amortisation of software 	1 111 	735
Assets arising from contracts with customers 	119 	58
Contract liabilities movement 	314 	109
Deferred acquisition costs 	(3) 	(72)
Derecognition and impairment of intangible assets 	234 	32
Derecognition and impairment of property and equipment 	25 	11
Depreciation 	643 	519
Fair value adjustment to liabilities under investment contracts 	151 	809
Gain from derivatives 	531 	(57)
Gain on dilution and disposal of equity-accounted investments 	(3) 	(844)
Gain on previously held interest in DiscoveryCard business 	– 	(761)
Hedge ineffectiveness 	13 	(5)
Impairment of goodwill 	9 	17
(Gain)/loss on disposal of property and equipment 	(3) 	2
Operating lease payments in advance 	– 	10
Provision for employee benefits 	48 	53
Share-based payment expenses – cash settled 	54 	455
Share-based payment expenses – equity settled 	164 	–
Share of profits from equity-accounted investments 	(264) 	(170)
Transfer to assets under insurance contracts 	(2 038) 	(5 321)
Transfer to assets under reinsurance contracts 	(53) 	(7)
Transfer to liabilities under insurance contracts 	9 418 	8 050
Transfer to liabilities under reinsurance contracts 	462 	1 984
Economic assumption adjustments net of discretionary margins 	5 708 	–
Translation differences 	(460) 	(3)
Unearned premiums 	844 	(1)
Unrealised losses/(gains) on investments at fair value through profit or loss 	215 	(599)
Working capital changes:
Insurance receivables, contract receivables and other receivables 	(3 957) 	(1 454)
Other payables at amortised cost 	5 651 	2 025
19 000 	12 779
36.2 Taxation paid
Balance at beginning of the year 	(140) 	(254)
Taxation charged for the year in the income statement 	(624) 	(1 305)
Adjustment for movement in deferred taxation 	(1 122) 	258
Taxation charged for the year in other comprehensive income 	32 	2
Translation differences 	(46) 	2
Balance at end of the year 	611 	140
(1 289) 	(1 157)

-- 119 of 198 --

122 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
36. 	CASH FLOW INFORMATION continued Group
2020
Group
2019
36.3 Proceeds from issuance of shares
Shares issued 	– 	1 854
Shares issue costs 	– 	(19)
– 	1 835
Group
2020
Group
2019
36.4 Movement of borrowings
Balance at beginning of the year excluding overdrafts with banks 	14 682 	14 073
Leased asset acquired and IFRS 16 transition 	792 	13
Increase in borrowings 	10 339 	2 147
Raising fees capitalised 	(29) 	(4)
Interest accrued on borrowings 	1 474 	1 331
Interest capitalised to intangible assets 	– 	47
Interest recognised in profit or loss 	1 474 	1 284
Interest paid on borrowings 	(1 289) 	(1 124)
Repayment of borrowings 	(6 639) 	(1 741)
Translation differences 	506 	(13)
Balance at end of the year excluding overdrafts with banks 	19 836 	14 682
37. 	COMMITMENTS
R million
Group
2020
Group
2019
37.1 Capital commitments
Capital expenditure approved but not contracted for at the reporting date is as follows:
Property and equipment including new head office leasehold improvements 	– 	22
Intangible assets 	189 	11
Development costs for Discovery Bank 	388 	67
577 	100
37.2 Operating lease commitments
Discovery has various operating lease agreements. Most leases contain renewal options.
Lease terms do not contain restrictions on Discovery’s activities concerning dividends,
additional debt or further leasing.
Discovery leases certain computer and office equipment under operating leases. The
remaining periods of the leases are from two months to four years. The future minimum
commitments are as follows:
Due within one year 	48
Due within two to five years 	154
Due after five years 	5
Cash flow commitment 	207
Discovery leases certain land and buildings under operating leases. The remaining
periods of the leases are from two months to ten years. The future minimum
commitments in terms of the leases of land and buildings:
Due within one year 	42
Due within two to five years 	126
Due after five years 	22
Cash flow commitment 	190
Accrued to a liability (refer to note 22) 	(53)
Net commitment 	137

-- 120 of 198 --

123 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
38. 	DIVIDENDS PER SHARE
38.1 Dividends per ordinary share
The dividends paid in 2020 totalled R1 413 million and comprised a final dividend of 114 cents per share paid on 7 October 2019
and an interim dividend of 101 cents per share paid on 23 March 2020.
The dividends paid in 2019 totalled R1 400 million and comprised a final dividend of 114 cents per share paid on 8 October 2018
and an interim dividend of 101 cents per share paid on 18 March 2019.
38.2 Dividends per preference share
The dividends paid in 2020 totalled R81 million and comprised a final dividend of 508.28767 cents per share paid on
23 September 2019 and an interim dividend of 505.41097 cents per share paid on 16 March 2020.
The dividends paid in 2019 totalled R81 million and comprised a final dividend of 501.91781 cents per share paid on
17 September 2018 and an interim dividend of 506.71233 cents per share paid on 11 March 2019.
39. 	CONTINGENCIES
The Group is exposed to no material contingencies at 30 June 2020.
40. 	RELATED PARTIES
40.1 List of related parties as defined
Subsidiaries
Details of subsidiaries directly and indirectly owned by Discovery Limited are contained in Company note 1. Also refer to Directors’
report ‘Nature of Business’.
Associates and Joint Ventures
Details of Discovery’s material associates and joint ventures are contained in note 11.
Corporate investors
Rand Merchant Investment Holdings Limited has a 25.04% shareholding in Discovery Limited.
Key management personnel
Key management personnel have been defined as directors of Discovery Limited, Discovery Health Proprietary Limited and
Discovery Life Limited, as these businesses constitute the majority of the Discovery Group.
A list of the directors and prescribed officers of Discovery Limited can be found in the Directors’ report.
To the extent specific transactions have occurred between Discovery and key management personnel, including close family
members of key management, (as defined in IAS 24) the details are included in the aggregate disclosure contained below under
key management and where significant, full details of all relationships and terms of the transactions are provided.

-- 121 of 198 --

124 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
40. 	RELATED PARTIES continued
40.2 Transactions with related parties
Where relevant, amounts are excluding VAT.
Rand Merchant Investment Holdings Limited (RMI)
During the prior year, Rand Merchant Insurance Holdings Limited (RMI) subscribed for 2 865 565 shares as part of the vendor
consideration placement and maintained its 25.04% shareholding in Discovery Limited (refer to note 17.1 for details of the
vendor consideration placement). RMI pre-agreed to participate in the share placement and earned an underwriting commission
of R1 million.
Discovery Health Medical Scheme (DHMS)
Discovery Health (part of the segment SA Health) administers DHMS and provides managed care services for which it charges an
administration fee and a managed healthcare fee respectively. These fees are determined on an annual basis and approved by
the trustees of DHMS. The fees totalled R6 190 million (2019: R5 853 million). Discovery offers the members of DHMS access to
the Vitality programme. Discovery Health also provides wellness services to DHMS. The fees received for these services totalled
R38 million (2019: R30 million).
Discovery Third Party Recovery Services (DTPRS) paid DHMS R16 million (2019: R14 million) to purchase all the risks and rewards
of ownership to the claims due from the Road Accident Fund up to 31 December 2019 (2019: 9 September 2019). DTPRS also
provides a service to DHMS to recover all claims that are due from the Compensation for Occupational Injuries and Diseases.
DTPRS received R15 million (2019: R22 million) for this service. DTPRS owes DHMS R3 million (2019: R6 million) at year-end.
Discovery Vitality receives monthly contributions from DHMS members that have activated the Vitality Wellness programme
through various product integrations. The membership fees totalled R1 687 million for the year ended 30 June 2020 (2019:
R1 591 million).
DHMS owes the Discovery Group R646 million (2019: R670 million) at year-end.
Closed schemes
Discovery Health administers the following restricted membership medical schemes:
– Anglo Medical Scheme. 	– Netcare Medical Scheme
– Anglovaal Group Medical Scheme. 	– Quantum Medical Aid Society.
– Bankmed Medical Scheme. 	– Remedi Medical Scheme.
– BMW Employees Medical Aid Scheme. 	– Retail Medical Scheme.
– Glencore Medical Scheme. 	– TFG Medical Scheme.
– LA Health Medical Scheme. 	– Tsogo Sun Group Medical Scheme.
– Lonmin Medical Scheme. 	– University of KwaZulu-Natal Medical Scheme.
– Malcor Medical Aid. 	– Engen Medical Benefit Fund.
– Naspers Medical Fund. 	– The South African Breweries Medical Aid.
Discovery Health charges these schemes administration fees which are determined on an annual basis and approved by the
trustees of the respective closed schemes. The fees totalled R1 141 million (2019: R1 064 million).
DTPRS paid Bankmed RNil million (2019: R6 million) to purchase all the risks and rewards of ownership for the claims due from
the Road Accident Fund (RAF) up to 31 July 2018. At 30 June 2020, R1 million (2019: RNil) was receivable from Bankmed, for
recovery services, performed by DTPRS on behalf of Bankmed members from the RAF. DTPRS also provides a service to Bankmed
to recover all claims that are due from the Compensation for Occupational Injuries and Diseases. DTPRS received R1 million
(2019: R1 million) for this service.
Discovery Vitality receives monthly contributions from the closed scheme members that have activated the Vitality Wellness
programme through various product integrations. The membership fees totalled R99 million (2019: R91 million).
Amounts due to the Discovery Group at year-end totalled R104 million (2019: R100 million).

-- 122 of 198 --

125 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
40. 	RELATED PARTIES continued
40.2 Transactions with related parties continued
Cambridge Mobile Telematics Inc. (CMT)
Discovery Insure paid fees on a monthly basis to CMT for the collation and interpretation of data and the translating of driving
behaviour into scorable events. Fees paid for the year totalled R11 million (2019: R11 million).
Discovery Franchises
Discovery has established a network of 32 franchises in order to establish a national footprint for its products. Discovery has paid
R239 million (2019: R262 million) in fees to the franchises.
The franchises participate in the Acquisition Scheme (refer to note 31 for further details). During the year, R4 million (2019:
R14 million) was accrued for in terms of this scheme.
The Discovery Foundation
The Discovery Foundation, which is an independent shareholder of Discovery, has become self-sustaining from the dividends
received on its shareholding in Discovery Limited and no further contributions or fees were received during the prior and
current year.
The Discovery Foundation has made no investments into the Discovery Unit Trusts during the current or prior year.
The Discovery Fund
A fund for sustainable non-governmental healthcare projects, especially in primary healthcare. These projects complement the
delivery of primary and preventative care in the public sector and help to relieve the burden on state facilities.
The Discovery Fund received contributions from Discovery of R23 million during the year (2019: R29 million). Discovery also paid
a management fee of R2 million (2019: R2 million).
Discovery staff pension and provident funds
The Discovery Pension and Provident Funds (“the Funds”) were set-up specifically for Discovery staff. Contributions to the Funds
during the year amounted to R461 million (2019: R250 million). The Funds have invested R27 million (2019: R1 226 million) into
financial assets managed by Discovery Life Collective Investments, and R1 320 million in unit linked insurance policies with
Discovery Life (2019: RNil million), these policies are linked to unit trusts managed by Discovery Life Collective Investments. In
February 2020 the Discovery Limited Board approved the appointment of the Discovery Retirement Funds comprising funds
underwritten by Discovery Life and registered as the Discovery Life Pension Umbrella Fund and the Discovery Life Provident
Umbrella Fund, as retirement fund provider to the Discovery Staff. In April 2020 the Board of the Funds resolved to transfer the
assets of the Funds to the Discovery Retirement Funds with effect from 1 July, this transfer is still subject to the regulated
Section 14 transfer process. The Board also resolved to close the Funds after the transfer is completed and there are no assets
remaining in the Funds.
Key management personnel of Discovery Limited, families of key management (as
defined in IAS 24) and entities significantly influenced or controlled by key management
INSURANCE CONTRACTS
Aggregated insured cover 	Premiums received 	Claims paid
R’000 	2020 	2019 	2020 	2019 	2020 	2019
Life insurance 	1 070 749 	1 361 601 	6 543 	10 097 	– 	–
Short-term insurance 	444 908 	547 607 	2 154 	2 380 	424 	745
Short-term health insurance 	– 	– 	53 	38 	4 	108

-- 123 of 198 --

126 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
40. 	RELATED PARTIES continued
40.2 Transactions with related parties continued
INVESTMENT CONTRACTS
Investment values 	Premiums received 	Withdrawal benefits 	Investment returns
R’000 	2020 	2019 	2020 	2019 	2020 	2019 	2020 	2019
Investment contracts 	62 735 	62 466 	6 634 	2 269 	8 322 	2 669 	3 391 	(3 709)
VITALITY LOYALTY PROGRAMME
Premiums received 	Amounts paid
R’000 	2020 	2019 	2020 	2019
Vitality benefits 	78 	59 	1 397 	1 870
DISCOVERYCARD
Card fees received 	Discounts paid
R’000 	2020 	2019 	2020 	2019
DiscoveryCard 	20 	177 	39 	17
DISCOVERYBANK
Loans 	Savings 	Fees
R’000 	2020 	2019 	2020 	2019 	2020 	2019
DiscoveryBank 	969 	– 	10 688 	247 	338 	330
Key management personnel, their families (as defined in IAS 24) and entities significantly influenced or controlled by key
management accrued 80 056 Discovery miles as part of the DiscoveryCard loyalty programme for the year ended 30 June 2020
(2019: 376 578).
Aggregate shareholdings of key management personnel, their families (as defined in IAS 24) and entities significantly influenced
or controlled by key management, in Discovery Limited as at 30 June 2020 was 87 263 243 ordinary shares (2019: 93 992 083
ordinary shares).
During the current financial year the following transaction occurred between Discovery and key management personnel, their
families (as defined in IAS 24) and entities significantly influenced or controlled by key management:
❚ 	sponsorship and enterprise development grants to the value of R1.7 million (2019: R1.5 million) were made to organisations
where members of key management personnel have significant influence.
❚ 	Discovery acquired signage for the new head office to the value of Rnil (2019: R1.2 million) from a company controlled by a
family member of key management personnel.

-- 124 of 198 --

127 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
41. 	CHANGE IN ACCOUNTING POLICY
IFRS 16 Leases
BACKGROUND
IFRS 16 replaces IAS 17 Leases, as well as the related interpretations. The core principle of IFRS 16 is that the lessee should
recognise all rights and obligations arising from leasing arrangements in its Statement of financial position. The most significant
change to Discovery pertains to the accounting treatment for those leases that were classified as operating leases from Discovery’s
perspective as the lessee.
IFRS 16 eliminates the classification of leases for lessees as either operating or finance leases as per IAS 17. Instead, IFRS 16
introduces a single lessee accounting model, where a right of use (ROU) asset together with a lease liability for the future
payments is recognised for all leases with a term of more than 12 months, unless the underlying asset is of a low value. Where
Discovery is the lessee, it has elected, in accordance with IFRS 16, not to apply the lessee accounting model where the lease is a
short-term lease. Short-term leases have a lease term of 12 months or less and does not include a renewal option. The rental
payments for short-term leases are expensed on a straight-line basis over the lease term.
IFRS 16 does not introduce significant changes for lessors, or to those leases previously classified as finance leases from the
lessee’s perspective, and as a result the accounting policies for these transactions had no material change.
ADOPTION AND TRANSITION
On adoption of IFRS 16, Discovery applied the modified retrospective approach to transition on 1 July 2019. This approach
requires the cumulative effect of initially applying IFRS 16 as an adjustment to the opening reserves at 1 July 2019. As required by
IFRS 16, Discovery did not restate its comparative financial results. Accordingly:
– Discovery’s previously reported financial results up to 30 June 2019 are presented in accordance with the requirements of
IAS 17; and
– From 1 July 2019 Discovery’s financial results are presented in terms of IFRS 16.
On adoption of IFRS 16, Discovery recognised lease liabilities in relation to leases which had previously been classified as operating
leases under the principles of IAS 17. These liabilities were measured at the present value of the remaining lease payments,
discounted using the lessee’s incremental borrowing rate as at 1 July 2019. The incremental borrowing rates were calculated for
each legal entity within the Group that entered into lease arrangements. The incremental borrowing rate considers a base
interest rate reflective of the jurisdiction in which the legal entity operates (South Africa, United Kingdom and United States of
America), the term of the lease arrangement and the nature of the assets.
ROU assets were measured retrospectively at the amount equal to the lease liability at the commencement of the lease, using the
discount rate as determined on 1 July 2019 for the lease liability, and depreciated from commencement date up until 30 June 2019.
The resulting difference between the lease liability and the ROU asset as at 1 July 2019 is recognised as an adjustment to the
opening retained earnings. In addition, any previously recognised rights (e.g. prepaid rentals) or obligations (e.g. straight-line
accruals) are also derecognised as adjustments to the opening retained earnings on 1 July 2019.
PRACTICAL EXPEDIENTS APPLIED
In applying IFRS 16 for the first time, Discovery used the following practical expedients permitted by IFRS 16:
– accounting for leases with a remaining lease term of less than 12 months as at 1 July 2019, as short-term leases, provided
there was no option to extend the term. For short-term rentals, the lessee recognises the payments as an expense on a
straight-line basis;
– the use of a single discount rate for a specified portfolio of leases that have reasonably similar characteristics. This was
applied to the Franchises offices;
– the exclusion of initial direct costs for the measurement of the ROU asset at the date of initial application; and
– the use of hindsight in determining the lease term where the contract contains options to extend or terminate the lease.
IDENTIFYING LEASES, LOW VALUE ASSETS AND LEASING ACTIVITIES
Effective 1 July 2019, all leases, which either had a term not less than 12 months or not deemed a low value asset, were recognised
as a ROU asset and a corresponding lease liability.
Discovery leases the following assets with a range of lease terms:
– Large offices 	5 – 15 years
– Small offices/Franchise offices (SA only) 	1 – 3 years
– Computer equipment (e.g. servers) (SA only) 	3 – 4 years
– Motor vehicles (UK only) 	3 years

-- 125 of 198 --

128 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
41. 	CHANGE IN ACCOUNTING POLICY continued
IFRS 16 Leases continued
Leases of low value assets relate to those categories of assets which at inception of the lease typically have a value, if bought new,
of no more than approximately R70 000. For Discovery, these categories include computer equipment such as desktops, laptops,
monitors and related IT peripherals.
Contracts where the service provider has a substantive right to substitute the asset for an alternative asset during the lease term
is not regarded as a lease, but instead a service contract. Accordingly, these contracts are not accounted for in accordance with
IFRS 16. For Discovery, such contracts include items such as vending machines.
EXTENSION OR TERMINATION OPTIONS
Extension or termination options are included in a number of the building leases across the Group. These terms are used to
maximise operational flexibility in terms of managing contracts. In determining the lease term, management considers all facts
and circumstances that create an economic incentive to exercise an extension option, or not exercise a termination option.
Extension options (or periods after termination options) are considered in the lease term when there is reasonable certainty that
those options will be exercised.
Effect of changes in IFRS 16 on date of initial application1
At 1 July 2019
R million
Group
30 June
2019
Previously
reported
Audited
IFRS 16
Adjustments
Group
1 July
2019
Restated
Assets
Property and equipment 	4 212 	638 	4 850
Total impact on assets 	638
Equity
Retained earnings 	31 710 	(41) 	31 669
Liabilities
Financial liabilities
Borrowings at amortised cost 	14 682 	748 	15 430
Other payables at amortised cost 	10 262 	(63) 	10 199
Deferred income tax liabilities 	8 697 	(6) 	8 691
Total impact on equity and liabilities 	638
The increase in Property and equipment and Borrowings at amortised cost related to:
R million
Property
and equipment
Borrowings at
amortised cost2
Land and buildings 	573 	681
Computer equipment and operating systems 	64 	66
Motor vehicles 	1 	1
638 	748
1 In the finalisation of accounts for the period 30 June 2020, Discovery identified that in its interim financial results, it incorrectly treated a reimbursement
of fit-out costs from the lessor in the measurement of its Buildings ROU asset. Discovery has corrected its calculation, and the values above are after
its correction. Accordingly, the values in the table above are R29 million less for its ROU asset, R1million less for Borrowing at amortised cost and
R28 million more for Retained earnings than those values included in the interim financial results. The change has no impact on earnings during
the period.
2 The ranges of incremental borrowing rates applied on transition was 8.02%-9.9% in South Africa, 1.92% – 4.43% in the UK and 7.25% within the US.

-- 126 of 198 --

129 Discovery Annual Financial Statements 2020
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
41. 	CHANGE IN ACCOUNTING POLICY continued
Reconciliation of lease liability
R million 	2020
Lease Commitments as at 30 June 20191 	1 058
Discounted using the group's incremental borrowing2 	(191)
Add: Finance lease liabilities recognised as at 30 June 2019 	3 648
Less: Short-term leases recognised on a straight-line basis as expense 	(10)
Less: Low-value leases recognised on a straight-line basis as expense 	(91)
Less: contract reassessed as service agreements 	(18)
Lease liability as at 1 July 2019 	4 396
1 Includes committed and uncommitted lease commitment at 30 June 2019.
2 The ranges of incremental borrowing rates applied on transition was 8.02% - 9.9% in South Africa, 1.92% - 4.43% in the UK and 7.25% within the US.
42. 	EVENTS AFTER REPORTING DATE
B preference share cash dividend declaration:
On 7 September 2020, the directors declared a final gross cash dividend of 433.21918 cents (346.57534 cents net of dividend
withholding tax) per B preference share for the period 1 January 2020 to 30 June 2020, payable from the income reserves of the
Company. A dividend withholding tax of 20% will be applicable to all shareholders who are not exempt.
The issued preference share capital at the declaration date is 8 million B preference shares.
The salient dates for the dividend will be as follows:
Last day of trade to receive a dividend 	Monday, 21 September 2020
Shares commence trading ex-dividend 	Tuesday, 22 September 2020
Record date 	Friday, 25 September 2020
Payment date 	Monday, 28 September 2020
B preference share certificates may not be dematerialised or rematerialised between Tuesday, 22 September 2020 and Friday,
25 September 2020, both days inclusive.
Ordinary share cash dividend declaration:
Due to uncertain and potentially volatile economic environment caused by the COVID-19 pandemic, Discovery will not be
recommending the payment of ordinary dividends. The reintroduction of dividends will be considered when appropriate.
Discovery Bank
Subsequent to year-end, Discovery Bank successfully migrated the DiscoveryCard Platinum client portfolio, comprising of
62 512 customers from the FNB platform onto its own platform. The transfer was funded by various institutional deposits
amounting to R1.3 billion.

-- 127 of 198 --

DISCOVERY
COMPANY ANNUAL
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE
2020

-- 128 of 198 --

R million 	Notes
Company
2020
Company
2019
Assets
Investments in subsidiaries 	2 	25 658 	22 739
Investment in associate and joint venture 	3 	991 	991
Financial assets
– Derivative financial instruments at fair value 	4 	242 	37
– Loans to subsidiaries 	5 	7 856 	6 135
– Loans to BEE partners 	6 	116 	73
– Other receivables 	7 	358 	17
Deferred income tax asset 	13 	– 	23
Current income tax asset 	– 	21
Cash and cash equivalents 	20.5 	188 	84
Total assets 	35 409 	30 120
Equity
Capital and reserves
Ordinary share capital and share premium 	8.1 	10 331 	10 331
Preference share capital 	8.2 	779 	779
Other reserves 	4 	192
Retained earnings 	5 085 	5 309
Total equity 	16 199 	16 611
Liabilities
Financial liabilities
– Borrowings at amortised cost 	9 	8 356 	6 841
– Derivative financial instruments at fair value 	10 	522 	220
– Financial guarantee contracts 	21 	52 	35
– Trade and other payables 	11 	9 088 	5 294
– Loans from subsidiaries 	12 	1 102 	1 119
Deferred income tax liability 	13 	1 	–
Current income tax liability 	89 	–
Total liabilities 	19 210 	13 509
Total equity and liabilities 	35 409 	30 120
COMPANY STATEMENT OF FINANCIAL POSITION
at 30 June 2020
131 Discovery Annual Financial Statements 2020

-- 129 of 198 --

R million 	Notes
Company
2020
Company
2019
Investment income 	14 	1 625 	1 776
– at amortised cost interest income, using the effective interest rate 	462 	400
– other investment income 	1 163 	1 376
Other income 	15 	35 	20
Net fair value gains/(losses) on financial instruments at fair value through
profit or loss 	16 	263 	(144)
Marketing and administration expenses 	17 	(14) 	(10)
Movement in allowance for expected credit losses 	18 	9 	(4)
Profit from operations 	1 918 	1 638
Finance costs 	(832) 	(759)
Foreign exchange gains/(losses) 	370 	(10)
Profit before tax 	1 456 	869
Taxation 	19 	(184) 	24
Profit for the year 	1 272 	893
Attributable to:
– ordinary shareholders 	1 191 	812
– preference shareholders 	81 	81
1 272 	893
R million
Company
2020
Company
2019
Profit for the year 	1 272 	893
Items that are or may be reclassified subsequently to profit or loss:
Cash flow hedges 	(350) 	(110)
– unrealised losses 	(360) 	(117)
– gains reclassified to profit or loss 	10 	7
Other comprehensive income for the year, net of tax 	(350) 	(110)
Total comprehensive income for the year 	922 	783
Attributable to:
– ordinary shareholders 	841 	702
– preference shareholders 	81 	81
922 	783
COMPANY INCOME STATEMENT
for the year ended 30 June 2020
COMPANY STATEMENT OF OTHER COMPREHENSIVE INCOME
for the year ended 30 June 2020
132 Discovery Annual Financial Statements 2020

-- 130 of 198 --

R million 	Notes
Company
2020
Company
2019
Cash flow from operating activities 	3 882 	4 045
Cash generated by operations 	20.1 	3 408 	3 340
Dividends received 	1 155 	1 364
Interest received 	113 	83
Interest paid 	(744) 	(671)
Taxation paid 	20.2 	(50) 	(71)
Cash flow from investing activities 	(3 780) 	(5 043)
Increase investment in subsidiary 	20.3 	(2 753) 	(4 570)
Increase investment in associate 	– 	(160)
Proceeds on disposal of financial assets 	– 	130
Increase in loans granted to subsidiaries 	5 	(2 302) 	3 391
Proceeds from settlement of subsidiary loans 	5 	1 275 	2 948
Cash flow from financing activities 	2 	1 043
Proceeds from long-term borrowings 	20.4 	5 104 	698
Repayment of long-term borrowings 	20.4 	(3 606) 	(7)
Proceeds from issuance of ordinary shares 	– 	1 854
Share issue costs 	– 	(19)
Dividends paid to ordinary shareholders 	(1 415) 	(1 402)
Dividends paid to preference shareholders 	(81) 	(81)
Net increase in cash and cash equivalents 	104 	45
Cash and cash equivalents at beginning of the year 	84 	39
Cash and cash equivalents at end of the year 	20.5 	188 	84
COMPANY STATEMENT OF CASH FLOWS
for the year ended 30 June 2020
133 Discovery Annual Financial Statements 2020

-- 131 of 198 --

Company
R million
Share
capital
and share
premium
Preference
share
capital
Hedging
reserve
Share-
based
payment
reserve
Retained
earnings 	Total
Year ended 30 June 2019
At beginning of the year 	8 496 	779 	(56) 	327 	5 899 	15 445
Total comprehensive income for the year 	– 	81 	(110) 	– 	812 	783
Profit for the year 	– 	81 	– 	– 	812 	893
Other comprehensive income 	– 	– 	(110) 	– 	– 	(110)
Transactions with owners 	1 835 	(81) 	– 	31 	(1 402) 	383
Share issue 	1 854 	– 	– 	– 	– 	1 854
Share issue costs 	(19) 	– 	– 	– 	– 	(19)
Increase in BEE share option scheme 	– 	– 	– 	31 	– 	31
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	(1 402) 	(1 402)
Dividends paid to preference shareholders 	– 	(81) 	– 	– 	– 	(81)
Balance at 30 June 2019 	10 331 	779 	(166) 	358 	5 309 	16 611
Year ended 30 June 2020
At beginning of the year 	10 331 	779 	(166) 	358 	5 309 	16 611
Total comprehensive income for the year 	– 	81 	(350) 	– 	1 191 	922
Profit for the year 	– 	81 	– 	– 	1 191 	1 272
Other comprehensive income 	– 	– 	(350) 	– 	– 	(350)
Transactions with owners 	– 	(81) 	– 	162 	(1 415) 	(1 334)
Increase in BEE share option scheme 	– 	– 	– 	162 	– 	162
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	(1 415) 	(1 415)
Dividends paid to preference shareholders 	– 	(81) 	– 	– 	– 	(81)
Balance at 30 June 2020 	10 331 	779 	(516) 	520 	5 085 	16 199
COMPANY STATEMENT OF CHANGES IN EQUITY
for the year ended 30 June 2020
134 Discovery Annual Financial Statements 2020

-- 132 of 198 --

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these separate financial statements are consistent with those set out in
Annexure A. In addition to those policies, the following policies apply specifically to these separate financial statements.
Investment in subsidiaries, associates and joint ventures
Investments in subsidiaries, are accounted for at cost less impairment. Cost is adjusted to reflect changes in consideration arising from
contingent consideration amendments. Cost also includes directly attributable cost of the investment.
Investments in associates and joint ventures are accounted for at cost less impairment. Cost is adjusted to reflect changes in consideration
arising from contingent consideration amendments. Cost also includes directly attributable cost of the investment.
Financial guarantee contracts
The Company accounts for financial guarantee contracts (FGCs) in accordance with IFRS 9 Financial Instruments (IFRS 9). The Company
issues FGCs to assist in securing funding for its subsidiaries.
FGCs are contracts which require the Company as the issuer of the contract, to make specified payments to reimburse the holder for a
loss that the holder incurs because the specified debtor fails to make payment when it is due under the original or modified terms of the
debt instrument.
The Company measures the FGC:
❚ 	Initially at fair value; and
❚ 	Subsequently at the higher of:
– The amount of expected credit losses determined under IFRS 9 (calculation 1); and
– The amount initially recognised less, when appropriate, the cumulative amount of income recognised under the principles of
IFRS 15 Revenue from Contracts with Customers (calculation 2).
Initial recognition
In the instances where the Company issues FGCs for the debt of a related entity in the Discovery Group, the Company determines the fair
value. These FGCs are seen as transactions in a capacity as shareholder and are treated as capital contributions.
In some instances, the other Discovery Group entity can also pay a premium to the issuer of the FGCs. The Company then determines if
the price represents the fair value, or whether there is still an additional benefit of the FGC that the Company should recognise.
In the instance where the Company does not receive all the premiums upfront, it recognises the FGC using a net approach. The net
approach requires that the Company presents the financial guarantee as its fair value less all future premiums.
Subsequent measurement
The Company recognises financial guarantee fee income as follows:
❚ 	Amortises the fair value recognised on initial recognition over the period that the FGC is outstanding, being generally the period of the
underlying debt.
❚ 	Recognises any premiums received for issuing the FGC also as financial guarantee fee income.
❚ 	Where the Company has applied the net approach, the Company adjusts for the premiums subsequently received to ensure it takes
into account all premiums in using calculation 2.
The Company calculates the lifetime expected credit losses for purposes of calculation 1.
Where the outcome is such that calculation 1 is more than calculation 2, differences are recognised and presented as part of expected
credit losses.
Where the outcome is such that calculation 2 is more than calculation 1, no adjustments are required. Any previously recognised expected
credit losses can be reversed, but limited to the total value previously recognised.
Derecognition
The Company derecognises FGCs when the FGC is extinguished, expires or the underlying debt is extinguished.
At the date of derecognition:
❚ 	Where the FGC is extinguished in exchange for a new FGC to the same holder and in respect of the same guaranteed entity, the FGC
derecognised is seen as compensation for the new FGC.
❚ 	In all other instances, the FGC is derecognised with an associated gain or loss in profit or loss.
NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS
for the year ended 30 June 2020
135 Discovery Annual Financial Statements 2020

-- 133 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	MANAGEMENT OF FINANCIAL RISK
The Company’s activities expose it to a variety of financial risks. Financial risks include market risk, credit risk and liquidity risk.
Refer to Group Note 3 ”Management of financial risk” for a detailed explanation of financial risks and how they are managed.
1.1 	Interest rate risk
Sensitivity to changes in interest rates is relevant to financial assets or liabilities bearing floating interest rates due to the risk that
future cash flows fluctuate. However, sensitivity will also be relevant to fixed-rated financial assets and financial liabilities that are
re-measured to fair value.
The table below details the specific interest rate risk that the Company is exposed to:
Company
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
At 30 June 2020
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	242 	– 	– 	242
Loan to subsidiaries 	7 856 	1 807 	3 367 	2 682
Loans to BEE partners 	116 	– 	116 	–
Trade and other receivables 	358 	– 	– 	358
Cash and cash equivalents 	188 	52 	136 	–
Total financial assets 	8 760 	1 859 	3 619 	3 282
Borrowings at amortised cost 	8 356 	3 819 	4 537 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	6 	– 	– 	6
– Used as cash flow hedges 	516 	516 	– 	–
Financial guarantee contracts 	52 	– 	– 	52
Trade and other payables 	9 088 	– 	– 	9 088
Loans from subsidiaries 	1 102 	– 	682 	420
Total financial liabilities 	19 120 	4 335 	5 219 	9 566
At 30 June 2019
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	37 	– 	– 	37
Loan to subsidiaries 	6 135 	966 	3 897 	1 272
Loans to BEE partners 	73 	– 	73 	–
Trade and other receivables 	17 	– 	– 	17
Cash and cash equivalents 	84 	22 	62 	–
Total financial assets 	6 346 	988 	4 032 	1 326
Borrowings at amortised cost 	6 841 	2 822 	4 019 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	64 	– 	– 	64
– Used as cash flow hedges 	156 	156 	– 	–
Financial guarantee contracts 	35 	– 	– 	35
Trade and other payables 	5 294 	– 	– 	5 294
Loans from subsidiaries 	1 119 	500 	619 	–
Total financial liabilities 	13 509 	3 478 	4 638 	5 393
A change of 1% in the interest rate would result in an increase/decrease of R34 million (2019: R32 million) in interest income and
R49 million (2019: R46 million) in finance costs. The sensitivity is based on the assumption that the interest rate has increased/
decreased by 1% with all other variables held constant.
136 Discovery Annual Financial Statements 2020

-- 134 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.2 	Currency risk
The Company operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and recognised
assets and liabilities.
The following table segregates the currency exposure by major currency:
Company
R million 	Total 	Rand 	GBP 	USD
At 30 June 2020
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	242 	242 	– 	–
Loans to subsidiaries 	7 856 	5 544 	2 312 	–
Loans to BEE partners 	116 	116 	– 	–
Trade and other receivables 	358 	110 	248 	–
Cash and cash equivalents 	188 	140 	48 	–
Total financial assets 	8 760 	6 152 	2 608 	–
Borrowings at amortised cost 	8 356 	8 356 	– 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	6 	6 	– 	–
– Used as cash flow hedges 	516 	516 	– 	–
Financial guarantee contracts 	52 	47 	5 	–
Trade and other payables 	9 088 	9 088 	– 	–
Loans from subsidiaries 	1 102 	1 102 	– 	–
Total financial liabilities 	19 120 	19 115 	5 	–
At 30 June 2019
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	37 	37 	– 	–
Loans to subsidiaries 	6 135 	4 715 	1 420 	–
Loans to BEE partners 	73 	73 	– 	–
Trade and other receivables 	17 	– 	– 	17
Cash and cash equivalents 	84 	84 	– 	–
Total financial assets 	6 346 	4 909 	1 420 	17
Borrowings at amortised cost 	6 841 	6 841 	– 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	64 	64 	– 	–
– Used as cash flow hedges 	156 	156 	– 	–
Financial guarantee contracts 	35 	35 	– 	–
Trade and other payables 	5 294 	5 294 	– 	–
Loans from subsidiaries 	1 119 	1 119 	– 	–
Trade and other payables 	13 509 	13 509 	– 	–
1.3 	Credit risk
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge
an obligation.
Key areas where the Company is exposed to credit risk are:
❚ 	Financial assets comprising money market and debt instruments – The Company is exposed to the issuer’s credit standing on
these instruments which is monitored by the CCIC by setting a minimum credit rating. The aggregate credit risk exposure for
financial assets categorised by credit ratings is provided on the next page.
❚ 	Cash and cash equivalents – This risk is managed by monitoring exposure to external financial institutions against limits set by
the CCIC.
137 Discovery Annual Financial Statements 2020

-- 135 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.3 	Credit risk continued
Credit exposure for debt instruments, money market instruments and cash and cash
equivalents
The following table provides information regarding the credit risk exposure categorised by Moody’s credit ratings. These are
credit ratings for assets in stage 1 (refer to note 18) in the Company financial statements:
Company
R million 	Total 	Aaa 	Aa1-3 	A1-3 	Baa1-3 	Ba1-3 	Govt 1
Internally
rated/
assessed
At 30 June 2020
Derivative financial instruments
at fair value:
– Not designated as hedging
instruments 	242 	– 	– 	65 	177 	– 	– 	–
Loans to subsidiaries 	7 856 	– 	– 	– 	– 	– 	– 	7 856
Loans to BEE partners 	116 	– 	– 	– 	– 	– 	– 	116
Cash and cash equivalents 	188 	78 	50 	– 	59 	– 	1 	–
8 402 	78 	50 	65 	236 	– 	1 	7 972
At 30 June 2019
Derivative financial instruments
at fair value:
– Not designated as hedging
instruments 	37 	– 	– 	– 	26 	11 	– 	–
Loans to subsidiaries 	6 135 	– 	– 	– 	– 	– 	– 	6 135
Loans to BEE partners 	73 	– 	– 	– 	– 	– 	– 	73
Cash and cash equivalents 	84 	27 	51 	1 	1 	– 	– 	4
6 329 	27 	51 	1 	27 	11 	– 	6 212
1 These instruments are held in the South African government.
Long-term credit ratings were used in the above credit risk analysis.
Discovery Limited has issued financial guarantees as security of loans incurred by subsidiaries in the Group. The carrying amount
of the underlying loans are R5 979 million (2019: R3 607 million) and have a credit risk similar to Discovery Limited.
1.4 	Liquidity risk
Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities due to
insufficient cash available to meet commitments as and when due.
Cash flow forecasting is performed by the Company and liquidity requirements are monitored to ensure it has sufficient cash
to meet operational needs. Such forecasting takes into consideration the Company’s debt financing plans and
covenant compliance.
Cash held by the Company is managed by Group Treasury. Treasury invests it in interest-bearing accounts, term deposits and
money market deposits, choosing instruments with appropriate maturities or sufficient liquidity to provide headroom as
determined by the above-mentioned forecasts. At the reporting date, the Company had money market funds and cash and cash
equivalents of R188 million (2019: R84 million).
138 Discovery Annual Financial Statements 2020

-- 136 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.4 	Liquidity risk continued
The table below analyses Discovery Limited’s financial liabilities into relevant maturity groupings based on the remaining period
at the reporting date to the contractual maturity date. These amounts do not agree to the Statement of financial position as these
are the undiscounted contractual payments.
Company
R million 	Total 	<1 year
1 – 2
years
3 – 5
years
6 – 10
years
Open
ended
At 30 June 2020
Borrowings 	11 777 	802 	1 304 	8 541 	1 130 	–
Derivatives not designated as
hedging instruments 	6 	6 	– 	– 	– 	–
Trade and other payables 	9 088 	9 088 	– 	– 	– 	–
Loans from subsidiaries:
– interest-free loans 	420 	– 	– 	420 	– 	–
– interest-bearing loans 	624 	– 	– 	624 	– 	–
21 915 	9 896 	1 304 	9 585 	1 130 	–
Financial guarantee contracts 	5 979 	5 979 	– 	– 	– 	–
27 894 	15 875 	1 304 	9 585 	1 130 	–
At 30 June 2019
Borrowings 	9 269 	1 370 	1 585 	4 399 	1 915 	–
Derivatives not designated as
hedging instruments 	64 	64 	– 	– 	– 	–
Trade and other payables 	5 294 	5 294 	– 	– 	– 	–
Loans from subsidiaries:
– interest-free loans 	500 	– 	– 	500 	– 	–
– interest-bearing loans 	851 	– 	– 	851 	– 	–
15 978 	6 728 	1 585 	5 750 	1 915 	–
Financial guarantee contracts 	3 607 	3 607 	– 	– 	– 	–
19 585 	10 335 	1 585 	5 750 	1 915 	–
1.5 	Fair value estimation
Discovery Limited’s financial instruments measured at fair value have been disclosed using a fair value hierarchy. The hierarchy
has three levels that reflect the significance of the inputs used in measuring fair value. These are as follows:
Level 1 includes financial instruments that are measured using unadjusted, quoted prices in an active market for identical financial
instruments. Quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or
regulatory agency and those prices represent actual and regularly occurring market transactions on an arm’s length basis.
Level 2 includes financial instruments that are valued using techniques based significantly on observable market data.
Instruments in this category are valued using:
(a) Quoted prices for similar instruments or identical instruments in markets which are not considered to be active; or
(b) Valuation techniques where all the inputs that have a significant effect on the valuation are directly or indirectly based on
observable market data.
Level 3 includes financial instruments that are valued using valuation techniques that incorporate information other than
observable market data and where at least one input (which could have a significant effect on instrument’s valuation) cannot be
based on observable market data.
139 Discovery Annual Financial Statements 2020

-- 137 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.5 	Fair value estimation continued
Company
R million 	Total 	Level 1 	Level 2 	Level 3
At 30 June 2020
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	242 	– 	242 	–
Total financial assets 	242 	– 	242 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	6 	– 	6 	–
– Used as cash flow hedges 	516 	– 	516 	–
Total financial liabilities 	522 	– 	522 	–
At 30 June 2019
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	37 	– 	37 	–
Total financial assets 	37 	– 	37 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	64 	– 	64 	–
– Used as cash flow hedges 	156 	– 	156 	–
Total financial liabilities 	220 	– 	220 	–
2. 	INVESTMENTS IN SUBSIDIARIES
Issued ordinary
capital
R million
Effective
percentage holding
%
Investment
in subsidiaries4
R million
2020 	2019 	2020 	2019 	2020 	2019
Vitality Group International Inc.1 	2 621 	2 552 	100 	100 	815 	746
Discovery Connect Distribution Services
(Pty) Ltd 	555 	* 	100 	100 	555 	*
Discovery Central Services (Pty) Ltd 	* 	* 	100 	100 	33 	33
Discovery Finance Company Europe Ltd 2 	393 	393 	100 	100 	394 	395
Discovery Group Europe Ltd 2 	13 340 	12 274 	100 	100 	13 332 	12 261
Discovery Health (Pty) Ltd 	271 	271 	100 	100 	527 	495
Discovery Insure Ltd 	2 402 	2 315 	100 	100 	1 515 	1 423
Discovery Life Ltd 	1 416 	1 416 	100 	100 	1 722 	1 704
Discovery Life Collective Investments
(Pty) Ltd 	15 	15 	100 	100 	15 	15
Discovery Life Investment Services (Pty) Ltd 	3 	3 	100 	100 	3 	3
Discovery Pref Holdings Company (RF) Ltd 	* 	* 	100 	100 	* 	*
Discovery Vitality (Pty) Ltd 	* 	* 	100 	100 	11 	8
Discovery Partner Market Asia Private Ltd 3 	211 	211 	100 	100 	113 	113
Discovery Bank Holdings Ltd 	6 495 	5 520 	100 	100 	6 623 	5 543
25 658 	22 739
* Amount is less than R500 000.
1 Incorporated in the United States of America.
2 Incorporated in England and Wales.
3 Incorporated in Singapore.
4 Investments in subsidiaries include cost less impairments plus the value of share options issued to subsidiary staff.
Refer to company note 20.3 for a detailed movement analysis.
140 Discovery Annual Financial Statements 2020

-- 138 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
3. 	INVESTMENT IN ASSOCIATE AND JOINT VENTURE
R million
% ownership interest Company
2020
Company
2019	2020 	2019
Investment at cost:
– Ping An Health Insurance Company in China, Limited 	25% 	25% 	991 	991
– AIA Vitality (Hong Kong) Limited 	44% 	44% 	* 	*
991 	991
* Amount is R103.
Refer to Group note 11 for disclosure of the investment in associate and joint ventures.
4. 	DERIVATIVE FINANCIAL ASSETS
R million
Company
2020
Company
2019
Derivatives not designated as hedging instruments 	242 	37
– Current 	242 	37
Refer to Group note 3.4 ’Currency derivative contracts’ for a detailed description of the derivative financial instruments listed above.
5. 	LOANS TO SUBSIDIARIES1
R million
Company
2020
Company
2019
Balance at beginning of the year 	6 135 	5 419
Additional loan granted 	2 302 	3 391
Repayment of loans 	(1 275) 	(2 948)
Interest receivable 	352 	325
Allowance for expected credit losses 	34 	(43)
Foreign exchange revaluations 	308 	(9)
Balance at end of the year 	7 856 	6 135
Discovery Group Europe Ltd 	i 	2 312 	1 822
Discovery Health (Pty) Ltd 	ii 	2 862 	2 586
Discovery Connect Distribution Services (Pty) Ltd 	iii 	– 	455
Discovery Central Services (Pty) Ltd 	iv 	2 263 	772
Discovery Life Investment Services (Pty) Ltd 	v 	419 	500
7 856 	6 135
Current 	3 317 	773
Non-current 	4 539 	5 362
7 856 	6 135
1 All loans to subsidiaries are measured at amortised cost, which approximates to fair value.
141 Discovery Annual Financial Statements 2020

-- 139 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
5. 	LOANS TO SUBSIDIARIES continued
i. Discovery Limited has granted nine GBP denominated loans and one ZAR denominated loan to Discovery Group Europe
Limited (DGEL), a foreign subsidiary of Discovery Limited, the terms are as follows:
GBP denominated
Loan 1 – accrues interest at 400 basis points above 3 month LIBOR and is repayable on 31 July 2020. The value of the loan
outstanding at 30 June 2020 is R315 million (GBP 14.7 million) (2019: R251 million (GBP 14 million)).
Loan 2 – accrues interest at 200 basis points above 3 month LIBOR and is repayable on 1 April 2027. The value of the loan
outstanding at 30 June 2020 is R527 million (GBP 24.7 million) (2019: R434 million (GBP 24.7 million)).
Loan 3 – accrues interest at 600 basis points above 3 month LIBOR and is repayable on 1 November 2027. The value of the
loan outstanding at 30 June 2020 is R128 million (GBP 6 million) (2019: R106 million (GBP 6 million)).
Loan 4 – accrues interest at 600 basis points above 3 month LIBOR and is repayable on 1 June 2028. The value of the loan
outstanding at 30 June 2020 is R224 million (GBP 10.5 million) (2019: R185 million (GBP 10.5 million)).
Loan 5 – accrues interest at 600 basis points above 3 month LIBOR and is repayable on 21 August 2028. The value of the loan
outstanding at 30 June 2020 is R192 million (GBP 9 million) (2019: R158 million (GBP 9 million)).
Loan 6 – accrues interest at 600 basis points above 3 month LIBOR and is repayable on 24 November 2028. The value of the
loan outstanding at 30 June 2020 is R139 million (GBP 6.5 million) (2019: R114 million (GBP 6.5 million)).
Loan 7 – accrues interest at 615 basis points above the Bank of England base rate and is repayable on 1 March 2029. The value
of the loan outstanding at 30 June 2020 is R60 million (GBP 2.8 million) (2019: R49 million (GBP 2.8 million)).
Loan 8 – accrues interest at 615 basis points above the Bank of England base rate and is repayable on 1 June 2029. The value
of the loan outstanding at 30 June 2020 is R152 million (GBP 7.1 million) (2019: R126 million (GBP 7.1 million)).
Loan 9 – accrued interest at 615 basis points above the Bank of England base rate and is repayment on 31 July 2029. The value
of the loan outstanding at 30 June 2020 is R139 million (GBP 6.5 million).
ZAR denominated
Loan 1 – accrues interest at 200 basis points above the 3 month JIBAR and is repayable on 11 November 2022. The value of
the loan outstanding at 30 June 2020 is R436 million (2019: R399 million).
Interest of R143 million was earned in respect of these loans in the current financial year (2019: R114 million) and R307 million
foreign exchange gains was recognised in profit and loss (2019: R9 million gain).
ii. Discovery Limited has granted loans of R727 million and R1 283 million to Discovery Health. The loan for R727 million, accrues
interest at 240 basis points above the 3 month JIBAR and is repayable on 30 June 2021. The loan for R1 283 million, accrues
interest at a fixed rate of 10.2% and is repayable on 31 July 2022. The loans will become payable upon maturity and interest is
payable quarterly, with the option available for Discovery Health to capitalise the interest to the value of the loan. The value
of the loans outstanding at 30 June 2020 is R2 862 million (2019: R2 586 million).
iii. Discovery Limited granted loans totalling R387 million to Discovery Connect Distribution Services. The loans accrued interest
at First National Bank’s published prime overdraft lending rate. The loans were repaid on 30 June 2020.
iv. During 2020, Discovery Central Services increased the interest free loan from Discovery Limited by R1 490 million (2019: R589
million decrease). The value of the loan outstanding at 30 June 2020 is R2 263 million (2019: R772 million).
v. Discovery Limited granted an interest-free subordinated loan to Discovery Life Investment Services. The value of the loan
outstanding at 30 June 2020 is R419 million (2019: R500 million).
142 Discovery Annual Financial Statements 2020

-- 140 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
6. 	LOANS TO BEE PARTNERS1
R million
Company
2020
Company
2019
Balance at the beginning of the year 	73 	111
Interest receivable 	3 	5
Additional loan granted 	40 	54
Repayment of loans 	– 	(97)
Balance at end of the year 	116 	73
Current 	116 	73
Non-current 	– 	–
116 	73
1 All loans to BEE partners are measured at amortised cost, which approximates to fair value.
Financial assistance was provided to Discovery's BEE Partners in April 2015 to assist them in following their rights in terms of the
Discovery Limited's rights issue. Interest accrues at a rate of prime less 0.5% and is repayable on 31 March 2021. However,
the outstanding balance is repayable immediately if they are no longer a BEE partner. Discovery further increased bridge loans
by R40m in 2020 at an interest rate of prime less 2%. There is no fixed term to this loan.
7. 	OTHER RECEIVABLES
R million
Company
2020
Company
2019
Value-added tax 	* 	*
Other debtors 	– 	17
Intercompany receivables 	248 	*
Prepayments 	110 	–
358 	17
Intercompany receivables include:
– Discovery Pref Holdings Company (RF) Ltd 	– 	*
– Discovery Holdings Europe Ltd 	235 	–
– Discovery Finance Co Europe Ltd 	13 	–
248 	*
* Amount is less than R500 000.
8. 	SHARE CAPITAL AND SHARE PREMIUM
8.1 	Ordinary share capital and share premium
Number
of shares
Share
capital
R million
Share
premium
R million
Total
R million
Issued
At 1 July 2018 	646 844 992 	1 	8 495 	8 496
Share movements:
– shares issued 	11 445 744 	* 	1 854 	1 854
– share issue costs 	– 	– 	(19) 	(19)
At 30 June 2019 	658 290 736 	1 	10 330 	10 331
At 30 June 2020 	658 290 736 	1 	10 330 	10 331
* Amount is less than R500 000.
The total authorised number of ordinary shares is 1 billion (2019: 1 billion), with a par value of 0.1 cent per share.
143 Discovery Annual Financial Statements 2020

-- 141 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
8. 	SHARE CAPITAL AND SHARE PREMIUM continued
8.2 	Preference share capital
R million
Company
2020
Company
2019
Authorised
40 000 000 A no par value preference shares 	– 	–
20 000 000 B preference shares of R100 each 	2 000 	2 000
20 000 000 C no par value preference shares 	– 	–
2 000 	2 000
Issued
8 000 000 B preference shares of R100 each 	800 	800
Share issue costs 	(21) 	(21)
At 30 June 2020 	779 	779
The preference shares are non-compulsory, non-cumulative, non-participating, non-convertible, voluntarily redeemable (at
option of Discovery Limited) preference shares and were issued at a coupon rate of 85% of prime rate. With the introduction of
dividend withholding tax on 1 April 2012, the coupon rate on the preference shares was increased to 100% of the prime rate.
9. 	BORROWINGS AT AMORTISED COST
R million
Company
2020
Company
2019
Borrowings from banks1 	8 356 	6 841
Current 	53 	711
Non-current 	8 303 	6 130
8 356 	6 841
1 Collateral in the form of financial guarantees by Discovery Health and Discovery Vitality has been given to secure these borrowings.
Bank borrowings
In 2017, Discovery registered an unsecured R10 billion Domestic Medium Term Note (DMTN) programme. In terms of this programme,
Discovery issued R1.5 billion (2019: R0.7 billion) JSE Listed Notes during the current year. The carrying amount of the listed notes
approximates their fair value. During the current year, 5 year bank facility loans totalling R3.6 billion entered into in 2016 were
refinanced for a further 3 and 5 years, through the issue of unlisted DTMN notes of R1.1 billion and R2.5 billion maturing in March
2023 and February 2025, respectively. These unlisted notes have been structured through an underwritten subscription agreement
with a Bank. Discovery Limited has other borrowings of R1 billion (2019: R4.6 billion) for long term funding requirements. The
borrowings were acquired for general corporate purposes in order to fund the various growth initiatives within the Group.
The facility has the following profile and salient terms:
Facility amount
R million 	Interest rate per annum 	Maturity date
Capital
repayment
500 	Fixed at 9.71% 1 	21 November 2022 	Maturity
1 000 	Fixed at 10.28%1 	02 March 2023 	Maturity
1 100 	Fixed at 8.92% 	10 March 2023 	Maturity
800 	Fixed at 10.31%1 	21 November 2024 	Maturity
1 200 	Fixed at 9.21%1 	21 November 2024 	Maturity
200 	Fixed at 10.46%2 	21 November 2024 	Maturity
2 500 	Fixed at 9.62% 	22 February 2025 	Maturity
700 	Fixed at 10.29%1 	21 August 2026 	Maturity
300 	Fixed at 9.40%1 	21 November 2026 	Maturity
8 300
1 The interest rate has been fixed through interest rate swaps.
2 Interest is payable semi-annually in arrears.
The borrowings are unsecured senior debt and are not callable or convertible. Interest is payable quarterly in arrears other
footnote 2 in the table above. Refer to company note 20.4 for movement analysis.
Also refer Goup note 20.
144 Discovery Annual Financial Statements 2020

-- 142 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
10. 	DERIVATIVE FINANCIAL LIABILITIES
R million
Company
2020
Company
2019
Interest rate swap – used as cash flow hedges 	516 	156
Derivatives not designated as hedging instruments 	6 	64
522 	220
Current 	6 	64
Non-current 	516 	156
522 	220
Refer to Group note 3.4.1, for a detailed description of the derivative financial instruments listed above.
11. 	TRADE AND OTHER PAYABLES
R million
Company
2020
Company
2019
Accrued expenditure 	6 	2
Dividends due to shareholders 	10 	4
Intercompany payables 	9 072 	5 288
9 088 	5 294
Intercompany payables include:
– Discovery Health (Pty) Ltd 	i 	3 973 	3 850
– Discovery Connect Distribution (Pty) Ltd 	* 	–
– Discovery Life Ltd 	ii 	5 099 	1 438
9 072 	5 288
* Amount is less than R500 000.
i. 	Discovery Limited receives funds from Discovery Health Proprietary Limited through a loan account, based on operational
requirements. The loan is interest free and is settled as and when sufficient cash becomes available.
ii. 	Discovery Limited received funds from Discovery Life Limited in 2020 to assist with operational requirements. The loan is
interest-free and is settled as and when sufficient cash becomes available.
The amortised cost of the trade and other payables approximate the fair value due to the short term nature of these payables.
12. 	LOANS FROM SUBSIDIARIES
R million
Company
2020
Company
2019
Discovery Life Ltd 	i 	1 102 	1 119
1 102 	1 119
i. Discovery Limited issued 5-year term Investment Notes totalling R500 million to Discovery Life on 30 June 2017. Investment
Notes bear interest at variable 3 month JIBAR, currently 8.44% per annum (2019: 10.69%) and is repayable in arrears together
with capital on 30 June 2022. Discovery Life further granted Discovery Limited an interest-free loan of R500 million in 2019,
which matures on 20 June 2024. The amortised cost of these instruments approximates the fair value.
145 Discovery Annual Financial Statements 2020

-- 143 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
13. 	DEFERRED INCOME TAX (LIABILITY)/ASSET
R million
Company
2020
Company
2019
Deferred tax asset – non-current 	– 	23
Deferred tax liability – non-current 	(1) 	–
(1) 	23
Movement summary:
Balance at beginning of the year 	23 	(1)
Income statement charge 	(24) 	24
Balance at end of the year 	(1) 	23
Deferred taxation comprises:
Assessed losses 	* 	24
Unrealised gains on financial instruments 	(1) 	(1)
(1) 	23
* Amount is less than R500 000.
14. 	INVESTMENT INCOME1
R million
Company
2020
Company
2019
Cash and cash equivalents interest income 	8 	12
At amortised cost interest income, using the effective interest rate 	462 	400
Dividends received from subsidiaries and equity-accounted investments 	1 155 	1 364
1 625 	1 776
* Amount is less than R500 000.
Dividends received from subsidiaries and equity-accounted investments include:
– Discovery Health (Pty) Ltd 	1 148 	1 100
– AIA Vitality (Hong Kong) Ltd 	– 	18
– Discovery Life Investment Services (Pty) Ltd 	– 	150
– Discovery Partner Markets Asia 	7 	–
– Discovery Pref Holding Company (RF) Ltd 	– 	96
1 155 	1 364
1 Investment income for Discovery Limited is seen as Revenue.
15. 	OTHER INCOME
R million
Company
2020
Company
2019
Guarantee fees 	i 	22 	20
Amortisation of financial guarantee contract 	ii 	13 	–
35 	20
i. Discovery Limited issued guarantees in respect of Discovery Finance Company Europe obligations. A guarantee fee is charged
by Discovery Limited to Discovery Finance Company Europe.
ii. Amortisation of initial financial guarantee contracts over the term of the loan. Refer to Company note 21 for a list of all the
guarantees that Discovery Limited has issued.
146 Discovery Annual Financial Statements 2020

-- 144 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
16. 	NET FAIR VALUE GAINS/(LOSSES) ON FINANCIAL INSTRUMENTS AT
FAIR VALUE THROUGH PROFIT OR LOSS
R million
Company
2020
Company
2019
Realised loss on derivatives not designated as hedging instruments 	(3) 	(7)
Fair value gains/(losses) on derivatives not designated as hedging instruments 	266 	(137)
263 	(144)
17. 	MARKETING AND ADMINISTRATION EXPENSES
R million
Company
2020
Company
2019
Marketing and administration expenses comprises:
– Audit fees 	3 	4
– Professional fees 	8 	3
– Other 	3 	3
14 	10
18. 	MOVEMENT IN ALLOWANCE FOR EXPECTED CREDIT LOSSES1
R million
Company
2020
Company
2019
Loans to subsidiaries:
– Discovery Health (Pty) Ltd 	(10) 	(3)
– Discovery Central Services (Pty) Ltd 	– 	(1)
– Discovery Life Investment Services (Pty) Ltd 	1 	*
– Discovery Pref Holding Company (RF) Ltd 	* 	*
– Discovery Group Europe Ltd 	(24) 	9
– Discovery Connect Distribution Services (Pty) Ltd 	(1) 	(1)
– Discovery Holdings Europe Limited 	* 	–
– Discovery Finance Company Europe Limited 	* 	–
Financial guarantee contracts:
– Discovery Central Services Pty Ltd 	25 	–
(9) 	4
* Amount is less than R500 000.
1 In determining the expected credit loss, Discovery assigned risk ratings to subsidiaries relative to Discovery Limited where a Moody’s rating was not
available. All these loans are high quality.
12 month
credit losses
Lifetime
credit losses 	Total
30 June 2020
Balance at beginning of the year 	43 	– 	43
Decrease in allowance 	(9) 	– 	(9)
Balance at end of the year 	34 	– 	34
30 June 2019
Balance at beginning of the year 	39 	– 	39
Increase in allowance 	4 	– 	4
Balance at end of the year 	43 	– 	43
147 Discovery Annual Financial Statements 2020

-- 145 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
19. 	TAXATION
R million
Company
2020
Company
2019
South African normal taxation
Current tax 	(160) 	–
Prior year over provision 	* 	*
Deferred tax 	(24) 	24
(184) 	24
* Amount is less than R500 000.
% 	%
Taxation rate reconciliation
Effective taxation rate 	(12.6) 	2.8
Capital profits and dividend income 	(22.2) 	(43.9)
Disallowed expenditure: Capital in nature 	6.7 	11.5
Taxable Income: International tax adjustments 	0.1 	1.6
Standard rate of taxation 	(28) 	(28)
20. 	CASH FLOW INFORMATION
R million
Company
2020
Company
2019
20.1 Cash generated by operations
Profit before taxation 	1 456 	869
Adjusted for:
Interest received 	(470) 	(412)
Dividends received 	(1 155) 	(1 364)
Realised gains on derivatives not designated as hedging instruments 	– 	(18)
Finance costs 	832 	759
Non-cash items:
Movement in expected credit losses 	(9) 	4
Fee income from financial guarantee contracts 	(13) 	–
Fair value (gains)/losses on derivatives not designated as hedging instruments 	(263) 	162
Unrealised foreign exchange (gains)/losses 	(370) 	10
Working capital changes:
Loans and receivables 	(298) 	(53)
Trade and other payables and loans from subsidiaries 	3 698 	3 383
3 408 	3 340
20.2 Taxation paid
Balance at beginning of the year 	21 	(50)
Taxation charged for the year in the Statement of other comprehensive income 	(160) 	–
Balance at end of the year 	89 	(21)
(50) 	(71)
20.3 Increase in investment in subsidiary
Balance at beginning of the year 	22 739 	18 103
Value of share options issued to subsidiary staff 	162 	31
Financial guarantee contracts raised 	9 	35
Financial guarantee contracts derecognised 	(5) 	–
Balance at end of the year 	(25 658) 	(22 739)
(2 753) 	(4 570)
148 Discovery Annual Financial Statements 2020

-- 146 of 198 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2020
R million
Company
2020
Company
2019
20.4 Long-term borrowings
Balance at beginning of the year 	6 841 	6 132
Interest accrued 	708 	652
Interest paid 	(691) 	(634)
Settlement of derivative capitalised to loan by counterparty 	(6) 	(7)
Increase in borrowings 	5 120 	700
Raising fees capitalised 	(16) 	(2)
Repayment of borrowings 	(3 600) 	–
Balance at end of the year 	8 356 	6 841
20.5 Cash and cash equivalents
Cash at bank and in hand 	57 	1
Short-term deposits 	131 	83
188 	84
21. 	FINANCIAL GUARANTEE CONTRACTS
R million
Company
2020
Company
2019
Discovery Limited has provided guarantees for the following subsidiaries:
Discovery Finance Co Europe Ltd 	i 	1 	2
Discovery Central Services (Pty) Ltd 	ii 	47 	33
Discovery Insure Ltd 	– 	*
Discovery Holdings Europe Ltd 	iii 	4 	–
Discovery Bank Ltd 	iv 	* 	–
52 	35
* Amount is less than R500 000.
i 	Discovery Limited has issued a guarantee for 2 facilities in respect of the obligations of Discovery Finance Company Europe
Limited in the amount of GBP 80 million and GBP 28 million. As at 30 June 2020, Discovery Finance Company Europe Limited
owed GBP 108.2 million (2019: GBP 89.7 million) in respect of these borrowing facilities.
ii During 2018, Discovery Central Services entered into borrowing facilities for an amount of R650 million to fund the systems
build of Discovery Bank. The full amount has been drawn down and the balance outstanding at 30 June 2020 is R596 miilion
(2019: R548 million). In 2019, Discovery Central Services entered into a 5 year borrowing facility for an amount of R1.4 billion.
These funds were acquired for general corporate purposes and the full facility was used. Discovery Health, Discovery Vitality
and Discovery Limited have provided guarantees in respect of these facilities.
iii During 2020, Discovery Holdings Europe Limited entered into borrowing facilities for an amount of GBP 55 million to fund its
operations. This facility has been guaranteed by Discovery Limited.
iv Discovery Limited issued a guarantee for a facility in respect of the obligations of Discovery Bank in the amount of R500 million.
This facility has also been guaranteed by Discovery Vitality and Discovery Health.
22. 	EVENTS AFTER REPORTING DATE
Refer to Group note 42 for a list of the events after reporting date.
149 Discovery Annual Financial Statements 2020

-- 147 of 198 --

DISCOVERY
ANNEXURES

-- 148 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES
for the year ended 30 June 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these consolidated and separate financial statements are set out below. These
policies have been consistently applied to all the years presented, except for those accounting policies resulting from the initial application
of IFRS 16 Leases and the change in the accounting policy on presentation of insurance and reinsurance finance income and finance expenses
– refer to note 41 which sets out the adoption of these new accounting policies. Other interpretations, amendments and annual improvements
effective for the first time in the current year have been considered and have no impact on the current reporting period.
1. 	Basis of presentation
The consolidated and separate Annual Financial Statements have been prepared in accordance with International Financial
Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), its interpretations adopted by the
IASB, the South African Institute of Chartered Accountants (SAICA), Financial Reporting Guides as issued by the Accounting Practices
Committee, the JSE Listings Requirements as well as the South African Companies Act. They have been prepared in accordance
with the going concern principle using the historical cost basis except where otherwise stated in the accounting policies below.
The preparation of financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also
requires management to exercise its judgement in the process of applying Discovery’s accounting policies. The areas involving a
higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial
statements, are outlined in Group note 4 to the Annual Financial Statements.
All monetary information and figures presented in these financial statements are stated in millions of Rand (R million), unless
otherwise indicated.
New standards and amendments which became effective during the financial year
During the financial period, the following standards and amendments that have a significant impact on Discovery became effective:
❚ 	IFRS 16 Leases. Refer to accounting policy 22 Leases and Note 41 Changes in accounting policy in the consolidated financial
statements.
New standards and amendments to published standards not yet effective
❚ 	Discovery has not early adopted any accounting standards, amendments or annual improvements issued but not yet effective.
❚ 	The accounting standards, amendments and annual improvements described below are those that are expected to have an
impact on Discovery’s results and/or disclosures. Accounting standards, amendments and annual improvements not
mentioned below are not expected to have a significant impact on recognised amounts.
Title and
Effective date 	Scope 	Potential impact
IFRS 17 Insurance
Contracts
Effective date:
1 July 2023
IFRS 17 was issued in May 2017, with amendments
issued in June 2020.
General model
INITIAL RECOGNITION
Under IFRS 17, the general model requires entities to
measure an insurance contract at initial recognition at:
❚ 	the total of the fulfilment cash flows, comprising:
– the estimated future cash flows;
– an adjustment to reflect the time value of
money; and
– an explicit risk adjustment for non- financial
risk; and
❚ 	the contractual service margin (CSM).
Discovery has implement an IFRS 17 transition
programme under the sponsorship of the Chief
Financial 	Officer. 	Discovery 	has 	allocated
sufficient resources over the project life to
ensure successful implementation.
The CFO heads up the Steering Committee
comprises of the respective Insurance business
CFOs, Chief Actuaries, Internal Audit and IT
specialist. The Steering Committee is supported
by a Technical Advisory Group comprising of
IFRS Specialists, Actuaries, Financial Managers,
Tax and external auditors.
151 Discovery Annual Financial Statements 2020

-- 149 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
1. 	Basis of presentation continued
Title and
Effective date 	Scope 	Potential impact
IFRS 17 Insurance
Contracts
Effective date:
1 July 2023
SUBSEQUENTLY:
Subsequent to initial recognition, the liability of a
group of insurance contracts comprises the liability of
remaining coverage (fulfilment cash flows and CSM) as
well as the liability for incurred claims (claims and
expenses already incurred but not yet paid).
❚ 	The fulfilment cash flows are remeasured at each
reporting period to reflect current estimates.
Changes in fulfilment cash flows are treated in a
number of ways:
– Change in time value of money (i.e. yields) and
financial risk (e.g. inflation indices) are reflected
in profit or loss, or other comprehensive income
of both dependent on accounting policy elections;
– Changes in past and current services are
recognized in profit or loss; and
– Changes related to future services are recognized
in the CSM to the extent there is CSM. Any excess
is recognized in profit or loss immediately.
❚ 	The 	CSM 	(representing 	unearned 	profit) 	is
recognised as the entity provides services over the
coverage period.
PRESENTATION:
❚ 	Insurance revenue, derived from change in liability
for remaining coverage;
❚ 	Investment 	components 	are 	excluded 	from
insurance 	revenue 	and 	insurance 	services
expenses;
❚ 	Insurance 	finance 	income 	and 	expenses 	is
presented separately from insurance revenue; and
❚ 	Entities can choose to disaggregate the presentation
of insurance finance income or expenses between
profit or loss and other comprehensive income
(OCI).
During 2018 to 2020 Discovery completed the
initial impact assessments, including several
pilot projects on selected products aimed at
assessing the financial impacts of the standard.
Significant progress has been made on the
development of accounting and actuarial
policies and methodologies.
The most significant impact will be within the
long-term insurance businesses of Discovery
Life and VitalityLife, including their respective
investment businesses.
It is expected that that impact will be minimal
within the short-term insurance businesses,
which are expected to apply the PAA. These
business include Discovery Insure, Group Life
and Vitality Health.
The following tentative observations are made
in the IFRS 17 project:
❚ 	Discovery is still assessing if it will early adopt
IFRS 17 or only adopt at the mandatory date.
Should Discovery elect to early adopt, it will
do so one year early;
❚ 	Discovery is considering the accounting
policy election of IFRS 17 to present
‘insurance finance income and expenses’ in
other 	comprehensive 	income 	with 	a
subsequent release to profit or loss;
❚ 	Discovery believes it has sufficient robust
data to enable it to apply IFRS 17 with full
retrospective statement; and
❚ 	Discovery 	believes 	that 	many 	of 	its
accounting policies today (e.g. discounting at
a current rate, build-up of compulsory and
discretionary margins as well as its best
estimates of income and costs) places it in a
strong position to transition smoothly to
IFRS 17.
152 Discovery Annual Financial Statements 2020

-- 150 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
1. 	Basis of presentation continued
Title and
Effective date 	Scope 	Potential impact
Simplified model
Aside from this general model, the standard provides,
as a simplification, the premium allocation approach
(PAA). This simplified approach is applicable for certain
types of contract, including those with a coverage
period of one year or less.
Variable fee approach
For insurance contracts with direct participation
features, the variable fee approach applies. The
variable fee approach is a variation on the general
model. When applying the variable fee approach, the
entity’s share of the fair value changes of the underlying
items is included in the contractual service margin. As
a consequence, the fair value changes are not
recognised in profit or loss in the period in which they
occur but over the remaining life of the contract.
The focus within the next period is the
formalization and sign-off of policies and
methodologies internally by all committees and
external auditors. Discovery aims to implement
the CSM engine and models into production to
produce required disclosures.
Amendment to
definition of
material –
amendments to
IAS 1 and IAS 8
Effective date:
1 July 2020
The definition of material has been amended in both
IAS 1 and IAS 8. This new definition states that
“information is material if omitting, misstating or
obscuring it could reasonably be expected to influence
the decisions that the primary users of general
purpose financial statements make on the basis of
those financial statements”. The new elements
incorporated 	in 	the 	definition 	are: 	obscuring
information; expected to influence decisions and that
the users are the primary users of general purpose
financial statements. These amendments are not
expected to have a significant impact on the financial
statements but could change the way information in
the financial statements is presented. This is
particularly relevant in the clarity of disclosures to not
obscure information. In addition, the clarification of
the users to determine what is material, could result in
a more focused group being considered in making
materiality judgements.
This amendment is not expected to have a
significant impact on Discovery’s results, but
would be considered prospectively in making
materiality 	judgements 	as 	part 	of 	the
preparation of the financial statements.
Definition of a
business –
amendments to
IFRS 3
Effective date:
1 July 2020
The amendments to IFRS 3 revise the definition of a
business and the related application guidance in
determining whether an acquisition is a business. The
amendments indicate that outputs are not critical to a
business, however inputs and a substantial process
are the defining factors. The application of the
definitions is also dependent on whether the process
acquired includes a workforce, and whether the
process can be easily replaced without significant cost
or effort, particularly where there are no outputs.
The amendments also include a simplified optional
“fair value concentration test”. For acquisitions where
substantially all of the fair value of the assets acquired
is concentrated in a single asset or group of similar
assets the acquisition is not a business and is
accounted for as an asset acquisition. This optional
test is applicable on a transaction by transaction basis.
The amendment will apply prospectively to
business acquired on or after 1 July 2020 and will
therefore not impact completed transactions.
153 Discovery Annual Financial Statements 2020

-- 151 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
2. 	Consolidation
The consolidated financial statements include the assets, liabilities and results of the operations of the holding company and its
subsidiaries, joint ventures and associates.
2.1 	Business combinations
The acquisition method of accounting is used to account for business combinations by the Group. The consideration transferred
for the acquisition of a business is the fair values of the assets transferred, the liabilities incurred and the equity interests issued
by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent
consideration arrangement. Acquisition-related costs are expensed as incurred.
Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at
their fair values at the acquisition date. On an acquisition-by-acquisition basis, Discovery recognises any non-controlling interest
in the acquiree either at fair value or at the non-controlling interest’s proportionate share of the acquiree’s net assets. The excess
of the consideration transferred, being the amount of any non-controlling interest in the acquiree and the acquisition-date fair
value of any previous equity interest in the acquiree over the fair value of the identifiable net assets acquired, is recorded as
goodwill. If this is less than the fair value of the net assets of the subsidiary acquired in the case of a bargain purchase, the
difference is recognised directly in profit or loss.
2.2 	Consolidation of entities in which the Group holds less than 50%
Discovery analysed its relationships with the Discovery Unit Trusts and has determined that it has significant power to direct the
relevant activities of the funds, has sufficient exposure to the variable returns of the funds and the ability to use its power over
the investee to affect its returns. This analysis concluded that Discovery has control of the Discovery Unit Trusts even if the
economic interest is less than 50% and is therefore required to consolidate these funds.
Of the 27 (2019: 27) Discovery Unit Trusts consolidated at 30 June 2020 Discovery holds less than a 50% economic interest in
3 (2019: 3) of these funds. Refer to page 17 for a list of consolidated unit trusts.
2.3 	Subsidiaries
Subsidiaries are all entities (including structured entities) over which Discovery has control. Discovery controls an entity when it
is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns
through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to Discovery.
Consolidation is discontinued from the date on which control ceases.
Intra-group transactions, balances and unrealised gains on intra-group transactions are eliminated. Unrealised gains or losses
are also eliminated. Subsidiaries’ accounting policies have been changed where necessary to ensure consistency with the policies
adopted by Discovery.
2.4 	Associates and joint ventures
Associates are entities over which Discovery has the ability to exercise significant influence but not control over the financial and
operational policies. Significant influence is determined based primarily on percentage voting rights, generally between 20% and
50%, together with other factors such as board participation and participation in the policy-making process. In certain instances,
Discovery holds less than 20% equity interests, but holds rights that still give it significant influence. These are equity accounted.
A joint venture is a joint arrangement whereby the parties have joint control of an arrangement and have rights to the net assets
of the arrangement.
Discovery recognises its interest in an associate or a joint venture as an investment and accounts for that investment using the
equity method. Under the equity method, on initial recognition the investment in an associate or a joint venture is recognised at
cost. The carrying amount is adjusted to recognise Discovery’s share of the post-acquisition profit or loss of the investee and is
recognised in profit or loss. Distributions received from an investee reduce the carrying amount of the investment. Adjustments
to the carrying amount may also be necessary for changes in Discovery’s proportionate interest in the investee arising from
changes in the investee’s other comprehensive income. Such changes include those arising from foreign exchange translation
differences. Discovery’s share of those changes is recognised in other comprehensive income. Discovery will discontinue the use
of the equity method from the date when its investment ceases to be an associate or a joint venture.
154 Discovery Annual Financial Statements 2020

-- 152 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
2. 	Consolidation continued
2.4 	Associates and joint ventures continued
Discovery discontinues equity accounting when the carrying amount of the investment in an associate or a joint venture reaches
zero, unless it has incurred obligations, guaranteed obligations or made payments on behalf of the associate or the joint venture.
Discovery resumes equity accounting only after its share of the profits equals the share of losses not recognised. Discovery increases
the carrying amount of investments with its share of the associate’s or joint venture’s income when equity accounting is resumed.
As Discovery’s investment in an associate or a joint venture includes goodwill identified on acquisition, Discovery assesses at each
reporting date whether there is objective evidence that an associate or a joint venture is impaired. If such evidence of impairment
exists, Discovery calculates the amount of impairment as the difference between the recoverable amount of the investment and
its carrying value.
Unrealised gains or losses on transactions between Discovery and its associates or joint ventures are eliminated to the extent of
the Group’s interest in these entities unless the transaction provides evidence of an impairment of the asset transferred.
Accounting policies of associates and joint ventures have been changed where necessary to ensure consistency with the policies
adopted by the Group. (The carrying amount of equity-accounted investments are tested for impairment (see accounting
policy 9.3 for the policy on impairment).
3. 	Foreign currency translation
3.1 	Functional and presentation currency
Items included in the financial statements of each of Discovery’s entities are measured using the currency of the primary
economic environment in which the entity operates (the functional currency). The consolidated financial statements are
presented in Rand, which is the functional and presentation currency of Discovery Limited.
3.2 	Transactions and balances
Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the
transactions. Foreign exchange gains and losses resulting from:
❚ 	The settlement of trading transactions is included in the results of operating activities in profit or loss;
❚ 	The settlement of financing transactions and from the translation at year-end exchange rates of assets and liabilities
denominated in foreign currencies are recognised in profit or loss as foreign exchange gains and losses; and
❚ 	Qualifying cash flow hedges are deferred in the statement of other comprehensive income and are recycled to profit or loss
in the periods in which the hedged item affects profit or loss.
3.3 	Group companies
The results and financial position of all Discovery entities (none of which has the currency of a hyperinflationary economy) that
have a functional currency different from the presentation currency are translated into the presentation currency as follows:
❚ 	Assets and liabilities for each Statement of financial position presented are translated at the closing rate at the date of that
statement of financial position;
❚ 	Income and expenses for each Income statement are translated at average exchange rates (unless this average is not a
reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and
expenses are translated at rates at the date of the transactions); and
❚ 	All resulting exchange differences are recognised as a separate component of equity, namely the foreign currency
translation reserve.
On consolidation, exchange differences arising from the translation of the net investment in foreign entities are recognised in the
foreign currency translation reserve in the Statement of other comprehensive income. When a foreign operation is partially
disposed of or sold, such exchange differences are recognised in profit or loss as part of the gain or loss on sale. Goodwill and
fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and
translated at the closing rate.
155 Discovery Annual Financial Statements 2020

-- 153 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
4. 	Property and equipment
Property and equipment are stated at historical cost less depreciation and impairment. Historical cost includes expenditure that
is directly attributable to the acquisition of the items.
Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is
probable that future economic benefits associated with the item will flow to Discovery and the cost of the item can be measured
reliably. All other repairs and maintenance are charged to profit or loss during the financial period in which they are incurred.
Property and equipment are depreciated using the straight-line method to allocate their cost to their residual values over their
estimated useful lives, as follows:
Owner occupied property 	40 years
Leasehold improvements 	Shorter of estimated life or period of lease
Leased asset 	3 – 15 years
Computer equipment 	3 – 7 years
Furniture, fittings and building fit out 	5 – 15 years
Motor vehicles 	4 years
Telematics devices 	2 – 5 years
The assets’ residual values and useful lives are reviewed at each reporting period and adjusted if appropriate. An asset’s carrying
amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated
recoverable amount. The recoverable amount is the higher of the asset’s fair value less costs to dispose and value-in-use.
Gains or losses on disposals are determined by comparing the proceeds with the carrying amount. These are recorded in profit
or loss.
5. 	Intangible assets
5.1 	Computer software development costs
Costs associated with maintaining computer software programmes are recognised as an expense as incurred. Development
costs that are directly attributable to the design and testing of identifiable software products controlled by Discovery are
recognised as intangible assets when the following criteria are met:
❚ 	It is technically feasible to complete the software product so that it will be available for use;
❚ 	Management intends to complete the software product and use or sell it;
❚ 	There is an ability to use or sell the software product;
❚ 	It can be demonstrated how the software product will generate probable future economic benefits;
❚ 	Adequate technical, financial and other resources to complete the development and to use or sell the software product are
available; and
❚ 	The expenditure attributable to the software product during its development can be reliably measured.
Directly attributable costs that are capitalised as part of the software product, include the software development employee costs
and an appropriate portion of directly attributable overheads.
Other development expenditures that do not meet these criteria are recognised as an expense as incurred. Development costs
previously recognised as an expense are not recognised as an asset in a subsequent period.
Computer software development costs are recognised as assets from the point where the recognition criteria above are satisfied,
and are amortised once the asset is ready for use, over their useful lives (between three and ten years). The amortisation is
reflected under marketing and administration expenses in profit or loss.
Computer software development costs recognised as assets are amortised over their useful lives.
Software 	3 – 7 years
Core Systems 	10 years
156 Discovery Annual Financial Statements 2020

-- 154 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
5. 	Intangible assets continued
5.2 	Other intangible assets
Discovery does not recognise costs incurred to internally developed trademarks, patents and similar rights and assets, including
franchises and management contracts. These costs are recognised in profit or loss in the period in which they are incurred.
Purchased intangible assets which represent rights to receive future profits are capitalised at their fair values, represented by the
estimated net present value of future cash flows relating to existing business, or at a value as determined by an independent
valuer. These intangible assets are amortised into profit or loss as profits are expected to emerge and only tested for impairment
if an indication of impairment arises.
Intangible assets acquired as part of business combinations were capitalised at their fair value, represented by the estimated net
present value of future cash flows relating to existing business, or at a value as determined by an independent valuer. These
intangible assets are amortised over their useful lives and only tested for impairment if an indication of impairment arises.
6. 	Deferred acquisition costs
The direct costs of acquiring new business, which are expected to be recovered out of future revenue margins, are deferred over
the period in which the related performance obligations are satisfied and recognised as an asset in the Statement of financial
position. The accounting policies relating specifically to deferred acquisition costs for insurance are detailed in accounting policies 13.
7. 	Goodwill
Goodwill arises on the acquisition of businesses and represents the excess of the consideration transferred, the amount of any
non-controlling interest in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the
fair value of the identifiable net assets acquired.
Goodwill is reviewed for impairment annually or more frequently if events or changes in circumstances indicate a potential
impairment. The carrying value of the cash generating unit (CGU) containing the goodwill is compared to the recoverable amount,
which is the higher of value in use and the fair value less costs of disposal. Any impairment is recognised immediately as an
expense and is not subsequently reversed.
For the purpose of impairment testing, goodwill acquired in a business combination is allocated to each of the CGUs, or groups
of CGUs that is expected to benefit from the synergies of the combination. Each unit or group of units to which the goodwill is
allocated represents the lowest level within the entity at which the goodwill is monitored for internal management purposes.
Goodwill is monitored at the operating segment level.
8. 	Impairment of non-financial assets
Goodwill is tested annually for impairment or more frequently if events or changes in circumstances indicate that goodwill may
be impaired.
Other assets, including equity accounted investments, intangible assets and costs of obtaining contracts, other than those
relating to insurance contracts (see accounting policy 13), are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount may not be recoverable. Such indicators include continued losses, changes in
technology, market, economic, legal and operating environments.
An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The
recoverable amount is measured using the higher of the fair value less costs to sell and the value-in-use. Value-in-use is the
present value of projected cash flows covering the remaining useful life of the asset. An impairment loss is recognised in profit or
loss immediately.
Other assets, other than goodwill, that suffered an impairment are reviewed for possible reversal of the impairment at the end
of each reporting period.
9. 	Financial instruments
Discovery initially recognises financial instruments when it becomes party to the contract.
Financial instruments are measured at initial recognition at fair value net of directly attributable transaction costs, unless the
financial instrument is classified as fair value through profit or loss. For instruments classified at fair value through profit or loss
attributable transaction costs are immediately expensed.
157 Discovery Annual Financial Statements 2020

-- 155 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments
9.1 	Financial assets
9.1.1 	RECOGNITION, CLASSIFICATION, MEASUREMENT AND DERECOGNITION
At initial recognition, the Group considers the appropriate classification as at Amortised cost (AC); Fair value through profit or loss
(FVTPL) or Fair value through other comprehensive income (FVOCI) for debt instruments. Discovery considers:
❚ 	Whether the contractual cash flows of the financial asset are solely payments of principal and interest (‘SPPI’). Such contractual
cash flows are consistent with a basic lending arrangement, and compensates Discovery for the elements of time value of
money, credit risk and other basic lending risks and a profit margin. Examples of such instruments include Treasury Bills,
Government Bonds, cash and fixed term deposits. It excludes instruments such as equity-linked financial assets or puttable
investments in unit trusts; and
❚ 	The business model for holding the financial assets.
Based on the criteria above, Discovery will classify a debt instrument as at:
❚ 	Amortised cost, if the financial asset meets the SPPI criterion and is held for the purpose to collect the contractual cash flows.
Examples of this include loans and advances to customers (e.g. credit card advances) and fixed term deposits;
❚ 	Fair value with changes in other comprehensive income (debt instruments), if the financial asset meets the SPPI criterion and
is held both to collect contractual cash flows and by selling the financial assets. Discovery currently does not hold financial
assets in this category. However, specified associates do have certain of their debt instruments in the category.
❚ 	Fair value through profit or loss, for all other financial assets that do not meet the criteria above (mandatorily). In addition,
Discovery can designate financial assets into this category if this will reduce measurement inconsistencies (i.e. ‘accounting
mismatch’) (designated). Discovery’s business includes, amongst others, providing unit-linked insurance, unit-linked
investment and non-linked insurance products to customers. Financial assets and liabilities in these portfolios are managed
to achieve the objectives of the portfolio and to ensure that liabilities are appropriately matched with assets. In considering
whether the objective of a portfolio is to collect contractual cash flows or to trade in financial instruments, Discovery considers
the purpose for which instruments are held, the methods of risk management in a portfolio, the manner of performance
reporting on a portfolio and the basis for determining compensation to managers for asset performance. For those financial
assets backing insurance contracts, Discovery measures these financial assets at fair value through profit or loss. Unit-linked
investment contracts are also mandatorily classified at fair value through profit or loss. For those financial assets backing
insurance contracts, Discovery measures these financial assets at fair value through profit or loss. Unit-linked investment
contracts are also mandatorily classified at fair value through profit or loss.
For equity instruments Discovery is permitted to make the irrevocable election to present changes in fair value in other
comprehensive income, however cumulative gains or losses recognised cannot be reclassified to profit or loss on disposal. This
election is available on an instrument by instrument basis. This election has only been made in the accounting records of specified
associates. All other equity instruments are measured at FVTPL.
Subsequent measurement
Amortised cost (AC) 	These instruments are measured at amortised cost using the effective interest
rate method. Movements in the balance of the instrument relate to expected
credit losses, interest income and foreign exchange gains and losses which are
recognised on profit or loss.
(Fair value through
profit or loss (FVTPL)
These instruments are measured at fair value with gains and losses, interest and
dividends recognised in profit or loss.
Fair value through other comprehensive
income (FVOCI) – equity
These instruments are measured at fair value with gains and losses recognised in
other comprehensive income. Dividends are recognised in profit or loss.
Fair value through other comprehensive
income (FVOCI) – debt
These instruments are measured at fair value with changes in fair value recognised
in other comprehensive income. Discovery recognises interest using effective
interest rate method, movements in the balance related to expected credit losses,
interest income and foreign exchange gains and losses which in profit or loss.
There are no financial assets that have been designated at fair value through profit or loss.
The business model for managing a group of financial instruments is expected to remain stable, in rare instances where the
business model changes there can be a reclassification of the business model. Any reclassifications are applied prospectively
from the first day of the first reporting period after the change in business model, with no restatement of any previously
recognised gains, losses or interest. Discovery has not had any changes in business models in the current reporting period and
consequently there have been no reclassifications.
Financial assets are derecognised when the rights to receive cash flows from them have expired or where they have been
transferred and Discovery has also transferred substantially all risks and rewards of ownership.
158 Discovery Annual Financial Statements 2020

-- 156 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments continued
9.1 	Financial assets continued
9.1.2 	EXPECTED CREDIT LOSSES
Expected credit losses are recognised on the following items:
❚ 	Debt instrument at amortised cost, which includes treasury bills, banking loans and advances and fixed deposits. This also
includes loan commitment for undrawn credit facilities;
❚ 	Lease receivables;
❚ 	Financial guarantee contracts;
❚ 	Other receivables which are financial assets at amortised cost;
❚ 	Contract receivables and contracts assets with non-insurance customers and cash and cash equivalents.
Discovery has a multitude of different debtors and loans included in other receivables which are financial assets, which do not
represent a homogeneous group of assets. The approach to determining credit losses varies according to the asset type, past bad
debt experience and the potential to incorporate forward looking information. In certain instances, financial assets have been
grouped based on shared characteristics (i.e. debt payment pattern similarities, financial instruments with collateral, debtor
type), and expected credit losses determined on a collective basis.
The general expected credit loss approach requires that Discovery assess the credit risk of the instrument and determine whether
there has been a significant increase in credit risk since initial recognition.
❚ 	Where there has not been a significant increase in credit risk since initial recognition expected credit losses are measured as
the 12 month expected credit losses.
❚ 	Where there has been a significant increase in credit risk, expected credit losses are recognised as the life time credit losses.
Discovery measures expected credit losses on:
❚ 	financial assets that are not credit-impaired at the reporting date as the present value of all cash shortfalls (i.e. the difference
between the cash flows due to the entity in accordance with the contract and the cash flows that Discovery expects to receive);
❚ 	financial assets that are credit-impaired at the reporting date: as the difference between the gross carrying amount and the
present value of estimated future cash flows; and
❚ 	undrawn loan commitments: as the present value of the difference between the contractual cash flows that are due to Discovery
if the commitment is drawn down and the cash flows that Discovery expects to receive (adjusted using a credit conversion factor).
Discovery does not recognise expected credit losses on Treasury Bills issued by the South African Reserve Bank as well as cash
and cash equivalents receivable on demand due to the assessment that it is immaterial
SIGNIFICANT INCREASE IN CREDIT RISK
At each reporting date, Discovery assesses whether the credit risk on a financial asset has increased significantly since initial
recognition. When making the assessment, an entity shall use the change in the risk of a default occurring over the expected life
of the financial instrument instead of the change in the amount of expected credit losses.
Qualitative 	Quantitative
❚ 	when contractual payments are more than 30 days past
due the presumption is applied in conjunction with
Discovery Risk Grade (DRG)
❚ 	the eligibility rules used in the credit under-writing and
account management strategies are considered as triggers
of significant increase in credit risk, since they provide a
view in terms of how the client performs on their other
credit facilities outside Discovery Bank. The rules comprise
of a list of statuses at the bureau such as: judgements;
adverse; deceased; and debt counselling statuses.
❚ 	performing (up-to-date and current) accounts that have
shown deterioration with respect to Discovery Bank risk
grades will also be regarded as a significant increase in
credit risk.
Currently the Discovery Bank is not considering the
quantitative triggers of significant increase in credit risk due
to lack of origination data on the back book (ie DiscoveryCard
joint venture data). As the book in Discovery Bank matures it
will be in a position to perform the assessment
159 Discovery Annual Financial Statements 2020

-- 157 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments continued
9.1 	Financial assets continued
9.1.2 	EXPECTED CREDIT LOSSES continued
CREDIT IMPAIRED AND DEFAULT
Discovery considers a financial instrument to be credit-impaired where current circumstances and economic conditions indicate
that the expected future cash flows from a financial instrument may not be recoverable. These circumstances include but are not
limited to: evidence of financial or operational challenges for the debtor and missed contractual payments.
Default is defined on a facility level and considers both quantitative and qualitative factors as provided in the Basel capital
framework. The qualitative criterion requires banks to identify credit deterioration before the exposure becomes delinquent
“unlikeliness to pay” events, while the quantitative criterion requires banks to look at the material delinquency status.
The following factors are what constitutes default from a qualitative and quantitative perspective, and it is in line with the
South African Reserve Bank definition.
Qualitative 	Quantitative
❚ 	The borrower is placed in debt counselling/debt review
❚ 	The borrower is deceased
❚ 	The facility has undergone a distressed restructure/
special arrangement
❚ 	The facility has been transferred to charge off/legal
status or
❚ 	The client is under debt review;
❚ 	The client is insolvent;
❚ 	The facility is written off
A material amount on the facility is 90 days or more in arrears,
whereby material is set to avoid technical defaults.
WRITE-OFF
Discovery Bank will reduce the gross carrying amount of a financial asset when the it has no reasonable expectation of recovering
a financial asset in its entirety or a portion thereof. Currently the write-off point is based on time in default and is set as 12 months
in default. To ensure the appropriateness of the write-off point, the proposed write-off point will be assessed on an annual basis
and both time in default and recency of repayments will be considered.
Where Discovery has no reasonable expectation of recovery of a debt the amount is written off, this is considered to occur when
all avenues of legal recourse to recover the debt have been unsuccessful.
9.2 	Financial liabilities
At initial recognition, the Group considers the appropriate classification as at Amortised costs (AC) or Fair value through profit or
loss (FVTPL).
Financial liabilities are measured at FVTPL if:
❚ 	is it is held for trading; or
❚ 	if the financial liabilities are part of a group of financial assets and financial liabilities which are managed and performance
evaluated on a fair value basis. These include financial liabilities held within the portfolios of unit-linked insurance, unit-linked
investments.
All other financial liabilities in Discovery is measured at amortised cost.
Qualitative 	Subsequent measurement
Amortised cost (AC) 	These instruments are measured at amortised cost using the effective interest rate method.
Interest income and foreign exchange gains and losses are recognised on profit or loss.
Fair value through profit
or loss (FVTPL)
These instruments are measured at fair value with gains and losses and any interest recognised
in profit or loss.
Discovery has investment contracts which have financial risk, and are consequently recognised and measured in terms of IFRS 9
rather than IFRS 4 Insurance Contracts. These contracts are classified at fair value through profit or loss. The policies are linked
to the return on underlying financial assets and are directly matched. The movement on Discovery’s own credit risk is considered
immaterial. The remaining financial liabilities are carried at amortised cost.
Financial liabilities are derecognised when the obligation is extinguished.
160 Discovery Annual Financial Statements 2020

-- 158 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments continued
9.3 	Offset
Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is a legally
enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and
settle the liability simultaneously. The legally enforceable right must not be contingent on future events and must be enforceable
in the normal course of business and in the event of default, insolvency or bankruptcy of Discovery or the counterparty.
9.4 	Modifications
Where an existing financial asset or liability is replaced by another with the same counterparty on substantially different terms,
or the terms of an existing financial asset or liability are substantially modified, such an exchange or modification is treated as a
derecognition of the original asset or liability and the recognition of a new asset or liability at fair value, including calculating a
new effective interest rate, with the difference in the respective carrying amounts being recognised in other gains and losses on
financial instruments within non-interest revenue. The date of recognition of a new asset is consequently considered to be the
date of initial recognition for impairment calculation purposes.
If the terms are not substantially different for financial assets or financial liabilities, the group recalculates the new gross carrying
amount by discounting the modified cash flows of the financial asset or financial liability using the original effective interest rate.
The difference between the new gross carrying amount and the original gross carrying amount is recognised as a modification
gain or loss within credit impairments (for distressed financial asset modifications) or in other gains and losses on financial
instruments within noninterest revenue (for all other modifications).
In assessing whether a financial asset was substantially modified, Discovery performs a qualitative assessment to determine if
the terms were substantially modified. In assessing whether a financial liability has been substantially modified Discovery
performs both a qualitative and quantitative (10% threshold) assessment to determine if the terms were substantially modified.
10. 	Derivative financial instruments
Derivative financial instruments are classified as held for trading unless they are designated as effective hedging instruments.
Discovery initially recognises derivative financial instruments in the Statement of financial position at fair value on the date which
a derivative contract is entered into (the best evidence of fair value on day one is the transaction price) and subsequently re-
measures these instruments to fair value. The method of recognising the resulting fair value gain or loss depends on whether the
derivative is designated as a hedging instrument, and if so, the nature of the item being hedged. Fair values are obtained from
quoted prices in active markets, including recent market transactions, and valuation techniques, including discounted cash flow
models and options pricing models, as appropriate. All derivatives are carried as assets when the fair value is positive and as
liabilities when the fair value is negative.
Discovery is permitted to designate certain derivatives as either:
❚ 	Hedges of the fair value of recognised assets or liabilities or firm commitments (fair value hedges), or
❚ 	Hedges of highly probable forecast transactions (cash flow hedges).
Discovery documents at the inception of the transaction the relationship between hedging instruments and hedged items, as well
as its risk management objective and strategy for undertaking various hedge transactions. Discovery also documents its
assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions are
expected to be and have been highly effective in offsetting changes in fair values or cash flows of hedged items. Discovery continues
to apply hedge accounting, as permitted in IFRS, consistent with IAS 39 Financial Instruments: Recognition and Measurements.
10.1 	Cash flow hedge
Discovery recognises the effective portion of fair value changes of derivatives that are designated as cash flow hedges in the cash
flow hedging reserve in the Statement of other comprehensive income. The gain or loss relating to the ineffective portion is
recognised immediately in profit or loss, within net fair value gains on financial assets at fair value through profit or loss in the
income statement.
Amounts accumulated in the Statement of other comprehensive income are recycled to profit or loss in the period in which the
hedged item will affect profit or loss. Where the forecast transaction or a foreign currency firm commitment results in the
recognition of a non-financial asset or liability, the gains and losses previously deferred are transferred from the Statement of
other comprehensive income and included in the initial measurement of the cost of the non-financial asset or liability. Where the
forecast transaction subsequently results in the recognition of a financial asset or liability, gains or losses deferred in equity are
transferred from the statement of other comprehensive income when the financial asset or liability is sold or impaired.
161 Discovery Annual Financial Statements 2020

-- 159 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
10. 	Derivative financial instruments continued
10.1 	Cash flow hedge continued
When a hedging instrument expires or is sold, or when a hedge no longer meets the criteria for hedge accounting, any cumulative
gain or loss existing in equity at that time remains in equity and is recognised when the forecast transaction is ultimately
recognised in profit or loss. When a forecast transaction is no longer expected to occur, the cumulative gain or loss that was
reported in equity is immediately transferred to profit or loss.
10.2 	Derivatives that do not qualify for hedge accounting
Certain derivative instruments do not qualify for hedge accounting. Changes in the fair value of all such derivative instruments
are recognised immediately in profit or loss, within net fair value gains on financial assets at fair value through profit or loss in
the income statement.
10.3 	Hedging reserve
The hedging reserve includes the cash flow hedge reserve. The cash flow hedge reserve is used to recognise the effective portion
of gains or losses on derivatives that are designated and qualify as cash flow hedges. Amounts are subsequently recycled to profit
or loss as follows:
❚ 	For the effective portion recycled for hedges relating to share-based payments, as part of marketing and administration
expenses (staff costs); and
❚ 	For the effective portion recycled for hedges relation to interest rate risk, as part of finance costs.
11. 	Cash and cash equivalents
Cash and cash equivalents comprise:
❚ 	Cash in hand;
❚ 	Deposits held at call and short notice; and
❚ 	Balances with banks.
Cash and cash equivalents only include items held for the purpose of meeting short-term cash commitments rather than for
investing or other purposes. Cash and cash equivalents have a maturity of less than three months from the date of acquisition.
Cash and cash equivalents are carried at amortised cost (or in specified instances at fair value through profit or loss) which due
to their short-term nature approximates fair value.
Due to Discovery’s sweeping arrangements in-force with various financial institutions, positive and negative cash balances are
presented on a net basis for the purpose of presenting cash and cash equivalents in the statement of cash flows.
12. 	Share capital
Shares are classified as equity when there is no contractual obligation to transfer cash or other financial assets to the holder.
Incremental costs directly related to the issue of new shares or options are shown in equity as a deduction from the proceeds,
net of tax.
Where any Group company purchases Discovery Limited equity share capital (treasury shares), the consideration paid, including
any directly attributable incremental costs (net of income taxes), is deducted from equity attributable to Discovery Limited equity
holders. Where such shares are subsequently sold, reissued or otherwise disposed of, any consideration received is included in
equity attributable to Discovery Limited equity holders, net of any directly attributable incremental transaction costs and the
related income tax effects.
13. 	Insurance contracts
Insurance contracts are those contracts that transfer significant insurance risk. Such contracts may also transfer financial risk.
Discovery defines significant insurance risk as the possibility of having to pay benefits, on the occurrence of an insured event, that
are significantly more than the benefits payable if the insured event did not occur.
Discovery developed its accounting policies for insurance contracts before the adoption of IFRS 4. As provided for in IFRS 4,
Discovery continues to apply these same accounting policies for the recognition and measurement of obligations arising from
insurance contracts that it issues and reinsurance contracts that it holds.
162 Discovery Annual Financial Statements 2020

-- 160 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement
Insurance contracts are classified into four main categories, depending on the duration of the risk and the type of risk insured.
13.1.1 INDIVIDUAL LIFE INSURANCE
These contracts insure against a comprehensive spectrum of risks, including life, disability, severe illness and income continuation
cover. These contracts are long-term in nature.
VALUATION OF POLICYHOLDER LIABILITIES
For the published accounts, the actuarial value of policyholder liabilities is determined based on a prospective discounted cash
flow valuation basis calculated as the difference between the present value of future benefit payments plus expenses and the
present value of future premiums. Best estimate assumptions regarding the future expected claims experience, premium
income, expenses and commission are used. Where the same policy includes both insurance and investment components and
where the policy is classified as an insurance policy, the liability for the insurance benefits and investment benefits are separately
calculated. These components of the liability are not unbundled for reporting purposes. (Refer to accounting policy 14 for the
recognition and measurement of investment benefit liabilities).
Where the value of policyholder liabilities is negative in aggregate, this is shown as assets arising from insurance contracts.
Applying the valuation basis using the best estimate assumptions described above, would result in a gain at initial recognition.
Compulsory and discretionary margins are therefore added to the best estimate assumption to avoid the premature recognition
of future profits. At initial recognition, profits are recognised to the extent of the actual acquisition costs incurred but considering
the premium loadings available on the total portfolio to recoup acquisition costs.
Discretionary and compulsory margins are therefore added to the best estimate assumptions within the following framework.
❚ 	All margins are at least equal to the compulsory margins prescribed by regulations.
❚ 	For the discount rate and lapse rate margins, the direction of the margins may vary based on policy type and duration to
ensure that the margin is in the conservative direction, overall.
❚ 	Given the level of uncertainty in the best estimate assumptions for lapse, mortality and morbidity, margins are added to
protect against future possible adverse experience.
❚ 	Additional margins are added to allow for the release of profit over the term of the policy.
❚ 	Margins are released over the term of a policy in line with the risk borne.
❚ 	The best estimate assumptions and margins are reset at every valuation date to reflect the underlying profitability of the
portfolio. Changes to assumptions, models and benefits are therefore offset at the portfolio level through an increase in
discretionary margin (or release if sufficient discretionary margin exists). The impact of experience variances (with the
exception of lapse and mortality experience) on the end-of-period prospective liability recognised in respect of in-force
policies is offset at the portfolio level against an increase in discretionary margin (or release if sufficient discretionary margin
exists). The impact of experience variances on the in-period cash flows is accounted for in profit or loss for the period and not
offset through changes in discretionary margins.
❚ 	Where there are insufficient discretionary margins to offset losses arising from negative changes in economic assumptions or
changes in non-economic assumptions, models and benefit, those losses in excess of the discretionary margin are recognised
immediately in profit or loss.
❚ 	In subsequent periods, positive changes in economic assumptions and positive variance in non-economic assumptions,
models and benefits are first recognised separately in profit or loss to extent that it reverses related losses previously
recognised in profit or loss.
Contractual premium and benefit increases are included in the valuation of the policyholder liability. It is further assumed that
no voluntary benefits are taken up where a future take-up of these benefits would reduce the liability. This is in line with South
African actuarial guidance which requires that expected profits in respect of future options that may be taken up by policyholders
should not be recognised in the policyholder liability.
The actuarial liabilities are calculated gross of reinsurance. The expected impact of reinsurance is valued separately.
The valuation basis meets the requirement of the liability adequacy test as required by IFRS 4 for individual life insurance and no
additional tests are performed.
The liability estimates are reviewed at every reporting period and any changes in estimates to the liability are reflected in profit
or loss as they occur.
163 Discovery Annual Financial Statements 2020

-- 161 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement continued
13.1.1 INDIVIDUAL LIFE INSURANCE continued
PREMIUM REVENUE
For individual life insurance contracts, premiums are recognised as revenue when due. Premiums are shown net of premium
discounts received, premiums provided for as bad debts and before the deduction of commission. Premiums exclude taxes
and levies.
INSURANCE BENEFITS AND CLAIMS
Insurance benefits and claims relating to individual life insurance contracts are recognised in profit or loss based on the estimated
liability for benefits owed to the contract holder. Death, disability and severe illness and surrender claims are accounted for when
notified. These claims include claims reported but not yet validated. The estimate is determined taking into account the likelihood
of the claim being valid and the expected severity of the claim given that the claim is valid. The proportion to be included is
estimated separately for each benefit type. An estimate of the expected claim amount is charged to profit or loss and included in
liabilities under insurance contracts. Maturity and income disability are recorded as incurred. Liabilities are held to reflect
incurred but not yet reported (IBNR) claims. The IBNR liabilities are modified to reflect actual current operating conditions. The
liabilities are calculated gross of reinsurance. An asset is then raised to allow for the expected recoveries from reinsurers.
ACQUISITION COSTS
Acquisition costs for these contracts represent commission and other costs that relate to the securing of new contracts and the
renewing of existing contracts. The valuation basis for valuing insurance contracts makes implicit allowance for the deferral of
acquisition costs and hence no explicit deferred acquisition cost asset is recognised in the Statement of financial position. These
are expensed in profit or loss.
13.1.2 GROUP LIFE INSURANCE
These contracts insure against a comprehensive spectrum of protection benefits on a group basis. Life cover, severe illness,
disability and income continuation benefits are offered. These contracts are short-term in nature.
PREMIUM REVENUE
For group life insurance contracts, premiums are recognised as revenue when due. Premiums are shown net of premiums
provided for as bad debts, before the deduction of commission and exclude taxes and levies.
INSURANCE BENEFITS AND CLAIMS
Insurance benefits and claims relating to group life insurance contracts are recognised in profit or loss based on the estimated
liability for benefits owed to the contract holder. Death, disability and severe illness and surrender claims are accounted for when
notified. These claims include claims reported but not yet validated. The estimate is determined taking into account the likelihood
of the claim being valid and the expected severity of the claim given that the claim is valid. The proportion to be included is
estimated separately for each benefit type. An estimate of the expected claim amount is charged to profit or loss and included in
liabilities under insurance contracts. Maturity and income disability are recorded as incurred. Liabilities are held to reflect IBNR
claims. The IBNR is modified to reflect actual current operating conditions. The liabilities are calculated gross of reinsurance. An
asset is then raised to allow for the expected recoveries from reinsurers.
ACQUISITION COSTS
Acquisition costs for group life insurance contracts comprise all direct costs arising from the sale of insurance contracts.
Commissions are expensed as incurred.
13.1.3 HEALTH INSURANCE
These contracts insure policyholders against healthcare-related claims.
PREMIUM REVENUE
Health insurance premiums received in respect of annual contracts are recognised proportionally over the period of the coverage. The
portion of the premium received on in-force contracts that relates to unexpired risks at the reporting period is reported as unearned
premiums within liabilities arising from insurance contracts. The unearned premium income is amortised on a straight- line basis.
INSURANCE BENEFITS AND CLAIMS
Benefits payable under health insurance contracts are accounted for as incurred. Liabilities are held to reflect IBNR claims. The
IBNR calculation is performed using the chain ladder approach. This allows for the historic patterns of claims payment in
determining the likely future emergence of claims. The IBNR is further modified to reflect current operational conditions or known
events. The liabilities are calculated gross of reinsurance. An asset is then raised to allow for the expected recovery from reinsurers.
164 Discovery Annual Financial Statements 2020

-- 162 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement continued
13.1.3 HEALTH INSURANCE continued
DEFERRED ACQUISITION COSTS
The direct costs (commissions) of acquiring short-term health insurance business which are incurred during the year, but which
are expected to be recoverable out of future revenue margins, are deferred and disclosed as an asset in the Statement of
financial position (gross of tax). The costs are deferred over the period of the contract and amortised on a straight-line basis in
line with unearned premiums.
FINANCIAL REINSURANCE
Where a financial reinsurance contract is taken out to protect against lapses, all acquisition costs related to the policy are
effectively deferred over the period of the reinsurance contract.
13.1.4 SHORT-TERM INSURANCE
These monthly contracts insure policyholders against a comprehensive spectrum of short-term risks including, but not limited to,
motor vehicle and household cover.
PREMIUM REVENUE
Short-term insurance premiums received in respect of monthly contracts are recognised as revenue when due. Premiums are
shown before the deduction of commission, less the fuel cash back rewards described below, and exclude value-added tax.
UNEARNED PREMIUM PROVISION
An unearned premium provision is created at the commencement of each insurance contract and is released as the risk covered
by the contract expires. The Unearned Premium Provision, represents a proportion of premiums underwritten in the current
year, which relate to risks which have not expired by the end of the financial year. This is calculated on a time-proportionate basis
for even risks. Therefore, the unearned premium is released over the period of insurance using a method which approximates
the time period of the risk covered. The unearned premium provision is calculated on a gross basis.
REINSURANCE COMMISSION INCOME
Reinsurance commission income is recognised in profit or loss over the period of the related direct insurance business assumed.
INSURANCE BENEFITS AND CLAIMS
Claims are accounted for as incurred and consist of claims paid, movement in the provision for outstanding claims and related
claims handling expenses.
The provision for outstanding claims is based on estimates of the cost of settling all claims incurred but unpaid at the reporting
date, whether reported or not. Related anticipated reinsurance recoveries are disclosed separately as assets in the Statement of
financial position and are included in recoveries from reinsurers in profit or loss.
SALVAGE AND SUBROGATION RECOVERIES
Certain short-term insurance contracts allow Discovery to sell property acquired as a result of a claim (salvage). Discovery may
also have the legal right to pursue third parties for payment of some or all of the costs (subrogation).
The estimated salvage and subrogation reimbursements are treated as a reduction in the measurement of claims liability.
ACQUISITION COSTS
Acquisition costs for these contracts comprise all direct costs arising from the sale of insurance contracts and are recognised in
profit or loss for monthly policies and deferred in acquisition costs for future periods, over the term of the contract.
INSURE FUNDER ACCOUNT (IFA)
This relates to a benefit on a short-term insurance product. A fuel cash back can be used to either reduce the premium that the
policyholder is required to pay for the month in question or can be doubled and paid into an IFA.
Where the policyholder has used the fuel cash back to reduce the monthly premium, the reduction has been shown in insurance
premium revenue in profit or loss as incurred.
165 Discovery Annual Financial Statements 2020

-- 163 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement continued
13.1.4 SHORT-TERM INSURANCE continued
If the policyholder has elected to double the fuel cash back and paid it into an EFA, an EFA liability is raised. The EFA liability is
calculated using a discounted cash flow approach and is disclosed in liabilities arising from insurance contracts in the Statement
of financial position and the movement is disclosed in the transfer to liabilities under insurance contracts.
When the member uses funds in the EFA to pay for his excess or other costs, the excess is paid by Discovery and an expense is
included in claims in the income statement.
Where the member withdraws the funds after three years, the member is paid out in cash and an expense is disclosed against
insurance premium revenue in the income statement.
13.2 	Embedded derivatives arising from insurance contracts
A unit-linked insurance contract is an insurance contract with an embedded derivative linking payments on the contract to units
of an investment fund purchased with the consideration received from the contract holders. This embedded derivative meets the
definition of an insurance contract and is therefore not accounted for separately from the host insurance contract. The liability
for such contracts is adjusted for all changes in the fair value of the underlying assets.
Discovery does not separately measure embedded derivatives that meet the definition of an insurance contract or options to
surrender insurance contracts for a fixed amount (or amount based on a fixed amount and an interest rate). All other embedded
derivatives are separated and carried at fair value if they are not closely related to the host insurance contract and meet the
definition of a derivative. Embedded derivatives that are separated from the host contract are fair valued through profit or loss.
13.3 	Liability adequacy test
At the reporting date, liability adequacy tests are performed to ensure the adequacy of the contract liabilities net of related
deferred acquisition costs. In performing these tests, current best estimates of future contractual cash flows and claims handling
and administration expenses are used. Any deficiency is immediately charged to profit or loss initially by writing off deferred
acquisition costs and by subsequently establishing a provision for losses arising from the liability adequacy test.
13.4 	Reinsurance contracts
Contracts entered into by Discovery with reinsurers under which Discovery is compensated for insured events on one or more
contracts that meet the classification requirements for insurance contracts are classified as reinsurance contracts. Contracts that
do not meet these classification requirements are classified as financial assets.
Amounts recoverable from or due to reinsurers are measured consistently with the amounts associated with the reinsured
insurance contracts and in accordance with the terms of each reinsurance contract.
The amounts Discovery is required to pay under its reinsurance contracts held are recognised as reinsurance liabilities (liabilities
arising from reinsurance contracts).
Outward reinsurance premiums are recognised as an expense and are accounted for when due under the reinsurance contract. The
amounts due to Discovery under its reinsurance contracts are recognised as reinsurance assets (classified within insurance receivables).
Discovery assesses its reinsurance assets for impairment on an annual basis.
In certain cases there is a net gain or loss at inception of a reinsurance contract:
❚ 	Where these amounts relate directly to a reimbursement of expenses the gain is disclosed as a recovery of expenses from
reinsurers; or
❚ 	Other gains or losses are amortised over the life of the reinsurance contract on a consistent basis as the profit is expected to
emerge on the underlying policies but considering the contractual terms and intent of the specific reinsurance contract.
In certain cases there is a net gain or loss upon early termination of a reinsurance contract. Where these amounts result directly
from the termination, they are recognised as at the termination date and disclosed as recapture of reinsurance in profit or loss.
13.5 	Receivables and payables related to insurance contracts
Receivables and payables are recognised when due. These include amounts due to and from agents, brokers and insurance
contract holders. Discovery assesses its receivables for expected credit losses on an annual basis following the same method
used for financial assets.
166 Discovery Annual Financial Statements 2020

-- 164 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
14. 	Investment contracts
Investment contracts are those contracts that transfer financial risk without significant insurance risk. Financial risk refers to the
risk of a possible future change in the value of an asset or financial instrument due to a change in interest rate, commodity price,
index of prices, foreign exchange rate or other measurable variables.
Discovery issues investment contracts without fixed benefits (e.g. unit-linked and structured products) and investment contracts
with fixed and guaranteed benefits (e.g. term certain annuity).
Valuation of policyholder liabilities
Investment contracts without fixed benefits are financial liabilities whose fair value is dependent on the fair value of the underlying
financial assets and derivatives (unit-linked) which are classified at fair value through profit or loss. Discovery designates these
investment contracts to be measured at fair value through profit or loss because it eliminates or significantly reduces a
measurement or recognition inconsistency that would otherwise arise from measuring assets or liabilities or recognising the
gains and losses on them on different bases. See accounting policy 7 for the financial assets backing these liabilities.
Discovery’s main valuation techniques incorporate all factors that market participants would consider and are based on
observable market data. The fair value of a unit-linked financial liability is determined using the current unit price that reflects the
fair values of the financial assets contained within Discovery’s unitised investment funds linked to the financial liability. The fair
value of the financial liabilities is obtained by multiplying the number of units attributed to each policyholder at the reporting date
by the unit price for the same date.
For investment contracts with fixed and guaranteed terms, valuation techniques are used to establish the fair value at inception
and at each reporting date. Valuation techniques include discounted cash flow analysis using current market rates of interest and
reference to other instruments that are substantially the same.
Premium revenue
All premiums received under investment contracts are recorded as deposits to investment contract liabilities and claims incurred
on investment contracts are recorded as deductions from investment contract liabilities.
Fees on investment contracts
Service fee income on investment management contracts is recognised over time as and when the related performance obligation
is satisfied. Refer accounting policy note 20. Fees on investment contracts are included in fee income from administrative business.
A deferred revenue liability (DRL) is recognised as a contract liability to contracts with customers in respect of upfront fees for
financial advice, investment management and other services which are directly attributable to a contract that are charged for
securing the investment management service contract. The DRL is then released to revenue when the performance obligations
are satisfied, which corresponds to the underlying expected profit signature of the contract.
Regular fees are charged to the customer monthly either directly or by making a deduction from invested funds.
Costs of obtaining contracts
Deferred acquisition costs on investment contracts represent the contractual customer relationship and the right to receive
future investment management fees. Incremental costs directly attributable to securing rights to receive policy fees for services
sold with investment contracts, are recognised as an asset where they can be identified separately and measured reliably and it
is probable that they will be recovered. An incremental cost is one that would not have been incurred if the Group had not
secured the investment contract.
The asset represents the Group’s contractual right to benefit from providing asset management services and is amortised over
the expected life of the contract as the entity recognises the related revenue.
167 Discovery Annual Financial Statements 2020

-- 165 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
15. 	Borrowings
Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently measured at
amortised cost. Any difference between the proceeds and the redemption value is recognised in profit or loss over the period of
the borrowings using the effective interest rate method.
Fees paid on the establishment of loan facilities are recognised as transaction costs against the loan to the extent that it is
probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the
extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a
prepayment and amortised over the period of the facility to which it relates.
Preference shares, which are mandatorily redeemable on a specific date, are classified as liabilities. The dividends on these
preference shares are recognised in profit or loss as finance costs using the effective interest rate method.
16. 	Deferred income tax
Discovery calculates deferred income tax on all temporary differences using the Statement of financial position approach.
Deferred tax liabilities or assets are calculated by applying corporate tax rates that have been substantively enacted to the
temporary differences between the tax values of assets and liabilities and their carrying amount, where such temporary
differences are expected to result in taxable or deductible amounts in determining taxable income for future periods when the
carrying amount of the assets or liabilities are recovered or settled.
Discovery recognises deferred tax assets if the directors of Discovery consider it probable that future taxable income will be
available against which the tax losses can be utilised.
Temporary differences arise primarily from the difference between accounting and tax balances arising from insurance contracts,
depreciation of property and equipment, effect of accounting for leases, revaluation of certain financial assets and liabilities,
provisions for leave pay, provisions for share-based payments and tax losses carried forward. For leases, Discovery assesses the
lease asset and lease liability together as a single transaction and assesses the temporary difference on a net basis.
Deferred income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a
business combination that at the time of the transaction affects neither accounting nor taxable income.
Deferred tax related to cash flow hedges, which are charged or credited directly to the statement of other comprehensive income,
is also credited or charged directly to the statement of other comprehensive income and is subsequently recognised in profit or
loss when the gain or loss is realised.
Deferred income tax assets and liabilities are offset when:
❚ 	There is a legally enforceable right to offset current tax assets against current tax liabilities; and
❚ 	When the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the
taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.
If offsetting does not apply, Discovery separately discloses the deferred tax asset and deferred tax liability.
17. 	Employee benefits
17.1 	Post-employment benefits
Discovery operates defined contribution schemes, the assets of which are held in separate private trustee-administered funds.
Discovery pays contributions to these funds on a mandatory basis. These funds are registered in terms of the Pension Funds Act,
1956, and membership is compulsory for all Discovery employees. Qualified actuaries perform annual valuations. Discovery has
no further payment obligations once the contributions have been paid. The contributions are recognised as an employee benefit
expense when they are due.
168 Discovery Annual Financial Statements 2020

-- 166 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
17. 	Employee benefits continued
17.2 	Share-based compensation
Discovery operates equity-settled and cash-settled share-based compensation plans.
EQUITY-SETTLED SHARE-BASED COMPENSATION PLANS
Discovery expenses the fair value of the employee services received in exchange for the grant of the options, over the vesting period
of the awards, as employee costs, with a corresponding credit to a share-based payment reserve in the Statement of changes in
equity. The total value of the services received is calculated with reference to the fair value of the options on grant date.
The fair values of the options are determined excluding non-market vesting conditions. These vesting conditions are included in the
assumptions of the number of options expected to vest. At each reporting date, Discovery revises its estimate of the number of
options expected to vest. Any changes to the estimated number of options are recognised in profit or loss immediately.
CASH-SETTLED SHARE-BASED COMPENSATION PLANS
Discovery recognises employee services received in exchange for cash-settled share-based payments at the fair value of the
liability incurred and expenses these services over the vesting period of the benefits, as employee costs.
The liability is re-measured at each reporting period to its fair value, with all changes recognised immediately in profit or loss.
17.3 	Leave pay
Discovery accrues in full the employees’ rights to annual leave entitlement in respect of past service. This is expensed over the
period the services are rendered.
17.4 	Profit share and bonus plan
Discovery operates several other profit sharing and bonus compensation arrangements and recognises these when a constructive
obligation has been created by past practice. These are calculated with reference to predetermined formulae. The Group has
other deferred compensation schemes in place where employees are incentivised based on a variable other than the share price
of Discovery Limited, such as embedded value, value of in-force and earnings multiples. Discovery recognises a liability and the
related expense is included in employee costs in profit or loss.
18. 	Trade and other payables
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from
suppliers. Trade payables are classified as current liabilities if payment is due within one year or less from the reporting date. If
not, they are presented as non-current liabilities.
Trade payables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest
rate method.
19. 	Contingent liabilities
Discovery discloses a contingent liability when:
❚ 	It has a possible obligation arising from past events, the existence of which will be confirmed only by the occurrence or non-
occurrence of one or more uncertain future events not wholly within the control of the entity; or
❚ 	It has a present obligation that arises from past events but not recognised because:
– It is not probable that an outflow of resources will be required to settle an obligation; or
– The amount of the obligation cannot be measured with sufficient reliability.
20. 	Revenue recognition
The Group’s primary source of revenue arises on the sale of insurance contracts which are accounted for under IFRS 4 Insurance
Contracts and are excluded from the scope of IFRS 15 Revenue from Contracts with Customers. IFRS 15 is applicable to the
Group’s revenue from administration business, Vitality income and banking fee and commission income.
IFRS 15 requires that once contracts have been identified, the entity identifies the performance obligations in the contract. This
is determined on the basis of whether the customer can benefit from the promised good or service individually or together with
other readily available resources and whether the performance obligation is distinct in the context of the contract. For the Group,
most contracts contained a single performance obligation.
169 Discovery Annual Financial Statements 2020

-- 167 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
20. 	Revenue recognition continued
The timing of revenue recognition is dependent on whether the entity transfers control over the good or service over time or at a point
in time. In determining the appropriate timing for revenue recognition, the Group considers whether the customer benefits as the
entity performs. For most revenue types, Group entities provide stand ready services to customers, where customers benefit as the
entities services are consumed. In limited instances where revenue is not recognised over time it is recognised at a point in time when
control transfers. For revenue recognised over time the stand ready service is recognised straight line over the term of the contract.
In determining the amount of revenue to recognise, the Group considers any uncertainty created through variable consideration
contained in the contract, and constrains the recognition of revenue in order to recognise revenue only to the extent that it is highly
probably that a significant reversal in the amount of cumulative revenue recognised will not occur when the associated uncertainty is
resolved. The Group also considers the impact of the timing of receiving payments for revenue transactions and determines whether
a significant financing component should be taken into account in the measurement of the transaction price. As the Group’s contracts
routinely include single performance obligations, there is limited complexity in allocating transaction prices to performance obligations.
Payment terms vary across the different revenue types earned by the Group.
Where contracts with customers involve a third party, the Group considers whether it is acting as the principal or the agent in the
delivery of the promised goods or services to the customer. This assessment is based on whether the Group controls the goods
or services before it is transferred to the customer.
For certain contracts with customers, Discovery receives income in advance of discharging the related performance obligation. In
these instances, the amount is recognised as a contract liability incurred in the acquisition or fulfilment of a contract. Discovery
considers whether there are costs incurred for the acquisition or fulfilment of a contract. These costs are recognised as an asset
and amortised over the expected period over which performance obligations under the contract are satisfied. Contract costs
incurred that are considered to be of a general and administrative nature, (that are not explicitly recovered from the customer),
are expensed as incurred.
Where the transaction price included in a contract is payable less than 12 months from the date of satisfying the related
performance obligation the practical expedient is applied in that a significant financing component is not recognised. Similarly,
where costs of obtaining a contract would be amortised over 1 year or less the costs are not recognised as a separate asset.
Nature of
performance
obligations
Fee 	income 	is 	recognised 	on 	health
administration and managed care services
rendered. Fee income is also generated on
asset administration and fees earned on use
of intellectual property. In the respective
business these are considered revenue and
are seen as single performance obligations in
the respective legal entities. These are
separated by underlying reported entity in
the segmental report shown in note 1.
Vitality income includes the
fee income that members of
corporations pay to access
the Vitality benefit, as well as
various activation fees for
activating additional benefits.
The performance obligation
relates to access to the Vitality
rewards 	programme 	and
partner benefits provided to
members.
Banking fee and commission
income 	includes 	banking
service 	fees 	for 	banking
services. The performance
obligation 	relates 	to 	the
access 	to 	banking 	and
banking services rendered.
Commission income relates
to the interchange fees which
Discovery Bank earns on
transactions using debit or
credit cards. The performance
obligation 	relates 	to
settlement of transactions via
the card network.
When does
control pass –
Point in time
(PIT) vs over
time
Performance 	obligation 	to 	provide
administration services are considered
stand ready services, the customer obtains
control over the service as the entity makes its
services available on an “as and when” basis.
As a result, revenue is recognised over time, as
the respective entity makes the services
available, based on the passage of time.
Performance obligations to
provides access to benefits
are considered stand ready
services as the customers
obtains benefits over the
duration of the contract and
when 	required 	by 	the
customers. 	As 	a 	results
revenue is recognised over
times based on the passage
of time.
The performance obligation
associated with the banking
fee and commission income
are passes over time because
the client obtains substantially
all of the remaining benefits
from the service over the
period of the month for which
the banking fee was charged.
170 Discovery Annual Financial Statements 2020

-- 168 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
20. 	Revenue recognition continued
Fee income from administration business 	Vitality Income
Banking fee and
commission income
When are
amounts
payable
Amounts 	are 	billed 	on 	health
administration and managed care business
at the end of the respective month with
amounts paid within 30 days. For fees on
asset administration business, amounts are
disinvested for the units held at the end of
the related month. Certain fees for example
advisor fees are received upfront but are
deferred as a contract liability over the
expected term of the entity’s performance.
Amounts are billed either
monthly, 	payable 	within
30 	days, 	or 	billed 	on
activation of the benefit,
payable immediately.
Banking fees are charged
monthly 	and 	payment 	is
immediate. 	Interchange
income is charges at point of
payment and settled daily in
batch format.
Variable
consideration
and estimates
There is no potential for amounts of revenue
to vary relating to discounts or rebates on
the health administration business.
For the asset administration business, fees are
determined with reference to assets under
management at a point in time. There are no
benchmark performance based fees. The
nature of the integrated products that
Discovery sells related to the invest business
allows for fee discounts and rebates to be
determined based on client behaviour.
Revenue is estimated and recognised in line
with the constraint on variable consideration,
only to the extent that it is highly probable
that there will not be a significant reversal of
revenue 	already 	recognised 	once 	the
uncertainty is resolved.
The fee discounts and rebates are determined
according to a fixed methodology incorporating
policyholder specific information including
Vitality status. Discovery has experience in
estimating these amounts, which are based on
a limited number of outcomes. There is no
financing component.
There are no adjustments to
the 	transaction 	price 	as
a result of any variable
consideration. 	There 	is
no 	significant 	financing
component.
There are no adjustments to
the 	transaction 	price 	as
a 	result 	of 	any 	variable
consideration. 	There 	is
no 	significant 	financing
component.
Costs to
capitalise
Where costs are incurred directly to secure a
new health administration customer, and
the contract is expected to exceed 12
months, the costs are capitalised and
amortised over the expected term of the
contract. Costs are routinely incurred on the
asset administration business related to
commission and other incremental costs of
entering into the contract. These are
capitalised and recognised over the expected
duration of the customer relationship. These
assets are tested for impairment to the
extent that the carrying amount of the asset
exceeds the expected remaining net cash
inflows form the customer contract.
In respect of the Apple watch
benefit, 	Discovery 	incurs
costs upfront to purchase
the device and provide it to
the customer. These costs
are deferred and recognised
over the two year term of the
benefit
None.
Insurance premium revenue
Insurance premium revenue includes individual life insurance premiums, group life insurance premiums, health insurance
premiums and short-term insurance premiums. These are accounted for as described in accounting policy 13.
171 Discovery Annual Financial Statements 2020

-- 169 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
21. 	Other non-revenue income
21.1 	Investment income
Investment income comprises dividends and received interest received from assets held at amortised cost and cash and cash
equivalents.
Discovery recognises dividends when Discovery’s right-to-receive payment is established. This is on the “last day to trade” for
listed shares and on the “date of declaration” for unlisted shares. Dividend income includes scrip dividends, irrespective of
whether there is an option to receive cash instead of shares.
Interest is accounted for on an accrual basis using the effective interest rate method.
21.2 	Net fair value gains on financial assets at fair value through profit or loss
Net fair value gains on financial assets at fair value through profit or loss include gains arising from interest, dividends and net
realised and unrealised gains on financial assets held at fair value through profit or loss.
22. 	Leases
22.1 	Leases after 1 July 2019
This policy applies from 1 July 2019 to leases.
IDENTIFICATION OF A LEASE
At inception of a contract, Discovery assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To assess
whether a contract conveys the right to control the use of an identified asset, Discovery uses the definition of a lease in IFRS 16.
Contracts where the service provider has a substantive right to substitute the asset for an alternative asset during the lease term
is not regarded as a lease, but instead a service contract. Accordingly, these contracts are not accounted for in accordance with
IFRS 16. For Discovery, such contracts include items such as vending machines.
At commencement or on modification of a contract that contains a lease component, Discovery allocates the consideration in the
contract to each lease component on the basis of its relative stand-alone prices. However, for the leases of property Discovery has
elected not to separate non-lease components and account for the lease and non-lease components as a single lease component
Discovery recognises a right-of-use asset and a lease liability at the lease commencement date. Discovery presents right-of-use
assets in ‘Property and equipment’ and lease liabilities in ‘Borrowings at amortised cost’ in the Statement of financial position.
Discovery leases the following assets with a range of lease terms:
– Large offices 	5 – 15 years
– Small offices/Franchise offices (SA only) 	1 – 3 years
– Computer equipment (e.g. servers) (SA only) 	3 – 4 years
– Motor vehicles (UK only) 	3 years
MEASUREMENT
LEASE LIABILITY
The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date,
discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the lessee’s incremental
borrowing rate. Generally, Discovery uses its incremental borrowing rate as the discount rate.
Discovery determines its incremental borrowing rate by obtaining interest rates from various external financing sources and
makes certain adjustments to reflect the terms of the lease and type of the asset leased. The incremental borrowing rates were
calculated for each legal entity within Discovery that entered into lease arrangements. The incremental borrowing rate considers
a base interest rate reflective of the jurisdiction in which the legal entity operates (South Africa, United Kingdom and United
States of America), the term of the lease arrangement and the nature of the assets.
172 Discovery Annual Financial Statements 2020

-- 170 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
22. 	Leases continued
22.1 	Leases after 1 July 2019 continued
Lease payments included in the measurement of the lease liability comprise the following:
❚ 	fixed payments, including in-substance fixed payments;
❚ 	variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
❚ 	amounts expected to be payable under a residual value guarantee; and
❚ 	the exercise price under a purchase option that Discovery is reasonably certain to exercise, lease payments in an optional
renewal period if Discovery is reasonably certain to exercise an extension option, and penalties for early termination of a lease
unless Discovery is reasonably certain not to terminate early.
Extension or termination options are included in a number of the building leases across Discovery. These terms are used to
maximise operational flexibility in terms of managing contracts. In determining the lease term, management considers all facts
and circumstances that create an economic incentive to exercise an extension option, or not exercise a termination option.
Extension options (or periods after termination options) are considered in the lease term when there is reasonable certainty that
those options will be exercised.
The lease liability is measured at amortised cost using the effective interest method. It is remeasured when there is a change in
future lease payments arising from a change in an index or rate, if there is a change in Discovery’s estimate of the amount
expected to be payable under a residual value guarantee, if Discovery changes its assessment of whether it will exercise a
purchase, extension or termination option or if there is a revised in-substance fixed lease payment. When the lease liability is
remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in
profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.
RIGHT-OF-USE ASSET
The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease
payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle
and remove the underlying asset or to restore the underlying asset, less any lease incentives received. Discovery receives
incentives such as reimbursements for installations or rent free periods.
The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of
the lease term, unless the lease transfers ownership of the underlying asset to Discovery by the end of the lease term or the cost
of the right-of-use asset reflects that Discovery will exercise a purchase option.
In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same
basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses, if any,
and adjusted for certain remeasurements of the lease liability.
SHORT-TERM LEASES AND LOW VALUE ITEMS
Discovery has elected not to recognise right-of-use assets and lease liabilities for leases of low-value assets and short-term
leases. Discovery recognises the lease payments associated with these leases as an expense on a straight-line basis over the
lease term.
Leases of low value assets relate to those categories of assets which at inception of the lease typically have a value, if bought new,
of no more than approximately R70 000. For Discovery, these categories include computer equipment such as desktops, laptops,
monitors and related IT peripherals.
Short-term leases are those leases with a lease term of less than 12 months.
22.2 	Leases prior to 1 July 2019
FINANCE LEASES
Discovery classifies leases as finance leases where it assumes substantially all the benefits and risks of ownership, based on the
substance of the arrangement at inception of the lease.
Finance leases are capitalised at the fair value of the leased asset at the inception of the lease, or, if lower, at the estimated
present value of the minimum lease payments. Discovery allocates each lease payment between the liability and finance costs to
achieve a constant rate of interest on the finance balance outstanding. The finance cost is recognised in profit or loss.
The assets acquired are depreciated over the useful life of the assets, unless it is not probable that Discovery will take ownership
of the assets, in which case the assets are depreciated over the shorter of the useful life of the asset or the lease period, on a basis
consistent with similar owned property and equipment.
173 Discovery Annual Financial Statements 2020

-- 171 of 198 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
22. 	Leases continued
22.2 	Leases prior to 1 July 2019 continued
OPERATING LEASES
Discovery classifies leases as operating leases where the lessor effectively retains the risks and benefits of ownership. Operating
lease payments are recognised in profit or loss on a straight-line basis over the period of the lease. Minimum rentals due after
year-end are reflected under commitments.
Discovery recognises as an expense any penalty payment to the lessor for early termination of an operating lease, in the period
in which termination takes place.
23. 	Marketing and administration expenses
Marketing and administration expenses include marketing and development expenditure, all other non-acquisition related
expenditure and benefits paid under the Vitality programme. These costs are expensed in profit or loss as incurred.
24. 	Finance costs
Finance costs (net of investment income earned on the temporary investment of specific borrowings pending their expenditure
on qualifying assets) directly attributable to the acquisition, construction or production of assets that necessarily take a substantial
period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are
substantially ready for their intended use or sale. All other finance costs are recognised as an expense in profit or loss on an
accrual basis using the effective interest rate method.
In addition, finance costs include any recycled gains or losses from other comprehensive income arising from cash flow hedges
of interest rates, amortisation of financing related fees such as loan commitment fees and letter of credit fees as well as
modification gains and losses on borrowings.
25. 	Direct and indirect taxes
Direct taxes include South African and foreign jurisdiction corporate tax payable and are disclosed as taxation in profit or loss.
Indirect taxes include various other taxes paid to central and local governments, including value-added tax and skills development
levies. Indirect taxes are included as part of marketing and administration expenses in profit or loss.
The charge for current tax is based on the results for the year as adjusted for items which are non-taxable or disallowed. It is
calculated using taxation rates that have been enacted or substantively enacted by the reporting date, in each particular
jurisdiction within which the Discovery entities operate.
Taxation in respect of the South African life insurance operations is determined in accordance with the rates and basis applicable
to section 29A of the Income Tax Act at the reporting date.
26. 	Dividend distribution
Dividend distribution to Discovery Limited’s shareholders is recognised as a liability in the Group’s financial statements in the
period in which the dividends are approved.
174 Discovery Annual Financial Statements 2020

-- 172 of 198 --

ANNEXURE B – DIRECTORATE
REMUNERATION AND FEES
Payment to directors for the year ended 30 June 2020 for services rendered are set out in the table below. It should be noted that these
payments reflect cash payments made to directors during the financial year and therefore all variable pay components are reflective of
performance measurements relating to previous periods). The variable pay components relating to the current year under review are
physically paid in the following financial year and are analysed in detail in the Group’s annual remuneration report and are more reflective
of the performance of the period under review.
Payments to directors for the year ended 30 June 2020 for services rendered are as follows:
R’000
Services
as
directors 9
Basic
salary9
Perfor-
mance
bonus
Phantom
scheme
payments
Provident
fund
contri-
butions
Other
benefits1 	Total
Executive
A Gore 	– 	6 767 	4 375 	3 636 	1 088 	413 	16 279
HD Kallner 	– 	5 105 	7 258 	11 036 	271 	168 	23 838
NS Koopowitz2,10 	– 	19 858 	18 798 	44 887 	214 	541 	84 298
HP Mayers3,10 	– 	11 644 	7 598 	50 258 	1 160 	1 205 	71 865
Dr A Ntsaluba 	– 	4 281 	3 417 	2 400 	342 	273 	10 713
A Pollard4 	– 	7 857 	4 323 	5 191 	197 	298 	17 866
B Swartzberg 	– 	4 902 	3 682 	3 166 	470 	173 	12 393
DM Viljoen 	– 	4 419 	3 350 	2 331 	722 	89 	10 911
Sub-total 	– 	64 833 	52 801 	122 905 	4 464 	3 160 	248 163
Non-executive
ME Tucker5 	5 448 	– 	– 	– 	– 	– 	5 448
HL Bosman 6 	1 524 	– 	– 	– 	– 	– 	1 524
Dr BA Brink 	944 	– 	– 	– 	– 	– 	944
SE De Bruyn 	1 364 	– 	– 	– 	– 	– 	1 364
R Farber 7 	2 445 	– 	– 	– 	– 	3 764 	6 209
FN Khanyile 8 	769 	– 	– 	– 	– 	– 	769
D Macready 	693 	– 	– 	– 	– 	– 	693
DR TV Maphai* 	1 263 	– 	– 	– 	– 	– 	1 263
H Mayers 	420 	– 	– 	– 	– 	– 	420
AL Owen 5 	2 224 	– 	– 	– 	– 	185 	2 409
SV Zilwa* 	1 832 	– 	– 	– 	– 	– 	1 832
Sub-total 	18 926 	– 	– 	– 	– 	3 949 	22 875
Total 	18 926 	64 833 	52 801 	122 905 	4 464 	7 109 	271 038
Less: paid by subsidiaries 	(18 926) 	(64 833) 	(52 801) 	(122 905) 	(4 464) 	(7 109) 	(271 038)
Paid by holding company 	– 	– 	– 	– 	– 	– 	–
1 “Other benefits” comprise medical aid contributions, travel and other allowances.
2 Salary and incentive are paid in GBP.
3 Remuneration consists of GBP and Rands components.
4 Salary and incentive are paid in USD.
5 Salary and incentive are paid in GBP.
6 Director's fees for services rendered by HL Bosman are paid to Rand Merchant Investment Holdings Limited.
7 Director's fees for services rendered are paid in AUD.
8 Director's fees for services rendered by F Khanyile are paid to WDB Investment Holdings Proprietary Limited.
9 In response to the Presidents call, all executive and certain non-executive directors heeded by forfeiting an effective one-month's salaries/fees to enable the
Company to donate further towards the Solidarity Fund and similar charities. Executive directors forfeited R1.7m and non-executive directors forfeited R1.4m.
Executive directors forfeited a further R0.9m in FY21.
10 The phantom scheme payment amounts for NS Koopowitz and HP Mayers include the once-off vesting of special phantom share allocations linked to the final
buy-out in 2014 of Vitality UK and therefore represents a multi-year scheme with single maturity. These special phantom allocations were designed to align
with the VitalityHealth and VitalityLife minority interest share participation in which other UK senior management obtained a physical minority share interests
and where participants had the option to sell such shares to Discovery Group Europe Limited after maturity. NS Koopowitz and HP Mayers were not participants
in the physical share scheme but were awarded phantom shares that replicated the scheme and also forfeited the normal 2014 long term incentive plan
awards. The once-off and final amounts paid under this phantom scheme amounted to £1,453,400 each (R28.7 million).
* Black non-executive directors participated in the Discovery Limited BEE transaction and have R18.6m loans outstanding to the Company.
175 Discovery Annual Financial Statements 2020

-- 173 of 198 --

ANNEXURE B – DIRECTORATE continued
REMUNERATION AND FEES continued
Payment to directors for the year ended 30 June 2019 for services rendered are set out in the table below. It should be noted that these
payments reflect cash payments made to directors during the financial year and therefore all variable pay components are reflective of
performance measurements relating to previous periods). The variable pay components relating to the current year under review are
physically paid in the following financial year and are analysed in detail in the Group’s annual remuneration report and are more reflective
of the performance of the period under review.
Payments to directors for the year ended 30 June 2019 for services rendered are as follows:
R’000
Services
as
directors
Basic
salary
Perfor-
mance
bonus
Phantom
scheme
payments
Provident
fund
contri-
butions
Other
benefits1 	Total
Executive
A Gore 	– 	6 910 	6 590 	6 259 	1 036 	391 	21 186
HD Kallner 	– 	5 176 	7 922 	10 016 	259 	157 	23 530
NS Koopowitz 2 	– 	16 344 	17 334 	7 922 	180 	429 	42 209
HP Mayers 3 	– 	15 823 	18 394 	3 235 	1 657 	384 	39 493
Dr A Ntsaluba 	– 	4 338 	4 278 	4 894 	325 	252 	14 087
A Pollard 4 	– 	6 433 	2 486 	5 689 	129 	250 	14 987
JM Robertson 5 	– 	660 	640 	4 881 	135 	17 	6 333
B Swartzberg 	– 	5 165 	5 090 	5 122 	266 	160 	15 803
DM Viljoen 	– 	4 510 	4 440 	2 748 	688 	77 	12 463
Sub-total 	– 	65 359 	67 174 	50 766 	4 675 	2 117 	190 091
Non-executive
ME Tucker 	1 477 	– 	– 	– 	– 	– 	1 477
HL Bosman 9 	1 448 	– 	– 	– 	– 	– 	1 448
Dr BA Brink 	1 306 	– 	– 	– 	– 	– 	1 306
SE De Bruyn 	1 247 	– 	– 	– 	– 	– 	1 247
R Enslin 6 	970 	– 	– 	– 	– 	– 	970
R Farber 8 	3 074 	– 	– 	– 	– 	3 072 	6 146
MI Hilkowitz 	4 213 	– 	– 	– 	– 	– 	4 213
FN Khanyile 10 	631 	– 	– 	– 	– 	– 	631
Dr TV Maphai 	1 011 	– 	– 	– 	– 	– 	1 011
TT Mboweni 	317 	– 	– 	– 	– 	– 	317
AL Owen 7 	2 755 	– 	– 	– 	– 	194 	2 949
SV Zilwa 	1 741 	– 	– 	– 	– 	– 	1 741
Sub-total 	20 190 	– 	– 	– 	– 	3 266 	23 456
Total 	20 190 	65 359 	67 174 	50 766 	4 675 	5 383 	213 547
Less: paid by subsidiaries 	(20 190) 	(65 359) 	(67 174) 	(50 766) 	(4 675) 	(5 383) 	(213 547)
Paid by holding company 	– 	– 	– 	– 	– 	– 	–
1 “Other benefits” comprise medical aid contributions, travel and other allowances.
2 Salary and incentive are paid in GBP.
3 Remuneration consists of GBP and Rand components.
4 Salary and incentive are paid in USD.
5 JM Robertson retired as executive director from the Board of Discovery Limited with effect from 31 August 2018.
6 Director’s fees for services rendered are paid in USD.
7 Director’s fees for services rendered are paid in GBP.
8 Director’s fees for services rendered are paid in AUD and Rand components.
9 Director’s fees for services rendered by HL Bosman are paid to Rand Merchant Investment Holdings Limited.
10 Director’s fees for services rendered by F Khanyile are paid to WDB Investment Holdings Proprietary Limited.
176 Discovery Annual Financial Statements 2020

-- 174 of 198 --

ANNEXURE B – DIRECTORATE continued
DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES
Discovery’s directors and prescribed officers participate in the various long-term incentive schemes offered by the Group and their
participation is disclosed below. Refer to Group note 31.1 for a detailed description of the various schemes offered.
Discovery Limited phantom share scheme
Directors and prescribed officers participation as at 30 June 2020:
Directors and prescribed officers
Outstanding
shares
Date
granted
Strike
price
R
Final
vesting
date
Value at
30 June 2020
R
A Gore 	3 614 	30/09/2015 	– 	30/09/2020 	377 844
7 228 	30/09/2015 	134.94 	30/09/2020 	–
16 212 	30/09/2016 	– 	30/09/2021 	1 694 965
41 841 	30/09/2017 	– 	30/09/2022 	4 374 477
48 027 	30/09/2018 	– 	30/09/2023 	5 021 223
HD Kallner 	2 410 	30/09/2015 	– 	30/09/2020 	251 913
4 819 	30/09/2015 	134.94 	30/09/2020 	–
37 959 	30/09/2016 	– 	30/09/2021 	3 968 613
28 062 	30/09/2017 	– 	30/09/2022 	2 933 882
219 941 	01/04/2018 	– 	01/04/2023 	22 994 858
32 211 	30/09/2018 	– 	30/09/2023 	3 367 660
HP Mayers 	2 410 	30/09/2015 	– 	30/09/2020 	251 913
4 819 	30/09/2015 	134.94 	30/09/2020 	–
A Ntsaluba 	2 410 	30/09/2015 	– 	30/09/2020 	251 913
4 819 	30/09/2015 	134.94 	30/09/2020 	–
19 115 	30/09/2016 	– 	30/09/2021 	1 998 421
14 799 	30/09/2017 	– 	30/09/2022 	1 547 235
29 599 	30/09/2017 	141.65 	30/09/2022 	–
28 312 	30/09/2018 	– 	30/09/2023 	2 960 020
A Pollard 	803 	30/09/2015 	– 	30/09/2020 	83 980
1 606 	30/09/2015 	134.94 	30/09/2020 	–
3 794 	30/09/2016 	– 	30/09/2021 	396 610
7 588 	30/09/2016 	114.96 	30/09/2021 	–
5 693 	30/09/2017 	– 	30/09/2022 	595 229
11 386 	30/09/2017 	141.65 	30/09/2022 	–
6 560 	30/09/2018 	– 	30/09/2023 	685 848
B Swartzberg 	2 410 	30/09/2015 	– 	30/09/2020 	251 913
4 819 	30/09/2015 	134.94 	30/09/2020 	–
21 747 	30/09/2016 	– 	30/09/2021 	2 273 597
5 894 	30/09/2017 	– 	30/09/2022 	616 165
11 786 	30/09/2017 	141.65 	30/09/2022 	–
11 274 	30/09/2018 	– 	30/09/2023 	1 178 697
DM Viljoen 	37 893 	01/05/2017 	– 	30/04/2022 	3 961 666
16 838 	30/09/2017 	– 	30/09/2022 	1 760 361
33 674 	30/09/2017 	141.65 	30/09/2022 	–
30 388 	30/09/2018 	– 	30/09/2023 	3 177 065
177 Discovery Annual Financial Statements 2020

-- 175 of 198 --

ANNEXURE B – DIRECTORATE continued
DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES continued
Discovery Limited long-term incentive plan
Directors and prescribed officers participation as at 30 June 2020:
Directors and prescribed officers
Outstanding
shares
Date
granted
Exercise
price
R
Final
vesting
date
Value at
30 June 2020
R
A Gore 	76 399 	30/09/2019 	– 	30/09/2024 	7 987 515
HD Kallner 	51 240 	30/09/2019 	– 	30/09/2024 	5 357 142
A Ntsaluba 	45 253 	30/09/2019 	– 	30/09/2024 	4 731 201
A Pollard 	14 662 	30/09/2019 	– 	30/09/2024 	1 532 912
B Swartzberg 	15 372 	30/09/2019 	– 	30/09/2024 	1 607 143
DM Viljoen 	48 340 	30/09/2019 	– 	30/09/2024 	5 053 947
The Vitality Group Inc. stock plan
Directors and prescribed officers participation as at 30 June 2020:
Directors and prescribed officers
Outstanding
shares
Date
granted
Exercise
price
US$
Final
vesting
date
Value at
30 June 2020
US$
A Pollard 	118 592 	01/10/2016 	0.73 	01/10/2020 	220 757
The Vitality Group Cash-settled plan
Directors and prescribed officers
Directors and prescribed officers
Outstanding
units
Date
granted
Exercise
price
US$
Final
vesting
date
Value at
30 June 2020
US$
A Pollard 	184 207 	2017/09/30 	– 	2022/09/30 	184 207
145 859 	2018/09/30 	– 	2023/09/30 	145 859
278 536 	2019/09/30 	– 	2024/09/30 	278 536
B Swartzberg 	190 683 	2017/09/30 	– 	2022/09/30 	190 683
250 654 	2018/09/30 	– 	2023/09/30 	250 654
287 542 	2019/09/30 	– 	2024/09/30 	287 542
The VitalityHealth and VitalityLife phantom share schemes
Directors and prescribed officers participation as at 30 June 2020:
Directors and prescribed officers
Outstanding
shares
Date
granted
Exercise
price
GBP
Final
vesting
date
Value at
30 June 2020
GBP
NS Koopowitz 	6 498 	31/10/2016 	– 	2020 	217 943
9 750 	06/11/2017 	– 	2021 	382 688
14 041 	05/11/2018 	– 	2022 	532 013
13 007 	01/03/2020 	– 	2023 	535 238
178 Discovery Annual Financial Statements 2020

-- 176 of 198 --

ANNEXURE B – DIRECTORATE continued
DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES continued
Other development segment schemes
Directors and prescribed officers participation as at 30 June 2020:
Directors and prescribed officers
Outstanding
shares
Date
granted
Exercise
price
R
Final
vesting
date
Value at
30 June 2020
R
HD Kallner 	6 335 	01/07/2017 	– 	30/09/2020 	662 282
7 408* 	01/07/2017 	– 	30/06/2021 	774 506
* Participation in scheme commenced on 1 July 2017, allocated value was only converted into shares on 1 July 2019.
DIRECTORS’ INTERESTS IN SHARES
According to the Register of Directors’ Interests, maintained by Discovery in accordance with the provisions of section 30(4)(d) of the
Companies Act, directors and prescribed officers of Discovery have disclosed the following interest in the ordinary shares of the Company
at 30 June 2020:
Directors and prescribed officers
Direct
beneficial
Indirect
beneficial
Total
2020
Direct
beneficial
Indirect
beneficial
Total
2019
A Gore 	– 	50 496 7751 	50 496 775 	– 	50 496 775 	50 496 775
H Bosman 	– 	77 027 	77 027 	– 	77 027 	77 027
Dr BA Brink 	– 	– 	– 	20 000 	– 	20 000
SE De Bruyn 	1 800 	– 	1 800 	65 800 	– 	65 800
R Farber 	55 076 	– 	55 076 	55 076 	– 	55 076
HD Kallner 	100 398 	– 	100 398 	100 398 	– 	100 398
F Khanyile 	800 	– 	800 	800 	– 	800
NS Koopowitz 	– 	962 004 	962 004 	– 	962 004 	962 004
Dr TV Maphai 	1 919 	407 395 	409 314 	1 919 	407 395 	409 314
HP Mayers 	36 948 	7 699 716 2 	7 736 664 	36 948 	8 599 716 	8 636 664
A Ntsaluba 	90 164 	– 	90 164 	103 164 	– 	103 164
A Pollard 	1 193 099 	– 	1 193 099 	1 193 099 	– 	1 193 099
B Swartzberg 	3 384 227 	22 733 1153 	26 117 342 	3 384 227 	22 733 115 	26 117 342
DM Viljoen 	10 000 	– 	10 000 	10 000 	– 	10 000
SV Zilwa 	– 	12 780 	12 780 	– 	27 780 	27 780
4 874 431 	82 388 812 	87 263 243 	6 542 459 	87 449 624 	93 992 083
1 Includes 42 400 000 ordinary shares which are subject to security.
2 Includes 7 699 716 ordinary shares which are subject to security.
3 Includes 10 200 000 ordinary shares which are subject to security.
There has been no change in the directors’ interests in Discovery Limited’s shares between 30 June 2020 and the date of publication of
this annual report.
179 Discovery Annual Financial Statements 2020

-- 177 of 198 --

ANNEXURE C – ANALYSIS OF SHAREHOLDERS
at 30 June 2020
ORDINARY SHAREHOLDERS
Number of
shareholders
% of total
shareholders
Number of
shares
% of
issued
capital
Shareholder spread
1 – 1 000 shares 	26 080 	81.79 	5 509 578 	0.84
1 001 – 10 000 shares 	4 701 	14.74 	13 279 288 	2.02
10 001 – 100 000 shares 	832 	2.61 	25 234 734 	3.83
100 001 – 1 000 000 shares 	194 	0.61 	58 736 135 	8.92
1 000 001 shares and over 	79 	0.25 	555 531 001 	84.39
31 886 	100.00 	658 290 736 	100
Public/non-public shareholders
Non-public shareholders 	24 	0.08 	254 567 150 	38.67
– Directors of the Company 	14 	0.05 	87 263 243 	13.26
– BEE employee share trust 	1 	0.00 	966 460 	0.14
– Own holdings 	1 	0.00 	680 268 	0.10
– Key management personnel 	5 	0.02 	836 311 	0.13
– Trustees of pension funds 	2 	0.01 	10 278 	0.00
– Strategic holdings (more than 10%) 	1 	0.00 	164 810 590 	25.04
Public shareholders 	31 862 	99.92 	403 723 586 	61.33
31 886 	100 	658 290 736 	100
Number of
shares 	%
Beneficial shareholders’ holding of 5% or more
Rand Merchant Investment Holdings Limited 	164 810 590 	25.04
Government Employees Pension Fund 	57 334 567 	8.71
B PREFERENCE SHAREHOLDERS
Number of
shareholders
% of total
shareholders
Number of
shares
% of
issued
capital
Shareholder spread
1 – 1 000 shares 	1 364 	61.00 	366 850 	4.58
1 001 – 10 000 shares 	765 	34.22 	2 255 636 	28.20
10 001 – 100 000 shares 	94 	4.20 	2 693 353 	33.67
100 001 – 1 000 000 shares 	13 	0.58 	2 684 161 	33.55
2 236 	100 	8 000 000 	100
Public/non-public shareholders
Non-public shareholders (more than 5%) 	2 	0.09 	2 328 758 	29.11
– Strategic holdings (more than 5%) 	2 	0.09 	2 328 758 	29.11
Public shareholders 	2 234 	99.91 	5 671 242 	70.89
2 236 	100 	8 000 000 	100
Number of
shares 	%
Beneficial shareholders’ holding of 5% or more
Outsurance Insurance Company Ltd 	500 000 	6.25
500 000 	6.25
180 Discovery Annual Financial Statements 2020

-- 178 of 198 --

ANNEXURE D – EMBEDDED VALUE
REPORT ON THE REVIEW OF THE EMBEDDED VALUE STATEMENT
OF DISCOVERY LIMITED AND ITS SUBSIDIARIES TO THE DIRECTORS OF DISCOVERY LIMITED
INTRODUCTION
We have reviewed the Embedded Value Statement of Discovery Limited (the “Company”) and its subsidiaries (together the “Group”) for
the year ended 30 June 2020, as set out on pages 182 to 191 of the Discovery Annual Financial Statements for the year ended 30 June 2020
(the “Report”). The Report is prepared for the for the purpose of determining the value and performance of the Group. The directors of
Discovery Limited are responsible for the preparation and presentation of the Report in accordance with the embedded value basis set
out in the Basis of Preparation section of the Report and for determining that the basis of preparation is acceptable in the circumstances.
Our responsibility is to express a conclusion on this Report based on our review.
SCOPE OF REVIEW
We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410 “Review of Interim Financial
Information Performed by the Independent Auditor of the Entity.” A review of financial information consists of making inquiries, primarily
of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially
less in scope that an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to
obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not
express an audit opinion.
CONCLUSION
Based on our review, nothing has come to our attention that causes us to believe that the Report is not prepared, in all material respects,
in accordance with the basis set out in the Basis of Preparation section of the Report.
BASIS OF ACCOUNTING AND RESTRICTION ON USE
Without modifying our conclusion, we draw attention to the Basis of Preparation section of the Report, which describes the basis of
accounting. The Report is prepared for the purpose of determining the value and performance of the Group. As a result, the Report may
not be suitable for another purpose. Our report is intended solely for the directors of Discovery Limited and should not be used by any
other parties. We agree to the publication of our report in the Discovery Annual Financial Statements for the year ended 30 June 2020
provided it is clearly understood by the recipients of the Discovery Annual Financial Statements for the year ended 30 June 2020 that they
enjoy such receipt for information only and that we accept no duty of care to them in respect of our report.
PricewaterhouseCoopers Inc.
Director: Andrew Graham Taylor
Registered Auditor
Johannesburg
15 September 2020
181 Discovery Annual Financial Statements 2020

-- 179 of 198 --

ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
The embedded value of Discovery consists of the following components:
❚ 	the adjusted net worth attributed to the business at the valuation date;
❚ 	plus: the present value of expected future shareholder cash flows from the in-force covered business;
❚ 	less: the cost of required capital.
The present value of future shareholder cash flows from the in-force covered business is calculated as the value of projected future
after-tax shareholder cash flows of the business in-force at the valuation date, discounted at the risk discount rate.
The required capital are the assets attributed to the covered business above the amount required to back covered business liabilities,
whose distribution to shareholders is restricted as they are allocated to cover regulatory and internal capital requirements.
The value of new business is the present value, at the point of sale, of the projected future after-tax shareholder cash flows of the new
business written by Discovery, discounted at the risk discount rate, less an allowance for the reserving strain, initial expenses and cost
of required capital. The value of new business is calculated using the current reporting date assumptions.
The embedded value includes the insurance and administration profits of the covered business in the Discovery Limited group.
Covered business includes business written in South Africa through Discovery Life (“Life”), Discovery Invest (“Invest”), Discovery Health
(“Health”) and Discovery Vitality (“Vitality”), and in the United Kingdom through VitalityLife and VitalityHealth. For Vitality Group, Ping An
Health, MyOwn Health, Discovery Insure, Discovery Bank and VitalityInvest, no published value has been placed on the current in-force
business as the businesses have not yet reached suitable scale with predictable experience.
In August 2011, Discovery raised R800 million through the issue of non-cumulative, non-participating, non-convertible preference
shares. For embedded value purposes this capital, net of share issue expenses, has been excluded from the adjusted net worth.
The embedded value at 30 June 2020 has been materially impacted by the COVID-19 global pandemic, resulting in both experience
variances and short term provisions for adverse future experience. Refer to Tables 5 and 6 for details.
Following the finalisation of the agreement with Prudential in February 2020 to delay the transfer of the VitalityLife business on the
Prudential licence to the Vitality Life Limited licence (“the Part VII transfer”, which is subject to the relevant legal and regulatory
approvals), an adjustment has been made in the embedded value to allow for the cost of this arrangement and the cost of the
required capital for VitalityLife.
The 30 June 2020 embedded value results and disclosures were subjected to an external review.
182 Discovery Annual Financial Statements 2020

-- 180 of 198 --

TABLE 1: GROUP EMBEDDED VALUE
R million
30 June
2020
30 June
2019
%
change
Shareholders’ funds 	44 553 	43 083 	3
Adjustment to shareholders’ funds from published basis1 	(32 080) 	(32 690)
Adjusted net worth2 	12 473 	10 393
Value of in-force covered business before cost of required capital 	64 305 	63 862
Cost of required capital 	(5 944) 	(3 038)
Discovery Limited embedded value 	70 834 	71 217 	(1)
Number of shares (millions) 	656.6 	656.6
Embedded value per share 	R107.88 	R108.46 	(1)
Diluted number of shares (millions) 	657.6 	657.6
Diluted embedded value per share3 	R107.71 	R108.30 	(1)
1 A breakdown of the adjustment to shareholders’ funds is shown in the table below. Note that where relevant, adjustments have been converted using the
closing exchange rate of R21.44/GBP (June 2019: R17.98/GBP)
R million
30 June
2020
30 June
2019
Life and Invest net assets under insurance contracts 	(18 564) 	(20 764)
Vitality Life Limited and Discovery funded VitalityLife business on the Prudential licence net assets under
insurance contracts 	(6 320) 	(5 812)
VitalityHealth financial reinsurance asset 	(3 078) 	(2 315)
VitalityHealth and VitalityHealth Insurance Limited deferred acquisition costs (net of deferred tax) 	(467) 	(382)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) 	(21) 	(19)
Goodwill relating to the acquisition of Standard Life Healthcare and the Prudential joint venture 	(2 653) 	(2 225)
Intangible assets (net of deferred tax) in covered businesses 	(945) 	(800)
Net preference share capital 	(779) 	(779)
Reversal of 1 Discovery Place IAS 17 financial lease accounting 	747 	406
Equity settled share based payment provision adjustment 	0 	–
(32 080) 	(32 690)
The “equity settled share based payment provision adjustment” adjustment reflects the difference between the provision in the IFRS equity and the mark-to-
market value of the equity settled share based payments. At 30 June 2020 this adjustment is R0.33 million.
2 The following table sets out the capital position of the covered businesses with the required capital on a consistent basis to that used in the embedded
value:
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
183 Discovery Annual Financial Statements 2020

-- 181 of 198 --

R million
30 June
2020
30 June
2019
Shareholders’ funds 	44 553 	43 083
Adjustment to shareholders' funds 	(32 080) 	(32 690)
Adjusted net worth 	12 473 	10 393
Excess of available capital over adjusted net worth 	23 231 	26 773
Available capital 	35 704 	37 166
Required capital 	29 932 	30 987
Excess available capital 	5 772 	6 179
The excess of available capital over adjusted net worth reflects the difference between the adjusted net worth and the available capital. This includes:
◼ The net preference share capital of R779 million which is included as available capital.
◼ The difference between Vitality Life Limited’s Solvency II Pillar 1 Own Funds and its adjusted net worth and adds back the negative reserves eliminated on the
Discovery funded VitalityLife business on the Prudential licence.
◼ The difference between Life and Invest’s Pillar 1 Own Funds and its adjusted net worth.
The required capital at June 2020 for Life and Invest is R18 544 million (June 2019: R21 724 million), for Health and Vitality is R935 million (June 2019:
R909 million), for VitalityHealth is R2 963 million (June 2019: R2 350 million) and for VitalityLife is R7 490 million (June 2019: R6 004 million). For Life and
Invest, the required capital was set equal to 1.25 times the SAM Pillar 1 Solvency Capital Requirement. For Health and Vitality, the required capital was set
equal to two times the monthly renewal expense and Vitality benefit cost. For VitalityHealth, the required capital amount was set equal to 1.35 times the
Solvency II Pillar 1 Solvency Capital Requirement. For the VitalityLife business on the Prudential licence, the required capital was set equal to the UK
Solvency I long term insurance capital requirement as per the agreement with Prudential up to the Part VII transfer, thereafter it is set equal to 1.4 times
the Solvency II Pillar 1 Solvency Capital Requirement. For the business sold on the Vitality Life Limited licence, the required capital was set equal to 1.4
times the Solvency II Pillar 1 Solvency Capital Requirement.
3 The diluted embedded value per share adjusts for treasury shares held in the Discovery BEE Share Trust where the impact is dilutive.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
184 Discovery Annual Financial Statements 2020

-- 182 of 198 --

TABLE 2: VALUE OF IN-FORCE COVERED BUSINESS
R million
Value before
cost of
required
capital
Cost of
required
capital
Value after
cost of
required
capital
at 30 June 2020
Health and Vitality 	22 321 	(419) 	21 902
Life and Invest1 	23 752 	(1 244) 	22 508
VitalityHealth 2 	10 077 	(495) 	9 582
VitalityLife 2, 3 	8 155 	(3 786) 	4 369
Total 	64 305 	(5 944) 	58 361
at 30 June 2019
Health and Vitality 	21 465 	(394) 	21 071
Life and Invest1 	27 277 	(1 177) 	26 100
VitalityHealth2 	7 840 	(378) 	7 462
VitalityLife 2 	7 280 	(1 089) 	6 191
Total 	63 862 	(3 038) 	60 824
1 Included in the Life and Invest value of in-force covered business is R1 440 million (June 2019: R1 429 million) in respect of investment management services
provided on off balance sheet investment business. The net assets of the investment service provider are included in the adjusted net worth.
2 The value of in-force has been converted using the closing exchange rate of R21.44/GBP (June 2019: R17.98/GBP).
3 The increase over the financial year in the cost of required capital for VitalityLife is explained under Table 6.
TABLE 3: GROUP EMBEDDED VALUE EARNINGS
Twelve months ended
R million
30 June
2020
30 June
2019
Embedded value at end of period 	70 834 	71 217
Less: Embedded value at beginning of period 	(71 217) 	(65 624)
Increase in embedded value 	(383) 	5 593
Net change in capital1 	– 	(1 839)
Dividends paid 	1 494 	1 481
Transfer to hedging reserve 	430 	175
Employee share option schemes 	(164) 	(33)
Increase in treasury shares 	4 	5
Acquisition of subsidiaries with non-controlling interest2 	(6) 	–
Change in ownership3 	– 	1 104
IFRS transitional arrangements 4 	41 	73
Embedded value earnings 	1 416 	6 559
Annualised return on opening embedded value 	2.0% 	10.0%
1 The net change in capital reflects share issues (net of costs) and an increase (decrease) in treasury shares in the period.
2 This balance arose from the acquisition of the MSO Group in Health.
3 The change in ownership reflects the acquisition of the remaining 48.87% interest in Discovery Bank from FRIHL, being the non-controlling interest.
4 The IFRS transitional arrangements reflects the retrospective adjustments arising from the adoption of IFRS 9 and IFRS 15 to the opening balances at
1 July 2018.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
185 Discovery Annual Financial Statements 2020

-- 183 of 198 --

TABLE 4: COMPONENTS OF GROUP EMBEDDED VALUE EARNINGS
Twelve months ended 30 June 2020
Year ended
30 June 2019
R million
Net
worth
Cost of
required
capital
Value of
in-force
covered
business
Embedded
value
Embedded
value
Total profit from new business (at point of
sale) 	(4 614) 	(271) 	6 807 	1 922 	2 622
Profit from existing business
◼ Expected return 	6 125 	72 	191 	6 388 	6 000
◼ Change in methodology and assumptions1 	2 871 	(2 118) 	(9 512) 	(8 759) 	(1 930)
◼ Experience variances 	250 	(107) 	(10) 	133 	19
Impairment, amortisation and fair value
adjustment2 	(16) 	– 	– 	(16) 	(37)
Increase in goodwill and intangibles 	(313) 	– 	– 	(313) 	(244)
Other initiative costs3 	(93) 	– 	44 	(49) 	914
Non-recurring expenses 	(181) 	– 	– 	(181) 	(3)
Acquisition costs4 	(7) 	– 	(5) 	(12) 	(39)
Finance costs 	(1 368) 	– 	– 	(1 368) 	(1 060)
Foreign exchange rate movements 	899 	(482) 	2 927 	3 344 	(178)
Other5 	18 	– 	1 	19 	76
Return on shareholders’ funds6 	308 	– 	– 	308 	419
Embedded value earnings 	3 879 	(2 906) 	443 	1 416 	6 559
1 The changes in methodology and assumptions will vary over time to reflect adjustments to the model and assumptions as a result of changes to the
operating and economic environment. The current period’s changes are described in detail in Table 6 below (for previous periods refer to previous
embedded value statements).
2 This item reflects the amortisation of the intangible assets reflecting the banking costs, the PrimeMed acquisition and capital expenditure in VitalityInvest
and Discovery Group Europe Limited.
3 This item includes the profits of non–covered businesses (including Discovery Insure, Vitality Group and Ping An Health) and costs of start–up businesses
(including Discovery Bank, VitalityInvest, a commercial offering in Discovery Insure, and an Umbrella Fund offering in Invest). Head office costs which relate
to non–covered business are also included in this item.
4 Acquisition costs relate to commission paid on the Life business and expenses incurred in writing Health and Vitality business that has been written over
the period but will only be activated and on risk after the valuation date. These policies are not included in the embedded value or the value of new business
and therefore the costs are not deducted from the value of new business.
5 This item includes, among other items, the tax benefits or losses that will emerge as the VitalityHealth DAC and intangible software assets amortise or
increase.
6 The return on shareholders’ funds is shown net of tax and management charges.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
186 Discovery Annual Financial Statements 2020

-- 184 of 198 --

TABLE 5: EXPERIENCE VARIANCES
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
R million
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force 	Total
Renewal expenses 	74 	– 	3 	(2) 	(43) 	– 	10 	– 	42
Lapses and surrenders 1 	(10) 	(298) 	88 	23 	– 	295 	(99) 	(147) 	(148)
Mortality and morbidity2 	– 	– 	147 	(1) 	(151) 	– 	(103) 	– 	(108)
Policy alterations3 	– 	40 	(516) 	174 	– 	– 	(9) 	(73) 	(384)
Premium and fee income 	127 	– 	(23) 	106 	69 	– 	(10) 	(51) 	218
Economic4 	19 	335 	(499) 	(557) 	– 	– 	– 	– 	(702)
Commission 	– 	– 	– 	– 	(27) 	– 	– 	– 	(27)
Tax 5 	90 	– 	603 	(566) 	170 	– 	55 	– 	352
Reinsurance 	– 	– 	– 	– 	(2) 	– 	49 	(31) 	16
Maintain modelling term6 	– 	369 	– 	189 	– 	66 	– 	– 	624
Vitality benefits 	(27) 	– 	– 	– 	– 	– 	65 	– 	38
Other 	(2) 	2 	(26) 	61 	188 	– 	40 	(51) 	212
Total 	271 	448 	(223) 	(573) 	204 	361 	(2) 	(353) 	133
1 For Health and Vitality, the lapse and surrender experience variance relates to lower than expected replacement of exiting members in compulsory
membership schemes. For VitalityLife, the experience variance relates largely to adverse lapse experience on the term indexed optimiser product.
2 The mortality and morbidity experience for VitalityHealth includes a premium deferral provision for non–COVID–19 claims delayed due to private hospital
utilisation by the National Health Service during the pandemic.
3 The policy alterations experience for Life and Invest arises largely due to servicing and fund switches.
4 For Health and Vitality, the economic experience variance relates to the impact on administration and managed care fees of in–period inflation being
higher than that assumed. The experience for Life and Invest arises largely due to lower than expected linked asset growth for the period under review.
5 The tax variance for Life and Invest arises due to a movement in the deferred tax asset which delays the payment of tax.
6 The projection term for Health and Vitality, Life and VitalityHealth at 30 June 2020 has not been changed from that used in the 30 June 2019 embedded
value calculation. Therefore, an experience variance arises because the total term of the in–force covered business is effectively increased by twelve months.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
187 Discovery Annual Financial Statements 2020

-- 185 of 198 --

TABLE 6: METHODOLOGY AND ASSUMPTION CHANGES
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
R million
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force 	Total
Modelling changes 1 	– 	– 	(99) 	116 	– 	– 	(6) 	(849) 	(838)
Expenses2 	– 	(239) 	(9) 	(51) 	– 	– 	17 	(374) 	(656)
Lapses3 	– 	(394) 	106 	(936) 	– 	– 	24 	(404) 	(1 604)
Mortality and morbidity4 	– 	– 	– 	(844) 	– 	– 	(107) 	(165) 	(1 116)
Benefit changes 	– 	(25) 	– 	– 	– 	– 	– 	– 	(25)
Tax 5 	– 	– 	– 	– 	– 	(187) 	– 	18 	(169)
Economic assumptions 6 	– 	(805) 	(40) 	(2 716) 	– 	299 	(397) 	(1 136) 	(4 795)
Premium and fee income 7 	24 	545 	– 	– 	– 	– 	(40) 	(115) 	414
Reinsurance and financing8 	– 	– 	1 412 	(1 490) 	– 	(26) 	– 	– 	(104)
Other 9 	– 	– 	1 843 	(1 486) 	– 	– 	143 	(366) 	134
Total 	24 	(918) 	3 213 	(7 407) 	– 	86 	(366) 	(3 391) 	(8 759)
1 For VitalityLife, the cost of required capital following the Part VII transfer has been updated following the February 2020 agreement with Prudential. This
cost is sensitive to the economic conditions and the business mix at the time of the Part VII transfer. This impact is partially offset by a methodology change
in the calculation of the lapse risk component of the required capital and a change in the risk–free rate to be set with reference to UK swap rates rather
than the IFRS interest rate.
2 For VitalityLife, the value of in–force includes the fees payable to Prudential for the delay of the Part VII transfer.
3 The lapse assumption includes the impact of a short term stress to lapse assumptions in anticipation of adverse economic conditions over the next two
years.
4 For Life and VitalityLife, the mortality and morbidity assumption change relates to the increased provision for COVID–19 related claims.
5 For VitalityHealth the tax relates to the UK future tax rate changing from 17% to 19%.
6 For Life, Invest, Health and Vitality the economic assumptions item relates to the impact of updating the assumptions relative to the Johannesburg Stock
Exchange nominal and real yield risk–free curves at 30 June 2020. For VitalityHealth the item relates to the impact of changing the risk discount rate. For
VitalityLife the item relates to the impact of updating the assumptions relative to the Solvency II yield curves and the IFRS interest rates, offset by a gain in
the interest rate hedge.
7 For Health and Vitality, the premium and fee income item relates to an update of the contractual administration and managed care fees charged for
DHMS.
8 For Life, the reinsurance and financing item primarily relates to the impact of financing arrangements.
9 For VitalityLife, the other item relates to the margin reset to offset experience variances, as per the accounting policy, as well as an adjustment in the value
of in-force for the market value of the swaption as at 30 June 2020. For Life the other item relates to the change in the matching strategy for long-term
claims reserves.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
188 Discovery Annual Financial Statements 2020

-- 186 of 198 --

TABLE 7: EMBEDDED VALUE OF NEW BUSINESS
Twelve months ended
R million
30 June
2020
30 June
2019
%
change
Health and Vitality
Present value of future profits from new business (at point of sale) 	910 	832
Cost of required capital 	(27) 	(27)
Present value of future profits from new business (at point of sale) after cost of
required capital 	883 	805 	10
New business annualised premium income1 	3 972 	3 716 	7
Life and Invest
Present value of future profits from new business (at point of sale)2 	668 	1 242
Cost of required capital 	(82) 	(82)
Present value of future profits from new business (at point of sale) after cost of
required capital 	586 	1 160 	(49)
New business annualised premium income3 	2 886 	2 897 	(0)
Annualised profit margin4 	2.5% 	4.6%
Annualised profit margin excluding Invest business 	5.8% 	10.2%
VitalityHealth5
Present value of future profits from new business (at point of sale) 	262 	330
Cost of required capital 	(56) 	(59)
Present value of future profits from new business (at point of sale) after cost of
required capital 	206 	271 	(24)
New business annualised premium income (Rand)6 	1 308 	1 294 	1
Annualised profit margin4 	2.5% 	3.2%
VitalityLife7
Present value of future profits from new business (at point of sale) 	353 	520
Cost of required capital 	(106) 	(134)
Present value of future profits from new business (at point of sale) after cost
of required capital 	247 	386 	(36)
New business annualised premium income (Rand) 	956 	995 	(4)
Annualised profit margin4 	3.2% 	5.0%
1 Health new business annualised premium income is the gross contribution to the medical schemes. The new business annualised premium income shown
above excludes premiums in respect of members who join an existing employer where the member has no choice of medical scheme, as well as premiums
in respect of new business written during the period but only activated after 30 June 2020.
The total Health and Vitality new business annualised premium income written over the period was R6 146 million (June 2019: R6 831 million).
2 Included in the Life and Invest embedded value of new business is R29 million (June 2019: R70 million) in respect of investment management services
provided on off balance sheet investment business.
Risk business written prior to the valuation date allows certain Invest business to be written at financially advantageous terms, the impact of which has
been recognised in the value of new business.
3 Life new business is defined as Life policies to which Life became contractually bound during the reporting period, including policies whose first premium
is due after the valuation date. Invest new business is defined as business where at least one premium has been received and which has not been refunded
after receipt. Invest new business also includes Discovery Retirement Optimiser policies to which Life and Invest became contractually bound during the
reporting period, including policies whose first premium is due after the valuation date.
The new business annualised premium income of R2 886 million (June 2019: R2 897 million) (single premium APE: R1 453 million (June 2019: R1 321
million)) shown above excludes automatic premium increases and servicing increases in respect of existing business. The total new business annualised
premium income written over the period, including automatic premium increases of R1 496 million (June 2019: R1 370 million) and servicing increases of
R576 million (June 2019: R648 million), was R4 958 million (June 2019: R4 915 million) (single premium APE: R1 507 million (June 2019: R1 382 million)).
Single premium business is included at 10% of the value of the single premium.
Policy alterations and internal replacement policies, including Discovery Retirement Optimisers added to existing Life Plans, are shown in Table 5 as
experience variances and not included as new business. Term extensions on existing contracts are not included as new business.
4 The annualised profit margin is the value of new business expressed as a percentage of the present value of future premiums.
5 The VitalityHealth value of new business is calculated as the value at point of sale of the new business written premium in–force at the valuation date
multiplied by the Margin multiplied by the Annuity Factor less the new business cash flows from point of sale to the valuation date. The assumptions for
the Margin and Annuity Factor are shown in Table 8.
6 VitalityHealth new business is defined as individuals and employer groups which incepted during the reporting period. The new business annualised
premium income shown above has been adjusted to exclude premiums in respect of members who join an existing employer group after the first month,
as well as premiums in respect of new business written during the period but only activated after 30 June 2020.
7 VitalityLife new business is defined as policies to which VitalityLife became contractually bound during the reporting period, including policies whose first
premium is due after the valuation date.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
189 Discovery Annual Financial Statements 2020

-- 187 of 198 --

BASIS OF PREPARATION
TABLE 8: EMBEDDED VALUE ECONOMIC ASSUMPTIONS
30 June
2020
30 June
2019
Beta coefficient 	0.75 	0.75
Equity risk premium (%) 	3.5 	3.5
Risk discount rate (%)
Health and Vitality 1 	14.125 	11.875
Life and Invest1 	15.125 	13.125
VitalityHealth 	2.89 	3.61
VitalityLife 	3.065 	4.725
Rand/GB Pound exchange rate
Closing 	21.44 	17.98
Average 	19.75 	18.32
Margin over Expense inflation to derive Medical inflation (%)
South Africa 	3.00 	3.00
Expense inflation (%)2
South Africa 	– Health and Vitality 	7.39 	6.13
– Life and Invest 	8.33 	7.24
United Kingdom 	2.50 	2.50
Pre-tax investment return (%)
South Africa 	– Cash1 	11.00 	9.00
– Life and Invest bonds3 	12.50 	10.50
– Health and Vitality bonds3 	11.50 	9.25
– Equity1 	16.00 	14.00
United Kingdom – VitalityHealth risk-free rate 	0.27 	0.99
– VitalityLife risk–free rate 	0.44 	2.10
– VitalityLife IFRS interest rate 	1.35 	2.50
– VitalityLife investment return 	1.58 	2.50
Income tax rate (%)
South Africa 	28 	28
United Kingdom – long term 	19 	17
VitalityHealth Assumptions
– Margin (net of tax and cost of capital) (%) 	14.1 	14.1
– Annuity Factor 	6.37 	6.13
Projection term
– Health and Vitality 	20 years 	20 years
– Discovery Life – ViF 	40 years 	40 years
– Group Life 	10 years 	10 years
– VitalityLife 	No cap 	No cap
– VitalityHealth 4 	20 years 	20 years
1 Derived as a margin over (or below for cash) the respective pre–tax investment return for bonds.
2 The inflation assumption is derived as the difference between the nominal and real yield curve at each duration. As an indication, the cash flow weighted
average inflation is shown in the table. For the United Kingdom, the expense inflation assumption is 1.50% in the first year.
3 As indications, the cash flow weighted averages derived from the relevant yield curve(s) are shown.
4 The VitalityHealth projection term of 20 years is used in the derivation of the Annuity Factor.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
190 Discovery Annual Financial Statements 2020

-- 188 of 198 --

The Discovery Limited embedded value is calculated based on a risk discount rate using the CAPM approach with specific reference to
the Discovery beta coefficient. The assumed beta is fixed at 0.75. This has been set such that the risk discount rate proxies the result
of a Weighted Average Cost of Capital approach with reference to the capital structure of the Group and the observed beta calculated
using daily returns over a long time period. The observed beta is calculated with reference to the ALSI. The assumed beta will only
change if the capital structure of the Group and / or the observed beta calculated using daily returns over a long time period suggest
the beta assumption should depart significantly from the assumption at the financial year end. As beta values reflect the historic
performance of share prices relative to the market they may not allow fully for non–market related and non–financial risk. Investors
may want to form their own view on an appropriate allowance for these risks which have not been modelled explicitly.
Life and Invest mortality, morbidity and lapse and surrender assumptions were derived from internal experience, where available,
augmented by reinsurance and industry information.
The Health and Vitality lapse assumptions were derived from the results of recent experience investigations.
The VitalityHealth assumptions were derived from internal experience.
VitalityLife assumptions were derived from internal experience, where available, augmented by reinsurance, industry and Discovery
Limited group information.
Renewal expense assumptions were based on the results of the latest expense and budget information.
The initial expenses included in the calculation of the embedded value of new business are the actual costs incurred excluding
expenses of an exceptional or non–recurring nature.
From 30 June 2020, the yield curve underlying the embedded value calculations were changed from the Prudential Authority yield
curves to the Johannesburg Stock Exchange (“JSE”) yield curves. The South African investment return assumptions for Life, Invest,
Health and Vitality were based on the publicly available JSE risk–free nominal yield curve. The real yield assumption was set based on
the publicly available JSE risk–free real yield curve, adjusted to remove volatility due to the nature of the index linked government
bond market. Other economic assumptions were set relative to these two yield curves.
The current and projected tax position of the policyholder funds within the Life company has been taken into account in determining
the net investment return assumption.
The risk–free rate assumption for VitalityHealth was based on the single interest rate derived from the risk–free zero coupon sterling
yield curve.
From 30 June 2018, VitalityHealth calculate the value in–force at the valuation date as the in–force written premium multiplied by the
Margin multiplied by the Annuity Factor, as set out in the table above. The Annuity Factor assumption is derived from assumed future
lapse rates and premium increases. The Margin assumption reflects profit margins after tax and Cost of Capital. The assumptions
underlying the Annuity Factor and Margin are set taking into account the current experience in the business at different durations.
From 30 June 2020, VitalityLife bases the risk–free rate on UK swap rates. The inflation rate is set in line with the short–term
expectation of inflation for the first year, and beyond that is consistent with the Bank of England inflation target.
The cost of required capital is calculated using the difference between the risk discount rate and the net of tax asset return on tangible
assets. The Vitality Life Limited and the VitalityLife business on the Prudential licence required capital amount is assumed to earn the
investment return assumption, which is set based on the return on a portfolio of government and corporate bonds assumed to back
the required capital. The Life and Invest cost of required capital is calculated assuming shareholder cash flow is limited to the cash
flow available after having met both the required capital amount and an internally defined liquidity target capital requirement of
tangible assets.
The embedded value has been calculated in accordance with the Actuarial Society of South Africa’s Advisory Practice Note (“APN”) 107:
Embedded Value Reporting, except the recommended disclosure of Free Surplus and Required Capital has been adjusted to take into
account the nature of the capital requirements in the covered businesses, as can be seen in Table 1 note 2.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
191 Discovery Annual Financial Statements 2020

-- 189 of 198 --

Sensitivity to the embedded value assumptions
The risk discount rate uses the CAPM approach with specific reference to the Discovery beta coefficient. As beta values reflect the
historic performance of share prices relative to the market they may not allow fully for non–market related and non–financial risk.
Investors may want to form their own view on an appropriate allowance for these risks which have not been modelled explicitly. The
sensitivity of the embedded value and the embedded value of new business at 30 June 2020 to changes in the risk discount rate is
included in the tables below.
For each sensitivity illustrated below, all other assumptions have been left unchanged. No allowance has been made for management
action such as risk premium increases where future experience is worse than the base assumptions.
TABLE 9: EMBEDDED VALUE SENSITIVITY
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
Embedded
value
%
change	R million
Adjusted
net worth 2
Value
of
in-force
Cost of
required
capital
Value
of
in-force
Cost of
required
capital
Value
of
in-force
Cost of
required
capital
Value
of
in-force
Cost of
required
capital
Base 	12 473 	22 321 	(419) 	23 752 	(1 244) 	10 077 	(495) 	8 155 	(3 786) 	70 834
Impact of:
Risk discount rate +1% 	12 473 	21 039 	(451) 	21 552 	(1 165) 	9 544 	(470) 	7 516 	(5 327) 	64 711 	(9)
Risk discount rate -1% 	12 473 	23 740 	(382) 	26 342 	(1 336) 	10 667 	(524) 	8 850 	(1 904) 	77 926 	10
Lapses -10% 	12 080 	23 115 	(441) 	25 143 	(1 321) 	11 402 	(560) 	8 782 	(4 260) 	73 940 	4
Interest rates -1% 1 	10 848 	22 250 	(403) 	24 290 	(1 229) 	10 560 	(524) 	8 356 	(4 530) 	69 618 	(2)
Equity and property market value -10% 	12 435 	22 321 	(419) 	23 845 	(1 263) 	10 076 	(495) 	8 155 	(3 786) 	70 869 	0
Equity and property return +1% 	12 473 	22 321 	(419) 	24 031 	(1 250) 	10 088 	(495) 	8 155 	(3 786) 	71 118 	0
Renewal expenses -10% 	12 556 	24 416 	(388) 	24 247 	(1 220) 	10 826 	(495) 	8 297 	(3 754) 	74 485 	5
Mortality and morbidity -5% 	12 674 	22 321 	(419) 	25 312 	(1 123) 	11 625 	(495) 	8 354 	(3 742) 	74 507 	5
Projection term +1 year 	12 473 	22 644 	(422) 	23 890 	(1 255) 	10 153 	(499) 	8 155 	(3 786) 	71 353 	1
1 All economic assumptions were reduced by 1%.
2 The sensitivity impact on the VitalityLife net of tax change in negative reserves is included in the adjusted net worth column.
The following table shows the effect of using different assumptions on the embedded value of new business.
TABLE 10: VALUE OF NEW BUSINESS SENSITIVITY
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
Value of
new
business
%
change	R million
Value of
new
business
Cost of
required
capital
Value of
new
business
Cost of
required
capital
Value of
new
business
Cost of
required
capital
Value of
new
business
Cost of
required
capital
Base 	910 	(27) 	668 	(82) 	262 	(56) 	353 	(106) 	1 922
Impact of:
Risk discount rate +1% 	836 	(30) 	453 	(77) 	186 	(52) 	220 	(137) 	1 399 	(27)
Risk discount rate -1% 	993 	(25) 	921 	(88) 	346 	(60) 	504 	(55) 	2 536 	32
Lapses -10% 	969 	(29) 	888 	(87) 	396 	(63) 	525 	(146) 	2 453 	28
Interest rates -1% 1 	918 	(26) 	699 	(81) 	335 	(60) 	383 	(106) 	2 062 	7
Equity and property return +1% 	910 	(27) 	692 	(82) 	263 	(56) 	353 	(106) 	1 947 	1
Renewal expense -10% 	1 032 	(26) 	708 	(80) 	340 	(56) 	380 	(100) 	2 198 	14
Mortality and morbidity -5% 	910 	(27) 	764 	(74) 	422 	(56) 	398 	(96) 	2 241 	17
Projection term +1 year 	928 	(28) 	682 	(83) 	272 	(57) 	353 	(106) 	1 961 	2
Acquisition costs -10% 	939 	(27) 	820 	(82) 	298 	(56) 	483 	(106) 	2 269 	18
1 All economic assumptions were reduced by 1%.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2020
Discovery Annual Financial Statements 2020 193	192 Discovery Annual Financial Statements 2020

-- 190 of 198 --

ANNEXURE E – FIVE-YEAR REVIEW
for the year ended 30 June 2020
Group
2016
Group
2017
Group
2018
Group
2019
Group
2020
Compound
growth %
Total new business API and other new business
(R million) 	15 207 	15 917 	16 878 	19 246 	20 307 	7%
Gross inflows under management (R million)
Gross inflows under management1 	104 409 	115 061 	125 554 	139 062 	154 833 	10%
Less: Collected on behalf of third parties 	(59 014) 	(68 165) 	(74 459) 	(80 199) 	(87 962) 	10%
Gross income of Group1 	45 395 	46 896 	51 095 	58 863 	66 871 	10%
Income statement extracts (R million)
Profit from operations 	5 803 	6 245 	8 260 	7 536 	1 532 	(28%)
Headline earnings 	3 641 	4 404 	5 803 	5 147 	296 	(47%)
Abnormal expenses/(income) 	671 	252 	(402) 	(112) 	3 451
Normalised headline earnings 	4 312 	4 656 	5 401 	5 035 	3 747 	(3%)
Diluted normalised headline earnings per share
(cents) 	671.1 	721.5 	836.9 	771.6 	566.7 	(4%)
Statement of financial position extracts
(R million)
Total assets 	118 577 	130 923 	157 982 	180 233 	210 328 	15%
Shareholders’ funds 	30 607 	32 290 	37 594 	43 083 	44 549 	10%
Embedded value
Embedded value (R million) 	53 080 	57 294 	65 624 	71 217 	70 834 	7%
Diluted embedded value per share (R) 	82.17 	88.67 	101.56 	108.30 	107.71 	7%
Key ratios
Return on average equity (%) 	13 	14 	16 	16 	0.4
Return on average assets (%) 	3 	4 	4 	4 	0.1
Exchange rates
Rand/US$
– Closing 	14.73 	13.12 	13.81 	14.15 	17.41
– Average 	14.60 	13.61 	12.86 	14.17 	15.70
Rand/GBP
– Closing 	19.78 	17.03 	18.16 	17.98 	21.44
– Average 	21.44 	17.29 	17.33 	18.32 	19.75
Share statistics
Number of ordinary shares in issue
– Weighted average (000’s) 	637 608 	644 651 	645 014 	652 295 	656 648
– Diluted weighted average (000’s) 	642 534 	645 236 	645 408 	652 568 	661 242
– End of period (000’s) 	647 428 	646 845 	646 845 	658 291 	658 291
Price/diluted headline earnings (times) 	18.3 	17.7 	17.6 	19.3 	18.3
Share price (cents per share):
– High 	15 467 	13 748 	19 000 	17 830 	15 163
– Low 	11 000 	10 910 	12 719 	13 287 	5 815
– Closing 	12 250 	12 792 	14 750 	14 911 	10 455
Market capitalisation (R million) 	79 310 	82 744 	95 410 	98 158 	68 824
1 IFRS 15 Revenue from Contracts with Customers became effective 1 July 2018. 'Gross inflows under management' and 'Gross income of Group' have not been restated.
194 Discovery Annual Financial Statements 2020

-- 191 of 198 --

ANNEXURE F – PRODUCT DESCRIPTIONS
Discovery enters into contracts that carry insurance risk or financial risk or both. The following table analyses the various contracts
offered by the Group and the risks these contracts transfer.
The risks identified for the contracts above and the management thereof will be discussed as follows:
❚ 	Management of insurance risks: pages 34 to 55.
❚ 	Management of financial risks: pages 56 to 82.
Contracts offered by the Group 	Risk type
2020
Number
of policies
2020
Annualised
Premium
income
(million)
2019
Number
of policies
2019
Annualised
premium
income
(million)
Discovery Individual Life 	446 713 	R11 389 	446 475 	R10 688
– Discovery Classic and Essential Life Plans 	Insurance
– Dollar Life Plan 	Insurance
– Business Life Plan 	Insurance
– Smart Life Plan 	Insurance
– Purple Life Plan 	Insurance
– Health Plan Protector1 	Insurance
– Medical Premium Waiver 	Insurance
– DiscoveryCard Protector1 	Insurance
– Standalone Global Education Protector2 	Insurance
– Supplementary Cancer Protector2 	Insurance
– Supplementary Gap Cover2 	Insurance
– Funeral Cover2 	Insurance
Discovery Employee Benefits 	608 787 	R2 451 	544 443 	R2 312
– Discovery Group Life3 	Insurance
– Discovery Umbrella Funds 	Financial
Discovery Life Other2 	46 260 	R200 	35 466 	R143
– PrimaryCare 	Insurance
Discovery Invest4 	322 221 	R12 559 	309 160 	R11 662
– Unit-linked contracts without significant insurance risk 	Financial
– Unit-linked contracts with significant insurance risk 	Both
– Guaranteed return plans 	Both
– Fixed annuities 	Both
– Discovery Retirement Optimiser: Linked 	Both
– Discovery Retirement Optimiser: Guaranteed 	Both
Discovery Insure 	135 559 	R451 	159 171 	R3 402
– Personal lines 	Insurance
– Commercial lines 	Insurance
VitalityHealth 	681 323
GBP 511
(R10 964) 	642 399
GBP 483
(R8 849)
– Individual product 	Insurance
– SME product 	Insurance
– Corporate product 	Insurance
VitalityLife 	473 872
GBP 310
(R6 654) 	434 072
GBP 288
(R5 276)
– VitalityLife Life Plan 	Insurance
– Essentials Plan 	Insurance
– Guaranteed 50s Plus Plan 	Insurance
– Relevant Life Plan 	Insurance
– Mortgage Plus Plan 	Insurance
– Business Protection Plan 	Insurance
– Vitality Optimiser 	Insurance
– Interest rate Optimiser 	Insurance
– Premium Optimiser 	Insurance
1 Discontinued
2 Note that these are on a stand-alone basis
3 Number of lives covered
4 Annualised premium income includes 10% of the value of single premium policies
195 Discovery Annual Financial Statements 2020

-- 192 of 198 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
Discovery Life
Discovery Life offers policyholders a range of insurance and financial solutions. The Discovery Life products reflect Discovery’s underlying
philosophy to make members healthier and to enhance and protect their lives.
Discovery Life offers some unique benefits that integrate with the benefits offered by Discovery Health, Discovery Vitality, DiscoveryCard,
Discovery Bank, Discovery Insure and Discovery Invest.
Discovery Life Plan
The Discovery Life Plan provides protection against a comprehensive spectrum of risks. Discovery Life offers a Classic Life Plan with broad
and comprehensive protection for the policyholder and his or her immediate family and an Essential Life Plan which offers cost effective
protection for the principal policyholder and his or her spouse.
The Discovery Life Plan covers:
❚ 	Life Cover Benefits.
❚ 	Disability Benefits.
❚ 	Severe Illness Benefits.
❚ 	Income Continuation Benefits.
The Life Fund forms the base amount of cover insured under the Life Plan (the basic sum assured amount). The Life Fund can be linked
to a benefit escalation rate, for example inflation, and will then automatically increase at each policy anniversary.
The key risk benefits are defined as a percentage of the Life Fund. The Life Fund is reduced by the amount of benefits paid from the Life
Fund. The Life Fund can be protected against claims by means of the Minimum Protected Fund. Multiple claims are allowed against the
Life Fund from the same benefit.
There are a number of risk benefits that are defined in monetary terms or in the form of indemnity benefits, rather than being expressed
as a percentage of the Life Fund. These benefits include:
❚ 	Income Continuation Benefit.
❚ 	Global Education Benefit.
❚ 	Global Health Protector.
The Life Plan has unique features allowing policyholders to add benefits for other family members. The Global Education Protector,
Global Health Protector, Childbirth Benefit, Child Severe Illness Benefit, Parent Severe Illness Benefit and Family Trauma Benefit allow
protection for the whole immediate family.
By actively maintaining and improving their health, Discovery Life policyholders, through the Integrator Benefit, could receive premium
discounts and refunds of premiums and/or increases in cover.
The Life Plan provides whole of life cover. Premium guarantees are offered and quantified on most benefits. For example, the premiums
for Life Cover are guaranteed not to increase by more than 25% for any 10-year period over and above contractual premium increases.
This percentage can be futher reduced through engagement in the Vitality programme.
Premiums are payable monthly. There are various funding methods that allow policyholders a choice of premium funding patterns. A
combination of level premium funding patterns and annually increasing premium patterns are offered. The higher the compulsory future
premium increase, the lower the starting premium.
The Dollar Life Plan, offers the ability to specify the sum insured in US Dollars and pay premiums in Rands, but linked to the Rand/Dollar
exchange rate. The Business Life Plan is tailored to the needs of business owners.
The Smart Life Plan enhances Discovery Life’s offering to a younger clientele, providing benefits which are tailored to appeal to individuals
aged between 18 and 29.
Health Plan Protector (discontinued)
The Health Plan Protector funds contributions to the Discovery Health Medical Scheme in the event of death, disability or severe illness.
It further rewards members for positive health management through the PayBack benefit and Health Dividends. The Health Plan Protector
can be added to the Life Plan or can be bought on a stand-alone basis. The Health Plan Protector provides cover up to age 65, however
premiums are not guaranteed.
196 Discovery Annual Financial Statements 2020

-- 193 of 198 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
Medical Premium Waiver
The Medical Premium Waiver funds contributions to a client’s Health Plan in the event of death, disability or severe illness and can be
bought on a stand-alone basis. The Health Plan Protector provides cover up to age 65, however premiums are not guaranteed.
DiscoveryCard Protector (discontinued)
The DiscoveryCard Protector covers the outstanding balance on the DiscoveryCard in the event of death, disability or severe illness. It
further provides a monthly benefit for a defined period equal to the average DiscoveryCard spend in the six-month period prior to the
life changing event.
Standalone Global Education Protector
The Global Education Protector funds education costs for children in the event of death, disability or severe illness of the insured life.
Cover is provided to the earlier of the insured life reaching age 65 or the child reaching age 24. This benefit can be purchased on a
standalone basis.
Supplementary Gap Cover
The Supplementary Gap Cover benefit offers lump sum cover for defined severe illnesses, funding for genomic sequencing of certain
cancers, a home support benefit as well as a health premium waiver given a defined life changing event.
Supplementary Cancer Protector
The Supplementary Cancer Protector benefit will pay defined monthly amounts which can be used to meet costs that arise when a family
is affected by cancer.
Funeral Cover
The Funeral Cover benefit will pay out a defined lump sum in the event of death which can be used to cover the costs of a funeral. This
lump sum is doubled in the event of accidental death. An education benefit is automatically included at a defined amount which aims to
fund the education costs for children upon death of the principal member or spouse. Optional memorial and grocery benefits may be
added to the policy.
PrimaryCare
The PrimaryCare benefit is a healthcare product that is sold to employer groups. The product provides indemnity cover for low-income
employees for primary healthcare including GP visits, dental benefits, and optical benefits. The PrimaryCare product is administered by
Discovery Health, but is written on the Discovery Life licence. Policies are annually reviewable.
DISCOVERY EMPLOYEE BENEFITS
Discovery Employee Benefits offers employers retirement funds and group risk solutions for their employees.
Group Life
Discovery Employee Benefits offers a comprehensive spectrum of protection benefits on a group basis. Life Cover, Severe Illness,
Disability and Income Continuation Benefits are offered. The policies offered under Group Life can be cancelled or the premiums adjusted
at the end of the contract term (usually one year). These benefits are written on the Discovery Life licence.
Umbrella Fund
Discovery Umbrella Fund, launched in May 2018, offers employer groups a unique platform for the investment of retirement assets for
their employees. Pension and provident funds are offered as well as in-fund preservation for members leaving the fund. Policies are
annual and all fees are reviewable annually.
The Fund offers a wide range of investment options to members on internal and external asset portfolios that are offered by Discovery
Invest; all funds offered are Regulation 28 compliant. Discovery Umbrella offers unique benefits in the form of investment boosts and fee
discounts for low income members.
Discovery Invest
Discovery Invest offers investors access to a comprehensive and flexible range of investment solutions which can be tailored to the needs
of each investor.
197 Discovery Annual Financial Statements 2020

-- 194 of 198 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
A range of investment wrappers are provided to ensure flexibility and to optimise the investments according to the investment objectives
and time horizon of the investor. A wrapper is the legal structure that allows policyholders to make underlying investments with different
tax and other legal implications.
The following wrappers are available:
❚ 	Endowment: A medium-term, local or offshore, investment vehicle that provides tax efficiencies for an investor with a five to ten-year
time horizon.
❚ 	Flexible investment: A flexible investment vehicle that allows tailor made investment solutions whilst providing immediate access
to funds.
❚ 	Retirement plan: A long-term investment vehicle providing a tax efficient structure for saving towards retirement.
❚ 	Preserver plans: An investment vehicle that helps to ensure retirement benefits continue to grow on a tax efficient basis once a
policyholder has left the retirement plan of an employer.
❚ 	Retirement income plan: Fixed and linked annuities are provided giving flexibility to meet retirement needs.
A comprehensive range of investment fund choices are provided including unique Discovery Invest funds. The funds include:
❚ 	Discovery Invest funds: Includes a comprehensive range of Discovery Invest’s single- and multi-manager funds across a range of
asset classes.
❚ 	Dynamically protected funds: Unique Discovery Invest funds that are designed to protect investors against the major risks associated
with investment choice, for example, underperformance by fund, asset class and geographic region.
❚ 	Special purpose funds: These funds are designed to provide solutions to investors looking to save for specific goals, such as
retirement. These funds provide alternative and innovative management expertise.
❚ 	External funds: Discovery Invest provides a broad range of externally managed funds.
Invest offers various benefits which reduces the cost of investment and enhances benefits available under the Invest plans.
❚ 	Investment Integrator: Uses inter alia the health improvements from Vitality and tax efficiencies created to offer a cost effective
endowment and increase the value of the investment. A fee reduction of up to 100% can be achieved on both administration and asset
management fees. This benefit is no longer available to new business.
❚ 	Annuity Integrator: By releasing the value of a policyholder’s life cover at retirement, the Annuity Integrator creates enhanced
benefits for Discovery Retirement Income Plan investors. The benefits include increased retirement income, protection against
longevity, protection against ill-health and protection against poor performance of underlying assets.
❚ 	Guaranteed return plans: Guaranteed return plans include the following:
– The Guaranteed Growth Plan is a single premium endowment that provides a guaranteed return at the end of five years.
– The Guaranteed Income Plan provides a guaranteed return at the end of five years on the chosen percentage of the lump sum
contribution. The remainder of the lump sum will provide a monthly or annual income.
❚ 	Upfront Investment Integrator: Provides an upfront boost to the member’s investment value of the lump sum Endowment plan.
❚ 	Life Booster: Provides a boost to the investment fund value on death of between 5% and 15% depending on the member’s Vitality status.
❚ 	Retirement Income Investment Integrator: Boosts annual annuity payments received by up to 50% depending on the member’s
Vitality status and chosen annual annuity income.
❚ 	Retirement Upfront Investment Integrator: Provides an upfront boost to the member’s investment value of the lump sum
Retirement and Preserver plans.
❚ 	Classic Benefits: Consists of a range of benefits which enhance and protect the member’s investment fund offered on the lump sum
Retirement plans, Preserver plans and lump sum Flexible Investment plans.
❚ 	Administration Fee Integrator: A fee discount of up to 100% can be achieved on the administration fee of the Investment plan,
where the discount is based on Vitality status and invested term.
❚ 	Flexible Pan Retirement Integrator: Provides a boost to the Retirement Upfront Investment Integrator of up to 50% of asset
management fees paid in the Flexible Investment Plan.
❚ 	Discovery Retirement Optimiser: Offers funding for retirement and offers unique benefits that, together with a Discovery Life Plan,
boosts retirement funding. Policyholders have a choice of linked investment portfolios or a portfolio that offers a guaranteed return
in real terms. Funds offering a guaranteed return have been closed to new business.
198 Discovery Annual Financial Statements 2020

-- 195 of 198 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
VITALITYLIFE
Vitalitylife Plan
The VitalityLife Plan is a lifestyle protection plan which allows customers to select from a menu of benefits which includes:
❚ 	Life cover.
❚ 	Serious illness cover.
❚ 	Capital disability cover.
❚ 	Income protection insurance.
❚ 	Family income cover.
❚ 	Education cover.
❚ 	Waiver of premium on death, serious illness and/or incapacity.
❚ 	Additional optional serious illness cover for children.
❚ 	Lifestyle care cover.
❚ 	Protected Life and Serious Illness cover.
❚ 	Dementia and Frail Care cover.
The VitalityLife Plan has at its basis a Plan Account. The Plan Account defines the amount paid out under any benefit that is attached to it
(the sum assured). The benefits that are attached to the Plan Account are expressed as a percentage of the Plan Account’s value.
The Plan Account can be structured to provide cover that is level, increasing or decreasing.
The VitalityLife Plan can be written on a single or joint life basis and cover may be stand-alone or limited to the Plan Account whereby
claims would accelerate payment of the Plan Account. Premiums are payable monthly in advance and can be guaranteed or reviewable.
Premiums can either be level, increase at a fixed rate or increase at a rate related to the Retail Price Index in the UK. The Plan does not
offer any surrender value. The VitalityLife Plan provides extensive severity-based cover for serious illness.
Essentials Plan
The Essentials Plan is a lower cost version of the VitalityLife Plan and provides roughly the same type of benefits and has the same structure.
Guaranteed 50 Plus Plan (run off existing book)
The Guaranteed 50 Plus Plan will pay out a fixed cash lump sum in the event of death, provided that the policy has been held for at least
one year. It also provides guaranteed acceptance for people aged between 50 and 75, living in the UK.
Relevant Life Plan
The Relevant Life Plan is a Life cover only plan with substantial tax benefits for employers wanting to provide life cover for their employees.
The structure is the same as for life cover on the above mentioned plans and includes the option to take different Vitality wellness
program benefits.
Business Protection Plan
The Business Protection Plan provides insurance protection for businesses via key person cover, shareholder/partnership cover and/or
loan protection.
Mortgage Plus Plan
The Mortgage Plus Plan provides insurance protection for individuals and families against death, disability and serious illness when taking
out a mortgage on their home.
Vitality Optimiser
The Vitality Optimiser offers an upfront premium discount that varies in size depending on the policy term. Depending on engagement in
the Vitality wellness programme, the premium discount can be increased, maintained or will be eroded over time.
Whole of Life Optimiser
The Whole of Life Premium Optimiser and Interest Rate Optimiser follows a similar structure to the Vitality Optimiser policy, offering an
upfront premium discount and premium changes at each anniversary. Unlike Vitality Optimiser, where premiums change depending on
Vitality Status, the annual premium changes are either fixed or depend on long-term interest rates.
199 Discovery Annual Financial Statements 2020

-- 196 of 198 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
Wellness Optimiser
Wellness Optimiser offers customers an upfront discount, similar to Vitality Optimiser. The future premiums will change annually depending
on the policyholder’s Wellness Status, and Vitality Status, which will be determined by the results of the on-going biennial health checks.
VITALITYHEALTH
VitalityHealth offers three main product types:
Individual product
This is offered to the retail market either direct or via a broker. The product features include:
❚ 	Private Medical Insurance: Cover is offered for a range of private healthcare-related claims. The cover is dependent on the plan type
chosen and includes hospital and outpatient cover for selected conditions.
❚ 	Renewal pricing: Prices offered at renewal depend on claims and Vitality status.
❚ 	Vitality rewards: A full Vitality package is offered, including gym offering and activity and status based healthcare-related rewards.
SME product
This is an age-rated product offered to small groups (typically 2-100 employees) either direct or via a broker. The product features include:
❚ 	Private Medical Insurance: Cover is offered for a range of private healthcare-related claims. The cover is dependent on the plan type
chosen and includes hospital and outpatient cover for selected conditions.
❚ 	Cashback for employers: A cashback is provided to employers after renewal depending on the levels of engagement achieved by
their employees in the previous year.
❚ 	Vitality rewards for employees: A full Vitality package is offered, including gym offering and activity and status based healthcare-
related rewards.
Corporate Product
This is an experience-rated product offered by brokers and employee benefit consultants. The product features include:
❚ 	Private Medical Insurance: Cover is offered for a range of private healthcare-related claims. The cover is dependent on the plan type
chosen and includes hospital and outpatient cover for selected conditions. Administration of healthcare trusts providing medical
benefits to employees of large corporates is also available.
❚ 	Vitality rewards for employees: A base level Vitality package is offered to all members, including gym offering and healthcare-
benefits. Employers can choose to add activity – and status-dependent rewards. A ‘stand-alone’ Vitality programme is also available to
large corporates where medical benefits are not provided.
DISCOVERY INSURE
Discovery Insure underwrites both personal and more recently commercial lines business, specific products are as follows:
Motor
Provides cover for loss, damage and liabilities arising from the use or ownership of motor vehicles. The cover includes comprehensive,
third party, fire, theft and third party liability cover.
Property
Provides cover for loss or damage from specified events – such as fire, storm, theft etc. – to movable and immovable property belonging
to the insured.
Liability
Provides cover for risks relating to the insured incurring personal liability to specified third parties which are not specifically covered
under another insurance contract.
Health Gap Cover
Provides cover shortfalls on specialist accounts for hospital admissions, shortfalls for specific treatment before and after hospital
admissions, as well as additional funds for cancer treatment. Note that this product is sold as part of personal lines insurance only.
200 Discovery Annual Financial Statements 2020

-- 197 of 198 --

Discovery Annual Financial Statements 2020 201
Discovery
+27 11 529 2888 | askthecfo@discovery.co.za | www.discovery.co.za
Subsidiaries of Discovery Limited are authorised financial services providers.

-- 198 of 198 --